[
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P28222', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 129, 'modifier': 'EXACT'}, 'end': {'value': 129, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190463'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23519210'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IAR'}], 'ligand': {'name': 'ergotamine', 'id': 'ChEBI:CHEBI:190463', 'note': 'agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 134, 'modifier': 'EXACT'}, 'end': {'value': 134, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190463'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23519210'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IAR'}], 'ligand': {'name': 'ergotamine', 'id': 'ChEBI:CHEBI:190463', 'note': 'agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 201, 'modifier': 'EXACT'}, 'end': {'value': 201, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190463'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23519210'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IAR'}], 'ligand': {'name': 'ergotamine', 'id': 'ChEBI:CHEBI:190463', 'note': 'agonist'}}, {'type': 'Site', 'location': {'start': {'value': 355, 'modifier': 'EXACT'}, 'end': {'value': 355, 'modifier': 'EXACT'}}, 'description': 'Important for species-specific agonist sensitivity', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23519210'}]}], 'extraAttributes': {'uniParcId': 'UPI00000007CB'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CCCN(CCCCNC(=O)c1cc(=O)oc2c3c4c(cc12)CCCN4CCC3)C1COc2cccc(OC)c2C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '9E-9', 'CHEMBLID': 'CHEMBL616798', 'description': 'The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes'}, {'\u5206\u5b50SMILES': 'CCCN(CCCCNc1ccc([N+](=O)[O-])c2nonc12)C1COc2cccc(OC)c2C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.4E-7', 'CHEMBLID': 'CHEMBL616798', 'description': 'The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes'}, {'\u5206\u5b50SMILES': 'CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4E-7', 'CHEMBLID': 'CHEMBL616798', 'description': 'The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes'}, {'\u5206\u5b50SMILES': 'CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.000001', 'CHEMBLID': 'CHEMBL616798', 'description': 'The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes'}, {'\u5206\u5b50SMILES': 'CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.000005', 'CHEMBLID': 'CHEMBL616798', 'description': 'The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Agmatine Enhances Dorsal Raphe Serotonergic Neuronal Activity via Dual Regulation of 5-HT', 'abstract': 'Agmatine is a naturally occurring biogenic amine that acts primarily as an inhibitor of neuronal nitric oxide synthase (nNOS). Previous studies have shown that both acute and chronic agmatine administration induced anxiolytic and antidepressant-like effects in rodents. In the dorsal raphe nucleus (DRN), nitric oxide (NO) donors inhibit serotonergic (5-HT) neuronal activity, with the nNOS-expressing 5-HT neurons showing lower baseline firing rates than the non-nNOS expressing neurons. Our study aimed to test the hypothesis that the psychoactive effects of agmatine are mediated, at least in part, via a mechanism involving the stimulation of the DRN 5-HT neurons, as well as to assess the molecular pathway allowing agmatine to modulate the excitability of 5-HT neurons. Using extracellular in vivo electrophysiology, we demonstrated that both acute (1-3 mg/kg, i.v.) and chronic (40 mg/kg/day, i.p., 14 days) agmatine administration significantly increased the firing rate of DRN 5-HT neurons. Quantitative PCR (qPCR) analysis revealed that chronic agmatine treatment selectively upregulated the expression of serotonin-1B (5-HT'}, {'title': 'Endothelial Serotonin Receptor 1B Acts as a Mechanosensor to Drive Atherosclerosis.', 'abstract': 'Atherosclerosis is characterized by the accumulation of fatty and fibrotic plaques, which preferentially develop at curvatures and branches along the arterial trees that are exposed to disturbed flow. However, the mechanisms by which endothelial cells sense disturbed flow are still unclear.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1898"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P41595', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 135, 'modifier': 'EXACT'}, 'end': {'value': 135, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190463'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23519215'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IB4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4NC3'}], 'ligand': {'name': 'ergotamine', 'id': 'ChEBI:CHEBI:190463', 'note': 'agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 140, 'modifier': 'EXACT'}, 'end': {'value': 140, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190463'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23519215'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IB4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4NC3'}], 'ligand': {'name': 'ergotamine', 'id': 'ChEBI:CHEBI:190463', 'note': 'agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 209, 'modifier': 'EXACT'}, 'end': {'value': 209, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190463'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23519215'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IB4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4NC3'}], 'ligand': {'name': 'ergotamine', 'id': 'ChEBI:CHEBI:190463', 'note': 'agonist'}}, {'type': 'Site', 'location': {'start': {'value': 209, 'modifier': 'EXACT'}, 'end': {'value': 209, 'modifier': 'EXACT'}}, 'description': 'Hydrophobic barrier that decreases the speed of ligand binding and dissociation', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28129538'}]}], 'extraAttributes': {'uniParcId': 'UPI0000001C05'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cn1ncc(C(=O)N2CCC(Nc3cc(=O)[nH]c4ccc(F)cc34)CC2)c1Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '-41900.0', 'CHEMBLID': 'CHEMBL3296313', 'description': 'Inhibition of 5HT2B receptor (unknown origin)'}, {'\u5206\u5b50SMILES': 'O=C(c1ccc(-c2ccc(F)cc2)cc1)N1CCC(Cc2ncc[nH]2)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL968750', 'description': 'Antagonist activity at 5-HT2B receptor expressed in CHOK1 cells assessed as inhibition of serotonin-induced intracellular Ca2+ flux by aequorin luminescence assay'}, {'\u5206\u5b50SMILES': 'CN(CCc1cn(C)c2cccc(O)c12)CC1CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.245', 'CHEMBLID': 'CHEMBL5058460', 'description': 'Modulation of human 5HT2B expressed in HEK293T cells co-transfected with Galphaq-RLuc8, Ggamma1-GFP2 and Gbeta1 assessed as dissociation of Galphaq from Ggamma1 preincubated for 1 hr followed by addition of coelenterazine 400a substrate and measured after 15 mins by BRET assay'}, {'\u5206\u5b50SMILES': 'O=S(=O)(c1ccc(-c2ccccc2)cc1)N1CCC(c2ncc[nH]2)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL968750', 'description': 'Antagonist activity at 5-HT2B receptor expressed in CHOK1 cells assessed as inhibition of serotonin-induced intracellular Ca2+ flux by aequorin luminescence assay'}, {'\u5206\u5b50SMILES': 'COc1ccc(CC2NCCc3c2[nH]c2ccc(C)cc32)cc1OC.Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.37', 'CHEMBLID': 'CHEMBL5324945', 'description': 'Antagonist activity at 5-HT2B receptor (unknown origin) by calcium flux assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'A 5-HT-mediated urethral defense against urinary tract infections.', 'abstract': \"The urethra is considered a passive conduit for urine. Here, we reveal a surprising multicellular signaling pathway guiding the urethra's dynamic response to an invading pathogen. Using a genetic approach in female mice, we deposited uropathogenic \"}, {'title': 'Mechanisms of constitutive and agonist-induced 5-HT', 'abstract': 'Certain ergot derivatives, particularly cabergoline, produce wash-resistant signaling through the 5-HT'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1833"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P21589', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 36, 'modifier': 'EXACT'}, 'end': {'value': 36, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22997138'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2B'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 36, 'modifier': 'EXACT'}, 'end': {'value': 36, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22997138'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 38, 'modifier': 'EXACT'}, 'end': {'value': 38, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22997138'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2B'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 85, 'modifier': 'EXACT'}, 'end': {'value': 85, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22997138'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2B'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 85, 'modifier': 'EXACT'}, 'end': {'value': 85, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22997138'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2B'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22997138'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2B'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 220, 'modifier': 'EXACT'}, 'end': {'value': 220, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22997138'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2B'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 243, 'modifier': 'EXACT'}, 'end': {'value': 243, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22997138'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2B'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 354, 'modifier': 'EXACT'}, 'end': {'value': 354, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:456215'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'AMP', 'id': 'ChEBI:CHEBI:456215'}}, {'type': 'Binding site', 'location': {'start': {'value': 354, 'modifier': 'EXACT'}, 'end': {'value': 354, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58053'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7PBA'}], 'ligand': {'name': 'IMP', 'id': 'ChEBI:CHEBI:58053'}}, {'type': 'Binding site', 'location': {'start': {'value': 390, 'modifier': 'EXACT'}, 'end': {'value': 390, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:456215'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'AMP', 'id': 'ChEBI:CHEBI:456215'}}, {'type': 'Binding site', 'location': {'start': {'value': 390, 'modifier': 'EXACT'}, 'end': {'value': 390, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58053'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7PBA'}], 'ligand': {'name': 'IMP', 'id': 'ChEBI:CHEBI:58053'}}, {'type': 'Binding site', 'location': {'start': {'value': 395, 'modifier': 'EXACT'}, 'end': {'value': 395, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:456215'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'AMP', 'id': 'ChEBI:CHEBI:456215'}}, {'type': 'Binding site', 'location': {'start': {'value': 395, 'modifier': 'EXACT'}, 'end': {'value': 395, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58053'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7PBA'}], 'ligand': {'name': 'IMP', 'id': 'ChEBI:CHEBI:58053'}}, {'type': 'Binding site', 'location': {'start': {'value': 417, 'modifier': 'EXACT'}, 'end': {'value': 417, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:456215'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'AMP', 'id': 'ChEBI:CHEBI:456215'}}, {'type': 'Binding site', 'location': {'start': {'value': 417, 'modifier': 'EXACT'}, 'end': {'value': 417, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58053'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7PBA'}], 'ligand': {'name': 'IMP', 'id': 'ChEBI:CHEBI:58053'}}, {'type': 'Binding site', 'location': {'start': {'value': 500, 'modifier': 'EXACT'}, 'end': {'value': 500, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:456215'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'AMP', 'id': 'ChEBI:CHEBI:456215'}}, {'type': 'Binding site', 'location': {'start': {'value': 500, 'modifier': 'EXACT'}, 'end': {'value': 500, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58053'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7PBA'}], 'ligand': {'name': 'IMP', 'id': 'ChEBI:CHEBI:58053'}}, {'type': 'Binding site', 'location': {'start': {'value': 506, 'modifier': 'EXACT'}, 'end': {'value': 506, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:456215'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H1Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4H2I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7P9N'}], 'ligand': {'name': 'AMP', 'id': 'ChEBI:CHEBI:456215'}}, {'type': 'Binding site', 'location': {'start': {'value': 506, 'modifier': 'EXACT'}, 'end': {'value': 506, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58053'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '34403084'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '7PBA'}], 'ligand': {'name': 'IMP', 'id': 'ChEBI:CHEBI:58053'}}, {'type': 'Site', 'location': {'start': {'value': 118, 'modifier': 'EXACT'}, 'end': {'value': 118, 'modifier': 'EXACT'}}, 'description': 'Transition state stabilizer', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23142347'}]}, {'type': 'Site', 'location': {'start': {'value': 121, 'modifier': 'EXACT'}, 'end': {'value': 121, 'modifier': 'EXACT'}}, 'description': 'Transition state stabilizer', 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '23142347'}]}], 'extraAttributes': {'uniParcId': 'UPI0000124F48'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@H](Nc1nc(Cl)nc2c1cnn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O)c1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0027', 'CHEMBLID': 'CHEMBL4668688', 'description': 'Inhibition of CD73 in human CD8-positive T cells using AMP as substrate preincubated for 60 mins followed by substrate addition and measured after 2.5 hrs by PiColorLock gold reagent based colorimetric assay'}, {'\u5206\u5b50SMILES': 'C[C@H](Nc1cc(Cl)nc2c1cnn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O)c1ccccc1F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.008', 'CHEMBLID': 'CHEMBL4668688', 'description': 'Inhibition of CD73 in human CD8-positive T cells using AMP as substrate preincubated for 60 mins followed by substrate addition and measured after 2.5 hrs by PiColorLock gold reagent based colorimetric assay'}, {'\u5206\u5b50SMILES': 'C[C@H](Nc1nc(Cl)nc2c1cnn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O)c1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0085', 'CHEMBLID': 'CHEMBL4668690', 'description': 'Inhibition of CD73 in human PBMC using AMP as substrate preincubated for 60 mins followed by substrate addition and measured after 2.5 hrs by PiColorLock gold reagent based colorimetric assay'}, {'\u5206\u5b50SMILES': 'C[C@H](Nc1cc(Cl)nc2c1cnn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O)c1ccc(F)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.01', 'CHEMBLID': 'CHEMBL4668688', 'description': 'Inhibition of CD73 in human CD8-positive T cells using AMP as substrate preincubated for 60 mins followed by substrate addition and measured after 2.5 hrs by PiColorLock gold reagent based colorimetric assay'}, {'\u5206\u5b50SMILES': 'C[C@H](Nc1cc(Cl)nc2c1cnn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O)c1ccccc1F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.011', 'CHEMBLID': 'CHEMBL4668690', 'description': 'Inhibition of CD73 in human PBMC using AMP as substrate preincubated for 60 mins followed by substrate addition and measured after 2.5 hrs by PiColorLock gold reagent based colorimetric assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': \"Synthesis, Characterization, Interactions, and Immunomodulatory Function of Ectonucleotidase CD39/CD73 Inhibitor 8-Butylthioadenosine 5'-Monophosphate.\", 'abstract': \"Ectonucleoside triphosphate diphosphohydrolase-1 (NTPDase1, CD39) catalyzes the extracellular hydrolysis of ATP generating AMP, while ecto-5'-nucleotidase (CD73) further hydrolyzes AMP yielding immunosuppressive adenosine. 8-Butylthioadenosine 5'-monophosphate (8-BuS-AMP) was described as a CD39 inhibitor but has been poorly characterized. The standard CD39 antagonist ARL 67156 is not suitable for in vivo studies due to metabolic instability. In the present study, we optimized and upscaled the synthesis of 8-BuS-AMP and performed a comprehensive investigation of its properties. It behaves as a competitive inhibitor at human and mouse CD39, and additionally inhibits CD73. Docking studies using a homology model of human CD39 and determination of an atomic-resolution (1.06 \u00c5) cocrystal structure with human CD73 indicated the inhibitor's interactions within the substrate binding pockets and explained the compound's stability toward hydrolysis. 8-BuS-AMP is metabolically highly stable in human and mouse liver microsomes. It inhibited \u03b5-adenosine formation from \u03b5-ATP and \u03b5-AMP in human synovial fluid and enhanced activation and proliferation of peripheral human T lymphocytes. Thus, 8-BuS-AMP is a recommended tool compound for studying purinergic signaling in vitro and in vivo, being superior to the standard CD39 inhibitor ARL 67156. Moreover, it may serve as a lead structure to develop drugs for the immunotherapy of cancer.\"}, {'title': 'Human na\u00efve B cells show evidence of anergy and clonal redemption following vaccination.', 'abstract': 'In an era of predicted emerging pandemics, the production of effective vaccines may require an in-depth understanding of the biology of human naive B (B'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5957"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P36639', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 8, 'modifier': 'EXACT'}, 'end': {'value': 8, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:77897'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28035004'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHN'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5WS7'}], 'ligand': {'name': '2-oxo-dATP', 'id': 'ChEBI:CHEBI:77897'}}, {'type': 'Binding site', 'location': {'start': {'value': 8, 'modifier': 'EXACT'}, 'end': {'value': 8, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:63224'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21787772'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZR0'}], 'ligand': {'name': '8-oxo-dGMP', 'id': 'ChEBI:CHEBI:63224'}}, {'type': 'Binding site', 'location': {'start': {'value': 8, 'modifier': 'EXACT'}, 'end': {'value': 8, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:77896'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26999531'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28035004'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5FSI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHI'}], 'ligand': {'name': '8-oxo-dGTP', 'id': 'ChEBI:CHEBI:77896'}}, {'type': 'Binding site', 'location': {'start': {'value': 8, 'modifier': 'EXACT'}, 'end': {'value': 8, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:144842'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '32144205'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6QVO'}], 'ligand': {'name': 'N(6)-methyl-AMP', 'id': 'ChEBI:CHEBI:144842'}}, {'type': 'Binding site', 'location': {'start': {'value': 8, 'modifier': 'EXACT'}, 'end': {'value': 8, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:169975'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '30304478'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5OTM'}], 'ligand': {'name': 'O(6)-methyl-dGMP', 'id': 'ChEBI:CHEBI:169975'}}, {'type': 'Binding site', 'location': {'start': {'value': 23, 'modifier': 'EXACT'}, 'end': {'value': 23, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:63224'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21787772'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZR0'}], 'ligand': {'name': '8-oxo-dGMP', 'id': 'ChEBI:CHEBI:63224'}}, {'type': 'Binding site', 'location': {'start': {'value': 23, 'modifier': 'EXACT'}, 'end': {'value': 23, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:77896'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28035004'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHI'}], 'ligand': {'name': '8-oxo-dGTP', 'id': 'ChEBI:CHEBI:77896'}}, {'type': 'Binding site', 'location': {'start': {'value': 23, 'modifier': 'EXACT'}, 'end': {'value': 23, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:144842'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '32144205'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6QVO'}], 'ligand': {'name': 'N(6)-methyl-AMP', 'id': 'ChEBI:CHEBI:144842'}}, {'type': 'Binding site', 'location': {'start': {'value': 23, 'modifier': 'EXACT'}, 'end': {'value': 23, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:169975'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '30304478'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5OTM'}], 'ligand': {'name': 'O(6)-methyl-dGMP', 'id': 'ChEBI:CHEBI:169975'}}, {'type': 'Binding site', 'location': {'start': {'value': 27, 'modifier': 'EXACT'}, 'end': {'value': 27, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:189076'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26999531'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5FSK'}], 'ligand': {'name': '8-oxo-ATP', 'id': 'ChEBI:CHEBI:189076'}}, {'type': 'Binding site', 'location': {'start': {'value': 33, 'modifier': 'EXACT'}, 'end': {'value': 33, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:77897'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28035004'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHQ'}], 'ligand': {'name': '2-oxo-dATP', 'id': 'ChEBI:CHEBI:77897'}}, {'type': 'Binding site', 'location': {'start': {'value': 33, 'modifier': 'EXACT'}, 'end': {'value': 33, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:63224'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21787772'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZR0'}], 'ligand': {'name': '8-oxo-dGMP', 'id': 'ChEBI:CHEBI:63224'}}, {'type': 'Binding site', 'location': {'start': {'value': 33, 'modifier': 'EXACT'}, 'end': {'value': 33, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:77896'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26999531'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28035004'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5FSI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHM'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHO'}], 'ligand': {'name': '8-oxo-dGTP', 'id': 'ChEBI:CHEBI:77896'}}, {'type': 'Binding site', 'location': {'start': {'value': 33, 'modifier': 'EXACT'}, 'end': {'value': 33, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:169975'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '30304478'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5OTM'}], 'ligand': {'name': 'O(6)-methyl-dGMP', 'id': 'ChEBI:CHEBI:169975'}}, {'type': 'Binding site', 'location': {'start': {'value': 35, 'modifier': 'EXACT'}, 'end': {'value': 38, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:77897'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28035004'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHN'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5WS7'}], 'ligand': {'name': '2-oxo-dATP', 'id': 'ChEBI:CHEBI:77897'}}, {'type': 'Binding site', 'location': {'start': {'value': 35, 'modifier': 'EXACT'}, 'end': {'value': 38, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:189076'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26999531'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5FSK'}], 'ligand': {'name': '8-oxo-ATP', 'id': 'ChEBI:CHEBI:189076'}}, {'type': 'Binding site', 'location': {'start': {'value': 35, 'modifier': 'EXACT'}, 'end': {'value': 38, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:77896'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26999531'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28035004'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5FSI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHM'}], 'ligand': {'name': '8-oxo-dGTP', 'id': 'ChEBI:CHEBI:77896'}}, {'type': 'Binding site', 'location': {'start': {'value': 36, 'modifier': 'EXACT'}, 'end': {'value': 36, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:18420'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'Q7ZWC3'}], 'ligand': {'name': 'Mg(2+)', 'id': 'ChEBI:CHEBI:18420', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 52, 'modifier': 'EXACT'}, 'end': {'value': 52, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:189076'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26999531'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5FSK'}], 'ligand': {'name': '8-oxo-ATP', 'id': 'ChEBI:CHEBI:189076'}}, {'type': 'Binding site', 'location': {'start': {'value': 52, 'modifier': 'EXACT'}, 'end': {'value': 52, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:18420'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'Q7ZWC3'}], 'ligand': {'name': 'Mg(2+)', 'id': 'ChEBI:CHEBI:18420', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 55, 'modifier': 'EXACT'}, 'end': {'value': 55, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:18420'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'Q7ZWC3'}], 'ligand': {'name': 'Mg(2+)', 'id': 'ChEBI:CHEBI:18420', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 56, 'modifier': 'EXACT'}, 'end': {'value': 56, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:189076'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26999531'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5FSK'}], 'ligand': {'name': '8-oxo-ATP', 'id': 'ChEBI:CHEBI:189076'}}, {'type': 'Binding site', 'location': {'start': {'value': 56, 'modifier': 'EXACT'}, 'end': {'value': 56, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:18420'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'Q7ZWC3'}], 'ligand': {'name': 'Mg(2+)', 'id': 'ChEBI:CHEBI:18420', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 100, 'modifier': 'EXACT'}, 'end': {'value': 100, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:18420'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'Q7ZWC3'}], 'ligand': {'name': 'Mg(2+)', 'id': 'ChEBI:CHEBI:18420', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 120, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:77897'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28035004'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHN'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5WS7'}], 'ligand': {'name': '2-oxo-dATP', 'id': 'ChEBI:CHEBI:77897'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 120, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:189076'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26999531'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5FSK'}], 'ligand': {'name': '8-oxo-ATP', 'id': 'ChEBI:CHEBI:189076'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 120, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:63224'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21787772'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZR0'}], 'ligand': {'name': '8-oxo-dGMP', 'id': 'ChEBI:CHEBI:63224'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 120, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:77896'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26999531'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28035004'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5FSI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHM'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5GHO'}], 'ligand': {'name': '8-oxo-dGTP', 'id': 'ChEBI:CHEBI:77896'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 120, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:144842'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '32144205'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6QVO'}], 'ligand': {'name': 'N(6)-methyl-AMP', 'id': 'ChEBI:CHEBI:144842'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 120, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:169975'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '30304478'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5OTM'}], 'ligand': {'name': 'O(6)-methyl-dGMP', 'id': 'ChEBI:CHEBI:169975'}}], 'extraAttributes': {'uniParcId': 'UPI0000157347'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC(=O)Nc1cc2c(c(-c3cccc(C)c3C)n1)CCCN2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.043', 'CHEMBLID': 'CHEMBL4345255', 'description': 'Inhibition of human recombinant human His-tagged MTH1 expressed in Escherichia coli BL21 (DE3) using 8-oxo-dGTP as substrate incubated for 15 mins followed by substrate addition and measured after 3 hrs by PPiLight Inorganic Pyrophosphate assay kit method'}, {'\u5206\u5b50SMILES': 'CNC(=O)Nc1cc2c(c(-c3cccc(C)c3C)n1)CCCN2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.05', 'CHEMBLID': 'CHEMBL4345255', 'description': 'Inhibition of human recombinant human His-tagged MTH1 expressed in Escherichia coli BL21 (DE3) using 8-oxo-dGTP as substrate incubated for 15 mins followed by substrate addition and measured after 3 hrs by PPiLight Inorganic Pyrophosphate assay kit method'}, {'\u5206\u5b50SMILES': 'Cc1cccc(-c2nc(NC(N)=O)cc3c2CCCN3)c1C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.05', 'CHEMBLID': 'CHEMBL4345255', 'description': 'Inhibition of human recombinant human His-tagged MTH1 expressed in Escherichia coli BL21 (DE3) using 8-oxo-dGTP as substrate incubated for 15 mins followed by substrate addition and measured after 3 hrs by PPiLight Inorganic Pyrophosphate assay kit method'}, {'\u5206\u5b50SMILES': 'Cc1cccc(-c2nc(NC(=O)C3CCC3)cc3c2CCCN3)c1C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.05', 'CHEMBLID': 'CHEMBL4345255', 'description': 'Inhibition of human recombinant human His-tagged MTH1 expressed in Escherichia coli BL21 (DE3) using 8-oxo-dGTP as substrate incubated for 15 mins followed by substrate addition and measured after 3 hrs by PPiLight Inorganic Pyrophosphate assay kit method'}, {'\u5206\u5b50SMILES': 'Cc1cccc(-c2nc(NC(=O)C3CC3)cc3c2CCCN3)c1C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.06', 'CHEMBLID': 'CHEMBL4345255', 'description': 'Inhibition of human recombinant human His-tagged MTH1 expressed in Escherichia coli BL21 (DE3) using 8-oxo-dGTP as substrate incubated for 15 mins followed by substrate addition and measured after 3 hrs by PPiLight Inorganic Pyrophosphate assay kit method'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Oncogenic KRAS addiction states differentially influence MTH1 expression and 8-oxodGTPase activity in lung adenocarcinoma.', 'abstract': 'The efficacy of strategies targeting oncogenic RAS, prevalent in lung adenocarcinoma (LUAD), is limited by rapid adaptive resistance mechanisms. These include loss of RAS addiction and hyperactivation of downstream signaling pathways, such as PI3K/AKT. We previously reported that oncogenic RAS-driven LUAD cells possess an enhanced reliance on MTH1, the mammalian 8-oxodGTPase, to prevent genomic incorporation of oxidized nucleotides, and that MTH1 depletion compromises tumorigenesis and oncogenic signaling. Here, we show that elevated MTH1 correlates with poor prognosis in LUAD and that its redox-protective 8-oxodGTPase activity is variably regulated in KRAS-addicted vs. non-addicted states. Multiple oncogenic KRAS mutants or overexpression of wildtype (wt) KRAS increased MTH1 expression. Conversely, KRAS depletion or its inhibition by AMG-510 (sotorasib) decreased MTH1 in KRASG12C-addicted LUAD cells. Separation-of-function MEK/ERK1/2-activating mutants recapitulated the elevated MTH1 expression induced by oncogenic RAS in wt KRAS LUAD cells. However, upon inhibition of the MEK/ERK1/2 pathway, compensatory AKT activation maintained MTH1 expression. Indeed, elevated AKT signaling maintained high MTH1 expression even when KRAS oncoprotein was low. We previously reported that cancer cells possess variable MTH1-specific and MTH1-independent 8-oxodGTPase activity levels. Whereas both ERK1/2 and AKT could regulate MTH1 protein levels in KRAS-addicted cells, only AKT signaling was associated with elevated MTH1-specific 8-oxodGTPase activity under KRAS-low or KRAS non-addicted states. Our studies suggest that despite loss of KRAS dependency, LUAD cells retain the requirement for high MTH1 8-oxodGTPase activity due to redox vulnerabilities associated with AKT signaling. Thus, MTH1 may serve as a novel orthogonal vulnerability in LUAD that has lost KRAS addiction.'}, {'title': 'Pharmacological inhibition of MutT homolog 1 (MTH1) in allergic airway inflammation as a novel treatment strategy.', 'abstract': 'Despite progress in the treatment of asthma, there is an unmet need for additional therapeutic strategies, not least to avoid side-effects of corticosteroids. The enzyme MutT homolog 1 (MTH1) hydrolyzes oxidized purines and prevents their insertion to DNA. Small molecule inhibition of MTH1 has shown promising therapeutic effects in both cancer and inflammatory conditions. In this study, a small molecule inhibitor of MTH1 (TH1579), was investigated in models of allergic inflammation.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3708265"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P30542', 'features': [], 'extraAttributes': {'uniParcId': 'UPI00000503E1'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cn1ncc(C(=O)N2CCC(Nc3cc(=O)[nH]c4cc(F)c(F)cc34)CC2)c1Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '-34000.0', 'CHEMBLID': 'CHEMBL3296314', 'description': 'Inhibition of adenosine A1 receptor (unknown origin)'}, {'\u5206\u5b50SMILES': 'CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.02951', 'CHEMBLID': 'CHEMBL3772951', 'description': 'Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis'}, {'\u5206\u5b50SMILES': 'CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.12', 'CHEMBLID': 'CHEMBL922121', 'description': 'Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells'}, {'\u5206\u5b50SMILES': 'OC[C@H]1O[C@@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H](O)[C@@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.14', 'CHEMBLID': 'CHEMBL4369949', 'description': 'Agonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 mins'}, {'\u5206\u5b50SMILES': 'CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2089', 'CHEMBLID': 'CHEMBL3772951', 'description': 'Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Inhibiting ADORA1 enhances glioma apoptosis and increases its sensitivity to anti-PD1 therapy.', 'abstract': 'Glioma, the primary cancerous tumor of the central nervous system in adults, has a poor outlook. Immune checkpoint blockade therapy has exhibited notable efficacy against various cancer types. Prior research has suggested that the adenosine A1 receptor (ADORA1) facilitates the proliferation of tumors in cancer. Nevertheless, the precise impact of ADORA1 on glioma progression and its influence on anti-programmed death receptor 1 (PD1) therapy, along with the underlying regulatory mechanisms, remain to be fully elucidated.'}, {'title': 'Norepinephrine signals through astrocytes to modulate synapses.', 'abstract': \"Locus ceruleus (LC)-derived norepinephrine (NE) drives network and behavioral adaptations to environmental saliencies by reconfiguring circuit functional connectivity, but the underlying synapse-level mechanisms are elusive. Here, we show that NE remodeling of synaptic function is completely independent from its binding on neuronal receptors. Instead, astrocytic adrenergic receptors and calcium dynamics fully gate the effect of NE on synapses. Additionally, we found that NE suppression of synaptic strength results from an adenosine 5'-triphosphate (ATP)-derived and A1 adenosine receptor-mediated control of presynaptic efficacy. These findings suggest that astrocytes are a core component of neuromodulatory systems and the circuit effector through which NE produces network and behavioral adaptations.\"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL226"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P29274', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 169, 'modifier': 'EXACT'}, 'end': {'value': 169, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16335'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21593763'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YDO'}], 'ligand': {'name': 'adenosine', 'id': 'ChEBI:CHEBI:16335', 'note': 'agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 253, 'modifier': 'EXACT'}, 'end': {'value': 253, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16335'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21593763'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YDO'}], 'ligand': {'name': 'adenosine', 'id': 'ChEBI:CHEBI:16335', 'note': 'agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 277, 'modifier': 'EXACT'}, 'end': {'value': 277, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16335'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21593763'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YDO'}], 'ligand': {'name': 'adenosine', 'id': 'ChEBI:CHEBI:16335', 'note': 'agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 278, 'modifier': 'EXACT'}, 'end': {'value': 278, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16335'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21593763'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YDO'}], 'ligand': {'name': 'adenosine', 'id': 'ChEBI:CHEBI:16335', 'note': 'agonist'}}], 'extraAttributes': {'uniParcId': 'UPI00000503E2'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Nc1nc(NCc2ccco2)nc2sc(-c3ccco3)nc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0016', 'CHEMBLID': 'CHEMBL4156075', 'description': 'Inverse agonist activity at human adenosine A2A receptor expressed in CHO cells assessed as inhibition of cAMP accumulation measured after 150 mins in presence of [3H]cAMP by scintillation counting method'}, {'\u5206\u5b50SMILES': 'Nc1nc(Nc2ccco2)nc2sc(Cc3cccnc3)nc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0016', 'CHEMBLID': 'CHEMBL5126834', 'description': 'Inverse agonist activity at human A2A receptor assessed as inhibition of basal cAMP level'}, {'\u5206\u5b50SMILES': 'Nc1nc(NCc2cccs2)nc2sc(-c3ccco3)nc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0017', 'CHEMBLID': 'CHEMBL4156075', 'description': 'Inverse agonist activity at human adenosine A2A receptor expressed in CHO cells assessed as inhibition of cAMP accumulation measured after 150 mins in presence of [3H]cAMP by scintillation counting method'}, {'\u5206\u5b50SMILES': 'COc1ccccc1CNc1nc(N)c2nc(-c3ccco3)sc2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0019', 'CHEMBLID': 'CHEMBL5126827', 'description': 'Inverse agonist activity at human A2A receptor assessed as inhibition of cAMP accumulation'}, {'\u5206\u5b50SMILES': 'COc1ccccc1CNc1nc(N)c2nc(-c3ccco3)sc2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0019', 'CHEMBLID': 'CHEMBL3878908', 'description': 'Inverse agonist activity at human adenosine A2A receptor expressed in CHO cells assessed as inhibition of cAMP accumulation measured after 150 mins in presence of [3H]cAMP by scintillation counting method'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'The Conformational Equilibria of a Human GPCR Compared between Lipid Vesicles and Aqueous Solutions by Integrative ', 'abstract': 'Endogenous phospholipids influence the conformational equilibria of G protein-coupled receptors, regulating their ability to bind drugs and form signaling complexes. However, most studies of GPCR-lipid interactions have been carried out in mixed micelles or lipid nanodiscs. Though useful, these membrane mimetics do not fully replicate the physical properties of native cellular membranes associated with large assemblies of lipids. We investigated the conformational equilibria of the human A'}, {'title': 'Arctiin, a lignan compound, enhances adipose tissue browning and energy expenditure by activating the adenosine A', 'abstract': 'The activation of brown adipose tissue (BAT) or the browning of white adipose tissue (WAT) represents a promising therapeutic strategy for obesity. Arctiin (ARC), a lignan compound known for its anti-inflammatory, anti-tumor, and hypoglycemic properties, has not been fully elucidated regarding its effects and mechanisms on obesity.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL251"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q8N5Z0', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 20, 'modifier': 'EXACT'}, 'end': {'value': 20, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 74, 'modifier': 'EXACT'}, 'end': {'value': 74, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 142, 'modifier': 'EXACT'}, 'end': {'value': 142, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 202, 'modifier': 'EXACT'}, 'end': {'value': 202, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 399, 'modifier': 'EXACT'}, 'end': {'value': 399, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}], 'extraAttributes': {'uniParcId': 'UPI00000711E6'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1cccc(Cn2cc3c(n2)N(O)C(=O)[C@@H](N)C3)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '8.93', 'CHEMBLID': 'CHEMBL3705555', 'description': 'Inhibition Spectra Assay : Formation of kynurenic acid (KYNA) is indirectly assessed by a decrease in light absorbance at 370 nm (OD370) as the L-kynurenine (KYN) substrate is converted by the human KAT II (hKAT II) enzyme into KYNA.'}, {'\u5206\u5b50SMILES': 'COc1cccc(Cn2cc3c(n2)N(O)C(=O)[C@@H](N)C3)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '8.93', 'CHEMBLID': 'CHEMBL3706077', 'description': 'Inhibition Spectra Assay: Formation of kynurenic acid (KYNA) is indirectly assessed by a decrease in light absorbance at 370 nm (OD370) as the L-kynurenine (KYN) substrate is converted by the human KAT II (hKAT II) enzyme into KYNA. An inhibitor would therefore inhibit the decrease in OD370.The protocol was performed by placing the following reagents into a Costar 384 well black plate (30 uL total assay volume/well):    10 uL of 3x concentrated compound;    10 uL of 3x concentrated substrate mix (BGG (Sigma G-5009); 3 mM L-Kynurenine in 150 mM Tris Acetate (Sigma K3750); 3 mM alpha-ketoglutaric acid in 150 mM Tris Acetate (Sigma K2010); and 210 uM pyridoxal 5-phosphate (PLP) in 150 mM Tris Acetate (Sigma 9255)); and    10 uL of 3x concentrated enzyme (15 nM enzyme in 150 mM Tris Acetate with 0.3% bovine serum).Plates were sealed and incubated at 37 C. for 15-20 h before reading OD370 on a SpectraMax Plus plate reader.'}, {'\u5206\u5b50SMILES': 'Cn1nc2c(c1Cc1ccccc1)C[C@H](N)C(=O)N2O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '11.5', 'CHEMBLID': 'CHEMBL3706077', 'description': 'Inhibition Spectra Assay: Formation of kynurenic acid (KYNA) is indirectly assessed by a decrease in light absorbance at 370 nm (OD370) as the L-kynurenine (KYN) substrate is converted by the human KAT II (hKAT II) enzyme into KYNA. An inhibitor would therefore inhibit the decrease in OD370.The protocol was performed by placing the following reagents into a Costar 384 well black plate (30 uL total assay volume/well):    10 uL of 3x concentrated compound;    10 uL of 3x concentrated substrate mix (BGG (Sigma G-5009); 3 mM L-Kynurenine in 150 mM Tris Acetate (Sigma K3750); 3 mM alpha-ketoglutaric acid in 150 mM Tris Acetate (Sigma K2010); and 210 uM pyridoxal 5-phosphate (PLP) in 150 mM Tris Acetate (Sigma 9255)); and    10 uL of 3x concentrated enzyme (15 nM enzyme in 150 mM Tris Acetate with 0.3% bovine serum).Plates were sealed and incubated at 37 C. for 15-20 h before reading OD370 on a SpectraMax Plus plate reader.'}, {'\u5206\u5b50SMILES': 'Cn1nc2c(c1Cc1ccccc1)C[C@H](N)C(=O)N2O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '11.5', 'CHEMBLID': 'CHEMBL3705555', 'description': 'Inhibition Spectra Assay : Formation of kynurenic acid (KYNA) is indirectly assessed by a decrease in light absorbance at 370 nm (OD370) as the L-kynurenine (KYN) substrate is converted by the human KAT II (hKAT II) enzyme into KYNA.'}, {'\u5206\u5b50SMILES': 'COc1ccc2c(c1)N(O)C(=O)[C@@H](N)C2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '22.0', 'CHEMBLID': 'CHEMBL2329110', 'description': 'Inhibition of human KAT2 using L-kynurenine as substrate measured after 15-20 hrs by SpectraMax plate reader analysis'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2046259"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q2M2I8', 'features': [{'type': 'Active site', 'location': {'start': {'value': 176, 'modifier': 'EXACT'}, 'end': {'value': 176, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}]}, {'type': 'Binding site', 'location': {'start': {'value': 52, 'modifier': 'EXACT'}, 'end': {'value': 60, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 74, 'modifier': 'EXACT'}, 'end': {'value': 74, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI0001881663'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC(C)C[C@](C)(N)COc1ccc(-c2ccnc3ccccc23)cc1C1CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.07', 'CHEMBLID': 'CHEMBL4022632', 'description': 'Inhibition of GST-Xa-tagged human AAK1 expressed in bacterial system using fluoresceinated peptide (5 -FAM)-Aha-KEEQSQITSQVTGQIGWR-NH2 and ATP incubated for 3 hrs'}, {'\u5206\u5b50SMILES': 'COC(=O)Nc1cc(-c2ccc(OC[C@@](C)(N)CC(C)C)c(OC(F)(F)F)c2)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL5161147', 'description': 'Inhibition of full length human AAK1 expressed in HEK293F cells assessed as suppression of AP2 phosphorylation measured after 3 hrs by Western blot analysis based cellular assay'}, {'\u5206\u5b50SMILES': 'CC(=O)Nc1cc(-c2ccc(OC[C@@H](N)CC(C)C)c(Cl)c2)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL5161147', 'description': 'Inhibition of full length human AAK1 expressed in HEK293F cells assessed as suppression of AP2 phosphorylation measured after 3 hrs by Western blot analysis based cellular assay'}, {'\u5206\u5b50SMILES': 'CC(C)C[C@](C)(N)COc1ccc(-c2ccnc3ccnn23)cc1C(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL4305771', 'description': 'Inhibition of thrombin-recognition site-fused GST-tagged human AAK1 expressed in bacterial expression system using 5-FAM-Aha-KEEQSQITSQVTGQIGWR-NH2 as substrate after 3 hrs in presence of ATP by fluorescence method'}, {'\u5206\u5b50SMILES': 'CC(C)C[C@](C)(N)COc1ncc(-c2ccnc3ccccc23)cc1C(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.23', 'CHEMBLID': 'CHEMBL4022632', 'description': 'Inhibition of GST-Xa-tagged human AAK1 expressed in bacterial system using fluoresceinated peptide (5 -FAM)-Aha-KEEQSQITSQVTGQIGWR-NH2 and ATP incubated for 3 hrs'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Synthesis of 3-heteroaryl-pyrrolo[2,3-b]pyridines as potent inhibitors of AP-2-associated protein kinase 1 (AAK1) with antiviral activity.', 'abstract': 'Inhibition of AP-2-associated protein kinase 1 (AAK1) has been shown to be a promising avenue for the development of broad-spectrum antiviral agents. On a previously described AAK1 inhibitor based on a pyrrolo[2,3-b]pyridine scaffold, the concept of isosterism was applied, by replacing a carboxamide linker by various five-membered heterocycles. It led to the discovery of a novel series of AAK1 inhibitors with IC'}, {'title': 'Numb-associated kinases regulate sandfly-borne Toscana virus entry.', 'abstract': 'Sandfly-borne Toscana virus (TOSV) is an enveloped tri-segmented negative single-strand RNA '}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3830"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q9Y478', 'features': [], 'extraAttributes': {'uniParcId': 'UPI000013C8F7'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'c1cc(N2CCOCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '39.9', 'CHEMBLID': 'CHEMBL2390519', 'description': 'Inhibition of AMPK (unknown origin)'}, {'\u5206\u5b50SMILES': 'COc1ccc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '44.0', 'CHEMBLID': 'CHEMBL2390519', 'description': 'Inhibition of AMPK (unknown origin)'}, {'\u5206\u5b50SMILES': 'c1cc(N2CCNCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '82.0', 'CHEMBLID': 'CHEMBL2390519', 'description': 'Inhibition of AMPK (unknown origin)'}, {'\u5206\u5b50SMILES': 'c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '234.6', 'CHEMBLID': 'CHEMBL2390519', 'description': 'Inhibition of AMPK (unknown origin)'}, {'\u5206\u5b50SMILES': 'c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '318.2', 'CHEMBLID': 'CHEMBL3707742', 'description': 'Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 \u03bcM. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 \u03bcM ATP and test compounds.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'TGF\u03b21 Restores Energy Homeostasis of Human Trophoblast Cells Under Hyperglycemia In Vitro by Inducing PPAR\u03b3 Expression, AMPK Activation, and HIF1\u03b1 Degradation.', 'abstract': 'Elevated glucose levels at the fetal-maternal interface are associated with placental trophoblast dysfunction and increased incidence of pregnancy complications. Trophoblast cells predominantly utilize glucose as an energy source, metabolizing it through glycolysis in the cytoplasm and oxidative respiration in the mitochondria to produce ATP. The TGF\u03b21/SMAD2 signaling pathway and the transcription factors PPAR\u03b3, HIF1\u03b1, and AMPK are key regulators of cell metabolism and are known to play critical roles in extravillous trophoblast cell differentiation and function. While HIF1\u03b1 promotes glycolysis over mitochondrial respiration, PPAR\u03b3 and AMPK encourage the opposite. However, the interplay between TGF\u03b21 and these energy-sensing regulators in trophoblast cell glucose metabolism remains unclear. This study aimed to investigate whether and how TGF\u03b21 regulates energy metabolism in trophoblast cells exposed to normal and high glucose conditions. The trophoblast JEG-3 cells were incubated in normal (5 mM) and high (25 mM) glucose conditions for 24 h in the absence and the presence of TGF\u03b21. The protein expression levels of phosphor (p)-SMAD2, GLUT1/3, HIF1\u03b1, PPAR\u03b3, p-AMPK, and specific OXPHOS protein subunits were determined by western blotting, and ATP and lactate production by bioluminescent assay kits. JEG-3 cells exposed to 25 mM glucose decreased ATP production but did not affect lactate production. These changes led to a reduction in the expression levels of GLUT1/3, mitochondrial respiratory chain proteins, and PPAR\u03b3, coinciding with an increase in HIF1\u03b1 expression. Conversely, TGF\u03b21 treatment at 25 mM glucose reduced HIF1\u03b1 expression while enhancing the expression levels of GLUT1/3, PPAR\u03b3, p-AMPK, and mitochondrial respiratory chain proteins, thereby rejuvenating ATP production. Our findings reveal that high glucose conditions disrupt cellular glucose metabolism in trophoblast cells by perturbing mitochondrial oxidative respiration and decreasing ATP production. Treatment with TGF\u03b21 appears to counteract this trend, probably by enhancing both glycolytic and mitochondrial metabolism, suggesting a potential regulatory role of TGF\u03b21 in placental trophoblast cell glucose metabolism.'}, {'title': 'Drug risks associated with sarcopenia: a real-world and GWAS study.', 'abstract': 'Drug-induced sarcopenia has not received adequate attention. Meanwhile, there is growing recognition of the importance of effective pharmacovigilance in evaluating the benefits and risks of medications.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3847"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q13131', 'features': [{'type': 'Active site', 'location': {'start': {'value': 150, 'modifier': 'EXACT'}, 'end': {'value': 150, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}]}, {'type': 'Binding site', 'location': {'start': {'value': 33, 'modifier': 'EXACT'}, 'end': {'value': 41, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 56, 'modifier': 'EXACT'}, 'end': {'value': 56, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI000020C9F6'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.4', 'CHEMBLID': 'CHEMBL4884203', 'description': 'Biochemical PRKAA1 assay with 10 \u00b5M ATP (Bayer in house)'}, {'\u5206\u5b50SMILES': 'N[C@H]1CC[C@@H](Nc2cc[nH]c(=O)c2-c2nc3ccccc3[nH]2)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5.5', 'CHEMBLID': 'CHEMBL3784665', 'description': 'Inhibition of AMPKa1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '7.0', 'CHEMBLID': 'CHEMBL5446158', 'description': 'Affinity Biochemical interaction: (Enzymatic inhibition assay) EUB0000311b PRKAA1'}, {'\u5206\u5b50SMILES': 'CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '7.0', 'CHEMBLID': 'CHEMBL4884205', 'description': 'Eurofins kinase panel (PRKAA1)'}, {'\u5206\u5b50SMILES': 'CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '10.0', 'CHEMBLID': 'CHEMBL4884218', 'description': 'AMPKalpha1(h) Eurofins kinase panel'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': '[Artificial light at night effects glucose metabolism in the developing jawbone by inhibiting melatonin secretion].', 'abstract': None}, {'title': 'Pan-cancer analysis combined with experimental validation revealed that ', 'abstract': 'Kinectin 1 ('}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4045"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P17174', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 39, 'modifier': 'EXACT'}, 'end': {'value': 39, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29991'}], 'ligand': {'name': 'L-aspartate', 'id': 'ChEBI:CHEBI:29991'}}, {'type': 'Binding site', 'location': {'start': {'value': 141, 'modifier': 'EXACT'}, 'end': {'value': 141, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29991'}], 'ligand': {'name': 'L-aspartate', 'id': 'ChEBI:CHEBI:29991'}}, {'type': 'Binding site', 'location': {'start': {'value': 195, 'modifier': 'EXACT'}, 'end': {'value': 195, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29991'}], 'ligand': {'name': 'L-aspartate', 'id': 'ChEBI:CHEBI:29991'}}, {'type': 'Binding site', 'location': {'start': {'value': 387, 'modifier': 'EXACT'}, 'end': {'value': 387, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29991'}], 'ligand': {'name': 'L-aspartate', 'id': 'ChEBI:CHEBI:29991'}}], 'extraAttributes': {'uniParcId': 'UPI000013CA75'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC(C)=CCc1cc(/C=C2\\\\OC(=O)C(c3cc(CC=C(C)C)c(O)cc3O)=C2O)ccc1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '2920.0', 'CHEMBLID': 'CHEMBL5105651', 'description': 'Inhibition of human recombinant GOT1 using aspartic acid and alpha-ketoglutaric acid as substrates incubated in presence of MDH1 and NADH'}, {'\u5206\u5b50SMILES': 'O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5390.0', 'CHEMBLID': 'CHEMBL5105638', 'description': 'Inhibition of GOT1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'CC(C)=CCc1cc(/C=C2\\\\OC(=O)C(c3ccc(O)c(CC=C(C)C)c3)=C2O)ccc1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5910.0', 'CHEMBLID': 'CHEMBL5105652', 'description': 'Inhibition of C-terminal His6-tagged human recombinant GOT1 expressed in Escherichia coli BL21 (DE3) cells using aspartic acid and alpha-ketoglutaric acid as substrates incubated in presence of MDH1 and NADH'}, {'\u5206\u5b50SMILES': 'NC1Cc2ccccc2N(O)C1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '8000.0', 'CHEMBLID': 'CHEMBL5105638', 'description': 'Inhibition of GOT1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'O=C(Nc1ccc(Cl)cc1)N1CCN(c2cccc3[nH]ccc23)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '8200.0', 'CHEMBLID': 'CHEMBL4232614', 'description': 'Inhibition of GOT1 (unknown origin) using aspartate and alpha-ketoglutarate as substrate after 20 mins by MDH1 enzyme-coupled fluorescence assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Acute Response of Hepatocyte MRP2 Internalization as an Indicator of Ischemia-Reperfusion Injury in Liver Transplantation.', 'abstract': 'The introduction of normothermic machine perfusion (NMP) offers new opportunities to evaluate liver graft viability before liver transplantation (LT). Under ischemic stress, multidrug resistance-associated protein 2 (MRP2) translocates from the hepatocyte membrane to the cytoplasm, resulting in loss of function.'}, {'title': 'HOTAIR Participation in Glycolysis and Glutaminolysis Through Lactate and Glutamate Production in Colorectal Cancer.', 'abstract': 'Metabolic reprogramming plays a crucial role in cancer biology and the mechanisms underlying its regulation represent a promising study area. In this regard, the discovery of non-coding RNAs opened a new regulatory landscape, which is in the early stages of investigation. Using a differential expression model of HOTAIR, we evaluated the expression level of metabolic enzymes, as well as the metabolites produced by glycolysis and glutaminolysis. Our results demonstrated the regulatory effect of HOTAIR on the expression of glycolysis and glutaminolysis enzymes in colorectal cancer cells. Specifically, through the overexpression and inhibition of HOTAIR, we determined its influence on the expression of the enzymes PFKFB4, PGK1, LDHA, SLC1A5, GLUD1, and GOT1, which had a direct impact on lactate and glutamate production. These findings indicate that HOTAIR plays a significant role in producing \"oncometabolites\" essential to maintaining the bioenergetics and biomass necessary for tumor cell survival by regulating glycolysis and glutaminolysis.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2189139"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P00519', 'features': [{'type': 'Active site', 'location': {'start': {'value': 363, 'modifier': 'EXACT'}, 'end': {'value': 363, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10028'}]}, {'type': 'Binding site', 'location': {'start': {'value': 248, 'modifier': 'EXACT'}, 'end': {'value': 256, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 271, 'modifier': 'EXACT'}, 'end': {'value': 271, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 316, 'modifier': 'EXACT'}, 'end': {'value': 322, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Site', 'location': {'start': {'value': 26, 'modifier': 'EXACT'}, 'end': {'value': 27, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form BCR-ABL and NUP214-ABL1 fusion proteins', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15361874'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '3021337'}]}], 'extraAttributes': {'uniParcId': 'UPI000013D6D4'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1ccccc1-c1ccc2nc(NC(=O)NCCN3CCN(C)CC3)sc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.015', 'CHEMBLID': 'CHEMBL5231405', 'description': 'Inhibition of Abl T315I mutant (unknown origin)'}, {'\u5206\u5b50SMILES': 'COc1ccccc1-c1ccc2nc(NC(=O)NCCN3CCN(C)CC3)sc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.015', 'CHEMBLID': 'CHEMBL2353816', 'description': 'Inhibition of breakpoint cluster region-Abelson tyrosine kinase T315I mutant (unknown origin) using [gamma-33P]ATP as substrate by radiometric kinase assay'}, {'\u5206\u5b50SMILES': 'COc1ccccc1-c1ccc2nc(NC(=O)NCCN3CCOCC3)sc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.021', 'CHEMBLID': 'CHEMBL2353816', 'description': 'Inhibition of breakpoint cluster region-Abelson tyrosine kinase T315I mutant (unknown origin) using [gamma-33P]ATP as substrate by radiometric kinase assay'}, {'\u5206\u5b50SMILES': 'CCNC(=O)Nc1nc2ccc(-c3ccccc3OCC)cc2s1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03', 'CHEMBLID': 'CHEMBL5231404', 'description': 'Inhibition of wild type Abl (unknown origin)'}, {'\u5206\u5b50SMILES': 'CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.06', 'CHEMBLID': 'CHEMBL5231404', 'description': 'Inhibition of wild type Abl (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Molecular characterization and predictors of relapse in patients with Ph\\u2009+\\u2009ALL after frontline ponatinib and blinatumomab.', 'abstract': 'Several studies have suggested that chemotherapy-free regimens consisting of blinatumomab and a BCR::ABL1 tyrosine kinase inhibitor are highly effective in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph\\u2009+\\u2009ALL). However, the clinical and molecular characteristics that predict for relapse with these chemotherapy-free regimens are largely unknown.'}, {'title': 'Structural Insights into the Dynamics of Water in SOD1 Catalysis and Drug Interactions.', 'abstract': 'Superoxide dismutase 1 (SOD1) is a crucial enzyme that protects cells from oxidative damage by converting superoxide radicals into H'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1862"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P00519', 'features': [{'type': 'Active site', 'location': {'start': {'value': 363, 'modifier': 'EXACT'}, 'end': {'value': 363, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10028'}]}, {'type': 'Binding site', 'location': {'start': {'value': 248, 'modifier': 'EXACT'}, 'end': {'value': 256, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 271, 'modifier': 'EXACT'}, 'end': {'value': 271, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 316, 'modifier': 'EXACT'}, 'end': {'value': 322, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Site', 'location': {'start': {'value': 26, 'modifier': 'EXACT'}, 'end': {'value': 27, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form BCR-ABL and NUP214-ABL1 fusion proteins', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15361874'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '3021337'}]}], 'extraAttributes': {'uniParcId': 'UPI000013D6D4'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1ccccc1-c1ccc2nc(NC(=O)NCCN3CCN(C)CC3)sc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.015', 'CHEMBLID': 'CHEMBL5231405', 'description': 'Inhibition of Abl T315I mutant (unknown origin)'}, {'\u5206\u5b50SMILES': 'COc1ccccc1-c1ccc2nc(NC(=O)NCCN3CCN(C)CC3)sc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.015', 'CHEMBLID': 'CHEMBL2353816', 'description': 'Inhibition of breakpoint cluster region-Abelson tyrosine kinase T315I mutant (unknown origin) using [gamma-33P]ATP as substrate by radiometric kinase assay'}, {'\u5206\u5b50SMILES': 'COc1ccccc1-c1ccc2nc(NC(=O)NCCN3CCOCC3)sc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.021', 'CHEMBLID': 'CHEMBL2353816', 'description': 'Inhibition of breakpoint cluster region-Abelson tyrosine kinase T315I mutant (unknown origin) using [gamma-33P]ATP as substrate by radiometric kinase assay'}, {'\u5206\u5b50SMILES': 'CCNC(=O)Nc1nc2ccc(-c3ccccc3OCC)cc2s1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03', 'CHEMBLID': 'CHEMBL5231404', 'description': 'Inhibition of wild type Abl (unknown origin)'}, {'\u5206\u5b50SMILES': 'CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.06', 'CHEMBLID': 'CHEMBL5231404', 'description': 'Inhibition of wild type Abl (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Molecular characterization and predictors of relapse in patients with Ph\\u2009+\\u2009ALL after frontline ponatinib and blinatumomab.', 'abstract': 'Several studies have suggested that chemotherapy-free regimens consisting of blinatumomab and a BCR::ABL1 tyrosine kinase inhibitor are highly effective in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph\\u2009+\\u2009ALL). However, the clinical and molecular characteristics that predict for relapse with these chemotherapy-free regimens are largely unknown.'}, {'title': 'Structural Insights into the Dynamics of Water in SOD1 Catalysis and Drug Interactions.', 'abstract': 'Superoxide dismutase 1 (SOD1) is a crucial enzyme that protects cells from oxidative damage by converting superoxide radicals into H'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1862"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P00519', 'features': [{'type': 'Active site', 'location': {'start': {'value': 363, 'modifier': 'EXACT'}, 'end': {'value': 363, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10028'}]}, {'type': 'Binding site', 'location': {'start': {'value': 248, 'modifier': 'EXACT'}, 'end': {'value': 256, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 271, 'modifier': 'EXACT'}, 'end': {'value': 271, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 316, 'modifier': 'EXACT'}, 'end': {'value': 322, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Site', 'location': {'start': {'value': 26, 'modifier': 'EXACT'}, 'end': {'value': 27, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form BCR-ABL and NUP214-ABL1 fusion proteins', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15361874'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '3021337'}]}], 'extraAttributes': {'uniParcId': 'UPI000013D6D4'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1ccccc1-c1ccc2nc(NC(=O)NCCN3CCN(C)CC3)sc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.015', 'CHEMBLID': 'CHEMBL5231405', 'description': 'Inhibition of Abl T315I mutant (unknown origin)'}, {'\u5206\u5b50SMILES': 'COc1ccccc1-c1ccc2nc(NC(=O)NCCN3CCN(C)CC3)sc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.015', 'CHEMBLID': 'CHEMBL2353816', 'description': 'Inhibition of breakpoint cluster region-Abelson tyrosine kinase T315I mutant (unknown origin) using [gamma-33P]ATP as substrate by radiometric kinase assay'}, {'\u5206\u5b50SMILES': 'COc1ccccc1-c1ccc2nc(NC(=O)NCCN3CCOCC3)sc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.021', 'CHEMBLID': 'CHEMBL2353816', 'description': 'Inhibition of breakpoint cluster region-Abelson tyrosine kinase T315I mutant (unknown origin) using [gamma-33P]ATP as substrate by radiometric kinase assay'}, {'\u5206\u5b50SMILES': 'CCNC(=O)Nc1nc2ccc(-c3ccccc3OCC)cc2s1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03', 'CHEMBLID': 'CHEMBL5231404', 'description': 'Inhibition of wild type Abl (unknown origin)'}, {'\u5206\u5b50SMILES': 'CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.06', 'CHEMBLID': 'CHEMBL5231404', 'description': 'Inhibition of wild type Abl (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Molecular characterization and predictors of relapse in patients with Ph\\u2009+\\u2009ALL after frontline ponatinib and blinatumomab.', 'abstract': 'Several studies have suggested that chemotherapy-free regimens consisting of blinatumomab and a BCR::ABL1 tyrosine kinase inhibitor are highly effective in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph\\u2009+\\u2009ALL). However, the clinical and molecular characteristics that predict for relapse with these chemotherapy-free regimens are largely unknown.'}, {'title': 'Structural Insights into the Dynamics of Water in SOD1 Catalysis and Drug Interactions.', 'abstract': 'Superoxide dismutase 1 (SOD1) is a crucial enzyme that protects cells from oxidative damage by converting superoxide radicals into H'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1862"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P42684', 'features': [{'type': 'Active site', 'location': {'start': {'value': 409, 'modifier': 'EXACT'}, 'end': {'value': 409, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10028'}]}, {'type': 'Binding site', 'location': {'start': {'value': 294, 'modifier': 'EXACT'}, 'end': {'value': 302, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 317, 'modifier': 'EXACT'}, 'end': {'value': 317, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 362, 'modifier': 'EXACT'}, 'end': {'value': 368, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI0000125140'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.5', 'CHEMBLID': 'CHEMBL1244324', 'description': 'Inhibition of ABL2'}, {'\u5206\u5b50SMILES': 'Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2nccn12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.0', 'CHEMBLID': 'CHEMBL2330092', 'description': 'Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins'}, {'\u5206\u5b50SMILES': 'Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2nccn12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '2.0', 'CHEMBLID': 'CHEMBL2330094', 'description': 'Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay'}, {'\u5206\u5b50SMILES': 'CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cnc5cnccn45)n(C)n3)cc2C(F)(F)F)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.0', 'CHEMBLID': 'CHEMBL2330094', 'description': 'Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay'}, {'\u5206\u5b50SMILES': 'Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.0', 'CHEMBLID': 'CHEMBL4766153', 'description': 'Inhibition of human recombinant ARG (38 to end residues) using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Bioinformatics Analysis of Cancer Related CBP Mutations on Copper Ion and Drug Binding.', 'abstract': 'In cancer biology, copper-binding proteins (CBPs) possess a wide range of roles that impact various aspects of tumour development and progression. Modifications in CBPs in malignancy may have an enormous effect on cellular processes essential for the development and growth of cancers. We utilised bioinformatics approaches to separate down CBPs in the cancer proteome, and 32 proteins have been determined to be putative CBPs. Twelve of these proteins were associated with a likelihood of metastatic spread from primary to secondary cancer regions. Results indicated that the point mutation causes structural and functional changes in the proteins. Point mutations also alter the Cu'}, {'title': 'Cryptic to conventional cytogenetics: Philadelphia-like ALL presenting with hypereosinophilia.', 'abstract': 'BCR::ABL1-like B-lymphoblastic leukaemia (B-ALL) neoplasms lack the BCR::ABL1 translocation but have a gene expression profile like BCR::ABL1 positive B-ALL. This includes alterations in cytokine receptors and signalling genes, such as '}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4014"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P22303', 'features': [{'type': 'Active site', 'location': {'start': {'value': 234, 'modifier': 'EXACT'}, 'end': {'value': 234, 'modifier': 'EXACT'}}, 'description': 'Acyl-ester intermediate'}, {'type': 'Active site', 'location': {'start': {'value': 365, 'modifier': 'EXACT'}, 'end': {'value': 365, 'modifier': 'EXACT'}}, 'description': 'Charge relay system'}, {'type': 'Active site', 'location': {'start': {'value': 478, 'modifier': 'EXACT'}, 'end': {'value': 478, 'modifier': 'EXACT'}}, 'description': 'Charge relay system'}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:178021'}], 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4EY6'}], 'ligand': {'name': 'galanthamine', 'id': 'ChEBI:CHEBI:178021'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:178022'}], 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4EY5'}], 'ligand': {'name': 'huperzine A', 'id': 'ChEBI:CHEBI:178022'}}, {'type': 'Binding site', 'location': {'start': {'value': 153, 'modifier': 'EXACT'}, 'end': {'value': 153, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188158'}], 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BDT'}], 'ligand': {'name': 'huprine W', 'id': 'ChEBI:CHEBI:188158'}}, {'type': 'Binding site', 'location': {'start': {'value': 164, 'modifier': 'EXACT'}, 'end': {'value': 164, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:178022'}], 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4EY5'}], 'ligand': {'name': 'huperzine A', 'id': 'ChEBI:CHEBI:178022'}}, {'type': 'Binding site', 'location': {'start': {'value': 233, 'modifier': 'EXACT'}, 'end': {'value': 234, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:178021'}], 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4EY6'}], 'ligand': {'name': 'galanthamine', 'id': 'ChEBI:CHEBI:178021'}}, {'type': 'Binding site', 'location': {'start': {'value': 234, 'modifier': 'EXACT'}, 'end': {'value': 234, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188158'}], 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BDT'}], 'ligand': {'name': 'huprine W', 'id': 'ChEBI:CHEBI:188158'}}, {'type': 'Binding site', 'location': {'start': {'value': 368, 'modifier': 'EXACT'}, 'end': {'value': 368, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:178021'}], 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4EY6'}], 'ligand': {'name': 'galanthamine', 'id': 'ChEBI:CHEBI:178021'}}, {'type': 'Binding site', 'location': {'start': {'value': 368, 'modifier': 'EXACT'}, 'end': {'value': 368, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:178022'}], 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4EY5'}], 'ligand': {'name': 'huperzine A', 'id': 'ChEBI:CHEBI:178022'}}, {'type': 'Binding site', 'location': {'start': {'value': 470, 'modifier': 'EXACT'}, 'end': {'value': 470, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188158'}], 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BDT'}], 'ligand': {'name': 'huprine W', 'id': 'ChEBI:CHEBI:188158'}}, {'type': 'Binding site', 'location': {'start': {'value': 478, 'modifier': 'EXACT'}, 'end': {'value': 478, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188158'}], 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BDT'}], 'ligand': {'name': 'huprine W', 'id': 'ChEBI:CHEBI:188158'}}], 'extraAttributes': {'uniParcId': 'UPI0000125216'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(OCCCCN[N+]3(C)CCN(c4ccc(/C=C5\\\\Cc6cc(OC)c(OC)cc6C5=O)cc4)CC3)cc1)C2.[Br-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0', 'CHEMBLID': 'CHEMBL4768259', 'description': \"Inhibition of human erythrocyte AChE using acetylthiocholine as substrate measured after 5 mins by Ellman's method\"}, {'\u5206\u5b50SMILES': 'COc1ccc2[nH]cc(CCNC(=O)CCCCNc3c4c(nc5ccccc35)CCCC4)c2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.000005', 'CHEMBLID': 'CHEMBL4342697', 'description': \"Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method\"}, {'\u5206\u5b50SMILES': 'COc1ccc2[nH]cc(CCNC(=O)CCCCCNc3c4c(nc5ccccc35)CCCC4)c2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.000005', 'CHEMBLID': 'CHEMBL4342697', 'description': \"Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method\"}, {'\u5206\u5b50SMILES': 'COc1ccc2[nH]cc(CCNC(=O)CCCCCCNc3c4c(nc5ccccc35)CCCC4)c2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.000005', 'CHEMBLID': 'CHEMBL4342697', 'description': \"Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method\"}, {'\u5206\u5b50SMILES': 'O=C(CCCCCCCNc1c2c(nc3ccccc13)CCCC2)NCCc1c[nH]c2ccccc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.000005', 'CHEMBLID': 'CHEMBL4342697', 'description': \"Inhibition of human erythrocyte acetylcholinesterase using acetylthiocholine as substrate by Ellman's method\"}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Stability of acetylcholinesterase (AChE) activity in blood: the effect of the preservative agent.', 'abstract': 'Fluoride anions are believed to inhibit acetylcholinesterase activity, thus there is a possibility that the activity may be affected by blood sampling into vials containing sodium fluoride as an anticoagulant. The paper aims to draw attention to the effect of the anticoagulant used in blood collection tubes on acetylcholinesterase activity. A stability study was conducted for 176 days on blood samples collected into tubes containing sodium fluoride or sodium EDTA. An improved Ellman procedure, utilizing spectrophotometric determination at 436 nm, was employed in order to determine acetylcholinesterase activity. An immediate decrease in acetylcholinesterase activity was observed in blood samples containing sodium fluoride. A significant decrease was evident immediately after blood collection and on the first day, after which the activity stabilized at 84% of the initial value. Subsequently, the activity increased to a level comparable to the initial value. In samples collected with EDTA, acetylcholinesterase activity was comparable to that in the sample without anticoagulant, and the activity remained constant for about 2 months. In conclusion, it is recommended that acetylcholinesterase activity be tested immediately after blood collection to reduce enzyme inhibition by fluoride anions, or that tubes with another anticoagulant, such as EDTA, be used.'}, {'title': \"Budget impact of lecanemab for medicare beneficiaries with early Alzheimer's disease in the United States: a subgroup analysis.\", 'abstract': \"In 2024, Alzheimer's disease affected approximately 6.9 million Americans aged 65 and older. Current therapies include acetylcholinesterase inhibitors, N-methyl-D-aspartate receptor inhibitors, and monoclonal antibodies. With an economic burden surpassing $345 billion, $222 billion borne by Medicare and Medicaid, this study evaluates lecanemab's budgetary impact for early AD, including subgroup analyses by gender and race.\"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL220"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P12821', 'features': [{'type': 'Active site', 'location': {'start': {'value': 391, 'modifier': 'EXACT'}, 'end': {'value': 391, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor 1', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '16154999'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '19773553'}]}, {'type': 'Active site', 'location': {'start': {'value': 520, 'modifier': 'EXACT'}, 'end': {'value': 520, 'modifier': 'EXACT'}}, 'description': 'Proton donor 1', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}]}, {'type': 'Active site', 'location': {'start': {'value': 989, 'modifier': 'EXACT'}, 'end': {'value': 989, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor 2', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '16154999'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '19773553'}]}, {'type': 'Active site', 'location': {'start': {'value': 1118, 'modifier': 'EXACT'}, 'end': {'value': 1118, 'modifier': 'EXACT'}}, 'description': 'Proton donor 2', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}]}, {'type': 'Binding site', 'location': {'start': {'value': 231, 'modifier': 'EXACT'}, 'end': {'value': 231, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 390, 'modifier': 'EXACT'}, 'end': {'value': 390, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20826823'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26403559'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2OC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3NXQ'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 394, 'modifier': 'EXACT'}, 'end': {'value': 394, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20826823'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26403559'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2OC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3NXQ'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 418, 'modifier': 'EXACT'}, 'end': {'value': 418, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20826823'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26403559'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2OC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3NXQ'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 529, 'modifier': 'EXACT'}, 'end': {'value': 529, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 791, 'modifier': 'EXACT'}, 'end': {'value': 791, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 829, 'modifier': 'EXACT'}, 'end': {'value': 829, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '3'}}, {'type': 'Binding site', 'location': {'start': {'value': 988, 'modifier': 'EXACT'}, 'end': {'value': 988, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23056909'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4APH'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 992, 'modifier': 'EXACT'}, 'end': {'value': 992, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23056909'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4APH'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 1016, 'modifier': 'EXACT'}, 'end': {'value': 1016, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23056909'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '7961923'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4APH'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 1090, 'modifier': 'EXACT'}, 'end': {'value': 1090, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 1094, 'modifier': 'EXACT'}, 'end': {'value': 1094, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 1127, 'modifier': 'EXACT'}, 'end': {'value': 1127, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '11432860'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '3'}}, {'type': 'Site', 'location': {'start': {'value': 523, 'modifier': 'EXACT'}, 'end': {'value': 523, 'modifier': 'EXACT'}}, 'description': 'Not glycosylated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20826823'}]}, {'type': 'Site', 'location': {'start': {'value': 1166, 'modifier': 'EXACT'}, 'end': {'value': 1167, 'modifier': 'EXACT'}}, 'description': 'Cleavage', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '7499427'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '8253769'}]}, {'type': 'Site', 'location': {'start': {'value': 1225, 'modifier': 'EXACT'}, 'end': {'value': 1225, 'modifier': 'EXACT'}}, 'description': 'Not glycosylated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9013598'}]}, {'type': 'Site', 'location': {'start': {'value': 1232, 'modifier': 'EXACT'}, 'end': {'value': 1233, 'modifier': 'EXACT'}}, 'description': 'Cleavage', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10769174'}]}, {'type': 'Binding site', 'location': {'start': {'value': 414, 'modifier': 'EXACT'}, 'end': {'value': 414, 'modifier': 'EXACT'}, 'sequence': 'P12821-3'}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24297181'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2R'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 418, 'modifier': 'EXACT'}, 'end': {'value': 418, 'modifier': 'EXACT'}, 'sequence': 'P12821-3'}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24297181'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2R'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 442, 'modifier': 'EXACT'}, 'end': {'value': 442, 'modifier': 'EXACT'}, 'sequence': 'P12821-3'}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24297181'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2R'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}], 'extraAttributes': {'uniParcId': 'UPI000002B8AD'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@H](CS)C(=O)N1[C@@H](SCCCc2ccccc2)CC[C@H]1C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.029', 'CHEMBLID': 'CHEMBL1004838', 'description': 'Inhibition of ACE'}, {'\u5206\u5b50SMILES': 'NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL2445167', 'description': 'Inhibition of human serum ACE'}, {'\u5206\u5b50SMILES': 'NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL648691', 'description': 'Inhibitory activity against Angiotensin I converting enzyme (ACE) from human blood serum'}, {'\u5206\u5b50SMILES': 'O=C(N[C@H]1CCS[C@H]2CCC[C@@H](C(=O)O)N2C1=O)[C@@H](S)Cc1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL4311874', 'description': 'Inhibition of recombinant human ACE using Mca-BK2 as substrate preincubated for 10 mins followed by fluorogenic substrate addition and measured after 20 mins by fluorescence assay'}, {'\u5206\u5b50SMILES': 'NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5152106', 'description': 'Inhibition of angiotensin converting enzyme (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations.', 'abstract': 'Evidence from clinical trials suggests that antihypertensive treatment is associated with an increased risk of common electrolyte abnormalities. We aimed to develop and validate two clinical prediction models to estimate the risk of hyperkalaemia and hyponatraemia, respectively, to facilitate targeted treatment and monitoring strategies for individuals indicated for antihypertensive therapy.'}, {'title': 'Short- and long-term outcomes of ST-segment elevation myocardial infarction treated with CABG: a population-based cohort study.', 'abstract': 'To investigate the outcomes of patients with ST-elevation myocardial infarction (STEMI) who were treated with coronary artery bypass grafting (CABG) surgery.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1808"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P12821', 'features': [{'type': 'Active site', 'location': {'start': {'value': 391, 'modifier': 'EXACT'}, 'end': {'value': 391, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor 1', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '16154999'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '19773553'}]}, {'type': 'Active site', 'location': {'start': {'value': 520, 'modifier': 'EXACT'}, 'end': {'value': 520, 'modifier': 'EXACT'}}, 'description': 'Proton donor 1', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}]}, {'type': 'Active site', 'location': {'start': {'value': 989, 'modifier': 'EXACT'}, 'end': {'value': 989, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor 2', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '16154999'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '19773553'}]}, {'type': 'Active site', 'location': {'start': {'value': 1118, 'modifier': 'EXACT'}, 'end': {'value': 1118, 'modifier': 'EXACT'}}, 'description': 'Proton donor 2', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}]}, {'type': 'Binding site', 'location': {'start': {'value': 231, 'modifier': 'EXACT'}, 'end': {'value': 231, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 390, 'modifier': 'EXACT'}, 'end': {'value': 390, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20826823'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26403559'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2OC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3NXQ'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 394, 'modifier': 'EXACT'}, 'end': {'value': 394, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20826823'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26403559'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2OC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3NXQ'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 418, 'modifier': 'EXACT'}, 'end': {'value': 418, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20826823'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26403559'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2OC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3NXQ'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 529, 'modifier': 'EXACT'}, 'end': {'value': 529, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 791, 'modifier': 'EXACT'}, 'end': {'value': 791, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 829, 'modifier': 'EXACT'}, 'end': {'value': 829, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '3'}}, {'type': 'Binding site', 'location': {'start': {'value': 988, 'modifier': 'EXACT'}, 'end': {'value': 988, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23056909'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4APH'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 992, 'modifier': 'EXACT'}, 'end': {'value': 992, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23056909'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4APH'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 1016, 'modifier': 'EXACT'}, 'end': {'value': 1016, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16476442'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23056909'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '7961923'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4APH'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 1090, 'modifier': 'EXACT'}, 'end': {'value': 1090, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 1094, 'modifier': 'EXACT'}, 'end': {'value': 1094, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 1127, 'modifier': 'EXACT'}, 'end': {'value': 1127, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU01355'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12540854'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '11432860'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996', 'label': '3'}}, {'type': 'Site', 'location': {'start': {'value': 523, 'modifier': 'EXACT'}, 'end': {'value': 523, 'modifier': 'EXACT'}}, 'description': 'Not glycosylated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20826823'}]}, {'type': 'Site', 'location': {'start': {'value': 1166, 'modifier': 'EXACT'}, 'end': {'value': 1167, 'modifier': 'EXACT'}}, 'description': 'Cleavage', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '7499427'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '8253769'}]}, {'type': 'Site', 'location': {'start': {'value': 1225, 'modifier': 'EXACT'}, 'end': {'value': 1225, 'modifier': 'EXACT'}}, 'description': 'Not glycosylated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9013598'}]}, {'type': 'Site', 'location': {'start': {'value': 1232, 'modifier': 'EXACT'}, 'end': {'value': 1233, 'modifier': 'EXACT'}}, 'description': 'Cleavage', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10769174'}]}, {'type': 'Binding site', 'location': {'start': {'value': 414, 'modifier': 'EXACT'}, 'end': {'value': 414, 'modifier': 'EXACT'}, 'sequence': 'P12821-3'}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24297181'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2R'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 418, 'modifier': 'EXACT'}, 'end': {'value': 418, 'modifier': 'EXACT'}, 'sequence': 'P12821-3'}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24297181'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2R'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 442, 'modifier': 'EXACT'}, 'end': {'value': 442, 'modifier': 'EXACT'}, 'sequence': 'P12821-3'}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24297181'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2R'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}], 'extraAttributes': {'uniParcId': 'UPI000002B8AD'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@H](CS)C(=O)N1[C@@H](SCCCc2ccccc2)CC[C@H]1C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.029', 'CHEMBLID': 'CHEMBL1004838', 'description': 'Inhibition of ACE'}, {'\u5206\u5b50SMILES': 'NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL2445167', 'description': 'Inhibition of human serum ACE'}, {'\u5206\u5b50SMILES': 'NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL648691', 'description': 'Inhibitory activity against Angiotensin I converting enzyme (ACE) from human blood serum'}, {'\u5206\u5b50SMILES': 'O=C(N[C@H]1CCS[C@H]2CCC[C@@H](C(=O)O)N2C1=O)[C@@H](S)Cc1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL4311874', 'description': 'Inhibition of recombinant human ACE using Mca-BK2 as substrate preincubated for 10 mins followed by fluorogenic substrate addition and measured after 20 mins by fluorescence assay'}, {'\u5206\u5b50SMILES': 'NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5152106', 'description': 'Inhibition of angiotensin converting enzyme (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations.', 'abstract': 'Evidence from clinical trials suggests that antihypertensive treatment is associated with an increased risk of common electrolyte abnormalities. We aimed to develop and validate two clinical prediction models to estimate the risk of hyperkalaemia and hyponatraemia, respectively, to facilitate targeted treatment and monitoring strategies for individuals indicated for antihypertensive therapy.'}, {'title': 'Short- and long-term outcomes of ST-segment elevation myocardial infarction treated with CABG: a population-based cohort study.', 'abstract': 'To investigate the outcomes of patients with ST-elevation myocardial infarction (STEMI) who were treated with coronary artery bypass grafting (CABG) surgery.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1808"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q15822', 'features': [], 'extraAttributes': {'uniParcId': 'UPI000013CA9F'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C=O)CS)[C@@H](C)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.75', 'CHEMBLID': 'CHEMBL828589', 'description': 'Inhibitory concentration against Nicotinic acetylcholine receptor alpha2-beta4; Range is 0.3-1.5 nM'}, {'\u5206\u5b50SMILES': 'CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C=O)CCCN=C(N)N', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.5', 'CHEMBLID': 'CHEMBL827552', 'description': 'Inhibitory concentration against Nicotinic acetylcholine receptor alpha2-beta4; Range is 0.3-1.5 nM'}, {'\u5206\u5b50SMILES': 'CCN1C[C@]2(COC(=O)c3ccccc3N3C(=O)C[C@H](C)C3=O)CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@](O)(C[C@@H]6OC)[C@](O)([C@@H](OC)[C@H]23)[C@@H]14', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1000.0', 'CHEMBLID': 'CHEMBL829397', 'description': 'Inhibitory concentration against Nicotinic acetylcholine receptor alpha2-beta4'}, {'\u5206\u5b50SMILES': 'COc1cc2c3cc1Oc1cccc(c1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)CC3N(C)CC2)CC[N+]1(C)C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '2300.0', 'CHEMBLID': 'CHEMBL829397', 'description': 'Inhibitory concentration against Nicotinic acetylcholine receptor alpha2-beta4'}, {'\u5206\u5b50SMILES': 'CNC1(C)C2CCC(C2)C1(C)C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3100.0', 'CHEMBLID': 'CHEMBL829397', 'description': 'Inhibitory concentration against Nicotinic acetylcholine receptor alpha2-beta4'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Incomplete incorporation of tandem subunits in recombinant neuronal nicotinic receptors.', 'abstract': 'Tandem constructs are increasingly being used to restrict the composition of recombinant multimeric channels. It is therefore important to assess not only whether such approaches give functional channels, but also whether such channels completely incorporate the subunit tandems. We have addressed this question for neuronal nicotinic acetylcholine receptors, using a channel mutation as a reporter for subunit incorporation. We prepared tandem constructs of nicotinic receptors by linking alpha (alpha2-alpha4, alpha6) and beta (beta2, beta4) subunits by a short linker of eight glutamine residues. Robust functional expression in oocytes was observed for several tandems (beta4_alpha2, beta4_alpha3, beta4_alpha4, and beta2_alpha4) when coexpressed with the corresponding beta monomer subunit. All tandems expressed when injected alone, except for beta4_alpha3, which produced functional channels only together with beta4 monomer and was chosen for further characterization. These channels produced from beta4_alpha3 tandem constructs plus beta4 monomer were identical with receptors expressed from monomer alpha3 and beta4 constructs in acetylcholine sensitivity and in the number of alpha and beta subunits incorporated in the channel gate. However, separately mutating the beta subunit in either the monomer or the tandem revealed that tandem-expressed channels are heterogeneous. Only a proportion of these channels contained as expected two copies of beta subunits from the tandem and one from the beta monomer construct, whereas the rest incorporated two or three beta monomers. Such inaccuracies in concatameric receptor assembly would not have been apparent with a standard functional characterization of the receptor. Extensive validation is needed for tandem-expressed receptors in the nicotinic superfamily.'}, {'title': 'alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.', 'abstract': 'Neuronal nicotinic acetylcholine receptors (nAChRs) with putative alpha3 beta4-subunits have been implicated in the mediation of signaling in various systems, including ganglionic transmission peripherally and nicotine-evoked neurotransmitter release centrally. However, progress in the characterization of these receptors has been hampered by a lack of alpha3 beta4-selective ligands. In this report, we describe the purification and characterization of an alpha3 beta4 nAChR antagonist, alpha-conotoxin AuIB, from the venom of the \"court cone,\" Conus aulicus. We also describe the total chemical synthesis of this and two related peptides that were also isolated from the venom. alpha-Conotoxin AuIB blocks alpha3 beta4 nAChRs expressed in Xenopus oocytes with an IC50 of 0.75 microM, a kon of 1.4 x 10(6) min-1 M-1, a koff of 0.48 min-1, and a Kd of 0.5 microM. Furthermore, alpha-conotoxin AuIB blocks the alpha3 beta4 receptor with >100-fold higher potency than other receptor subunit combinations, including alpha2 beta2, alpha2 beta4, alpha3 beta2, alpha4 beta2, alpha4 beta4, and alpha1 beta1 gamma delta. Thus, AuIB is a novel, selective probe for alpha3 beta4 nAChRs. AuIB (1-5 microM) blocks 20-35% of the nicotine-stimulated norepinephrine release from rat hippocampal synaptosomes, whereas nicotine-evoked dopamine release from striatal synaptosomes is not affected. Conversely, the alpha3 beta2-specific alpha-conotoxin MII (100 nM) blocks 33% of striatal dopamine release but not hippocampal norepinephrine release. This suggests that in the respective systems, alpha3 beta4-containing nAChRs mediate norepinephrine release, whereas alpha3 beta2-containing receptors mediate dopamine release.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2109230"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q07912', 'features': [{'type': 'Active site', 'location': {'start': {'value': 252, 'modifier': 'EXACT'}, 'end': {'value': 252, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor'}, {'type': 'Binding site', 'location': {'start': {'value': 132, 'modifier': 'EXACT'}, 'end': {'value': 140, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 158, 'modifier': 'EXACT'}, 'end': {'value': 158, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI000021D19E'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cc1cc(Nc2ncc3cc(-c4ccccc4Cl)c(=O)n(C[C@H]4CCCO4)c3n2)ccc1N1CCC(N(C)C)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL5341436', 'description': 'Inhibition of N-terminal His6-tagged ACK1 (117 to 389 residues) (unknown origin) expressed in Sf9 cells using ATP as substrate incubated for 1 hrs by ELISA'}, {'\u5206\u5b50SMILES': 'Cc1cc(Nc2ncc3cc(-c4ccccc4Cl)c(=O)n(C[C@H]4CCCO4)c3n2)ccc1N1CCC(N2CCN(C)CC2)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL5341436', 'description': 'Inhibition of N-terminal His6-tagged ACK1 (117 to 389 residues) (unknown origin) expressed in Sf9 cells using ATP as substrate incubated for 1 hrs by ELISA'}, {'\u5206\u5b50SMILES': 'COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2cc(-c3ccccc3Cl)c(=O)n(C[C@H]3CCCO3)c2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL5341436', 'description': 'Inhibition of N-terminal His6-tagged ACK1 (117 to 389 residues) (unknown origin) expressed in Sf9 cells using ATP as substrate incubated for 1 hrs by ELISA'}, {'\u5206\u5b50SMILES': 'Cc1cc(Nc2ncc3cc(-c4ccccc4Cl)c(=O)n(C[C@H]4CCCO4)c3n2)ccc1N1CCN(C)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.4', 'CHEMBLID': 'CHEMBL5341436', 'description': 'Inhibition of N-terminal His6-tagged ACK1 (117 to 389 residues) (unknown origin) expressed in Sf9 cells using ATP as substrate incubated for 1 hrs by ELISA'}, {'\u5206\u5b50SMILES': 'Cc1ccccc1-c1cc2cnc(Nc3ccc(N4CCN(C)CC4)c(C)c3)nc2n(C[C@H]2CCCO2)c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.6', 'CHEMBLID': 'CHEMBL5341436', 'description': 'Inhibition of N-terminal His6-tagged ACK1 (117 to 389 residues) (unknown origin) expressed in Sf9 cells using ATP as substrate incubated for 1 hrs by ELISA'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'ACK1/TNK2 kinase: molecular mechanisms and emerging cancer therapeutics.', 'abstract': 'Activated CDC42-associated kinase 1 (ACK1), encoded by the TNK2 gene, is a cytoplasmic non-receptor tyrosine kinase whose aberrant activation correlates positively with cancer severity. Recent research has revealed the functional relevance of this oncokinase - it is an epigenetic regulator that drives cancer progression in multiple malignancies. Although ACK1 is an attractive target for therapeutic intervention, incomplete knowledge of its diverse signaling mechanisms and the lack of specific inhibitors have challenged its clinical success. We summarize recent breakthroughs in understanding ACK1 regulation and cellular signaling, and shed light on its immunomodulatory role in balancing T cell activation. We provide a comprehensive overview of preclinical, proof-of-concept studies of potent ACK1-targeting small-molecule inhibitors that are expected to enter clinical trials for cancer patients.'}, {'title': 'ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.', 'abstract': 'Osteosarcoma is a diverse and aggressive bone tumor. Driver genes regulating osteosarcoma initiation and progression remains incompletely defined. Zinc finger protein 692 (ZNF692), a kind of Kr\u00fcppel C2H2 zinc finger transcription factor, exhibited abnormal expression in different types of malignancies and showed a correlation with the clinical prognosis of patients as well as the aggressive characteristics of cancer cells. Nevertheless, its specific role in osteosarcoma is still not well understood.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4599"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P11229', 'features': [{'type': 'Site', 'location': {'start': {'value': 170, 'modifier': 'EXACT'}, 'end': {'value': 170, 'modifier': 'EXACT'}}, 'description': 'Subtype-specific residue that binds to snake venom muscarinic toxin 7', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '32646996'}]}, {'type': 'Site', 'location': {'start': {'value': 172, 'modifier': 'EXACT'}, 'end': {'value': 172, 'modifier': 'EXACT'}}, 'description': 'Binds to snake venom muscarinic toxin 7', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '32646996'}]}, {'type': 'Site', 'location': {'start': {'value': 174, 'modifier': 'EXACT'}, 'end': {'value': 174, 'modifier': 'EXACT'}}, 'description': 'Subtype-specific residue that binds to snake venom muscarinic toxin 7', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '32646996'}]}, {'type': 'Site', 'location': {'start': {'value': 397, 'modifier': 'EXACT'}, 'end': {'value': 397, 'modifier': 'EXACT'}}, 'description': 'Subtype-specific residue that binds to snake venom muscarinic toxin 7', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '32646996'}]}, {'type': 'Site', 'location': {'start': {'value': 401, 'modifier': 'EXACT'}, 'end': {'value': 401, 'modifier': 'EXACT'}}, 'description': 'Subtype-specific residue that binds to snake venom muscarinic toxin 7', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '32646996'}]}], 'extraAttributes': {'uniParcId': 'UPI00001252AB'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CCCCCCSc1nsnc1C1=CCCN(C)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.001', 'CHEMBLID': 'CHEMBL881931', 'description': 'Efficacy at muscarinic acetylcholine receptor M1 measured by the ability to inhibit the electrically stimulated twitch of the rabbit vas deferens'}, {'\u5206\u5b50SMILES': 'CCCCCSc1nsnc1C1=CCCN(C)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.002', 'CHEMBLID': 'CHEMBL881931', 'description': 'Efficacy at muscarinic acetylcholine receptor M1 measured by the ability to inhibit the electrically stimulated twitch of the rabbit vas deferens'}, {'\u5206\u5b50SMILES': 'CCCCCOc1nsnc1C1=CCCN(C)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.004', 'CHEMBLID': 'CHEMBL881931', 'description': 'Efficacy at muscarinic acetylcholine receptor M1 measured by the ability to inhibit the electrically stimulated twitch of the rabbit vas deferens'}, {'\u5206\u5b50SMILES': 'CCCCCCOc1nsnc1C1=CCCN(C)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.008', 'CHEMBLID': 'CHEMBL881931', 'description': 'Efficacy at muscarinic acetylcholine receptor M1 measured by the ability to inhibit the electrically stimulated twitch of the rabbit vas deferens'}, {'\u5206\u5b50SMILES': 'C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03162', 'CHEMBLID': 'CHEMBL1291430', 'description': 'Displacement of [3H]NMS from human muscarinic M1 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': None, 'abstract': 'G protein-coupled receptors (GPCRs) are highly dynamic seven-transmembrane (7TM) proteins that respond to various extracellular stimuli and elicit diverse intracellular signaling cascades. The third intracellular loops (ICL3s) of the GPCRs are intrinsically disordered and play important roles in signaling. The muscarinic acetylcholine receptors (mAChRs) harbor extremely long ICL3s, which comprise over a hundred amino acid residues and contain multiple phosphorylation sites. Due to their intrinsic flexibility, ICL3s are commonly absent or unobservable in cryo-EM or X-ray structures, and there has been a lack of structural and dynamics study of these regions. Herein, we report the '}, {'title': 'From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials.', 'abstract': 'Since the 1950s, understanding of antipsychotic activity in schizophrenia has been largely grounded in the dopamine (DA) hypothesis. Most antipsychotics approved for schizophrenia interact with D2 DA receptors as an important part of their mechanism of action. While antipsychotics blocking D2 DA receptors can be effective for positive symptoms of schizophrenia, none are approved by regulatory authorities for predominant negative or cognitive symptoms. Moreover, many of these agents induce a range of problematic side effects related to D2 DA receptor blockade (eg, drug-induced parkinsonism, akathisia, tardive dyskinesia, hyperprolactinemia and related sexual side effects, sedation). This has prompted the search for novel mechanisms with improved efficacy and tolerability based on evidence supporting involvement of other neurotransmitter systems in schizophrenia pathophysiology, including acetylcholine, gamma-aminobutyric acid, and glutamate. Among these options, targeting muscarinic receptors emerged as a promising treatment strategy. In September 2024, the U.S. Food and Drug Administration approved xanomeline and trospium chloride for treatment of adults with schizophrenia based on results from three 5-week, randomized, double-blind, placebo-controlled trials and two 52-week open-label trials. In the placebo-controlled trials, xanomeline/trospium reduced symptoms of schizophrenia, was generally well tolerated, and was not associated with clinically meaningful motor symptoms, hyperprolactinemia, sexual side effects, or weight gain compared with placebo. The long-term safety of xanomeline/trospium was also confirmed in two 52-week, open-label trials. This paper reviews the preclinical and clinical rationale for muscarinic receptor activation as a treatment for schizophrenia and the efficacy, safety, and tolerability profile of xanomeline/trospium.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL216"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P08172', 'features': [], 'extraAttributes': {'uniParcId': 'UPI0000050410'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03162', 'CHEMBLID': 'CHEMBL1291431', 'description': 'Displacement of [3H]NMS from human muscarinic M2 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay'}, {'\u5206\u5b50SMILES': 'O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03981', 'CHEMBLID': 'CHEMBL1924274', 'description': 'Displacement of [3H]NMS from recombinant human M2 receptor expressed in CHO-K1 cells after 16 hrs'}, {'\u5206\u5b50SMILES': 'C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0631', 'CHEMBLID': 'CHEMBL1924274', 'description': 'Displacement of [3H]NMS from recombinant human M2 receptor expressed in CHO-K1 cells after 16 hrs'}, {'\u5206\u5b50SMILES': 'O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1259', 'CHEMBLID': 'CHEMBL1291431', 'description': 'Displacement of [3H]NMS from human muscarinic M2 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay'}, {'\u5206\u5b50SMILES': 'O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)[C@](O)(c1cccs1)C1CCCC1.[Br-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.14', 'CHEMBLID': 'CHEMBL1058941', 'description': 'Displacement of [3H]NMS from human muscarinic M2 receptor expressed in CHOK1 cells by microplate scintillation counting'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Sericin-Induced Hypophagia Mediates Via M1 Muscarinic, NMDA Glutamate and Glycine Receptors in Neonatal Chicken.', 'abstract': 'The objective of this study was to ascertain the interaction between muscarinic, NMDA glutamate, and glycine receptors on sericin-induced hypophagia in neonatal chickens. This study comprised six experiments, with four groups in each and 11 repeats per group. In Experiment 1, the chicken received an ICV injection of saline, sericin (0.5 nmol), or Telenzepine (an M1 muscarinic receptor antagonist, 125 nmol). Group 4 received a co-injection of sericin and Telenzepine. In experiments 2-6, the chicken received ICV injections of AF-DX116 (an M2 muscarinic receptor antagonist, 125 nmol), 4-DAMP (an M3 muscarinic receptor antagonist, 125 nmol), PD102807 (an M4 muscarinic receptor antagonist, 125 nmol), MK-801 (an NMDA glutamate receptor antagonist, 15 nmol), and strychnine (a glycine receptor antagonist, 100 nmol) instead of Telenzepine. Subsequently, the cumulative food intake was quantified at 30, 60, and 120 minutes post-injection. The results demonstrated that the ICV injection of sericin (0.5 nmol) led to a notable reduction in cumulative food intake when compared to the control group (P<0.05). The co-injection of telenzepine and sericin resulted in a notable reduction in the hypophagia induced by sericin, as evidenced by a statistically significant difference (P<0.05). The co-injection of MK-801 and sericin resulted in a reduction of the hypophagic effects of sericin when compared to the control group (P<0.05). The co-injection of strychnine and sericin resulted in a notable reduction in the hypophagic effects of sericin, as evidenced by a statistically significant difference when compared to the control group (P<0.05). These findings suggest that sericin-induced hypophagia is mediated via M1 muscarinic, NMDA glutamate, and glycine receptors in neonatal chickens.'}, {'title': 'Design, Synthesis, and Evaluation of a New Fluorescent Ligand for the M', 'abstract': 'The M'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL211"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P20309', 'features': [], 'extraAttributes': {'uniParcId': 'UPI0000050453'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@@](C(=O)O[C@H]1C[N+]2(CCc3cccc(Cl)c3)CCC1CC2)(c1ccccc1)N1CCCCC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03162', 'CHEMBLID': 'CHEMBL1924273', 'description': 'Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs'}, {'\u5206\u5b50SMILES': 'Cc1cc(CCC[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03162', 'CHEMBLID': 'CHEMBL3091164', 'description': 'Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method'}, {'\u5206\u5b50SMILES': 'C[C@@](C(=O)O[C@H]1C[N+]2(CCCc3ccccc3)CCC1CC2)(c1cccs1)N1CCCCC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03162', 'CHEMBLID': 'CHEMBL1924273', 'description': 'Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs'}, {'\u5206\u5b50SMILES': 'CC(C(=O)OC1CC[N+](C)(C)CC1)(c1ccccc1)C1CCCC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03162', 'CHEMBLID': 'CHEMBL3091164', 'description': 'Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method'}, {'\u5206\u5b50SMILES': 'Cc1cc(CCC[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03162', 'CHEMBLID': 'CHEMBL3091164', 'description': 'Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Epitomic profiling and functional characteristics of pemphigus vulgaris autoantibody binding to keratinocyte M3 muscarinic acetylcholine receptor.', 'abstract': 'Patients with pemphigus vulgaris (PV) develop IgG autoantibodies (AuAbs) binding to keratinocyte desmogleins (Dsg), acetylcholine (ACh) receptors, mitochondrial proteins, and some other self-antigens. In this study, we identified linear and discontinuous peptide tetrameric epitope segments (ES) of M3 muscarinic ACh receptor (M3AR) targeted by different anti-M3AR AuAbs. As positive controls, we identified Dsg1 and Dsg3 ES targeted by PV sera. Healthy individuals also possessed natural antibodies targeting M3AR, Dsg1 and Dsg3 epitopes that were different from those targeted by AuAbs produced by patients with PV. The two targeted M3AR pentameric ES encompass the 10 amino acids-long epitope LSEPTITFGT included the tetramer TFGT containing Thr235 which is a part of the ACh-binding pocket. Previously, it has been demonstrated that the anti-M3AR AuAb produces an agonist-like effect on downstream signaling, but its long-term effect is receptor desensitization. In this study, we compared the functional consequences of binding anti-M3AR AuAbs that target the ACh-binding pocket with that of AuAbs that target M3AR outside of its ACh-binding pocket. While the former AuAbs induced a very high elevation of phospholipase C, inositol triphosphate and diacylglycerol, which represents an agonist-like effect, the latter AuAbs produced a much weaker signaling response. These results indicate that patients with PV develop two types of anti-M3AR AuAbs. One type attaches to orthosteric, i.e., ACh-binding, site and elicits a strong signaling response comparable to that induced by a full pharmacologic agonist, whereas another type binds to an allosteric site and elicits submaximal signaling response comparable to that induced by a partial (allosteric) agonist.'}, {'title': 'Circulating Autoantibodies Against Vasoactive Biomarkers Related to Orthostatic Intolerance in Long COVID Patients Compared to No-Long-COVID Populations: A Case-Control Study.', 'abstract': 'Endothelial dysfunction mediated by elevated levels of autoantibodies against vasoactive peptides occurring after COVID-19 infection is proposed as a possible pathomechanism for orthostatic intolerance in long COVID patients. This case-control study comprised 100 long COVID patients from our prospective POSTCOV registry and three control groups, each consisting of 20 individuals (Asymptomatic post-COVID group; Healthy group = pan-negative for antispike protein of SARS-CoV-2; Vaccinated healthy group = no history of COVID-19 and vaccinated). Autoantibodies towards muscarinic acetylcholine receptor M3, endothelin type A receptor (ETAR), beta-2 adrenergic receptor (Beta-2 AR), angiotensin II receptor 1 and angiotensin 1-7 (Ang1-7) concentrations were measured by enzyme-linked immunosorbent assay in long COVID patients and controls. Orthostatic intolerance was defined as inappropriate sinus tachycardia, postural tachycardia, orthostatic hypotonia and other dysautonomia symptoms, such as dizziness or blurred vision ('}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL245"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P08173', 'features': [], 'extraAttributes': {'uniParcId': 'UPI00001252BB'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03981', 'CHEMBLID': 'CHEMBL1291432', 'description': 'Displacement of [3H]NMS from human muscarinic M4 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay'}, {'\u5206\u5b50SMILES': 'C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1585', 'CHEMBLID': 'CHEMBL1291432', 'description': 'Displacement of [3H]NMS from human muscarinic M4 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay'}, {'\u5206\u5b50SMILES': 'O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1995', 'CHEMBLID': 'CHEMBL1291432', 'description': 'Displacement of [3H]NMS from human muscarinic M4 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay'}, {'\u5206\u5b50SMILES': 'C[N+](C)(C)CCOC(N)=O.[Cl-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.4', 'CHEMBLID': 'CHEMBL749767', 'description': 'Compound was evaluated for its binding affinity at human muscarinic receptor m4 by the displacement of [3H]NMS radioligand using membranes from transfected chinese hamster ovarian cell'}, {'\u5206\u5b50SMILES': '[2H]C([2H])(C1CCOCC1)N1C[C@H]2C[C@H](Nc3ccc(-c4cc(F)ccc4Cl)nn3)C[C@H]2C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.4266', 'CHEMBLID': 'CHEMBL4839303', 'description': 'Antagonist activity at human muscarinic acetylcholine M4 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Weight Gain With Advancing Age Is Controlled by the Muscarinic Acetylcholine Receptor M4 in Male Mice.', 'abstract': 'Obesity is characterized by the excessive accumulation of adipose tissue, and it is a serious global health issue. Understanding the pathology of obesity is crucial for developing effective interventions. In this study, we investigated the role of muscarinic acetylcholine receptor M4 (mAChR-M4) in the regulation of obesity in Chrm4-knockout (M4-KO) mice. Male M4-KO mice showed higher weight gain and accumulation of white adipose tissue (WAT) with advancing age than the wild-type mice. The M4-KO mice also showed increased leptin expression at both the transcription and the translation levels. RNA sequencing and quantitative reverse transcription polymerase chain reaction analyses of subcutaneous adipose tissues revealed that the expression of WAT marker genes was significantly enhanced in the M4-KO mice. In contrast, the expression levels of brown adipose tissue/beige adipose tissue markers were strongly decreased in the M4-KO mice. To identify the Chrm4-expressing cell types, we generated Chrm4-mScarlet reporter mice and examined the localization of the mScarlet fluorescent signals in subcutaneous tissues. Fluorescent signals were prominently detected in WAT and mesenchymal stem cells. Additionally, we also found that choline acetyltransferase was expressed in macrophages, suggesting their involvement in acetylcholine (ACh) secretion. Corroborating this notion, we were able to quantitatively measure the ACh in subcutaneous tissues by liquid chromatography tandem mass spectrometry. Collectively, our findings suggest that endogenous ACh released from macrophages maintains the homeostasis of adipose cell growth and differentiation via mAChR-M4 in male mice. This study provides new insights into the molecular mechanisms underlying obesity and potential targets for therapeutic interventions.'}, {'title': 'Clemastine attenuates subarachnoid haemorrhage pathology in a mouse model via Nrf2/SQSTM1-mediated autophagy.', 'abstract': 'Subarachnoid haemorrhage (SAH) is an uncommon and severe subtype of stroke, but the availability of drugs for its treatment is limited. Enhanced autophagy is believed to attenuate SAH pathology; however, autophagy level is tentatively up-regulated and then down-regulated after SAH onset in mice. Clemastine, a first-generation histamine H1R antagonist, is believed to persistently enhance autophagy. However, the precise mechanism of clemastine in the treatment of SAH remains largely elusive.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1821"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q8TDX5', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 6, 'modifier': 'EXACT'}, 'end': {'value': 6, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19843166'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 8, 'modifier': 'EXACT'}, 'end': {'value': 8, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19843166'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 47, 'modifier': 'EXACT'}, 'end': {'value': 47, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '19843166'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 174, 'modifier': 'EXACT'}, 'end': {'value': 174, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19843166'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 291, 'modifier': 'EXACT'}, 'end': {'value': 291, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19843166'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}], 'extraAttributes': {'uniParcId': 'UPI000006FB91'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'N#Cc1c(-c2cccs2)nc(SCc2cccc(-c3nnn[nH]3)c2)[nH]c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.0', 'CHEMBLID': 'CHEMBL4028573', 'description': 'Inhibition of human ACMSD expressed in Pichia pastoris using ACMS as substrate by coupled spectrophotometric assay'}, {'\u5206\u5b50SMILES': 'N#Cc1c(-c2cccs2)nc(SCc2cccc(-c3nnn[nH]3)c2)[nH]c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5.0', 'CHEMBLID': 'CHEMBL4418029', 'description': 'Inhibition of human recombinant ACMSD1 expressed in Escherichia coli BL21 (DE3) cells assessed as reduction in conversion of 3-OH-anthranilic acid into ACMS by spectrophotometry'}, {'\u5206\u5b50SMILES': 'N#Cc1c(-c2cccs2)nc(SCc2cccc(CC(=O)O)c2)[nH]c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '10.0', 'CHEMBLID': 'CHEMBL4418029', 'description': 'Inhibition of human recombinant ACMSD1 expressed in Escherichia coli BL21 (DE3) cells assessed as reduction in conversion of 3-OH-anthranilic acid into ACMS by spectrophotometry'}, {'\u5206\u5b50SMILES': 'N#Cc1c(-c2cccs2)nc(SCc2cccc(C(=O)O)c2)[nH]c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '12.0', 'CHEMBLID': 'CHEMBL4418029', 'description': 'Inhibition of human recombinant ACMSD1 expressed in Escherichia coli BL21 (DE3) cells assessed as reduction in conversion of 3-OH-anthranilic acid into ACMS by spectrophotometry'}, {'\u5206\u5b50SMILES': 'N#Cc1c(-c2cccs2)nc(SCc2cccc(CC(=O)O)c2)[nH]c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '13.0', 'CHEMBLID': 'CHEMBL4028573', 'description': 'Inhibition of human ACMSD expressed in Pichia pastoris using ACMS as substrate by coupled spectrophotometric assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Dysregulated placental expression of kynurenine pathway enzymes is associated with inflammation and depression in pregnancy.', 'abstract': 'Perinatal depression (including antenatal-, postnatal-, and depression that spans both timepoints) is a prevalent disorder with high morbidity that affects both mother and child. Even though the full biological blueprints of perinatal depression remain incomplete, multiple studies indicate that, at least for antenatal depression, the disorder has an inflammatory component likely linked to a dysregulation of the enzymatic kynurenine pathway. The production of neuroactive metabolites in this pathway, including quinolinic acid (QUIN), is upregulated in the placenta due to the multiple immunological roles of the metabolites during pregnancy. Since neuroactive metabolites produced by the pathway also may affect mood by directly affecting glutamate neurotransmission, we sought to investigate whether the placental expression of kynurenine pathway enzymes controlling QUIN production was associated with both peripheral inflammation and depressive symptoms during pregnancy.'}, {'title': 'Effect of apigenin on tryptophan metabolic key enzymes expression in lipopolysaccharide-induced microglial cells and its mechanism.', 'abstract': '['}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4105941"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q04771', 'features': [{'type': 'Active site', 'location': {'start': {'value': 336, 'modifier': 'EXACT'}, 'end': {'value': 336, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}]}, {'type': 'Binding site', 'location': {'start': {'value': 214, 'modifier': 'EXACT'}, 'end': {'value': 222, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 235, 'modifier': 'EXACT'}, 'end': {'value': 235, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI000000163F'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COC(=O)N1C[C@@H](C)N(c2ncc3[nH]nc(-c4ccc(N5CCN[C@H](C)C5)nc4)c3n2)[C@@H](C)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.85', 'CHEMBLID': 'CHEMBL5125830', 'description': 'Inhibition of human recombinant N-terminal GST tagged ALK2 (147 to end residues) expressed in baculovirus infected in Sf9 cells assessed as loss of peptide phosphorylation activity using peptide substrate in presence of ATP and measured after 3 hrs by HTRF assay'}, {'\u5206\u5b50SMILES': 'COC(=O)N1C[C@@H](C)N(c2ncc3[nH]nc(-c4ccc(N5CCN(C)CC5)cc4)c3n2)[C@@H](C)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.98', 'CHEMBLID': 'CHEMBL5125830', 'description': 'Inhibition of human recombinant N-terminal GST tagged ALK2 (147 to end residues) expressed in baculovirus infected in Sf9 cells assessed as loss of peptide phosphorylation activity using peptide substrate in presence of ATP and measured after 3 hrs by HTRF assay'}, {'\u5206\u5b50SMILES': 'CN1CCN(c2ccc(-c3ccn4c(-c5csc6nccnc56)cnc4c3)cc2)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.0', 'CHEMBLID': 'CHEMBL4727748', 'description': 'Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay'}, {'\u5206\u5b50SMILES': 'COc1cc(-c2cc(-c3cccc(O)c3)cnc2N)cc(OC)c1OC', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.1', 'CHEMBLID': 'CHEMBL5133119', 'description': 'Inhibition of GST-tagged human recombinant ALK2 (145 to 509 residues) expressed in baculovirus expression system using casein as substrate in presence of [gamma-32P]ATP incubated for 45 mins by Microscint-20 scintillation counting analysis'}, {'\u5206\u5b50SMILES': 'C[C@@H]1CN(c2ccc(-c3n[nH]c4cnc(N5[C@H](C)CN(C(=O)N6CCCC6)C[C@@H]5C)nc34)cn2)CCN1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.2', 'CHEMBLID': 'CHEMBL5125830', 'description': 'Inhibition of human recombinant N-terminal GST tagged ALK2 (147 to end residues) expressed in baculovirus infected in Sf9 cells assessed as loss of peptide phosphorylation activity using peptide substrate in presence of ATP and measured after 3 hrs by HTRF assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Advancements in mechanisms and drug treatments for fibrodysplasia ossificans progressiva.', 'abstract': 'Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by congenital bilateral malformation of the large toe and progressive, extensive, and irreversible heterotopic ossification (HO) of soft tissues throughout the body, leading to severe disabilities. FOP is caused primarily by mutations in activin A receptor type 1 ('}, {'title': 'ACVR1 mediates renal tubular EMT in kidney fibrosis via AKT activation.', 'abstract': 'Tubulointerstitial fibrosis in the kidneys is a chronic and progressive process. Although studies suggested that tubular epithelial-mesenchymal transition (EMT) plays a key role in the development of kidney fibrosis, whether ACVR1, a member of the TGF\u03b2 superfamily, is involved in the EMT needs to be illustrated. Using bioinformatics analysis of bulk-seq data (GSE23338 and GSE168876), we found that TGF-\u03b21 perhaps activated the PI3K/AKT signaling pathway and induced the mRNA expression of ACVR1, fibronectin, and Collagen I in HK-2 cells (human renal tubular epithelial cell line). Furthermore, qPCR and western blotting results confirmed the high expressions of ACVR1 and EMT markers in TGF\u03b2-induced HK-2 cells. Similar results were also found in the UUO mouse model. Besides, different time-point immunofluorescent staining indicated a positive correlation between the expression of the ACVR1 and EMT marker vimentin in TGF-\u03b21-induced HK-2 cells. Consequently, knockdown ACVR1 effectively inhibited the expression of TGF-\u03b21-induced EMT markers and AKT phosphorylation in HK-2 cells. Moreover, treatment of HK-2 cells with MK2206 (an allosteric inhibitor of AKT) decreased the activation of AKT and the expression of \u03b1-SMA while treatment of cells with SC79 (a AKT activator) enhanced the expression of \u03b1-SMA. These findings suggest that ACVR1 regulated the EMT of renal tubular epithelial cells through activation of the AKT signaling pathway and that ACVR1 could be considered novel therapeutic targets for renal fibrosis.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5903"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P78536', 'features': [{'type': 'Active site', 'location': {'start': {'value': 406, 'modifier': 'EXACT'}, 'end': {'value': 406, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00276'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10095'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9520379'}]}, {'type': 'Binding site', 'location': {'start': {'value': 184, 'modifier': 'EXACT'}, 'end': {'value': 184, 'modifier': 'EXACT'}}, 'description': 'in inhibited form', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 405, 'modifier': 'EXACT'}, 'end': {'value': 405, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9520379'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 409, 'modifier': 'EXACT'}, 'end': {'value': 409, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9520379'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 415, 'modifier': 'EXACT'}, 'end': {'value': 415, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9520379'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}], 'extraAttributes': {'uniParcId': 'UPI00001254D4'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cc1cc(COc2ccc(C(=O)NC3(C)C(=O)NC(=O)NC3=O)cc2)c2ccccc2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.026', 'CHEMBLID': 'CHEMBL1003624', 'description': 'Inhibition of TACE'}, {'\u5206\u5b50SMILES': 'Cc1cc(COc2ccc(S(=O)(=O)N[C@H]3[C@@H](C(=O)NO)[C@@H]4C=C[C@H]3C4)cc2)c2ccccc2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL4024901', 'description': 'Inhibition of recombinant TACE catalytic domain (unknown origin) using pro-TNFalpha peptide Abz-LAQAVRSSSR-Dpa as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1cc(COc2ccc([C@]3(N)CCN([C@@H](C(=O)NO)C(C)C)C3=O)cc2)c2ccccc2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL1640792', 'description': 'Inhibition of human TACE by fluorescent spectroscopy'}, {'\u5206\u5b50SMILES': 'C#CCN1C[C@H](C(=O)NO)[C@H](NC(=O)c2ccc(OCc3cc(C)nc4ccccc34)cc2)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.14', 'CHEMBLID': 'CHEMBL1003624', 'description': 'Inhibition of TACE'}, {'\u5206\u5b50SMILES': 'C=CC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NC', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL820592', 'description': 'Inhibitory activity against Tumor necrosis factor alpha-converting enzyme (TACE) in blood.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Fever-range temperature alters continual efferocytosis mediated by mouse pro-inflammatory macrophages.', 'abstract': 'Fever, a cardinal sign of inflammation, has been shown to modulate macrophage functions. Here, we investigate whether fever affects macrophage efferocytosis. This process is essential for the resolution of inflammation and the return to homeostasis with the reprogramming of macrophages towards a pro-resolving phenotype. Using primary mouse bone marrow-derived macrophages stimulated with lipopolysaccharide and interferon-\u03b3 (i.e., pro-inflammatory macrophages), we first validated that exposure to febrile temperature (39.5\u00b0C) induced a heat shock protein response. Then, we observed that febrile temperature decreased the capacity of pro-inflammatory macrophages to uptake apoptotic cells. This reduced efferocytic capacity of macrophages exposed to febrile temperature resulted from a decreased capacity to interact with apoptotic cells and to internalize these dying cells. Exposure to febrile temperature reduced the cell motility of macrophages in response to apoptotic cells, as assessed by IncuCyte\u00ae live-cell imaging. RNA sequencing analysis of pro-inflammatory macrophages exposed to febrile temperature identified an upregulation of the Adam17 gene. As this gene encodes a protease that sheds the efferocytic receptor Mer, we determined cell surface expression of Mer and quantified soluble Mer in the culture supernatants of pro-inflammatory macrophages exposed to febrile temperature. While febrile hyperthermia induced the Mer cleavage from the cell surface of pro-inflammatory macrophages, ADAM17 inhibition during exposure to febrile temperature did not restore the efferocytic capacity of pro-inflammatory macrophages. Thus, reduction of Mer expression induced by hyperthermia did not represent the main mechanism explaining reduced efferocytosis. Nevertheless, our work suggests that fever, by decreasing efferocytic capacity of macrophages, maintains their pro-inflammatory state.'}, {'title': 'Mechanistic Insights into HOTAIR-Driven ADAM17/NF-\u039ab Activation and Endothelial Dysfunction in LPS-Challenged HUVECs.', 'abstract': 'HOX transcript antisense intergenic RNA (HOTAIR) has been implicated in inflammation and vascular pathology, but its role in regulation of ADAM17 and sepsis-induced endothelial injury remains unclear.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3706"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q9BZ11', 'features': [{'type': 'Active site', 'location': {'start': {'value': 346, 'modifier': 'EXACT'}, 'end': {'value': 346, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00276'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10095'}]}, {'type': 'Binding site', 'location': {'start': {'value': 133, 'modifier': 'EXACT'}, 'end': {'value': 133, 'modifier': 'EXACT'}}, 'description': 'in inhibited form', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 345, 'modifier': 'EXACT'}, 'end': {'value': 345, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14659745'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 349, 'modifier': 'EXACT'}, 'end': {'value': 349, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14659745'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 355, 'modifier': 'EXACT'}, 'end': {'value': 355, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14659745'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}], 'extraAttributes': {'uniParcId': 'UPI0000048F2A'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cc1cc(COc2ccc(S(=O)(=O)NC[C@@H](C(=O)NO)N3CCOCC3)cc2)c2ccccc2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '24.0', 'CHEMBLID': 'CHEMBL3706288', 'description': 'Enzymatic Assay: The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentration range of from 10 uM to 0.5 nM final concentration. The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19,155-161) and is added so as to have a signal equivalent to 6 times the background noise in 2 h at 37C. The reaction is carried out in 50 mM Tris buffered medium containing 4% glycerol, pH 7.4. The fluorescent substrate is MCA-Pro-Leu-Ala-Val-(Dpa)-Arg-Ser-Ser-Arg-NH2 (R&D systems, reference: ES003). The substrate is cleaved by the enzyme between the alanine and the valine, thus releasing a fluorescent peptide (excitation: 320 nm, emission: 420 nm). The substrate is used at 40 uM. The reaction is carried out in a final volume of 10 ul (4 ul inhibitor, 4 ul substrate, 2 ul enzyme) in a low volume 384-well plate (Corning reference: 3676).'}, {'\u5206\u5b50SMILES': 'Cc1cc(COc2ccc(S(=O)(=O)NC[C@@H](C(=O)NO)N3CCCCC3)cc2)c2ccccc2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '26.0', 'CHEMBLID': 'CHEMBL3706288', 'description': 'Enzymatic Assay: The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentration range of from 10 uM to 0.5 nM final concentration. The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19,155-161) and is added so as to have a signal equivalent to 6 times the background noise in 2 h at 37C. The reaction is carried out in 50 mM Tris buffered medium containing 4% glycerol, pH 7.4. The fluorescent substrate is MCA-Pro-Leu-Ala-Val-(Dpa)-Arg-Ser-Ser-Arg-NH2 (R&D systems, reference: ES003). The substrate is cleaved by the enzyme between the alanine and the valine, thus releasing a fluorescent peptide (excitation: 320 nm, emission: 420 nm). The substrate is used at 40 uM. The reaction is carried out in a final volume of 10 ul (4 ul inhibitor, 4 ul substrate, 2 ul enzyme) in a low volume 384-well plate (Corning reference: 3676).'}, {'\u5206\u5b50SMILES': 'Cc1cc(COc2ccc(S(=O)(=O)NC[C@@H](C(=O)NO)N3CCOCC3)cc2)c2ccccc2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '38.0', 'CHEMBLID': 'CHEMBL3706288', 'description': 'Enzymatic Assay: The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentration range of from 10 uM to 0.5 nM final concentration. The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19,155-161) and is added so as to have a signal equivalent to 6 times the background noise in 2 h at 37C. The reaction is carried out in 50 mM Tris buffered medium containing 4% glycerol, pH 7.4. The fluorescent substrate is MCA-Pro-Leu-Ala-Val-(Dpa)-Arg-Ser-Ser-Arg-NH2 (R&D systems, reference: ES003). The substrate is cleaved by the enzyme between the alanine and the valine, thus releasing a fluorescent peptide (excitation: 320 nm, emission: 420 nm). The substrate is used at 40 uM. The reaction is carried out in a final volume of 10 ul (4 ul inhibitor, 4 ul substrate, 2 ul enzyme) in a low volume 384-well plate (Corning reference: 3676).'}, {'\u5206\u5b50SMILES': 'Cc1cc(COc2ccc(S(=O)(=O)NC[C@@H](C(=O)NO)N3CCCCC3)cc2)c2ccccc2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '112.0', 'CHEMBLID': 'CHEMBL3706288', 'description': 'Enzymatic Assay: The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentration range of from 10 uM to 0.5 nM final concentration. The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19,155-161) and is added so as to have a signal equivalent to 6 times the background noise in 2 h at 37C. The reaction is carried out in 50 mM Tris buffered medium containing 4% glycerol, pH 7.4. The fluorescent substrate is MCA-Pro-Leu-Ala-Val-(Dpa)-Arg-Ser-Ser-Arg-NH2 (R&D systems, reference: ES003). The substrate is cleaved by the enzyme between the alanine and the valine, thus releasing a fluorescent peptide (excitation: 320 nm, emission: 420 nm). The substrate is used at 40 uM. The reaction is carried out in a final volume of 10 ul (4 ul inhibitor, 4 ul substrate, 2 ul enzyme) in a low volume 384-well plate (Corning reference: 3676).'}, {'\u5206\u5b50SMILES': 'O=C(NO)[C@H](CNS(=O)(=O)c1ccc(OCc2ccccc2)cc1)N1CCOCC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '147.0', 'CHEMBLID': 'CHEMBL3706288', 'description': 'Enzymatic Assay: The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentration range of from 10 uM to 0.5 nM final concentration. The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19,155-161) and is added so as to have a signal equivalent to 6 times the background noise in 2 h at 37C. The reaction is carried out in 50 mM Tris buffered medium containing 4% glycerol, pH 7.4. The fluorescent substrate is MCA-Pro-Leu-Ala-Val-(Dpa)-Arg-Ser-Ser-Arg-NH2 (R&D systems, reference: ES003). The substrate is cleaved by the enzyme between the alanine and the valine, thus releasing a fluorescent peptide (excitation: 320 nm, emission: 420 nm). The substrate is used at 40 uM. The reaction is carried out in a final volume of 10 ul (4 ul inhibitor, 4 ul substrate, 2 ul enzyme) in a low volume 384-well plate (Corning reference: 3676).'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'CTLA-4 rs5742909 but not ADAM33 rs2280091 is a predictor factor for COVID-19 mortality.', 'abstract': 'Research has demonstrated the association between susceptibility to coronavirus disease 2019 (COVID-19) and single nucleotide polymorphisms (SNPs). On the other hand, the cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) serves as a pivotal inhibitory receptor with a substantial impact on the advancement of viral infections. Besides, the disintegrin and metalloproteinase33 (ADAM33) gene is associated with both asthma and heightened airway responsiveness. Hence, this investigation sought to elucidate the potential association between the CTLA-4 rs5742909 and ADAM33 rs2280091 SNPs and the fatality rate of COVID-19 across various variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).'}, {'title': 'Allele-specific micro-RNA-mediated regulation of ADAM33 in childhood allergic asthma.', 'abstract': 'A disintegrin and metalloprotease 33 (ADAM33) is associated with asthma susceptibility, and its genetic variations impact susceptibility and disease severity. However, the mechanisms remain unclear. This study aimed to investigate ADAM33 single nucleotide polymorphisms (SNPs) in childhood asthma susceptibility and explore their regulatory mechanisms.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL6121"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P00813', 'features': [{'type': 'Active site', 'location': {'start': {'value': 217, 'modifier': 'EXACT'}, 'end': {'value': 217, 'modifier': 'EXACT'}}, 'description': 'Proton donor', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P03958'}]}, {'type': 'Binding site', 'location': {'start': {'value': 15, 'modifier': 'EXACT'}, 'end': {'value': 15, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'Reference', 'id': 'Ref.25'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 17, 'modifier': 'EXACT'}, 'end': {'value': 17, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.25'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IAR'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 17, 'modifier': 'EXACT'}, 'end': {'value': 17, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'Reference', 'id': 'Ref.25'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 19, 'modifier': 'EXACT'}, 'end': {'value': 19, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.25'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IAR'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 184, 'modifier': 'EXACT'}, 'end': {'value': 184, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.25'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IAR'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 214, 'modifier': 'EXACT'}, 'end': {'value': 214, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'Reference', 'id': 'Ref.25'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 295, 'modifier': 'EXACT'}, 'end': {'value': 295, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'Reference', 'id': 'Ref.25'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 296, 'modifier': 'EXACT'}, 'end': {'value': 296, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.25'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IAR'}], 'ligand': {'name': 'substrate'}}, {'type': 'Site', 'location': {'start': {'value': 58, 'modifier': 'EXACT'}, 'end': {'value': 58, 'modifier': 'EXACT'}}, 'description': 'Important for interaction with adenosine receptors and increasing their affinity for agonists', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23193172'}]}, {'type': 'Site', 'location': {'start': {'value': 62, 'modifier': 'EXACT'}, 'end': {'value': 62, 'modifier': 'EXACT'}}, 'description': 'Important for interaction with adenosine receptors and increasing their affinity for agonists', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23193172'}]}, {'type': 'Site', 'location': {'start': {'value': 238, 'modifier': 'EXACT'}, 'end': {'value': 238, 'modifier': 'EXACT'}}, 'description': 'Important for catalytic activity', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P03958'}]}], 'extraAttributes': {'uniParcId': 'UPI000000D982'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cn1cc(CC[C@H](CO)n2cnc(C(N)=O)c2)c2cc(OCCCc3ccc(Cl)cc3)ccc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.7', 'CHEMBLID': 'CHEMBL828409', 'description': 'Inhibitory concentration against adenosine deaminase'}, {'\u5206\u5b50SMILES': 'C[C@H](O)[C@@H](CCc1cccc2nc(-c3ccc(Cl)cc3)oc12)n1cnc(C(N)=O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '8.6', 'CHEMBLID': 'CHEMBL828409', 'description': 'Inhibitory concentration against adenosine deaminase'}, {'\u5206\u5b50SMILES': 'C[C@H](O)[C@@H](CCc1cccc2oc(-c3ccc(Cl)cc3)nc12)n1cnc(C(N)=O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '8.7', 'CHEMBLID': 'CHEMBL828409', 'description': 'Inhibitory concentration against adenosine deaminase'}, {'\u5206\u5b50SMILES': 'C[C@H](O)[C@@H](CCc1cccc(Cl)c1Cl)n1cnc(C(N)=O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '15.0', 'CHEMBLID': 'CHEMBL828409', 'description': 'Inhibitory concentration against adenosine deaminase'}, {'\u5206\u5b50SMILES': 'C[C@H](O)[C@@H](CCc1cccc2ccccc12)n1cnc(C(N)=O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '16.0', 'CHEMBLID': 'CHEMBL828409', 'description': 'Inhibitory concentration against adenosine deaminase'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'The Great Mimicker: Pancreatic Tuberculosis Masquerading as a Pancreatic Neoplasm.', 'abstract': 'Pancreatic tuberculosis is a rare manifestation\\u2002of extrapulmonary tuberculosis, often mimicking pancreatic cancer clinically and radiologically. We report a 26-year-old immunocompetent farmer from a tuberculosis-endemic area presenting with a two-month history of fever, night sweats, and significant weight loss. Although malignancy was suspected, contrast-enhanced computed tomography of the abdomen showed\\u2002a complex lesion in the pancreatic body with central necrosis and an enlarged lymph node. Fluorodeoxyglucose positron emission tomography\\u2002also revealed increased metabolic activity in the lesion. However, endoscopic ultrasound-guided fine-needle aspiration produced caseous necrotic material, and cytology revealed necrotizing granulomas with multinucleated giant cells. Molecular testing identified '}, {'title': 'Compromised adenosine-A2AR axis contributes to recurrent spontaneous abortion by promoting proinflammatory macrophage polarization.', 'abstract': 'This study investigates the association between recurrent spontaneous abortion (RSA) and macrophage polarization, exploring adenosine (Ado) as a potential biomarker and therapeutic target. By analyzing decidual tissues from RSA patients and normal pregnancies, we found reduced CD39 expression and lower adenosine levels in RSA, accompanied by increased M1 macrophage polarization and decreased M2 macrophage expression. In vitro experiments demonstrated that adenosine inhibited M1 polarization while promoting M2 polarization, an effect reversed by adenosine deaminase (ADA). Single-cell RNA sequencing revealed decreased adenosine receptor A2aR expression in M1 macrophages of RSA patients, while glycolysis-related enzyme hexokinase 2 (HK2) was overexpressed. These findings suggest that adenosine plays a key role in macrophage polarization and immune homeostasis at the maternal-fetal interface, with glycolysis potentially contributing to this process, highlighting its potential as a target for RSA diagnosis and treatment.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1910"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P55263', 'features': [{'type': 'Active site', 'location': {'start': {'value': 317, 'modifier': 'EXACT'}, 'end': {'value': 317, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9843365'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1BX4'}]}, {'type': 'Binding site', 'location': {'start': {'value': 35, 'modifier': 'EXACT'}, 'end': {'value': 35, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16335'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9843365'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1BX4'}], 'ligand': {'name': 'adenosine', 'id': 'ChEBI:CHEBI:16335'}}, {'type': 'Binding site', 'location': {'start': {'value': 49, 'modifier': 'EXACT'}, 'end': {'value': 49, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:18420'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9843365'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1BX4'}], 'ligand': {'name': 'Mg(2+)', 'id': 'ChEBI:CHEBI:18420', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 147, 'modifier': 'EXACT'}, 'end': {'value': 147, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:18420'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9843365'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1BX4'}], 'ligand': {'name': 'Mg(2+)', 'id': 'ChEBI:CHEBI:18420', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 148, 'modifier': 'EXACT'}, 'end': {'value': 148, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:18420'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9843365'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1BX4'}], 'ligand': {'name': 'Mg(2+)', 'id': 'ChEBI:CHEBI:18420', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 306, 'modifier': 'EXACT'}, 'end': {'value': 306, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16335'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9843365'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1BX4'}], 'ligand': {'name': 'adenosine', 'id': 'ChEBI:CHEBI:16335'}}], 'extraAttributes': {'uniParcId': 'UPI00001255EA'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Nc1ncnc2c1c(I)nn2[C@@H]1C[C@H](N)[C@@H](O)[C@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.06', 'CHEMBLID': 'CHEMBL4428688', 'description': 'Inhibition of human adenosine kinase assessed as reduction in conversion of adenosine to AMP'}, {'\u5206\u5b50SMILES': 'NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL643547', 'description': 'Inhibition of human adenosine kinase activity'}, {'\u5206\u5b50SMILES': 'NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL642225', 'description': 'Inhibition of recombinant human adenosine kinase'}, {'\u5206\u5b50SMILES': 'C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)Nc4ccc(Cl)cc4)ncnc32)[C@H](O)[C@@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL864546', 'description': 'Inhibitory activity against recombinant human adenosine kinase'}, {'\u5206\u5b50SMILES': 'NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL642225', 'description': 'Inhibition of recombinant human adenosine kinase'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Tetrandrine mediates autophagy via sirtuin 3/adenosine 5-monophosphate-activated protein kinase/mammalian target of rapamycin signal pathway to attenuate early brain injury after subarachnoid hemorrhage.', 'abstract': \"Early brain injury (EBI) is the main cause of poor outcomes in patients with subarachnoid hemorrhage (SAH). Tetrandrine (Tet) is the root of Stephania tetrandra S Moore extract that has been shown to promote neuronal survival and regulate a variety of signaling pathways; however, the mechanism through which it exerts neuroprotective effects in patients with SAH is unknown. This investigation was to examine Tet's effect on EBI in SAH rats. We divided the rats into four groups. The effects of Tet treatment on the pathological changes of neurons in rat brains were evaluated, as well as autophagy-related and signaling pathway proteins. We found that Tet had a neuroprotective effect on EBI after SAH, as evidenced by the fact that Tet ameliorated SAH-mediated neurologic impairment and neuronal morphological damage and reduced brain water content, neuronal apoptosis rate, and neuronal cell loss. Tet decreased the LC3II/LC3I ratio, elevated P62 protein expression, and inhibited autophagosome production after SAH. Tet may have increased sirtuin 3 (SIRT3) expression, decreased adenosine 5-monophosphate-activated protein kinase (AMPK) phosphorylation, and increased phosphor-mammalian target of rapamycin (mTOR) levels, all of which may have occurred particularly via SIRT3/AMPK/mTOR signaling pathway activation; However, this trend can be reversed by 3-(1H-1,2,3-triazol-4-yl) pyridine (SIRT3 inhibitors). Tet exerts neuroprotective effects by inhibiting autophagy, this may be associated with SIRT3's inhibitory effect on the AMPK/mTOR signaling pathway. This inhibition could function as a potential mechanism for the neuroprotective effects observed in patients suffering from SAH.\"}, {'title': 'Epilepsy and autophagy modulators: a therapeutic split.', 'abstract': 'Epilepsy is a neurological disease characterized by repeated unprovoked seizure. Epilepsy is controlled by anti-epileptic drugs (AEDs); however, one third of epileptic patients have symptoms that are not controlled by AEDs in a condition called refractory epilepsy. Dysregulation of macroautophagy/autophagy is involved in the pathogenesis of epilepsy. Autophagy prevents the development and progression of epilepsy through regulating the balance between inhibitory and excitatory neurotransmitters. Induction of autophagy and autophagy-related proteins could be a novel therapeutic strategy in the management of epilepsy. Despite the protective role of autophagy against epileptogenesis and epilepsy, its role in status epilepticus is perplexing and might reflect its nature as a double-edged sword. Autophagy inducers play a critical role in reducing seizure frequency and severity, and could be an adjuvant treatment in the management of epilepsy. However, autophagy inhibitors also have an anticonvulsant effect. Therefore, the aim of the present mini-review is to discuss the potential role of autophagy in the pathogenesis of epileptogenesis and epilepsy, and how autophagy modulators affect epileptogenesis and epilepsy.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3589"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P07550', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 113, 'modifier': 'EXACT'}, 'end': {'value': 113, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188146'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17952055'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17962520'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RH1'}], 'ligand': {'name': '(S)-carazolol', 'id': 'ChEBI:CHEBI:188146', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 113, 'modifier': 'EXACT'}, 'end': {'value': 113, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 118, 'modifier': 'EXACT'}, 'end': {'value': 118, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 203, 'modifier': 'EXACT'}, 'end': {'value': 203, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188146'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17952055'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17962520'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RH1'}], 'ligand': {'name': '(S)-carazolol', 'id': 'ChEBI:CHEBI:188146', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 293, 'modifier': 'EXACT'}, 'end': {'value': 293, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 312, 'modifier': 'EXACT'}, 'end': {'value': 312, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188146'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17952055'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17962520'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RH1'}], 'ligand': {'name': '(S)-carazolol', 'id': 'ChEBI:CHEBI:188146', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 312, 'modifier': 'EXACT'}, 'end': {'value': 312, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 316, 'modifier': 'EXACT'}, 'end': {'value': 316, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}], 'extraAttributes': {'uniParcId': 'UPI000013EAD0'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0013', 'CHEMBLID': 'CHEMBL1052906', 'description': 'Inhibition of beta2 adrenergic receptor'}, {'\u5206\u5b50SMILES': 'CC(C)NC[C@H](O)c1ccc(O)c(O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.05', 'CHEMBLID': 'CHEMBL3887982', 'description': 'Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37\u00b0 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37\u00b0 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.'}, {'\u5206\u5b50SMILES': 'C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.14', 'CHEMBLID': 'CHEMBL3887982', 'description': 'Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37\u00b0 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37\u00b0 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.'}, {'\u5206\u5b50SMILES': 'COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.17', 'CHEMBLID': 'CHEMBL3887982', 'description': 'Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37\u00b0 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37\u00b0 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.'}, {'\u5206\u5b50SMILES': 'CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1995', 'CHEMBLID': 'CHEMBL1947791', 'description': 'Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Norepinephrine mediates adrenergic receptor transcription and oncogenic gene expression in pancreatic ductal adenocarcinoma.', 'abstract': 'Adrenergic stimulation of \u03b2'}, {'title': 'Sini Powder Alleviates Stress Response and Suppresses Hepatocellular Carcinoma Development by Restoring Gut Microbiota.', 'abstract': 'To explore the underlying pharmacological mechanisms and its potential effects of Chinese medicine herbal formula Sini Powder (SNP) on hepatocellular carcinoma (HCC).'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL210"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P07550', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 113, 'modifier': 'EXACT'}, 'end': {'value': 113, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188146'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17952055'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17962520'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RH1'}], 'ligand': {'name': '(S)-carazolol', 'id': 'ChEBI:CHEBI:188146', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 113, 'modifier': 'EXACT'}, 'end': {'value': 113, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 118, 'modifier': 'EXACT'}, 'end': {'value': 118, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 203, 'modifier': 'EXACT'}, 'end': {'value': 203, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188146'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17952055'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17962520'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RH1'}], 'ligand': {'name': '(S)-carazolol', 'id': 'ChEBI:CHEBI:188146', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 293, 'modifier': 'EXACT'}, 'end': {'value': 293, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 312, 'modifier': 'EXACT'}, 'end': {'value': 312, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188146'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17952055'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17962520'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RH1'}], 'ligand': {'name': '(S)-carazolol', 'id': 'ChEBI:CHEBI:188146', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 312, 'modifier': 'EXACT'}, 'end': {'value': 312, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 316, 'modifier': 'EXACT'}, 'end': {'value': 316, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}], 'extraAttributes': {'uniParcId': 'UPI000013EAD0'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0013', 'CHEMBLID': 'CHEMBL1052906', 'description': 'Inhibition of beta2 adrenergic receptor'}, {'\u5206\u5b50SMILES': 'CC(C)NC[C@H](O)c1ccc(O)c(O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.05', 'CHEMBLID': 'CHEMBL3887982', 'description': 'Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37\u00b0 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37\u00b0 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.'}, {'\u5206\u5b50SMILES': 'C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.14', 'CHEMBLID': 'CHEMBL3887982', 'description': 'Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37\u00b0 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37\u00b0 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.'}, {'\u5206\u5b50SMILES': 'COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.17', 'CHEMBLID': 'CHEMBL3887982', 'description': 'Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37\u00b0 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37\u00b0 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.'}, {'\u5206\u5b50SMILES': 'CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1995', 'CHEMBLID': 'CHEMBL1947791', 'description': 'Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Norepinephrine mediates adrenergic receptor transcription and oncogenic gene expression in pancreatic ductal adenocarcinoma.', 'abstract': 'Adrenergic stimulation of \u03b2'}, {'title': 'Sini Powder Alleviates Stress Response and Suppresses Hepatocellular Carcinoma Development by Restoring Gut Microbiota.', 'abstract': 'To explore the underlying pharmacological mechanisms and its potential effects of Chinese medicine herbal formula Sini Powder (SNP) on hepatocellular carcinoma (HCC).'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL210"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P07550', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 113, 'modifier': 'EXACT'}, 'end': {'value': 113, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188146'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17952055'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17962520'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RH1'}], 'ligand': {'name': '(S)-carazolol', 'id': 'ChEBI:CHEBI:188146', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 113, 'modifier': 'EXACT'}, 'end': {'value': 113, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 118, 'modifier': 'EXACT'}, 'end': {'value': 118, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 203, 'modifier': 'EXACT'}, 'end': {'value': 203, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188146'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17952055'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17962520'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RH1'}], 'ligand': {'name': '(S)-carazolol', 'id': 'ChEBI:CHEBI:188146', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 293, 'modifier': 'EXACT'}, 'end': {'value': 293, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 312, 'modifier': 'EXACT'}, 'end': {'value': 312, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188146'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17952055'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17962520'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RH1'}], 'ligand': {'name': '(S)-carazolol', 'id': 'ChEBI:CHEBI:188146', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 312, 'modifier': 'EXACT'}, 'end': {'value': 312, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}, {'type': 'Binding site', 'location': {'start': {'value': 316, 'modifier': 'EXACT'}, 'end': {'value': 316, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:188157'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18547522'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3D4S'}], 'ligand': {'name': '(S)-timolol', 'id': 'ChEBI:CHEBI:188157', 'note': 'inverse agonist'}}], 'extraAttributes': {'uniParcId': 'UPI000013EAD0'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0013', 'CHEMBLID': 'CHEMBL1052906', 'description': 'Inhibition of beta2 adrenergic receptor'}, {'\u5206\u5b50SMILES': 'CC(C)NC[C@H](O)c1ccc(O)c(O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.05', 'CHEMBLID': 'CHEMBL3887982', 'description': 'Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37\u00b0 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37\u00b0 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.'}, {'\u5206\u5b50SMILES': 'C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.14', 'CHEMBLID': 'CHEMBL3887982', 'description': 'Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37\u00b0 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37\u00b0 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.'}, {'\u5206\u5b50SMILES': 'COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.17', 'CHEMBLID': 'CHEMBL3887982', 'description': 'Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37\u00b0 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37\u00b0 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.'}, {'\u5206\u5b50SMILES': 'CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1995', 'CHEMBLID': 'CHEMBL1947791', 'description': 'Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Norepinephrine mediates adrenergic receptor transcription and oncogenic gene expression in pancreatic ductal adenocarcinoma.', 'abstract': 'Adrenergic stimulation of \u03b2'}, {'title': 'Sini Powder Alleviates Stress Response and Suppresses Hepatocellular Carcinoma Development by Restoring Gut Microbiota.', 'abstract': 'To explore the underlying pharmacological mechanisms and its potential effects of Chinese medicine herbal formula Sini Powder (SNP) on hepatocellular carcinoma (HCC).'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL210"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P06280', 'features': [{'type': 'Active site', 'location': {'start': {'value': 170, 'modifier': 'EXACT'}, 'end': {'value': 170, 'modifier': 'EXACT'}}, 'description': 'Nucleophile', 'evidences': [{'evidenceCode': 'ECO:0000250'}]}, {'type': 'Active site', 'location': {'start': {'value': 231, 'modifier': 'EXACT'}, 'end': {'value': 231, 'modifier': 'EXACT'}}, 'description': 'Proton donor', 'evidences': [{'evidenceCode': 'ECO:0000250'}]}, {'type': 'Binding site', 'location': {'start': {'value': 203, 'modifier': 'EXACT'}, 'end': {'value': 207, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}], 'extraAttributes': {'uniParcId': 'UPI0000033A30'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '13.0', 'CHEMBLID': 'CHEMBL4002666', 'description': 'Inhibition of recombinant human alpha GAL-A using 4-methylumbelliferyl alpha-D-galactopyranoside as substrate at pH 7 after 15 mins by fluorescence assay'}, {'\u5206\u5b50SMILES': 'OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '42.0', 'CHEMBLID': 'CHEMBL4002665', 'description': 'Inhibition of recombinant human alpha GAL-A using 4-methylumbelliferyl alpha-D-galactopyranoside as substrate at pH 4.6 after 15 mins by fluorescence assay'}, {'\u5206\u5b50SMILES': 'NC[C@H]1N[C@H](CO)[C@H](O)[C@@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '53.0', 'CHEMBLID': 'CHEMBL3870370', 'description': 'Inhibition of human recombinant lysosomal alpha GAL-A using 4-methylberiilyl alpha-D-galactopyranoside as substrate at pH 7 after 15 mins by fluorescence assay'}, {'\u5206\u5b50SMILES': 'OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '70.0', 'CHEMBLID': 'CHEMBL1168041', 'description': 'Inhibition of human lysosome alpha-galactosidase assessed as p-nitrophenol release by spectrometric analysis'}, {'\u5206\u5b50SMILES': 'OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '70.0', 'CHEMBLID': 'CHEMBL831670', 'description': 'Inhibitory concentration against human alpha-galactosidase'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Potential Pathogenetic Role of the D313Y Mutation in the ', 'abstract': 'Anderson Fabry disease (AFD) is an X-linked hereditary lysosomal abnormality that causes the accumulation of glycosphingolipids in body fluids and tissues, leading to progressive organ damage and a shortened life span. More than 1000 mutations in the '}, {'title': 'Correlation of enzyme activities and genotype with clinical manifestations in Chinese patients of different sexes with classical and late-onset Fabry disease.', 'abstract': 'Fabry disease, a rare genetic disorder affecting multiple organs, has understudied correlations among enzyme activity, genotype, and clinical manifestations in patients of different sexes with classical and late-onset phenotypes. In this study, clinical data, \u03b1-Gal A activity, and GLA gene test results of 311 patients, who were categorized by classical and late-onset phenotypes, \u2a7d5% and > 5% of the normal mean value of enzyme activity, and truncated and nontruncated mutation groups, were collected. The common clinical manifestations of Fabry disease included acroparesthesia, hypohidrosis/anhidrosis, neuropsychiatric system, and renal and cardiovascular involvement. Multiorgan involvement was higher in males and classical phenotype patients. In both sexes, classical patients commonly presented with acroparesthesia and multiorgan involvement, whereas late-onset patients showed renal, neuropsychiatric, and cardiovascular involvement. Male and classical patients had lower enzyme activity than female and late-onset patients, respectively. Classical males with enzyme activity of \u2a7d5% of the normal mean level showed higher multiorgan involvement frequency than those with enzyme activity of > 5%, whereas no significant difference was observed among females. Ninety-five gene mutation sites were detected, with significant phenotype heterogeneity in patients with the same mutation. No significant difference in enzyme activity or clinical manifestations was observed between truncated and nontruncated mutations. Overall, male patients with Fabry disease, regardless of classical or late-onset phenotype, have a higher frequency of multiple-organ involvement and lower \u03b1-Gal A activity than female patients. \u03b1-Gal A activity was closely correlated with clinical symptoms in males but weakly correlated with clinical manifestations in females. The clinical manifestations of patients with the same mutation are heterogeneous, and the correlation between gene mutation and enzyme activity or clinical manifestation is weak.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2524"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P30556', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 15, 'modifier': 'EXACT'}, 'end': {'value': 15, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '30639100'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6DO1'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 17, 'modifier': 'EXACT'}, 'end': {'value': 17, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '30639100'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '32079768'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6DO1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6OS0'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 167, 'modifier': 'EXACT'}, 'end': {'value': 167, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '30639100'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '32079768'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6DO1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6OS0'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 182, 'modifier': 'EXACT'}, 'end': {'value': 182, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '30639100'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '32079768'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6DO1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6OS0'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 183, 'modifier': 'EXACT'}, 'end': {'value': 183, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '30639100'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '32079768'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6DO1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6OS0'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 184, 'modifier': 'EXACT'}, 'end': {'value': 184, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '30639100'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '32079768'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6DO1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6OS0'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 199, 'modifier': 'EXACT'}, 'end': {'value': 199, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '30639100'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '32079768'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6DO1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6OS0'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}], 'extraAttributes': {'uniParcId': 'UPI0000039D66'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CCc1nc2c(C)cc(C)nc2n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)C(c2ccccc2)c2ccccc2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.05', 'CHEMBLID': 'CHEMBL647575', 'description': 'Inhibition of Angiotensin II receptor, type 1'}, {'\u5206\u5b50SMILES': 'CCCCc1nc2ccc(NC(=O)N(C)C(C)C)cc2c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL881768', 'description': 'Inhibitory concentration against angiotensin II receptor, type 1'}, {'\u5206\u5b50SMILES': 'CCCc1nc(CC)c(C(=O)OCCCOCc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL648492', 'description': 'Binding affinity for Angiotensin II receptor, type 1'}, {'\u5206\u5b50SMILES': 'CCCCCOC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)OCCC(=O)Nc2ccccc2)c(F)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL648492', 'description': 'Binding affinity for Angiotensin II receptor, type 1'}, {'\u5206\u5b50SMILES': 'CCCc1nc(CC)c(C(=O)OCCC(=O)Nc2ccccc2)n1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)OCCC(C)C)cc1F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL648492', 'description': 'Binding affinity for Angiotensin II receptor, type 1'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Metabolic syndrome and effect of gene polymorphisms: ADIPOQ, AGT, AGTR1, AGTR2, ApoC-III, NR3C1 and GNB3 gene polymorphisms.', 'abstract': 'Metabolic syndrome (MetS) is defined as a metabolic dysfunction characterized by the co-occurrence of multiple risk factors. Our study aimed to elucidate the effects of ADIPOQ rs266729, rs17300539, and rs2241766, AGT rs699 and rs4762, AGTR1 rs5186, AGTR2 rs11091046, ApoC-III rs2854116 and rs2854117, NR3C1 rs10052957 and rs41423247, and GNB3 rs5443 gene polymorphisms on MetS.'}, {'title': 'AGTR1 potentiates the chemotherapeutic efficacy of cisplatin in esophageal carcinoma through elevation of intracellular Ca', 'abstract': 'Cisplatin is one of the principal chemotherapeutic agents used for esophageal cancer (EC) treatment; however, EC mortality remains high. It is therefore imperative to find new therapeutic targets and approaches to potentiate the chemotherapeutic efficacy of cisplatin. Angiotensin II receptor type 1 (AGTR1) is a potential therapeutic target in multiple cancer types. In the present study, RNA\u2011sequencing analysis of EC and normal esophageal tissues was performed and AGTR1 was identified as a differentially expressed gene that is markedly downregulated in recurrent and metastasized EC. AGTR1 upregulation in the esophageal squamous cell carcinoma cell lines, KYSE\u2011150 and EC109, promoted their chemosensitivity to cisplatin both '}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL227"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P50052', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 103, 'modifier': 'EXACT'}, 'end': {'value': 103, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '31899086'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6JOD'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 104, 'modifier': 'EXACT'}, 'end': {'value': 104, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '31899086'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6JOD'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 182, 'modifier': 'EXACT'}, 'end': {'value': 182, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '31899086'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6JOD'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 204, 'modifier': 'EXACT'}, 'end': {'value': 204, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '31899086'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6JOD'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 215, 'modifier': 'EXACT'}, 'end': {'value': 215, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '29967536'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '31899086'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5XJM'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6JOD'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 279, 'modifier': 'EXACT'}, 'end': {'value': 279, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '29967536'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '31899086'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5XJM'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '6JOD'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}, {'type': 'Binding site', 'location': {'start': {'value': 297, 'modifier': 'EXACT'}, 'end': {'value': 297, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58506'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '29967536'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5XJM'}], 'ligand': {'name': 'angiotensin II', 'id': 'ChEBI:CHEBI:58506'}}], 'extraAttributes': {'uniParcId': 'UPI0000125687'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.08', 'CHEMBLID': 'CHEMBL3779531', 'description': 'Displacement of [125I]CGP42112A from human recombinant AT2 receptor expressed in HEK293 cells'}, {'\u5206\u5b50SMILES': 'CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.08', 'CHEMBLID': 'CHEMBL3876344', 'description': 'Displacement of [125I]CGP 42112A from human recombinant AT2 receptor expressed in HEK293 cells measured after 4 hrs by scintillation counting method'}, {'\u5206\u5b50SMILES': 'CCCCC(=O)Nc1ccc(Br)c(-n2nc(CC)n(Cc3ccc(-c4ccccc4S(=O)(=O)NC(=O)OC(C)(C)C)cc3F)c2=O)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.12', 'CHEMBLID': 'CHEMBL643595', 'description': 'Inhibition of Angiotensin II receptor, type 2'}, {'\u5206\u5b50SMILES': 'CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.13', 'CHEMBLID': 'CHEMBL2395772', 'description': 'Binding affinity to human angiotensin AT2 receptor by radioligand displacement assay'}, {'\u5206\u5b50SMILES': 'CCc1nc2c(C)cc(C)nc2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL1670671', 'description': 'Binding affinity to angiotensin AT2 receptor'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'The angiotensin II type 2 receptor antagonists, PD123,319 ((S-(\\u2009+)-1-[(4-(dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid), EMA300 (5-(2,2-diphenylacetyl)-4-[(4-methoxy-3-methylphenyl)methyl]-1,4,6,7-tetrahydroimidazo[4,5-c]pyridine-6-carboxylic acid) and EMA401 ((3S)-5-(benzyloxy)-2-(2,2-diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid), evoke pain relief in a varicella zoster virus-induced rat model of neuropathic pain.', 'abstract': 'Post-herpetic neuralgia (PHN) is a type of neuropathic (nerve) pain that persists for more than 3\\xa0months after crusting of the last shingles lesion. It is difficult to relieve with analgesic/adjuvant medications, and so novel analgesics are needed. Our aim was to use a rat model of varicella zoster virus (VZV)-induced neuropathic pain to assess the pain relief efficacy of several small molecule angiotensin II type 2 (AT'}, {'title': 'A strategy for selective screening of dual-target bioactive compounds against hypertrophic scar through inhibiting angiotensin II type 1 receptor while stimulating type 2 receptor from Chinese herbs.', 'abstract': 'Cutaneous hypertrophic scar is a fibro-proliferative hard-curing disease. Recent studies have proved that antagonists of angiotensin II type 1 receptor (AT'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4607"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'O60218', 'features': [{'type': 'Active site', 'location': {'start': {'value': 49, 'modifier': 'EXACT'}, 'end': {'value': 49, 'modifier': 'EXACT'}}, 'description': 'Proton donor', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18087047'}]}, {'type': 'Binding site', 'location': {'start': {'value': 20, 'modifier': 'EXACT'}, 'end': {'value': 22, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18087047'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 44, 'modifier': 'EXACT'}, 'end': {'value': 44, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18087047'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 111, 'modifier': 'EXACT'}, 'end': {'value': 111, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18087047'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 160, 'modifier': 'EXACT'}, 'end': {'value': 161, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18087047'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 184, 'modifier': 'EXACT'}, 'end': {'value': 184, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18087047'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 210, 'modifier': 'EXACT'}, 'end': {'value': 217, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18087047'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 261, 'modifier': 'EXACT'}, 'end': {'value': 273, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18087047'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Site', 'location': {'start': {'value': 78, 'modifier': 'EXACT'}, 'end': {'value': 78, 'modifier': 'EXACT'}}, 'description': 'Lowers pKa of active site Tyr', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P14550'}]}], 'extraAttributes': {'uniParcId': 'UPI00000362E9'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'O=C(NCCCc1ccc(F)cc1)c1cc2ccc(O)cc2oc1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.5', 'CHEMBLID': 'CHEMBL4020427', 'description': 'Inhibition of recombinant human AKR1B10 using pyridine-3-aldehyde as substrate'}, {'\u5206\u5b50SMILES': 'O=C(NCCCc1ccc(O)cc1)c1cc2ccc(O)cc2oc1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.2', 'CHEMBLID': 'CHEMBL4020427', 'description': 'Inhibition of recombinant human AKR1B10 using pyridine-3-aldehyde as substrate'}, {'\u5206\u5b50SMILES': 'COc1ccc(/N=c2\\\\oc3cc(O)ccc3cc2C(=O)NCc2ccccc2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.7', 'CHEMBLID': 'CHEMBL4020462', 'description': 'Inhibition of AKR1B10 (unknown origin)'}, {'\u5206\u5b50SMILES': 'COc1ccc(/N=c2\\\\oc3cc(O)ccc3cc2C(=O)NCc2ccccc2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.7', 'CHEMBLID': 'CHEMBL2444357', 'description': 'Inhibition of human recombinant N-terminal His6-tagged AKR1B10 expressed in Escherichia coli by fluorescence assay in presence of NADPH'}, {'\u5206\u5b50SMILES': 'COc1ccc(/N=c2\\\\oc3cc(O)ccc3cc2C(=O)Nc2ccccn2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.0', 'CHEMBLID': 'CHEMBL1174247', 'description': 'Inhibition of reductase activity of N-terminal 6His-tagged AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as inhibition of NADPH linked pyridine-3-aldehyde reduction'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Identification of key hub genes associated with anti-gastric cancer effects of lotus plumule based on machine learning algorithms.', 'abstract': 'Lotus plumule and its active components have demonstrated inhibitory effects on gastric cancer (GC). However, the molecular mechanism of lotus plumule against GC remains unclear and requires further investigation.'}, {'title': 'DDX24 inhibits clear cell renal cell carcinoma progression by directly regulating AKR1B10.', 'abstract': 'Clear cell renal cell carcinoma (ccRCC) is one of the most common malignancies worldwide, but only a few markers have been used to diagnose ccRCC. Here, we report the critical roles of DEAD-box helicase 24 (DDX24), a member of the DEAD-box RNA helicase family, in ccRCC. The DDX24 expression level and its prognostic value were initially detected in public data and then verified in a ccRCC tissue microarray. Subsequent in vitro and in vivo experiments were conducted on representative ccRCC cell lines. RNA sequencing and experimental studies were performed to explore the underlying mechanisms, and the associations between DDX24 expression and immune characteristics were evaluated. DDX24 levels were significantly lower in ccRCC tissues and negatively correlated with advanced clinical stage and overall survival. Functional analyses showed that DDX24 overexpression inhibited ccRCC cell proliferation, migration, and invasion, while DDX24 knockdown enhanced these phenotypes. Mechanistic studies revealed that DDX24 regulated the expression of aldo-keto reductase family 1 member B10 (AKR1B10) and epithelial-mesenchymal transition (EMT)-related transcription factors. Given the low expression of DDX24, ccRCC patients may benefit more from immunotherapies. In conclusion, these findings demonstrate that DDX24 suppresses ccRCC progression through direct regulation of AKR1B10, potentially mediated by EMT-related pathways, which provides potential therapeutic targets for ccRCC.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5983"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q04828', 'features': [{'type': 'Active site', 'location': {'start': {'value': 55, 'modifier': 'EXACT'}, 'end': {'value': 55, 'modifier': 'EXACT'}}, 'description': 'Proton donor', 'evidences': [{'evidenceCode': 'ECO:0000250'}]}, {'type': 'Binding site', 'location': {'start': {'value': 20, 'modifier': 'EXACT'}, 'end': {'value': 24, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12899831'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21414777'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 24, 'modifier': 'EXACT'}, 'end': {'value': 24, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 50, 'modifier': 'EXACT'}, 'end': {'value': 50, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12899831'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21414777'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 166, 'modifier': 'EXACT'}, 'end': {'value': 167, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12899831'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21414777'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 190, 'modifier': 'EXACT'}, 'end': {'value': 190, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12899831'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21414777'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 216, 'modifier': 'EXACT'}, 'end': {'value': 222, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12899831'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21414777'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 222, 'modifier': 'EXACT'}, 'end': {'value': 222, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 227, 'modifier': 'EXACT'}, 'end': {'value': 227, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 270, 'modifier': 'EXACT'}, 'end': {'value': 280, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12899831'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21414777'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Site', 'location': {'start': {'value': 54, 'modifier': 'EXACT'}, 'end': {'value': 54, 'modifier': 'EXACT'}}, 'description': 'Important for substrate specificity', 'evidences': [{'evidenceCode': 'ECO:0000250'}]}, {'type': 'Site', 'location': {'start': {'value': 84, 'modifier': 'EXACT'}, 'end': {'value': 84, 'modifier': 'EXACT'}}, 'description': 'Lowers pKa of active site Tyr', 'evidences': [{'evidenceCode': 'ECO:0000250'}]}, {'type': 'Site', 'location': {'start': {'value': 222, 'modifier': 'EXACT'}, 'end': {'value': 222, 'modifier': 'EXACT'}}, 'description': 'May be involved in the mediating step between the transformation of progesterone and the release of the cofactor'}], 'extraAttributes': {'uniParcId': 'UPI0000125760'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'O=C(O)c1cc(Cl)cc(Cl)c1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.0', 'CHEMBLID': 'CHEMBL980737', 'description': 'Inhibition of 20-alpha HSD'}, {'\u5206\u5b50SMILES': 'COc1ccc2c(c1)c(C)c(CCC(=O)O)n2C(=O)c1ccc(Cl)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '17.73', 'CHEMBLID': 'CHEMBL3888492', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}, {'\u5206\u5b50SMILES': 'CCc1c(CCC(=O)O)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC)cc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '30.71', 'CHEMBLID': 'CHEMBL3888492', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}, {'\u5206\u5b50SMILES': 'O=C1OC(c2cc(Br)c(O)c(Br)c2)(c2cc(Br)c(O)c(Br)c2)c2ccccc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '33.0', 'CHEMBLID': 'CHEMBL980737', 'description': 'Inhibition of 20-alpha HSD'}, {'\u5206\u5b50SMILES': 'CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '48.0', 'CHEMBLID': 'CHEMBL980737', 'description': 'Inhibition of 20-alpha HSD'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Discovery of highly potent AKR1Cs pan-inhibitors as chemotherapeutic potentiators to restore breast cancer drug resistance.', 'abstract': 'The acquired resistance of doxorubicin (DOX) significantly limits their application in breast cancer treatment. In earlier investigations, a pan-inhibitor, S07-2010, exhibiting inhibitory activity against Aldo-Keto Reductase 1C1-1C4 (AKR1C1-1C4) was discovered through virtual screening. In this study, four rounds of structural modifications were conducted, and the optimized compound 29 exhibited potent inhibitory activity against AKR1C1-1C4 (AKR1C1 IC'}, {'title': 'AKR1C1 protects against intracerebral hemorrhage by suppressing neuronal cell death via the P53/SLC7A11/GPX4 axis.', 'abstract': 'Intracerebral hemorrhage (ICH) is associated with the highest rates of mortality and residual disability. To date, effective treatments to delay or prevent ICH are still lacking. Multiple forms of neuronal cell death have been discovered following ICH, including apoptosis, necrosis, autophagy, and ferroptosis. Aldo-keto reductase family 1 member C1 (AKR1C1) has been identified to act as a protective factor in ferroptosis. However, whether AKR1C1 was involved in the development of ICH was unknown. In this study, the left cerebral striatum of the Sprague-Dawley rat was injected with collagenase type IV to induce an in vivo model. Primary rat cortical neurons treated with oxygen hemoglobin (OxyHb) were applied to as an in vitro model. AKR1C1 was found to be downregulated and immunoreactivity colocalized with NeuN-positive neurons in the perihematomal region. Rats injected with lentiviral particles overexpressing AKR1C1 showed the reduction of cerebral hematoma and the remission of blood-brain barrier disruption. Moreover, AKR1C1 upregulation repressed cell apoptosis and ferroptosis induced by ICH through downregulating the expression of pro-apoptotic factors, inhibiting iron accumulation and lipid peroxidation, along with increasing the expression of solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4). The results of in vitro assays were consistent with results from the in vivo. Mechanistically, P53 overexpression augmented the cellular damage in OxyHb-stimulated neurons when AKR1C1 was overexpressed. Taken together, AKR1C1 improves ICH injury by inhibiting neuronal cell death via negatively regulating P53 expression and affecting the SLC7A11/GPX4 pathway.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5905"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P52895', 'features': [{'type': 'Active site', 'location': {'start': {'value': 55, 'modifier': 'EXACT'}, 'end': {'value': 55, 'modifier': 'EXACT'}}, 'description': 'Proton donor'}, {'type': 'Binding site', 'location': {'start': {'value': 20, 'modifier': 'EXACT'}, 'end': {'value': 24, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11513593'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11514561'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15929998'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17034817'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17442338'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 24, 'modifier': 'EXACT'}, 'end': {'value': 24, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 50, 'modifier': 'EXACT'}, 'end': {'value': 50, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11513593'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11514561'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15929998'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17034817'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17442338'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 166, 'modifier': 'EXACT'}, 'end': {'value': 167, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11513593'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11514561'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15929998'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17034817'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17442338'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 190, 'modifier': 'EXACT'}, 'end': {'value': 190, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11513593'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11514561'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15929998'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17034817'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17442338'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 216, 'modifier': 'EXACT'}, 'end': {'value': 222, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11513593'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11514561'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15929998'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17034817'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17442338'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 222, 'modifier': 'EXACT'}, 'end': {'value': 222, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 227, 'modifier': 'EXACT'}, 'end': {'value': 227, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 270, 'modifier': 'EXACT'}, 'end': {'value': 280, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11513593'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11514561'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15929998'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17034817'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17442338'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Site', 'location': {'start': {'value': 84, 'modifier': 'EXACT'}, 'end': {'value': 84, 'modifier': 'EXACT'}}, 'description': 'Lowers pKa of active site Tyr', 'evidences': [{'evidenceCode': 'ECO:0000250'}]}], 'extraAttributes': {'uniParcId': 'UPI0000111D9F'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1ccc2c(c1)c(C)c(CCC(=O)O)n2C(=O)c1ccc(Cl)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '14.5', 'CHEMBLID': 'CHEMBL3888493', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}, {'\u5206\u5b50SMILES': 'COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(C(F)(F)F)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '35.73', 'CHEMBLID': 'CHEMBL3888493', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}, {'\u5206\u5b50SMILES': 'COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(CCl)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '40.74', 'CHEMBLID': 'CHEMBL3888493', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}, {'\u5206\u5b50SMILES': 'CCc1c(CCC(=O)O)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC)cc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '49.57', 'CHEMBLID': 'CHEMBL3888493', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}, {'\u5206\u5b50SMILES': 'COc1ccc2c(c1)c(CC(=O)NS(=O)(=O)C(F)(F)F)cn2C(=O)c1ccc(Cl)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '50.13', 'CHEMBLID': 'CHEMBL3888493', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Specific and potent inhibition of steroid hormone pre-receptor regulator AKR1C2 by perfluorooctanoic acid: Implications for androgen metabolism.', 'abstract': 'Per- and polyfluoroalkyl substances (PFAS) are ubiquitous environmental pollutants that are highly stable synthetic organofluorine compounds. One congener perfluorooctanoic acid (PFOA) can be detected in nearly all humans and is recognized as an endocrine disrupting chemical (EDC). EDCs disrupt hormone synthesis and metabolism and receptor function. One mechanism of steroid hormone action is the pre-receptor regulation of ligand access to steroid hormone receptors by aldo-keto reductases. Here we report PFOA inhibition of AKR family 1 member C2 (AKR1C2), leading to dysregulation of androgen action. Spectrofluorimetric inhibitor screens identified PFOA as a competitive and tight binding inhibitor of AKR1C2, whose role is to inactivate 5\u03b1-dihydrotestosterone (5\u03b1-DHT). Further site directed mutagenesis studies along with molecular docking simulations revealed the importance of residue Valine 54 in mediating AKR1C2 inhibitor specificity. Binding site restrictions were explored by testing inhibition of other related PFAS chemicals, confirming that steric hinderance is a key factor. Furthermore, radiochromatography using HPLC and in line radiometric detection confirmed the accumulation of 5\u03b1-DHT as a result of PFOA inhibition of AKR1C2. We showed that PFOA could enhance the transactivation of AR in reporter genes assays in which 5\u03b1-DHT metabolism was blocked by AKR1C2 inhibition in HeLa cells. Taken together, these data suggest PFOA has a role in disrupting androgen action through inhibiting AKR1C2. Our work identifies an EDC function for PFOA not previously revealed.'}, {'title': 'Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer.', 'abstract': 'Prostate cancer development and progression are driven by androgens, and changes in androgen metabolic pathways can lead to prostate cancer progression or remission. AKR1C2 is a member of the aldo-keto reductase superfamily and plays an important role in the metabolism of steroids and prostaglandins.\\xa0Alterations in the expression and activity of AKR1C2 affect the homeostasis of active androgens, which in turn affects the progression of prostate cancer. AKR1C2 reduces the highly active dihydrotestosterone to the less active 3\u03b1-diol in the prostate, resulting in lower androgen levels. Whereas the expression of AKR1C2 is significantly reduced in prostate cancer tissues relative to normal prostate tissues, this results in a weakening of the dihydrotestosterone metabolic inactivation pathway, leading to the retention of dihydrotestosterone in the prostate cancer cells, which promotes the progress of prostate cancer. Given the critical role of AKR1C2 in prostate cancer cells, targeting AKR1C2 for the treatment of prostate cancer may be an effective strategy. It has been demonstrated that curcumin and neem leaf extract effectively inhibit prostate cancer in vitro and in vivo by modulating AKR1C2.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5847"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P42330', 'features': [{'type': 'Active site', 'location': {'start': {'value': 55, 'modifier': 'EXACT'}, 'end': {'value': 55, 'modifier': 'EXACT'}}, 'description': 'Proton donor', 'evidences': [{'evidenceCode': 'ECO:0000250'}]}, {'type': 'Binding site', 'location': {'start': {'value': 23, 'modifier': 'EXACT'}, 'end': {'value': 24, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14979715'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14996743'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15087468'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 50, 'modifier': 'EXACT'}, 'end': {'value': 50, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14979715'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14996743'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15087468'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 166, 'modifier': 'EXACT'}, 'end': {'value': 167, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14979715'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14996743'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15087468'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 190, 'modifier': 'EXACT'}, 'end': {'value': 190, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14979715'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14996743'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15087468'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 216, 'modifier': 'EXACT'}, 'end': {'value': 222, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14979715'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14996743'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15087468'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 270, 'modifier': 'EXACT'}, 'end': {'value': 272, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14979715'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14996743'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15087468'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 276, 'modifier': 'EXACT'}, 'end': {'value': 280, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14979715'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14996743'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15087468'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Site', 'location': {'start': {'value': 54, 'modifier': 'EXACT'}, 'end': {'value': 54, 'modifier': 'EXACT'}}, 'description': 'Important for substrate specificity', 'evidences': [{'evidenceCode': 'ECO:0000250'}]}, {'type': 'Site', 'location': {'start': {'value': 84, 'modifier': 'EXACT'}, 'end': {'value': 84, 'modifier': 'EXACT'}}, 'description': 'Lowers pKa of active site Tyr', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P14550'}]}, {'type': 'Site', 'location': {'start': {'value': 227, 'modifier': 'EXACT'}, 'end': {'value': 227, 'modifier': 'EXACT'}}, 'description': 'Involved in ligand recognition and product release', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15087468'}]}, {'type': 'Site', 'location': {'start': {'value': 306, 'modifier': 'EXACT'}, 'end': {'value': 306, 'modifier': 'EXACT'}}, 'description': 'Involved in ligand recognition and product release', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15087468'}]}], 'extraAttributes': {'uniParcId': 'UPI0000140951'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CCc1c(CCC(=O)O)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC)cc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.09', 'CHEMBLID': 'CHEMBL3888491', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}, {'\u5206\u5b50SMILES': 'COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(CCl)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.12', 'CHEMBLID': 'CHEMBL3888491', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}, {'\u5206\u5b50SMILES': 'COc1ccc2c(c1)c(C)c(CCC(=O)O)n2C(=O)c1ccc(Cl)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.13', 'CHEMBLID': 'CHEMBL3888491', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}, {'\u5206\u5b50SMILES': 'COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(C)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.16', 'CHEMBLID': 'CHEMBL3888491', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}, {'\u5206\u5b50SMILES': 'COc1ccc2c(c1)c1c(n2C(=O)c2ccc(Cl)cc2)CCC(C(=O)O)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.16', 'CHEMBLID': 'CHEMBL3888491', 'description': 'Inhibition Assay: Inhibitors were initially screened for an ability to block the NADP+ dependent oxidation of the artificial substrate S-tetralol catalyzed by AKR1C3. S-tetralol was used since it is also a substrate of the highly related AKR1C1 and AKR1C2 enzymes. Inhibition of AKR1C1 and AKR1C2 is undesirable in the context of prostate cancer since they are involved in the elimination of DHT (see FIG. 1B; see also Rizner et al, 2003; Steckelbroeck et al. 2004). All assays were performed at Km so that IC50 values across enzyme forms were comparable.An exemplary screening strategy was against homogeneous recombinant AKR1C3 and its highly related enzyme AKR1C2 to generate full dose-response curves and IC50 values.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Discovery and Optimization of a Covalent AKR1C3 Inhibitor.', 'abstract': 'Aldo-keto reductase family 1 member C3 (AKR1C3) is a member of the AKR superfamily of enzymes that metabolize androgen, estrogen, and prostaglandin substrates that drive proliferation in hormone-dependent cancers. Interest in developing selective inhibitors has produced tool compounds for the inactivation or degradation of AKR1C3 with varying degrees of selectivity among the 14 known AKR proteins. Selectivity of AKR1C3 inhibitors across the AKR family is critical since a clinical candidate failed due to hepatotoxicity from off-target inhibition of AKR1D1. Here, we report development of a sulfonyl-triazole (SuTEx) covalent AKR1C3 inhibitor (RJG-2051) that selectively engages a noncatalytic tyrosine residue (Y24) on AKR1C3. Importantly, RJG-2051 exhibited negligible cross-reactivity with AKRs or other proteins across 1800+ tyrosine and lysine sites quantified by chemical proteomics. Our disclosure of a covalent inhibitor for potent AKR1C3 inactivation with proteome-wide selectivity in cells will expedite cell biological studies for testing the therapeutic potential of this metabolic target.'}, {'title': 'YY1-induced transcription of AKR1C3 activates the Hedgehog signalling pathway to enhance lenalidomide resistance and glycolytic activity in multiple myeloma cells.', 'abstract': 'Lenalidomide (LEN) is a mainstay for treating multiple myeloma (MM), but its efficacy is often limited by resistance. We investigated the interaction between aldo-keto reductase family 1 member C3 (AKR1C3) and Yin Yang 1 (YY1) and their roles in LEN resistance. We induced LEN-resistant MM cell lines (H929R and U266R). Loss- or gain-of-function assays of AKR1C3 and YY1 were used to analyse the half maximal inhibitory concentration (IC'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4681"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P31749', 'features': [{'type': 'Active site', 'location': {'start': {'value': 274, 'modifier': 'EXACT'}, 'end': {'value': 274, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}]}, {'type': 'Binding site', 'location': {'start': {'value': 14, 'modifier': 'EXACT'}, 'end': {'value': 19, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12176338'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12964941'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 23, 'modifier': 'EXACT'}, 'end': {'value': 25, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12176338'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12964941'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 53, 'modifier': 'EXACT'}, 'end': {'value': 53, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12176338'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12964941'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 86, 'modifier': 'EXACT'}, 'end': {'value': 86, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12176338'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12964941'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 156, 'modifier': 'EXACT'}, 'end': {'value': 164, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 179, 'modifier': 'EXACT'}, 'end': {'value': 179, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Site', 'location': {'start': {'value': 462, 'modifier': 'EXACT'}, 'end': {'value': 462, 'modifier': 'EXACT'}}, 'description': 'Cleavage; by caspase-3', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P31750'}]}], 'extraAttributes': {'uniParcId': 'UPI0000070813'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cl.O=C(N[C@@H]1CNCC[C@H]1c1cc(F)cc(F)c1)c1cc2c(s1)OCCn1ncc(Br)c1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.01', 'CHEMBLID': 'CHEMBL5369550', 'description': 'Inhibition of AKT1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'Cl.O=C(N[C@@H]1CNCC[C@H]1c1cccc(F)c1)c1cc2c(s1)OCCn1ncc(Cl)c1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.01', 'CHEMBLID': 'CHEMBL5369550', 'description': 'Inhibition of AKT1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'Cl.O=C(N[C@@H]1CNCC[C@H]1c1cccc(F)c1)c1cc2c(s1)CCCn1ncc(Cl)c1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.02', 'CHEMBLID': 'CHEMBL5369550', 'description': 'Inhibition of AKT1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'Cl.O=C(N[C@@H]1CNCC[C@H]1c1ccc(F)c(F)c1)c1cc2c(s1)OCCn1ncc(Br)c1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.023', 'CHEMBLID': 'CHEMBL5369550', 'description': 'Inhibition of AKT1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'Cl.O=C(N[C@@H]1CNCC[C@H]1c1cc(F)c(F)c(F)c1)c1ccc2c(c1)OCCn1nccc1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.035', 'CHEMBLID': 'CHEMBL5369550', 'description': 'Inhibition of AKT1 (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Time-restricted feeding attenuated hypertension-induced cardiac remodeling by modulating autophagy levels in spontaneously hypertensive rats.', 'abstract': 'To investigate whether time-restricted feeding (TRF) can alleviate cardiac remodeling in spontaneously hypertensive rats (SHRs) by regulating autophagy levels. A 16-week TRF intervention was conducted on Wistar Kyoto (WKY) rats and SHRs, with dietary intake confined to the interval from 9:00 am to 5:00 pm each day. The study examined the impact of TRF on blood pressure (BP), cardiac morphology and function, and the expression levels of key proteins involved in autophagy and its associated signaling cascades. Transmission Electron Microscopy (TEM) was utilized to further evaluate autophagic changes in left ventricular (LV) tissues. TRF significantly mitigated systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean blood pressure (MBP) in SHRs. Additionally, TRF improved ejection fraction (EF) and diminished interventricular septal thickness at end-diastole (IVS-d). The study further revealed that TRF enhanced the expression of microtubule-associated protein-I light chain 3 (LC3-I), while reducing that of microtubule-associated protein-II light chain 3 (LC3-II). Moreover, TRF suppressed the expression levels of Beclin-1, phosphorylated phosphoinositide 3-kinase (p-PI3K), phosphorylated protein kinase B (p-AKT), and phosphorylated mechanistic target of rapamycin (p-mTOR) in the LV tissues. TEM analysis confirmed that TRF could inhibit autophagy levels in the LV tissues. TRF can attenuate cardiac remodeling in SHRs by regulating autophagy levels.'}, {'title': 'TIGIT deficiency promotes autoreactive CD4', 'abstract': 'Polymyositis (PM) is a systemic autoimmune disease characterized by muscular inflammatory infiltrates and degeneration. T-cell immunoreceptor with Ig and ITIM domains (TIGIT) contributes to immune tolerance by inhibiting T cell-mediated autoimmunity. Here, we show that a reduced expression of TIGIT in CD4'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4282"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P31749', 'features': [{'type': 'Active site', 'location': {'start': {'value': 274, 'modifier': 'EXACT'}, 'end': {'value': 274, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}]}, {'type': 'Binding site', 'location': {'start': {'value': 14, 'modifier': 'EXACT'}, 'end': {'value': 19, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12176338'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12964941'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 23, 'modifier': 'EXACT'}, 'end': {'value': 25, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12176338'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12964941'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 53, 'modifier': 'EXACT'}, 'end': {'value': 53, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12176338'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12964941'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 86, 'modifier': 'EXACT'}, 'end': {'value': 86, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12176338'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12964941'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 156, 'modifier': 'EXACT'}, 'end': {'value': 164, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 179, 'modifier': 'EXACT'}, 'end': {'value': 179, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Site', 'location': {'start': {'value': 462, 'modifier': 'EXACT'}, 'end': {'value': 462, 'modifier': 'EXACT'}}, 'description': 'Cleavage; by caspase-3', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P31750'}]}], 'extraAttributes': {'uniParcId': 'UPI0000070813'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cl.O=C(N[C@@H]1CNCC[C@H]1c1cc(F)cc(F)c1)c1cc2c(s1)OCCn1ncc(Br)c1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.01', 'CHEMBLID': 'CHEMBL5369550', 'description': 'Inhibition of AKT1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'Cl.O=C(N[C@@H]1CNCC[C@H]1c1cccc(F)c1)c1cc2c(s1)OCCn1ncc(Cl)c1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.01', 'CHEMBLID': 'CHEMBL5369550', 'description': 'Inhibition of AKT1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'Cl.O=C(N[C@@H]1CNCC[C@H]1c1cccc(F)c1)c1cc2c(s1)CCCn1ncc(Cl)c1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.02', 'CHEMBLID': 'CHEMBL5369550', 'description': 'Inhibition of AKT1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'Cl.O=C(N[C@@H]1CNCC[C@H]1c1ccc(F)c(F)c1)c1cc2c(s1)OCCn1ncc(Br)c1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.023', 'CHEMBLID': 'CHEMBL5369550', 'description': 'Inhibition of AKT1 (unknown origin)'}, {'\u5206\u5b50SMILES': 'Cl.O=C(N[C@@H]1CNCC[C@H]1c1cc(F)c(F)c(F)c1)c1ccc2c(c1)OCCn1nccc1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.035', 'CHEMBLID': 'CHEMBL5369550', 'description': 'Inhibition of AKT1 (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Time-restricted feeding attenuated hypertension-induced cardiac remodeling by modulating autophagy levels in spontaneously hypertensive rats.', 'abstract': 'To investigate whether time-restricted feeding (TRF) can alleviate cardiac remodeling in spontaneously hypertensive rats (SHRs) by regulating autophagy levels. A 16-week TRF intervention was conducted on Wistar Kyoto (WKY) rats and SHRs, with dietary intake confined to the interval from 9:00 am to 5:00 pm each day. The study examined the impact of TRF on blood pressure (BP), cardiac morphology and function, and the expression levels of key proteins involved in autophagy and its associated signaling cascades. Transmission Electron Microscopy (TEM) was utilized to further evaluate autophagic changes in left ventricular (LV) tissues. TRF significantly mitigated systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean blood pressure (MBP) in SHRs. Additionally, TRF improved ejection fraction (EF) and diminished interventricular septal thickness at end-diastole (IVS-d). The study further revealed that TRF enhanced the expression of microtubule-associated protein-I light chain 3 (LC3-I), while reducing that of microtubule-associated protein-II light chain 3 (LC3-II). Moreover, TRF suppressed the expression levels of Beclin-1, phosphorylated phosphoinositide 3-kinase (p-PI3K), phosphorylated protein kinase B (p-AKT), and phosphorylated mechanistic target of rapamycin (p-mTOR) in the LV tissues. TEM analysis confirmed that TRF could inhibit autophagy levels in the LV tissues. TRF can attenuate cardiac remodeling in SHRs by regulating autophagy levels.'}, {'title': 'TIGIT deficiency promotes autoreactive CD4', 'abstract': 'Polymyositis (PM) is a systemic autoimmune disease characterized by muscular inflammatory infiltrates and degeneration. T-cell immunoreceptor with Ig and ITIM domains (TIGIT) contributes to immune tolerance by inhibiting T cell-mediated autoimmunity. Here, we show that a reduced expression of TIGIT in CD4'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4282"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P31751', 'features': [{'type': 'Active site', 'location': {'start': {'value': 275, 'modifier': 'EXACT'}, 'end': {'value': 275, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}]}, {'type': 'Binding site', 'location': {'start': {'value': 158, 'modifier': 'EXACT'}, 'end': {'value': 166, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 181, 'modifier': 'EXACT'}, 'end': {'value': 181, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 280, 'modifier': 'EXACT'}, 'end': {'value': 280, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12434148'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035'}}, {'type': 'Binding site', 'location': {'start': {'value': 293, 'modifier': 'EXACT'}, 'end': {'value': 293, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12434148'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035'}}], 'extraAttributes': {'uniParcId': 'UPI0000049EDB'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CNC(=O)C[C@@H]1C[C@@H](c2ccc(F)c(F)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL4830025', 'description': 'Inhibition of N-terminal GST-tagged human AKT2 (120 to 481 residues) expressed in baculovirus infected Sf21 cells incubated for 1 hr in presence of ATP by mobility shift assay'}, {'\u5206\u5b50SMILES': 'CC1(O)CC(N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccc(C(N)=O)cc3-4)cc2)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.26', 'CHEMBLID': 'CHEMBL3708023', 'description': 'Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at \u00c3\u00a2 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.'}, {'\u5206\u5b50SMILES': 'COc1cc(OC)c2c(c1)OCn1c-2nc(-c2ccc(C3(N)CC(O)(C4CC4)C3)cc2)c1-c1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.27', 'CHEMBLID': 'CHEMBL3708023', 'description': 'Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at \u00c3\u00a2 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.'}, {'\u5206\u5b50SMILES': 'CNC(=O)c1ccc2c(c1)-c1nc(-c3ccc(C4(N)CC(C)(O)C4)cc3)c(-c3ccccc3)n1CO2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.28', 'CHEMBLID': 'CHEMBL3708023', 'description': 'Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at \u00c3\u00a2 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.'}, {'\u5206\u5b50SMILES': 'NC1(c2ccc(-c3nc4n(c3-c3ccccc3)COc3cccc(F)c3-4)cc2)CC(O)(C2CC2)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.29', 'CHEMBLID': 'CHEMBL3708023', 'description': 'Kinase Inhibition Assay: Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity were carried out with reference to the method disclosed in Biochem. J. Vol. 385, pp 399-408 (2005). In the preparation of AKT1 and AKT2, human AKT1 and AKT2 to which a middle T antigen tag was added were expressed in Sf 9 insect cells, and then AKT1 and AKT2 were prepared following affinity purification and activation by PDK1. The prepared AKT1 and AKT2 were stored at \u00c3\u00a2 80C. until the time of measurement of inhibitory activity of the compounds. In the measurement of inhibitory activity of the compounds, AKT1 or AKT2 and each compound of the present invention were preincubated at 25C. for 120 minutes in a buffer solution for reaction (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT). As a substrate, biotinylated Crosstide (bioton-KGSGSGRPRTSSFAEG), MgCl2, and ATP were added to final concentrations.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': '4-fluorophenylacetamide acetyl coumarin induces pro-inflammatory M1 macrophage polarization and suppresses the immunosuppressive M2 phenotype through PI3k/AKT/NF-\u03baB modulation.', 'abstract': 'The tumor microenvironment plays a critical role in cancer progression, with tumor-associated macrophages regulating immune responses. These macrophages can adopt a pro-inflammatory M1 phenotype that suppresses tumor growth or an anti-inflammatory M2 phenotype that promotes progression. Reprogramming macrophages toward the M1 phenotype is a therapeutic strategy. Previous studies showed that 4-Fluorophenylacetamide-acetyl coumarin (4-FPAC), a synthetic coumarin derivative, exhibits cytostatic activity in A549 lung carcinoma cells by modulating reactive oxygen species (ROS), nitric oxide synthase, and signaling pathways, including PI3K/AKT/NF-\u03baB. This study evaluates the impact of 4-FPAC on macrophage polarization.'}, {'title': 'Cell-intrinsic insulin signaling defects in human iPS cell-derived hepatocytes in type 2 diabetes.', 'abstract': 'Hepatic insulin resistance is central to type 2 diabetes (T2D) and metabolic syndrome, but defining the molecular basis of this defect in humans is challenging because of limited tissue access. Utilizing inducible pluripotent stem cells differentiated into hepatocytes from control individuals and patients with T2D and liquid chromatography with tandem mass spectrometry-based (LC-MS/MS-based) phosphoproteomics analysis, we identified a large network of cell-intrinsic alterations in signaling in T2D. Over 300 phosphosites showed impaired or reduced insulin signaling, including losses in the classical insulin-stimulated PI3K/AKT cascade and their downstream targets. In addition, we identified over 500 phosphosites of emergent, i.e., new or enhanced, signaling. These occurred on proteins involved in the Rho-GTPase pathway, RNA metabolism, vesicle trafficking, and chromatin modification. Kinome analysis indicated that the impaired phosphorylation sites represented reduced actions of AKT2/3, PKC\u03b8, CHK2, PHKG2, and/or STK32C kinases. By contrast, the emergent phosphorylation sites were predicted to be mediated by increased action of the Rho-associated kinases 1 and 2 (ROCK1/2), mammalian STE20-like protein kinase 4 (MST4), and/or branched-chain \u03b1-ketoacid dehydrogenase kinase (BCKDK). Inhibiting ROCK1/2 activity in T2D induced pluripotent stem cell-derived hepatocytes restored some of the alterations in insulin action. Thus, insulin resistance in the liver in T2D did not simply involve a loss of canonical insulin signaling but the also appearance of new phosphorylations representing a change in the balance of multiple kinases. Together, these led to altered insulin action in the liver and identified important targets for the therapy of hepatic insulin resistance.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2431"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P30838', 'features': [{'type': 'Active site', 'location': {'start': {'value': 210, 'modifier': 'EXACT'}, 'end': {'value': 210, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22021038'}]}, {'type': 'Active site', 'location': {'start': {'value': 244, 'modifier': 'EXACT'}, 'end': {'value': 244, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22021038'}]}, {'type': 'Binding site', 'location': {'start': {'value': 188, 'modifier': 'EXACT'}, 'end': {'value': 193, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57540'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'NAD(+)', 'id': 'ChEBI:CHEBI:57540'}}], 'extraAttributes': {'uniParcId': 'UPI000013C87C'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Br.N=C(N)SCc1ccc(CN2C(=O)C(=O)c3cc(Br)cc(Br)c32)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '193.0', 'CHEMBLID': 'CHEMBL4708028', 'description': 'Inhibition of ALDH3A1 (unknown origin) assessed as NADH formation using 4-nitrobenzaldehyde as substrate'}, {'\u5206\u5b50SMILES': 'Cc1nc2ccccc2n1S(=O)(=O)c1ccc(F)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '200.0', 'CHEMBLID': 'CHEMBL3118331', 'description': 'Inhibition of human ALDH3A1-mediated benzaldehyde oxidation preincubated for 1 min followed by substrate addition by spectrophotometric analysis'}, {'\u5206\u5b50SMILES': 'Cc1nc2ccccc2n1S(=O)(=O)c1ccc(F)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '200.0', 'CHEMBLID': 'CHEMBL3887164', 'description': 'Inhibiton Assay: IC50 values were determined for CB29 and its analogs using propionaldehyde as the substrate for ALDH1A1 and ALDH2 or benzaldehyde as the substrate for ALDH3A1. The assays were performed on a Beckman DU-640 spectrophotometer at various concentrations of inhibitors ranging from 50 nM to 250 \u03bcM following a 1 minute pre-incubation. There was no pre-incubation time-dependence to the inhibition. All reactions were initiated by the addition of the aldehyde substrate. The inhibition curves were fit to the Logistic four parameter IC50 equation using the SigmaPlot (v11, StatSys). We characterized the mode of inhibition using steady-state kinetics through co-variation of inhibitor and substrate concentrations. The steady state kinetic measurements were performed in 100 mM Na2HPO4 buffer, pH 7.5. The reaction mixture contained 10 nM ALDH3A1, varied benzaldehyde (50 \u03bcM-800 \u03bcM; fixed NADP+, 1.5 mM) and varied inhibitor concentrations. In all cases\u2212including the control reactions lacking inhibitors, the final reaction mixture contained 2% (v/v) DMSO. The reaction was initiated by addition of substrate and the initial rate of product formation was determined on a Beckman DU-640.'}, {'\u5206\u5b50SMILES': 'Br.N=C(N)SCc1ccc(CN2C(=O)C(=O)c3cc(Cl)cc(Cl)c32)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '219.0', 'CHEMBLID': 'CHEMBL4708028', 'description': 'Inhibition of ALDH3A1 (unknown origin) assessed as NADH formation using 4-nitrobenzaldehyde as substrate'}, {'\u5206\u5b50SMILES': 'Br.N=C(N)SCc1ccc(CN2C(=O)C(=O)c3cc(F)cc(Br)c32)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '219.0', 'CHEMBLID': 'CHEMBL4708028', 'description': 'Inhibition of ALDH3A1 (unknown origin) assessed as NADH formation using 4-nitrobenzaldehyde as substrate'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Proteomic analysis in pterygium; upregulated protein expression of ALDH3A1, PDIA3, and PRDX2.', 'abstract': 'To identify differentially expressed proteins in the pterygium compared to healthy conjunctiva using a proteomic analysis.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3578"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P02768', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 27, 'modifier': 'EXACT'}, 'end': {'value': 27, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:23378'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02770'}], 'ligand': {'name': 'Cu cation', 'id': 'ChEBI:CHEBI:23378'}}, {'type': 'Binding site', 'location': {'start': {'value': 30, 'modifier': 'EXACT'}, 'end': {'value': 30, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 37, 'modifier': 'EXACT'}, 'end': {'value': 37, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 91, 'modifier': 'EXACT'}, 'end': {'value': 91, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 264, 'modifier': 'EXACT'}, 'end': {'value': 264, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57977'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '656055'}], 'ligand': {'name': '(4Z,15Z)-bilirubin IXalpha', 'id': 'ChEBI:CHEBI:57977'}}, {'type': 'Binding site', 'location': {'start': {'value': 268, 'modifier': 'EXACT'}, 'end': {'value': 268, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 271, 'modifier': 'EXACT'}, 'end': {'value': 271, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 273, 'modifier': 'EXACT'}, 'end': {'value': 273, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 273, 'modifier': 'EXACT'}, 'end': {'value': 273, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 276, 'modifier': 'EXACT'}, 'end': {'value': 276, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 279, 'modifier': 'EXACT'}, 'end': {'value': 279, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 283, 'modifier': 'EXACT'}, 'end': {'value': 283, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Site', 'location': {'start': {'value': 28, 'modifier': 'EXACT'}, 'end': {'value': 28, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 44, 'modifier': 'EXACT'}, 'end': {'value': 44, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 65, 'modifier': 'EXACT'}, 'end': {'value': 65, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 88, 'modifier': 'EXACT'}, 'end': {'value': 88, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 97, 'modifier': 'EXACT'}, 'end': {'value': 97, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 130, 'modifier': 'EXACT'}, 'end': {'value': 130, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 160, 'modifier': 'EXACT'}, 'end': {'value': 160, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 183, 'modifier': 'EXACT'}, 'end': {'value': 183, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 198, 'modifier': 'EXACT'}, 'end': {'value': 198, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 205, 'modifier': 'EXACT'}, 'end': {'value': 205, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 214, 'modifier': 'EXACT'}, 'end': {'value': 214, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 219, 'modifier': 'EXACT'}, 'end': {'value': 219, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 223, 'modifier': 'EXACT'}, 'end': {'value': 223, 'modifier': 'EXACT'}}, 'description': 'Aspirin-acetylated lysine'}, {'type': 'Site', 'location': {'start': {'value': 229, 'modifier': 'EXACT'}, 'end': {'value': 229, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 236, 'modifier': 'EXACT'}, 'end': {'value': 236, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 264, 'modifier': 'EXACT'}, 'end': {'value': 264, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 286, 'modifier': 'EXACT'}, 'end': {'value': 286, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 298, 'modifier': 'EXACT'}, 'end': {'value': 298, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 310, 'modifier': 'EXACT'}, 'end': {'value': 310, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 383, 'modifier': 'EXACT'}, 'end': {'value': 383, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 396, 'modifier': 'EXACT'}, 'end': {'value': 396, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 413, 'modifier': 'EXACT'}, 'end': {'value': 413, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 426, 'modifier': 'EXACT'}, 'end': {'value': 426, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 438, 'modifier': 'EXACT'}, 'end': {'value': 438, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 456, 'modifier': 'EXACT'}, 'end': {'value': 456, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 460, 'modifier': 'EXACT'}, 'end': {'value': 460, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 490, 'modifier': 'EXACT'}, 'end': {'value': 490, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 499, 'modifier': 'EXACT'}, 'end': {'value': 499, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 524, 'modifier': 'EXACT'}, 'end': {'value': 524, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 543, 'modifier': 'EXACT'}, 'end': {'value': 543, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 548, 'modifier': 'EXACT'}, 'end': {'value': 548, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 562, 'modifier': 'EXACT'}, 'end': {'value': 562, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 565, 'modifier': 'EXACT'}, 'end': {'value': 565, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 581, 'modifier': 'EXACT'}, 'end': {'value': 581, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 584, 'modifier': 'EXACT'}, 'end': {'value': 584, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 588, 'modifier': 'EXACT'}, 'end': {'value': 588, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 598, 'modifier': 'EXACT'}, 'end': {'value': 598, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}], 'extraAttributes': {'uniParcId': 'UPI000002C1AC'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '19000.0', 'CHEMBLID': 'CHEMBL804547', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 3.0 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '23000.0', 'CHEMBLID': 'CHEMBL804546', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 2.1 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '43000.0', 'CHEMBLID': 'CHEMBL808311', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 1.3 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '80000.0', 'CHEMBLID': 'CHEMBL808310', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 0.7 M of FMS'}, {'\u5206\u5b50SMILES': '[N-]=[N+]=NC(F)(F)C(Cl)Br', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '300000.0', 'CHEMBLID': 'CHEMBL880920', 'description': 'Inhibitory concentration bound to tryptophan containing region of Serum albumin in fluorescence quenching'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Clinical significance of serum irisin, 25(OH)D3 and albumin in older adults with chronic disease and sarcopenia.', 'abstract': 'Sarcopenia, characterized by progressive muscle mass and strength decline, poses a significant health challenge among older adults, especially those with chronic diseases. Our study aims to evaluate the combined diagnostic potential of irisin, 25(OH)D3, and albumin for sarcopenia in older patients with chronic conditions.'}, {'title': 'The Role of Antipsychotic Medications on Metabolic and Hematological Parameters.', 'abstract': '\\xa0Psychiatric disorders, including schizophrenia, bipolar disorder, and drug-induced psychosis, are associated with significant biochemical and hematological alterations. Antipsychotic medications, particularly second-generation antipsychotics, have been implicated in metabolic disturbances, hormonal imbalances, and hematological changes.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3253"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P02768', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 27, 'modifier': 'EXACT'}, 'end': {'value': 27, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:23378'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02770'}], 'ligand': {'name': 'Cu cation', 'id': 'ChEBI:CHEBI:23378'}}, {'type': 'Binding site', 'location': {'start': {'value': 30, 'modifier': 'EXACT'}, 'end': {'value': 30, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 37, 'modifier': 'EXACT'}, 'end': {'value': 37, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 91, 'modifier': 'EXACT'}, 'end': {'value': 91, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 264, 'modifier': 'EXACT'}, 'end': {'value': 264, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57977'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '656055'}], 'ligand': {'name': '(4Z,15Z)-bilirubin IXalpha', 'id': 'ChEBI:CHEBI:57977'}}, {'type': 'Binding site', 'location': {'start': {'value': 268, 'modifier': 'EXACT'}, 'end': {'value': 268, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 271, 'modifier': 'EXACT'}, 'end': {'value': 271, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 273, 'modifier': 'EXACT'}, 'end': {'value': 273, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 273, 'modifier': 'EXACT'}, 'end': {'value': 273, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 276, 'modifier': 'EXACT'}, 'end': {'value': 276, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 279, 'modifier': 'EXACT'}, 'end': {'value': 279, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 283, 'modifier': 'EXACT'}, 'end': {'value': 283, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Site', 'location': {'start': {'value': 28, 'modifier': 'EXACT'}, 'end': {'value': 28, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 44, 'modifier': 'EXACT'}, 'end': {'value': 44, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 65, 'modifier': 'EXACT'}, 'end': {'value': 65, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 88, 'modifier': 'EXACT'}, 'end': {'value': 88, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 97, 'modifier': 'EXACT'}, 'end': {'value': 97, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 130, 'modifier': 'EXACT'}, 'end': {'value': 130, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 160, 'modifier': 'EXACT'}, 'end': {'value': 160, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 183, 'modifier': 'EXACT'}, 'end': {'value': 183, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 198, 'modifier': 'EXACT'}, 'end': {'value': 198, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 205, 'modifier': 'EXACT'}, 'end': {'value': 205, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 214, 'modifier': 'EXACT'}, 'end': {'value': 214, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 219, 'modifier': 'EXACT'}, 'end': {'value': 219, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 223, 'modifier': 'EXACT'}, 'end': {'value': 223, 'modifier': 'EXACT'}}, 'description': 'Aspirin-acetylated lysine'}, {'type': 'Site', 'location': {'start': {'value': 229, 'modifier': 'EXACT'}, 'end': {'value': 229, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 236, 'modifier': 'EXACT'}, 'end': {'value': 236, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 264, 'modifier': 'EXACT'}, 'end': {'value': 264, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 286, 'modifier': 'EXACT'}, 'end': {'value': 286, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 298, 'modifier': 'EXACT'}, 'end': {'value': 298, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 310, 'modifier': 'EXACT'}, 'end': {'value': 310, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 383, 'modifier': 'EXACT'}, 'end': {'value': 383, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 396, 'modifier': 'EXACT'}, 'end': {'value': 396, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 413, 'modifier': 'EXACT'}, 'end': {'value': 413, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 426, 'modifier': 'EXACT'}, 'end': {'value': 426, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 438, 'modifier': 'EXACT'}, 'end': {'value': 438, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 456, 'modifier': 'EXACT'}, 'end': {'value': 456, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 460, 'modifier': 'EXACT'}, 'end': {'value': 460, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 490, 'modifier': 'EXACT'}, 'end': {'value': 490, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 499, 'modifier': 'EXACT'}, 'end': {'value': 499, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 524, 'modifier': 'EXACT'}, 'end': {'value': 524, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 543, 'modifier': 'EXACT'}, 'end': {'value': 543, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 548, 'modifier': 'EXACT'}, 'end': {'value': 548, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 562, 'modifier': 'EXACT'}, 'end': {'value': 562, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 565, 'modifier': 'EXACT'}, 'end': {'value': 565, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 581, 'modifier': 'EXACT'}, 'end': {'value': 581, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 584, 'modifier': 'EXACT'}, 'end': {'value': 584, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 588, 'modifier': 'EXACT'}, 'end': {'value': 588, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 598, 'modifier': 'EXACT'}, 'end': {'value': 598, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}], 'extraAttributes': {'uniParcId': 'UPI000002C1AC'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '19000.0', 'CHEMBLID': 'CHEMBL804547', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 3.0 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '23000.0', 'CHEMBLID': 'CHEMBL804546', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 2.1 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '43000.0', 'CHEMBLID': 'CHEMBL808311', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 1.3 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '80000.0', 'CHEMBLID': 'CHEMBL808310', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 0.7 M of FMS'}, {'\u5206\u5b50SMILES': '[N-]=[N+]=NC(F)(F)C(Cl)Br', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '300000.0', 'CHEMBLID': 'CHEMBL880920', 'description': 'Inhibitory concentration bound to tryptophan containing region of Serum albumin in fluorescence quenching'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Clinical significance of serum irisin, 25(OH)D3 and albumin in older adults with chronic disease and sarcopenia.', 'abstract': 'Sarcopenia, characterized by progressive muscle mass and strength decline, poses a significant health challenge among older adults, especially those with chronic diseases. Our study aims to evaluate the combined diagnostic potential of irisin, 25(OH)D3, and albumin for sarcopenia in older patients with chronic conditions.'}, {'title': 'The Role of Antipsychotic Medications on Metabolic and Hematological Parameters.', 'abstract': '\\xa0Psychiatric disorders, including schizophrenia, bipolar disorder, and drug-induced psychosis, are associated with significant biochemical and hematological alterations. Antipsychotic medications, particularly second-generation antipsychotics, have been implicated in metabolic disturbances, hormonal imbalances, and hematological changes.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3253"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P02768', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 27, 'modifier': 'EXACT'}, 'end': {'value': 27, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:23378'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02770'}], 'ligand': {'name': 'Cu cation', 'id': 'ChEBI:CHEBI:23378'}}, {'type': 'Binding site', 'location': {'start': {'value': 30, 'modifier': 'EXACT'}, 'end': {'value': 30, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 37, 'modifier': 'EXACT'}, 'end': {'value': 37, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 91, 'modifier': 'EXACT'}, 'end': {'value': 91, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 264, 'modifier': 'EXACT'}, 'end': {'value': 264, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57977'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '656055'}], 'ligand': {'name': '(4Z,15Z)-bilirubin IXalpha', 'id': 'ChEBI:CHEBI:57977'}}, {'type': 'Binding site', 'location': {'start': {'value': 268, 'modifier': 'EXACT'}, 'end': {'value': 268, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 271, 'modifier': 'EXACT'}, 'end': {'value': 271, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 273, 'modifier': 'EXACT'}, 'end': {'value': 273, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 273, 'modifier': 'EXACT'}, 'end': {'value': 273, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 276, 'modifier': 'EXACT'}, 'end': {'value': 276, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 279, 'modifier': 'EXACT'}, 'end': {'value': 279, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 283, 'modifier': 'EXACT'}, 'end': {'value': 283, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Site', 'location': {'start': {'value': 28, 'modifier': 'EXACT'}, 'end': {'value': 28, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 44, 'modifier': 'EXACT'}, 'end': {'value': 44, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 65, 'modifier': 'EXACT'}, 'end': {'value': 65, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 88, 'modifier': 'EXACT'}, 'end': {'value': 88, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 97, 'modifier': 'EXACT'}, 'end': {'value': 97, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 130, 'modifier': 'EXACT'}, 'end': {'value': 130, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 160, 'modifier': 'EXACT'}, 'end': {'value': 160, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 183, 'modifier': 'EXACT'}, 'end': {'value': 183, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 198, 'modifier': 'EXACT'}, 'end': {'value': 198, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 205, 'modifier': 'EXACT'}, 'end': {'value': 205, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 214, 'modifier': 'EXACT'}, 'end': {'value': 214, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 219, 'modifier': 'EXACT'}, 'end': {'value': 219, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 223, 'modifier': 'EXACT'}, 'end': {'value': 223, 'modifier': 'EXACT'}}, 'description': 'Aspirin-acetylated lysine'}, {'type': 'Site', 'location': {'start': {'value': 229, 'modifier': 'EXACT'}, 'end': {'value': 229, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 236, 'modifier': 'EXACT'}, 'end': {'value': 236, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 264, 'modifier': 'EXACT'}, 'end': {'value': 264, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 286, 'modifier': 'EXACT'}, 'end': {'value': 286, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 298, 'modifier': 'EXACT'}, 'end': {'value': 298, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 310, 'modifier': 'EXACT'}, 'end': {'value': 310, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 383, 'modifier': 'EXACT'}, 'end': {'value': 383, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 396, 'modifier': 'EXACT'}, 'end': {'value': 396, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 413, 'modifier': 'EXACT'}, 'end': {'value': 413, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 426, 'modifier': 'EXACT'}, 'end': {'value': 426, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 438, 'modifier': 'EXACT'}, 'end': {'value': 438, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 456, 'modifier': 'EXACT'}, 'end': {'value': 456, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 460, 'modifier': 'EXACT'}, 'end': {'value': 460, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 490, 'modifier': 'EXACT'}, 'end': {'value': 490, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 499, 'modifier': 'EXACT'}, 'end': {'value': 499, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 524, 'modifier': 'EXACT'}, 'end': {'value': 524, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 543, 'modifier': 'EXACT'}, 'end': {'value': 543, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 548, 'modifier': 'EXACT'}, 'end': {'value': 548, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 562, 'modifier': 'EXACT'}, 'end': {'value': 562, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 565, 'modifier': 'EXACT'}, 'end': {'value': 565, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 581, 'modifier': 'EXACT'}, 'end': {'value': 581, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 584, 'modifier': 'EXACT'}, 'end': {'value': 584, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 588, 'modifier': 'EXACT'}, 'end': {'value': 588, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 598, 'modifier': 'EXACT'}, 'end': {'value': 598, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}], 'extraAttributes': {'uniParcId': 'UPI000002C1AC'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '19000.0', 'CHEMBLID': 'CHEMBL804547', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 3.0 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '23000.0', 'CHEMBLID': 'CHEMBL804546', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 2.1 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '43000.0', 'CHEMBLID': 'CHEMBL808311', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 1.3 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '80000.0', 'CHEMBLID': 'CHEMBL808310', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 0.7 M of FMS'}, {'\u5206\u5b50SMILES': '[N-]=[N+]=NC(F)(F)C(Cl)Br', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '300000.0', 'CHEMBLID': 'CHEMBL880920', 'description': 'Inhibitory concentration bound to tryptophan containing region of Serum albumin in fluorescence quenching'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Clinical significance of serum irisin, 25(OH)D3 and albumin in older adults with chronic disease and sarcopenia.', 'abstract': 'Sarcopenia, characterized by progressive muscle mass and strength decline, poses a significant health challenge among older adults, especially those with chronic diseases. Our study aims to evaluate the combined diagnostic potential of irisin, 25(OH)D3, and albumin for sarcopenia in older patients with chronic conditions.'}, {'title': 'The Role of Antipsychotic Medications on Metabolic and Hematological Parameters.', 'abstract': '\\xa0Psychiatric disorders, including schizophrenia, bipolar disorder, and drug-induced psychosis, are associated with significant biochemical and hematological alterations. Antipsychotic medications, particularly second-generation antipsychotics, have been implicated in metabolic disturbances, hormonal imbalances, and hematological changes.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3253"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P02768', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 27, 'modifier': 'EXACT'}, 'end': {'value': 27, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:23378'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02770'}], 'ligand': {'name': 'Cu cation', 'id': 'ChEBI:CHEBI:23378'}}, {'type': 'Binding site', 'location': {'start': {'value': 30, 'modifier': 'EXACT'}, 'end': {'value': 30, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 37, 'modifier': 'EXACT'}, 'end': {'value': 37, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 91, 'modifier': 'EXACT'}, 'end': {'value': 91, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 264, 'modifier': 'EXACT'}, 'end': {'value': 264, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57977'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '656055'}], 'ligand': {'name': '(4Z,15Z)-bilirubin IXalpha', 'id': 'ChEBI:CHEBI:57977'}}, {'type': 'Binding site', 'location': {'start': {'value': 268, 'modifier': 'EXACT'}, 'end': {'value': 268, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 271, 'modifier': 'EXACT'}, 'end': {'value': 271, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 273, 'modifier': 'EXACT'}, 'end': {'value': 273, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 273, 'modifier': 'EXACT'}, 'end': {'value': 273, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '28567254'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5IJF'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 276, 'modifier': 'EXACT'}, 'end': {'value': 276, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 279, 'modifier': 'EXACT'}, 'end': {'value': 279, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 283, 'modifier': 'EXACT'}, 'end': {'value': 283, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P02769'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Site', 'location': {'start': {'value': 28, 'modifier': 'EXACT'}, 'end': {'value': 28, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 44, 'modifier': 'EXACT'}, 'end': {'value': 44, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 65, 'modifier': 'EXACT'}, 'end': {'value': 65, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 88, 'modifier': 'EXACT'}, 'end': {'value': 88, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 97, 'modifier': 'EXACT'}, 'end': {'value': 97, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 130, 'modifier': 'EXACT'}, 'end': {'value': 130, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 160, 'modifier': 'EXACT'}, 'end': {'value': 160, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 183, 'modifier': 'EXACT'}, 'end': {'value': 183, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 198, 'modifier': 'EXACT'}, 'end': {'value': 198, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 205, 'modifier': 'EXACT'}, 'end': {'value': 205, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 214, 'modifier': 'EXACT'}, 'end': {'value': 214, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 219, 'modifier': 'EXACT'}, 'end': {'value': 219, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 223, 'modifier': 'EXACT'}, 'end': {'value': 223, 'modifier': 'EXACT'}}, 'description': 'Aspirin-acetylated lysine'}, {'type': 'Site', 'location': {'start': {'value': 229, 'modifier': 'EXACT'}, 'end': {'value': 229, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 236, 'modifier': 'EXACT'}, 'end': {'value': 236, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 264, 'modifier': 'EXACT'}, 'end': {'value': 264, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 286, 'modifier': 'EXACT'}, 'end': {'value': 286, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 298, 'modifier': 'EXACT'}, 'end': {'value': 298, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 310, 'modifier': 'EXACT'}, 'end': {'value': 310, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 383, 'modifier': 'EXACT'}, 'end': {'value': 383, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 396, 'modifier': 'EXACT'}, 'end': {'value': 396, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 413, 'modifier': 'EXACT'}, 'end': {'value': 413, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 426, 'modifier': 'EXACT'}, 'end': {'value': 426, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 438, 'modifier': 'EXACT'}, 'end': {'value': 438, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 456, 'modifier': 'EXACT'}, 'end': {'value': 456, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 460, 'modifier': 'EXACT'}, 'end': {'value': 460, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 490, 'modifier': 'EXACT'}, 'end': {'value': 490, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 499, 'modifier': 'EXACT'}, 'end': {'value': 499, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 524, 'modifier': 'EXACT'}, 'end': {'value': 524, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 543, 'modifier': 'EXACT'}, 'end': {'value': 543, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 548, 'modifier': 'EXACT'}, 'end': {'value': 548, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 562, 'modifier': 'EXACT'}, 'end': {'value': 562, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 565, 'modifier': 'EXACT'}, 'end': {'value': 565, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 581, 'modifier': 'EXACT'}, 'end': {'value': 581, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 584, 'modifier': 'EXACT'}, 'end': {'value': 584, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 588, 'modifier': 'EXACT'}, 'end': {'value': 588, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}, {'type': 'Site', 'location': {'start': {'value': 598, 'modifier': 'EXACT'}, 'end': {'value': 598, 'modifier': 'EXACT'}}, 'description': 'Not glycated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15047055'}]}], 'extraAttributes': {'uniParcId': 'UPI000002C1AC'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '19000.0', 'CHEMBLID': 'CHEMBL804547', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 3.0 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '23000.0', 'CHEMBLID': 'CHEMBL804546', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 2.1 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '43000.0', 'CHEMBLID': 'CHEMBL808311', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 1.3 M of FMS'}, {'\u5206\u5b50SMILES': 'CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '80000.0', 'CHEMBLID': 'CHEMBL808310', 'description': 'Evaluated for inhibition of Serum albumin evoked PNPA hydrolysis in presence of 0.7 M of FMS'}, {'\u5206\u5b50SMILES': '[N-]=[N+]=NC(F)(F)C(Cl)Br', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '300000.0', 'CHEMBLID': 'CHEMBL880920', 'description': 'Inhibitory concentration bound to tryptophan containing region of Serum albumin in fluorescence quenching'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Clinical significance of serum irisin, 25(OH)D3 and albumin in older adults with chronic disease and sarcopenia.', 'abstract': 'Sarcopenia, characterized by progressive muscle mass and strength decline, poses a significant health challenge among older adults, especially those with chronic diseases. Our study aims to evaluate the combined diagnostic potential of irisin, 25(OH)D3, and albumin for sarcopenia in older patients with chronic conditions.'}, {'title': 'The Role of Antipsychotic Medications on Metabolic and Hematological Parameters.', 'abstract': '\\xa0Psychiatric disorders, including schizophrenia, bipolar disorder, and drug-induced psychosis, are associated with significant biochemical and hematological alterations. Antipsychotic medications, particularly second-generation antipsychotics, have been implicated in metabolic disturbances, hormonal imbalances, and hematological changes.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3253"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P05091', 'features': [{'type': 'Active site', 'location': {'start': {'value': 285, 'modifier': 'EXACT'}, 'end': {'value': 285, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor'}, {'type': 'Active site', 'location': {'start': {'value': 319, 'modifier': 'EXACT'}, 'end': {'value': 319, 'modifier': 'EXACT'}}, 'description': 'Nucleophile'}, {'type': 'Binding site', 'location': {'start': {'value': 262, 'modifier': 'EXACT'}, 'end': {'value': 267, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57540'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'NAD(+)', 'id': 'ChEBI:CHEBI:57540'}}, {'type': 'Site', 'location': {'start': {'value': 186, 'modifier': 'EXACT'}, 'end': {'value': 186, 'modifier': 'EXACT'}}, 'description': 'Transition state stabilizer', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P20000'}]}], 'extraAttributes': {'uniParcId': 'UPI0000129293'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CN(C(=O)OC(C)(C)C)C1(C(=O)N2CC(C#Cc3ccc4c(=O)c(-c5ccc(NS(C)(=O)=O)cc5)coc4c3)C2)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '2.3', 'CHEMBLID': 'CHEMBL3705108', 'description': 'ALDH2 Assay: Standard ALDH2 reaction mixtures contained 150 uM formaldehyde, 2.5 mM NAD+, 10 mM MgCl2 and 10 nM recombinant human ALDH2 in 50 mM Hepes buffer, pH 7.4, 0.01% Tween 20 in a final volume of 50 ul using 384-well plates. After 60 min of pre-incubation of compound with ALDH2 and formaldehyde, the reaction was started by adding NAD+ and the reaction mixture was allowed to proceed for 90 minutes. Activity of the enzyme was determined by monitoring NADH formation using Perkin-Elmer Envision Reader with excitation and emission wavelengths set at 340 and 460 nm, respectively.'}, {'\u5206\u5b50SMILES': 'O=C(O)CCCCCCCCCCOc1ccc2c(=O)c(-c3ccc(O)cc3)coc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.0', 'CHEMBLID': 'CHEMBL641008', 'description': 'Inhibition of Hamster Liver mitochondrial ALDH-2'}, {'\u5206\u5b50SMILES': 'CS(=O)(=O)Nc1ccc(-c2coc3cc(C#CC4CN(C(=O)C5CCC5)C4)ccc3c2=O)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.0', 'CHEMBLID': 'CHEMBL3705108', 'description': 'ALDH2 Assay: Standard ALDH2 reaction mixtures contained 150 uM formaldehyde, 2.5 mM NAD+, 10 mM MgCl2 and 10 nM recombinant human ALDH2 in 50 mM Hepes buffer, pH 7.4, 0.01% Tween 20 in a final volume of 50 ul using 384-well plates. After 60 min of pre-incubation of compound with ALDH2 and formaldehyde, the reaction was started by adding NAD+ and the reaction mixture was allowed to proceed for 90 minutes. Activity of the enzyme was determined by monitoring NADH formation using Perkin-Elmer Envision Reader with excitation and emission wavelengths set at 340 and 460 nm, respectively.'}, {'\u5206\u5b50SMILES': 'O=C(O)CCCCCCCCCOc1ccc2c(=O)c(-c3ccc(O)cc3)coc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.0', 'CHEMBLID': 'CHEMBL641008', 'description': 'Inhibition of Hamster Liver mitochondrial ALDH-2'}, {'\u5206\u5b50SMILES': 'Cn1cncc1C#Cc1ccc2c(=O)c(-c3ccc(CN[SH](=O)=O)cc3)coc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.9', 'CHEMBLID': 'CHEMBL3705108', 'description': 'ALDH2 Assay: Standard ALDH2 reaction mixtures contained 150 uM formaldehyde, 2.5 mM NAD+, 10 mM MgCl2 and 10 nM recombinant human ALDH2 in 50 mM Hepes buffer, pH 7.4, 0.01% Tween 20 in a final volume of 50 ul using 384-well plates. After 60 min of pre-incubation of compound with ALDH2 and formaldehyde, the reaction was started by adding NAD+ and the reaction mixture was allowed to proceed for 90 minutes. Activity of the enzyme was determined by monitoring NADH formation using Perkin-Elmer Envision Reader with excitation and emission wavelengths set at 340 and 460 nm, respectively.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Diethyldithiocarbamate-Cu', 'abstract': 'Targeting cancer stem cells (CSCs)-mediated aggressive features of non-small cell lung cancer (NSCLC) is a promising anticancer approach. This can be accomplished via suppressing critical mediators, such as functional mitochondria, aldehyde dehydrogenase (ALDH)1A, and telomere protectors (telomerase reverse transcriptase (TERT) and telomere repeat binding factor (TRF)1).'}, {'title': 'Engineering ', 'abstract': 'Perillyl alcohol is a widely utilized antitumor agent in cancer therapy. Due to the limitations associated with chemical synthesis and plant extraction methods, bioengineering microorganisms for the production of perillyl alcohol and its precursor limonene offers a more scalable and industrially compatible approach. In this study, we present the design of an '}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1935"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P15121', 'features': [{'type': 'Active site', 'location': {'start': {'value': 49, 'modifier': 'EXACT'}, 'end': {'value': 49, 'modifier': 'EXACT'}}, 'description': 'Proton donor', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15272156'}]}, {'type': 'Binding site', 'location': {'start': {'value': 10, 'modifier': 'EXACT'}, 'end': {'value': 19, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000255'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Binding site', 'location': {'start': {'value': 111, 'modifier': 'EXACT'}, 'end': {'value': 111, 'modifier': 'EXACT'}}, 'description': '', 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 211, 'modifier': 'EXACT'}, 'end': {'value': 273, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:58349'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15146478'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15272156'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16337231'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17368668'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17418233'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17505104'}], 'ligand': {'name': 'NADP(+)', 'id': 'ChEBI:CHEBI:58349'}}, {'type': 'Site', 'location': {'start': {'value': 78, 'modifier': 'EXACT'}, 'end': {'value': 78, 'modifier': 'EXACT'}}, 'description': 'Lowers pKa of active site Tyr'}], 'extraAttributes': {'uniParcId': 'UPI000000D78E'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC(/C=C1\\\\SC(=S)N(CC(=O)O)C1=O)=C\\\\c1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03', 'CHEMBLID': 'CHEMBL1020264', 'description': 'Inhibition of human muscle recombinant aldose reductase by spectrophotometry'}, {'\u5206\u5b50SMILES': 'Oc1cc(Br)c(COCc2c(Br)c(O)c(O)c(Br)c2Br)c(Br)c1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.11', 'CHEMBLID': 'CHEMBL1020264', 'description': 'Inhibition of human muscle recombinant aldose reductase by spectrophotometry'}, {'\u5206\u5b50SMILES': 'O=C(O)CN1C(=O)S/C(=C/c2cccc([N+](=O)[O-])c2)C1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.13', 'CHEMBLID': 'CHEMBL3056339', 'description': 'Inhibition of aldose reductase (unknown origin)'}, {'\u5206\u5b50SMILES': 'O=C1NC(=O)/C(=C\\\\c2cccc(O)c2)S1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.15', 'CHEMBLID': 'CHEMBL3056339', 'description': 'Inhibition of aldose reductase (unknown origin)'}, {'\u5206\u5b50SMILES': 'O=C(O)CN1C(=O)S/C(=C\\\\c2ccc(Oc3ccccc3)cc2)C1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.17', 'CHEMBLID': 'CHEMBL3056339', 'description': 'Inhibition of aldose reductase (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Dissect Gender-Dependent Susceptibility SNPs in Progressive Osteoarthritis Using Regulator Motif Candidate of Genetic Association Strategy (RMCGA).', 'abstract': 'The role of gender in osteoarthritis (OA) has been reported. However, knowledge on whether gender-specific regulatory SNPs are determining factors in OA is limited. We aimed to identify susceptible gender-specific SNPs of transcription factor binding sites in OA. We used a modified NF-\u03baB binding motif from an RNA sequencing data-inferred OA-associated upstream regulator to define genome-wide potential NF-\u03baB binding sites, which were aligned to the Taiwan BioBank SNP database to identify susceptible SNPs. A case-control study was conducted to verify SNPs with OA determined by a logistic model. The functional assessment was validated using the Genotype-Tissue Expression Portal database. We collected 533 OA patients and 614 healthy controls. Two of nine novel OA-associated SNPs were identified to be significant. For males, the variant of rs73164856 in the aldose reductase gene enhancer was identified to be a protective factor of severe OA patients [odds ratio (OR): 0.17, 95% confidence interval (CI): 0.04-0.73]. For females, the variant of the rs545654 in the neuronal NOS (nNOS) gene was identified to be a detrimental factor of severe OA patients (OR: 2.07, 95% CI: 1.15-3.73). The gene expression analysis demonstrated a lower expression of the AKR1B15 gene ('}, {'title': 'A mechanistic experimental and computational exploration of aldose reductase inhibition by coumarins from Ruta chalepensis.', 'abstract': 'Aldose reductase (AR), a key enzyme in the polyol pathway, contributes to diabetic complications through oxidative stress and cellular damage. We investigated the inhibitory potential of coumarins from Ruta chalepensis as AR inhibitors, combining experimental and computational approaches. Among studied coumarins, aegelinol demonstrated the strongest AR inhibition with a mixed inhibition mode (IC'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1900"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q9UM73', 'features': [{'type': 'Active site', 'location': {'start': {'value': 1249, 'modifier': 'EXACT'}, 'end': {'value': 1249, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10028'}]}, {'type': 'Binding site', 'location': {'start': {'value': 1124, 'modifier': 'EXACT'}, 'end': {'value': 1124, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 1150, 'modifier': 'EXACT'}, 'end': {'value': 1150, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 1197, 'modifier': 'EXACT'}, 'end': {'value': 1199, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 1270, 'modifier': 'EXACT'}, 'end': {'value': 1270, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20632993'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Site', 'location': {'start': {'value': 1057, 'modifier': 'EXACT'}, 'end': {'value': 1058, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form the EML4-ALK fusion protein (variant 1)', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17625570'}]}, {'type': 'Site', 'location': {'start': {'value': 1058, 'modifier': 'EXACT'}, 'end': {'value': 1059, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form the EML4-ALK fusion protein (variant 2)', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17625570'}]}], 'extraAttributes': {'uniParcId': 'UPI00001684DA'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.07', 'CHEMBLID': 'CHEMBL3824709', 'description': 'Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr'}, {'\u5206\u5b50SMILES': 'COc1nn(C)c2c1-c1cnc(N)c(n1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.11', 'CHEMBLID': 'CHEMBL3293163', 'description': 'Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA'}, {'\u5206\u5b50SMILES': 'CCP(=O)(CC)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2OC)ncc1Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.12', 'CHEMBLID': 'CHEMBL3824709', 'description': 'Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr'}, {'\u5206\u5b50SMILES': 'COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.15', 'CHEMBLID': 'CHEMBL3824709', 'description': 'Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr'}, {'\u5206\u5b50SMILES': 'CC1(C)c2cc(N3CCC(N)CC3)c(Br)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.168', 'CHEMBLID': 'CHEMBL3887074', 'description': 'Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Phase I/II Study of Tifcemalimab, an Anti-B and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer.', 'abstract': 'Tifcemalimab is a recombinant humanized IgG4k monoclonal antibody targeting B and T-lymphocyte attenuator (BTLA). Co-blockade of BTLA and programmed death-1 pathways improved outcomes in non-clinical models. This phase I/II trial evaluated the safety and preliminary efficacy of tifcemalimab plus toripalimab in advanced lung cancer.'}, {'title': 'Radiomic features and tumor immune microenvironment associated with anaplastic lymphoma kinase-rearranged lung adenocarcinoma and their prognostic value.', 'abstract': 'To identify radiomic features from preoperative computed tomography (CT) images and characteristics of the tumor immune microenvironment (TIME) associated with anaplastic lymphoma kinase ('}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4247"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P04746', 'features': [{'type': 'Active site', 'location': {'start': {'value': 212, 'modifier': 'EXACT'}, 'end': {'value': 212, 'modifier': 'EXACT'}}, 'description': 'Nucleophile', 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '10091666'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '10769135'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '11914097'}]}, {'type': 'Active site', 'location': {'start': {'value': 248, 'modifier': 'EXACT'}, 'end': {'value': 248, 'modifier': 'EXACT'}}, 'description': 'Proton donor', 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '10091666'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '10769135'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '11772019'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '11914097'}]}, {'type': 'Binding site', 'location': {'start': {'value': 115, 'modifier': 'EXACT'}, 'end': {'value': 115, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10091666'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10769135'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11772019'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '8528071'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1HNY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108'}}, {'type': 'Binding site', 'location': {'start': {'value': 173, 'modifier': 'EXACT'}, 'end': {'value': 173, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10091666'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10769135'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11772019'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '8528071'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1HNY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108'}}, {'type': 'Binding site', 'location': {'start': {'value': 182, 'modifier': 'EXACT'}, 'end': {'value': 182, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10091666'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10769135'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11772019'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '8528071'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1HNY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108'}}, {'type': 'Binding site', 'location': {'start': {'value': 210, 'modifier': 'EXACT'}, 'end': {'value': 210, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10091666'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10769135'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11772019'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '8528071'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1HNY'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996'}}, {'type': 'Binding site', 'location': {'start': {'value': 216, 'modifier': 'EXACT'}, 'end': {'value': 216, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10091666'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10769135'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11772019'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '8528071'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1HNY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108'}}, {'type': 'Binding site', 'location': {'start': {'value': 313, 'modifier': 'EXACT'}, 'end': {'value': 313, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10091666'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10769135'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11772019'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '8528071'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1HNY'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996'}}, {'type': 'Binding site', 'location': {'start': {'value': 352, 'modifier': 'EXACT'}, 'end': {'value': 352, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:17996'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10091666'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10769135'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '11772019'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '8528071'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1HNY'}], 'ligand': {'name': 'chloride', 'id': 'ChEBI:CHEBI:17996'}}, {'type': 'Site', 'location': {'start': {'value': 315, 'modifier': 'EXACT'}, 'end': {'value': 315, 'modifier': 'EXACT'}}, 'description': 'Transition state stabilizer', 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '10091666'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '10769135'}, {'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '11914097'}]}], 'extraAttributes': {'uniParcId': 'UPI0000000C80'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CCCC[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(S(=O)(=O)O)cc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)OCCc1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL649516', 'description': 'Tested in vitro for inhibition of amylase release from rat pancreatic acini'}, {'\u5206\u5b50SMILES': 'CCCC[C@H](NC(=O)[C@H](Cc1ccc(S(=O)(=O)O)cc1)NC(=O)OC(C)(C)C)C(=O)NCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@H](CCCCc1ccccc1)CC(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.5', 'CHEMBLID': 'CHEMBL649516', 'description': 'Tested in vitro for inhibition of amylase release from rat pancreatic acini'}, {'\u5206\u5b50SMILES': 'CCCC[C@H](NC(=O)[C@H](Cc1ccc(S(=O)(=O)O)cc1)NC(=O)OC(C)(C)C)C(=O)NCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@H](CCCOc1ccccc1)CC(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.0', 'CHEMBLID': 'CHEMBL649516', 'description': 'Tested in vitro for inhibition of amylase release from rat pancreatic acini'}, {'\u5206\u5b50SMILES': 'CCCC[C@H](NC(=O)[C@H](Cc1ccc(S(=O)(=O)O)cc1)NC(=O)OC(C)(C)C)C(=O)NCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CCCOc1ccccc1)CC(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '8.0', 'CHEMBLID': 'CHEMBL649516', 'description': 'Tested in vitro for inhibition of amylase release from rat pancreatic acini'}, {'\u5206\u5b50SMILES': 'C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1NC1=C[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '2590.0', 'CHEMBLID': 'CHEMBL3618755', 'description': 'Inhibition of human pancreatic alpha-amylase expressed in Pichia pastoris using amylase as substrate preincubated with substrate for 10 mins followed by protein addition measured every 5 mins'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Inhibition of human maltase-glucoamylase, sucrase-isomaltase and \u03b1-amylases by gallotannins and ellagitannins.', 'abstract': 'This research explored the inhibitory effects of walnut (Juglans regia) (poly)phenols on key starch digesting enzymes including human brush border \u03b1-glucosidases, maltase-glucoamylase (MGAM) and sucrase-isomaltase (SI), as well as pancreatic and salivary \u03b1-amylases. SI was obtained from Caco-2/TC7 cell-free extracts, while, for the first time, full-length MGAM was obtained from human A549 cell lysates. Among the tested gallo- and ellagitannins, 1,2,6-tri-O-galloyl-\u03b2-d-glucose and 1,3,4,6-tetra-O-galloyl-\u03b2-d-glucose were good inhibitors of human SI activity (IC'}, {'title': 'Nutritional and Functional Values of Grape Seed Flour and Extract for Production of Antioxidative Dietary Supplements and Functional Foods.', 'abstract': 'The potential of the seed flours and extracts of the red grapes Pinot Noir and Marselan for application as food additives and antioxidative dietary supplements was determined. The differences between the quality characteristics of the seeds, flour, and extracts of the two grape varieties were examined. The polyphenol composition and antioxidant potential of the two extracts were compared. The extracts were rich in polyphenols, especially flavonoids (52.01 mg QE/g DW) and procyanidins (152.18 mg CE/g DW). The nutritional composition of the flours and extracts was determined. It was found that the content of ash, crude protein, crude fat, and total dietary fibers in the flour from the studied grape seeds was about 1.5 times higher than that in the extracts. Only the carbohydrate content was 2-2.5 times higher in both extracts compared to that in the flours. The content of macro and microelements in the seed extracts and in the flours was high. The inhibitory potential of the two seed extracts on three key enzymes affecting diabetes and obesity-\u03b1-amylase, \u03b1-glucosidase, and pancreatic lipase-was studied. The highest degree of extract inhibition against \u03b1-glucosidase was determined (IC'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2045"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P10275', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 706, 'modifier': 'EXACT'}, 'end': {'value': 706, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16330'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15563469'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16641486'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17591767'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '25091737'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T5Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T63'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T65'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1XJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AM9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AMA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AMB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PKL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PNU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7J'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YHD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3X'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZQT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HLW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4K7A'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OED'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEY'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5JJM'}], 'ligand': {'name': '17beta-hydroxy-5alpha-androstan-3-one', 'id': 'ChEBI:CHEBI:16330'}}, {'type': 'Binding site', 'location': {'start': {'value': 753, 'modifier': 'EXACT'}, 'end': {'value': 753, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16330'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15563469'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16641486'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17591767'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '25091737'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T5Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T63'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T65'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1XJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AM9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AMA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PKL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7J'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YHD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Z4J'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3X'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZQT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HLW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4K7A'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OED'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEY'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5JJM'}], 'ligand': {'name': '17beta-hydroxy-5alpha-androstan-3-one', 'id': 'ChEBI:CHEBI:16330'}}, {'type': 'Binding site', 'location': {'start': {'value': 878, 'modifier': 'EXACT'}, 'end': {'value': 878, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16330'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15563469'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16641486'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17591767'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '25091737'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T5Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T63'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T65'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1XJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AM9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AMA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PKL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7J'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YHD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Z4J'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3X'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZQT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HLW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4K7A'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OED'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEY'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5JJM'}], 'ligand': {'name': '17beta-hydroxy-5alpha-androstan-3-one', 'id': 'ChEBI:CHEBI:16330'}}, {'type': 'Site', 'location': {'start': {'value': 721, 'modifier': 'EXACT'}, 'end': {'value': 721, 'modifier': 'EXACT'}}, 'description': 'Interaction with coactivator LXXL and FXXFY motifs', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '25091737'}]}, {'type': 'Site', 'location': {'start': {'value': 898, 'modifier': 'EXACT'}, 'end': {'value': 898, 'modifier': 'EXACT'}}, 'description': 'Interaction with coactivator FXXLF and FXXFY motifs', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '25091737'}]}], 'extraAttributes': {'uniParcId': 'UPI0000167B08'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0', 'CHEMBLID': 'CHEMBL648079', 'description': 'Antagonist activity against Human Androgen receptor expressed in CV-1 cells'}, {'\u5206\u5b50SMILES': 'C[C@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0', 'CHEMBLID': 'CHEMBL648079', 'description': 'Antagonist activity against Human Androgen receptor expressed in CV-1 cells'}, {'\u5206\u5b50SMILES': 'CCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.009', 'CHEMBLID': 'CHEMBL830982', 'description': 'Inhibition of AR-dimerization in CHO-K1 cells expressing human androgen receptor'}, {'\u5206\u5b50SMILES': 'N#Cc1ccc(-c2ccccc2O)cc1C(F)(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.02', 'CHEMBLID': 'CHEMBL899496', 'description': 'Antagonist activity at human AR in MDA-MB453-MMTV-luci cells by functional assay'}, {'\u5206\u5b50SMILES': 'N#Cc1ccc(-c2ccccc2O)cc1C(F)(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.02', 'CHEMBLID': 'CHEMBL1032460', 'description': 'Antagonist activity against human androgen receptor expressed in human MDA-MB-453 cells assessed as inhibition of dihydrotestosterone-induced effect by luciferase receptor gene assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Relugolix in Combination with Androgen Receptor Pathway Inhibitors in the Treatment of Metastatic Prostate Cancer: A Clinical Perspective.', 'abstract': 'Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, has been established as an effective androgen deprivation therapy (ADT) for advanced prostate cancer, offering advantages over traditional GnRH agonists. The combination of relugolix with androgen receptor pathway inhibitors (ARPIs) is increasingly utilized in clinical practice, necessitating an understanding of its pharmacokinetics, efficacy, safety, and drug-drug interactions. This review explores the real-world data and clinical studies evaluating relugolix coadministration with ARPIs, including enzalutamide, abiraterone, apalutamide, and darolutamide. Pharmacokinetic interactions, particularly via the CYP3A4 enzyme system and P-glycoprotein (P-gp) transporter, influence drug exposure and, in theory, necessitate dose adjustments in certain combinations. However, clinical studies and real-world studies suggest that relugolix maintains testosterone suppression when combined with ARPIs even if administered in a standard dose. While these findings support the efficacy and safety of relugolix-based combination therapy, further large-scale prospective trials are needed to refine treatment recommendations and provide information on long-term outcomes.'}, {'title': 'Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer.', 'abstract': 'Circulating tumor DNA (ctDNA) acts as an early biomarker of the efficacy of androgen receptor signaling inhibitor (ARSI) therapy. In this study, we aimed to reveal if ctDNA can supplement imaging to better predict metastasis burden and radiographic progression disease (PD) in metastatic castration-resistant prostate cancer (mCRPC).'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1871"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P10275', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 706, 'modifier': 'EXACT'}, 'end': {'value': 706, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16330'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15563469'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16641486'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17591767'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '25091737'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T5Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T63'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T65'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1XJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AM9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AMA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AMB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PKL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PNU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7J'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YHD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3X'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZQT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HLW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4K7A'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OED'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEY'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5JJM'}], 'ligand': {'name': '17beta-hydroxy-5alpha-androstan-3-one', 'id': 'ChEBI:CHEBI:16330'}}, {'type': 'Binding site', 'location': {'start': {'value': 753, 'modifier': 'EXACT'}, 'end': {'value': 753, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16330'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15563469'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16641486'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17591767'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '25091737'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T5Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T63'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T65'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1XJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AM9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AMA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PKL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7J'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YHD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Z4J'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3X'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZQT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HLW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4K7A'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OED'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEY'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5JJM'}], 'ligand': {'name': '17beta-hydroxy-5alpha-androstan-3-one', 'id': 'ChEBI:CHEBI:16330'}}, {'type': 'Binding site', 'location': {'start': {'value': 878, 'modifier': 'EXACT'}, 'end': {'value': 878, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16330'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15563469'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16641486'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17591767'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '25091737'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T5Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T63'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1T65'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1XJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AM9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AMA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PKL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7J'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Q7L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YHD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2YLQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Z4J'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3X'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3L3Z'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZQT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HLW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4K7A'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OED'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEY'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OEZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFR'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4OFU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5JJM'}], 'ligand': {'name': '17beta-hydroxy-5alpha-androstan-3-one', 'id': 'ChEBI:CHEBI:16330'}}, {'type': 'Site', 'location': {'start': {'value': 721, 'modifier': 'EXACT'}, 'end': {'value': 721, 'modifier': 'EXACT'}}, 'description': 'Interaction with coactivator LXXL and FXXFY motifs', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '25091737'}]}, {'type': 'Site', 'location': {'start': {'value': 898, 'modifier': 'EXACT'}, 'end': {'value': 898, 'modifier': 'EXACT'}}, 'description': 'Interaction with coactivator FXXLF and FXXFY motifs', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '25091737'}]}], 'extraAttributes': {'uniParcId': 'UPI0000167B08'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0', 'CHEMBLID': 'CHEMBL648079', 'description': 'Antagonist activity against Human Androgen receptor expressed in CV-1 cells'}, {'\u5206\u5b50SMILES': 'C[C@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0', 'CHEMBLID': 'CHEMBL648079', 'description': 'Antagonist activity against Human Androgen receptor expressed in CV-1 cells'}, {'\u5206\u5b50SMILES': 'CCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.009', 'CHEMBLID': 'CHEMBL830982', 'description': 'Inhibition of AR-dimerization in CHO-K1 cells expressing human androgen receptor'}, {'\u5206\u5b50SMILES': 'N#Cc1ccc(-c2ccccc2O)cc1C(F)(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.02', 'CHEMBLID': 'CHEMBL899496', 'description': 'Antagonist activity at human AR in MDA-MB453-MMTV-luci cells by functional assay'}, {'\u5206\u5b50SMILES': 'N#Cc1ccc(-c2ccccc2O)cc1C(F)(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.02', 'CHEMBLID': 'CHEMBL1032460', 'description': 'Antagonist activity against human androgen receptor expressed in human MDA-MB-453 cells assessed as inhibition of dihydrotestosterone-induced effect by luciferase receptor gene assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Relugolix in Combination with Androgen Receptor Pathway Inhibitors in the Treatment of Metastatic Prostate Cancer: A Clinical Perspective.', 'abstract': 'Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, has been established as an effective androgen deprivation therapy (ADT) for advanced prostate cancer, offering advantages over traditional GnRH agonists. The combination of relugolix with androgen receptor pathway inhibitors (ARPIs) is increasingly utilized in clinical practice, necessitating an understanding of its pharmacokinetics, efficacy, safety, and drug-drug interactions. This review explores the real-world data and clinical studies evaluating relugolix coadministration with ARPIs, including enzalutamide, abiraterone, apalutamide, and darolutamide. Pharmacokinetic interactions, particularly via the CYP3A4 enzyme system and P-glycoprotein (P-gp) transporter, influence drug exposure and, in theory, necessitate dose adjustments in certain combinations. However, clinical studies and real-world studies suggest that relugolix maintains testosterone suppression when combined with ARPIs even if administered in a standard dose. While these findings support the efficacy and safety of relugolix-based combination therapy, further large-scale prospective trials are needed to refine treatment recommendations and provide information on long-term outcomes.'}, {'title': 'Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer.', 'abstract': 'Circulating tumor DNA (ctDNA) acts as an early biomarker of the efficacy of androgen receptor signaling inhibitor (ARSI) therapy. In this study, we aimed to reveal if ctDNA can supplement imaging to better predict metastasis burden and radiographic progression disease (PD) in metastatic castration-resistant prostate cancer (mCRPC).'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1871"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'O60678', 'features': [{'type': 'Active site', 'location': {'start': {'value': 329, 'modifier': 'EXACT'}, 'end': {'value': 329, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'O70467'}]}, {'type': 'Active site', 'location': {'start': {'value': 338, 'modifier': 'EXACT'}, 'end': {'value': 338, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'O70467'}]}, {'type': 'Binding site', 'location': {'start': {'value': 239, 'modifier': 'EXACT'}, 'end': {'value': 239, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57856'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.20'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2FYT'}], 'ligand': {'name': 'S-adenosyl-L-homocysteine', 'id': 'ChEBI:CHEBI:57856'}}, {'type': 'Binding site', 'location': {'start': {'value': 263, 'modifier': 'EXACT'}, 'end': {'value': 263, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57856'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.20'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2FYT'}], 'ligand': {'name': 'S-adenosyl-L-homocysteine', 'id': 'ChEBI:CHEBI:57856'}}, {'type': 'Binding site', 'location': {'start': {'value': 285, 'modifier': 'EXACT'}, 'end': {'value': 285, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57856'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.20'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2FYT'}], 'ligand': {'name': 'S-adenosyl-L-homocysteine', 'id': 'ChEBI:CHEBI:57856'}}, {'type': 'Binding site', 'location': {'start': {'value': 313, 'modifier': 'EXACT'}, 'end': {'value': 313, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57856'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.20'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2FYT'}], 'ligand': {'name': 'S-adenosyl-L-homocysteine', 'id': 'ChEBI:CHEBI:57856'}}, {'type': 'Binding site', 'location': {'start': {'value': 314, 'modifier': 'EXACT'}, 'end': {'value': 314, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57856'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.20'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2FYT'}], 'ligand': {'name': 'S-adenosyl-L-homocysteine', 'id': 'ChEBI:CHEBI:57856'}}, {'type': 'Binding site', 'location': {'start': {'value': 343, 'modifier': 'EXACT'}, 'end': {'value': 343, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57856'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.20'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2FYT'}], 'ligand': {'name': 'S-adenosyl-L-homocysteine', 'id': 'ChEBI:CHEBI:57856'}}, {'type': 'Site', 'location': {'start': {'value': 87, 'modifier': 'EXACT'}, 'end': {'value': 87, 'modifier': 'EXACT'}}, 'description': 'Not phosphorylated', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21059412'}]}], 'extraAttributes': {'uniParcId': 'UPI0000232A2C'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.0', 'CHEMBLID': 'CHEMBL4398124', 'description': 'Inhibition of PRMT3 (unknown origin) using biotinylated histone H4 (1 to 24 residues) as substrate in presence of [3H]SAM by scintillation proximity assay'}, {'\u5206\u5b50SMILES': 'CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.0', 'CHEMBLID': 'CHEMBL5030835', 'description': 'Inhibition of PRMT3 (unknown origin) by scintillation proximity assay'}, {'\u5206\u5b50SMILES': 'CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.0', 'CHEMBLID': 'CHEMBL3859038', 'description': 'Inhibition of human PRMT3 assessed as inhibition of methylation activity using biotin-labeled peptide as substrate and [3H]-SAM by scintillation proximity assay'}, {'\u5206\u5b50SMILES': 'O=C(NCC(=O)N1CCCC1)Nc1ccc2cnc(F)cc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '10.0', 'CHEMBLID': 'CHEMBL4027812', 'description': 'Inhibition of PRMT3 (unknown origin) using C-terminally biotinylated histone H4 as substrate in presence of [3H]S-adenosylmethionine by scintillation proximity assay'}, {'\u5206\u5b50SMILES': 'O=C(NCC(=O)N1CCCCCC1)Nc1ccc2cnccc2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '17.0', 'CHEMBLID': 'CHEMBL4027812', 'description': 'Inhibition of PRMT3 (unknown origin) using C-terminally biotinylated histone H4 as substrate in presence of [3H]S-adenosylmethionine by scintillation proximity assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub.', 'abstract': 'Latent HIV-1 presents a formidable challenge for viral eradication. HIV-1 transcription and latency reversal require interactions between the viral promoter and host proteins. Here, we perform the dCas9-targeted locus-specific protein analysis and discover the interaction of human arginine methyltransferase 3 (PRMT3) with the HIV-1 promoter. This interaction reverses latency in cell line models and primary cells from latently infected persons by increasing the levels of H4R3Me2a and transcription factor P-TEFb at the viral promoter. PRMT3 is found to promote chromatin accessibility and transcription of HIV-1 and a small subset of host genes in regions harboring the classical recognition motif for another transcription factor TEAD4. This motif attracts TEAD4 and PRMT3 to the viral promoter to synergistically activate transcription. Physical interactions among PRMT3, P-TEFb, and TEAD4 exist, which may help form a transcriptional hub at the viral promoter. Our study reveals the potential of targeting these hub proteins to eradicate latent HIV-1.'}, {'title': 'TRIB3 recruits and stabilizes CARM1 to confer chemoresistance by activating Akt signalling in clear cell renal cancer cells.', 'abstract': 'Sunitinib resistance remains a major obstacle in the treatment of clear cell renal cell carcinoma (ccRCC), yet the underlying mechanisms are poorly defined. Here, we identify a previously unrecognized axis involving Tribbles homolog 3 (TRIB3) and coactivator-associated arginine methyltransferase 1 (CARM1) that drives chemoresistance through modulation of Akt signaling. Mechanistically, TRIB3 directly interacts with CARM1, a pro-survival epigenetic regulator, and inhibits its ubiquitination to stabilize CARM1 protein levels. Elevated CARM1 further exacerbates therapeutic resistance, establishing a feedforward loop that sustains Akt activation. Our findings uncovering a novel TRIB3-CARM1-Akt axis as a central driver of sunitinib resistance. This study provides mechanistic insights into ccRCC chemoresistance and highlights therapeutic targeting of the TRIB3-CARM1 axis as a promising strategy to overcome treatment failure.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5891"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'O14744', 'features': [{'type': 'Active site', 'location': {'start': {'value': 435, 'modifier': 'EXACT'}, 'end': {'value': 435, 'modifier': 'EXACT'}}, 'description': 'Proton donor/acceptor', 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '23071334'}]}, {'type': 'Active site', 'location': {'start': {'value': 444, 'modifier': 'EXACT'}, 'end': {'value': 444, 'modifier': 'EXACT'}}, 'description': 'Proton donor/acceptor', 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '23071334'}]}, {'type': 'Binding site', 'location': {'start': {'value': 324, 'modifier': 'EXACT'}, 'end': {'value': 324, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:59789'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23071334'}], 'ligand': {'name': 'S-adenosyl-L-methionine', 'id': 'ChEBI:CHEBI:59789'}}, {'type': 'Binding site', 'location': {'start': {'value': 327, 'modifier': 'EXACT'}, 'end': {'value': 327, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:29965'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23071334'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541', 'note': 'substrate'}, 'ligandPart': {'name': 'L-arginine residue', 'id': 'ChEBI:CHEBI:29965'}}, {'type': 'Binding site', 'location': {'start': {'value': 333, 'modifier': 'EXACT'}, 'end': {'value': 334, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:59789'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23071334'}], 'ligand': {'name': 'S-adenosyl-L-methionine', 'id': 'ChEBI:CHEBI:59789'}}, {'type': 'Binding site', 'location': {'start': {'value': 392, 'modifier': 'EXACT'}, 'end': {'value': 392, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:59789'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23071334'}], 'ligand': {'name': 'S-adenosyl-L-methionine', 'id': 'ChEBI:CHEBI:59789'}}, {'type': 'Binding site', 'location': {'start': {'value': 419, 'modifier': 'EXACT'}, 'end': {'value': 420, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:59789'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23071334'}], 'ligand': {'name': 'S-adenosyl-L-methionine', 'id': 'ChEBI:CHEBI:59789'}}, {'type': 'Binding site', 'location': {'start': {'value': 435, 'modifier': 'EXACT'}, 'end': {'value': 435, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:29965'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23071334'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541', 'note': 'substrate'}, 'ligandPart': {'name': 'L-arginine residue', 'id': 'ChEBI:CHEBI:29965'}}, {'type': 'Binding site', 'location': {'start': {'value': 444, 'modifier': 'EXACT'}, 'end': {'value': 444, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:29965'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '23071334'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541', 'note': 'substrate'}, 'ligandPart': {'name': 'L-arginine residue', 'id': 'ChEBI:CHEBI:29965'}}, {'type': 'Site', 'location': {'start': {'value': 327, 'modifier': 'EXACT'}, 'end': {'value': 327, 'modifier': 'EXACT'}}, 'description': 'Critical for specifying symmetric addition of methyl groups', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P46580'}]}], 'extraAttributes': {'uniParcId': 'UPI000006F09F'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'NCC[C@H]1CCCN1C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '-7000.0', 'CHEMBLID': 'CHEMBL4731562', 'description': 'Inhibition of PRMT5 in human A549 cells assessed as reduction in arginine dimethylation of SmD1/3 after 48 hrs by Hoechst Stain/ CellMask Deep Red Stain based immunohistochemistry method'}, {'\u5206\u5b50SMILES': 'Nc1nc2cc(CC[C@@H]3C[C@H](n4ccc5c(N)ncnc54)[C@@H](O)[C@H]3O)ccc2cc1Br', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.13', 'CHEMBLID': 'CHEMBL5138249', 'description': 'Inhibition of PRMT5 (unknown origin)'}, {'\u5206\u5b50SMILES': 'Nc1nc2cc(CC[C@H]3C[C@@H](n4ccc5c(N)ncnc54)[C@H](O)[C@@H]3O)ccc2cc1Br', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.14', 'CHEMBLID': 'CHEMBL4327368', 'description': 'Inhibition of full-length human N-terminal FLAG-tagged PRMT5 expressed in Sf9 insect cells using histone H2A as peptide after 120 mins in presence of SAM by high throughput mass spectrometer assay'}, {'\u5206\u5b50SMILES': 'Nc1ccc2ccc(CC[C@H]3C[C@@H](n4ccc5c(N)ncnc54)[C@H](O)[C@@H]3O)cc2n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.16', 'CHEMBLID': 'CHEMBL4392562', 'description': 'Inhibition of PRMT5 in human A549 cells assessed as reduction in sDMA production after 48 hrs by Hoechst Stain/HCS CellMask Deep Red Stain based immunohistochemistry method'}, {'\u5206\u5b50SMILES': 'Nc1nc2cc(CC[C@H]3C[C@@H](n4ccc5c(N)ncnc54)[C@H](O)[C@@H]3O)ccc2cc1Br', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.25', 'CHEMBLID': 'CHEMBL4392562', 'description': 'Inhibition of PRMT5 in human A549 cells assessed as reduction in sDMA production after 48 hrs by Hoechst Stain/HCS CellMask Deep Red Stain based immunohistochemistry method'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'MTA-cooperative PRMT5 inhibitors from cofactor-directed DNA-encoded library screens.', 'abstract': 'Methylthioadenosine phosphorylase ('}, {'title': 'NELFCD Promotes Colon Cancer Progression by Regulating the DUSP2-p38 Axis.', 'abstract': 'To investigate the significance of the negative elongation factor complex member C/D (NELFCD) in colon cancer progression.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1795116"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P19801', 'features': [{'type': 'Active site', 'location': {'start': {'value': 373, 'modifier': 'EXACT'}, 'end': {'value': 373, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}]}, {'type': 'Active site', 'location': {'start': {'value': 461, 'modifier': 'EXACT'}, 'end': {'value': 461, 'modifier': 'EXACT'}}, 'description': 'Schiff-base intermediate with substrate; via topaquinone', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}]}, {'type': 'Binding site', 'location': {'start': {'value': 510, 'modifier': 'EXACT'}, 'end': {'value': 510, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29036'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Cu(2+)', 'id': 'ChEBI:CHEBI:29036'}}, {'type': 'Binding site', 'location': {'start': {'value': 512, 'modifier': 'EXACT'}, 'end': {'value': 512, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29036'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Cu(2+)', 'id': 'ChEBI:CHEBI:29036'}}, {'type': 'Binding site', 'location': {'start': {'value': 519, 'modifier': 'EXACT'}, 'end': {'value': 519, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 520, 'modifier': 'EXACT'}, 'end': {'value': 520, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 521, 'modifier': 'EXACT'}, 'end': {'value': 521, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 562, 'modifier': 'EXACT'}, 'end': {'value': 562, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 653, 'modifier': 'EXACT'}, 'end': {'value': 653, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 656, 'modifier': 'EXACT'}, 'end': {'value': 656, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 658, 'modifier': 'EXACT'}, 'end': {'value': 658, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 664, 'modifier': 'EXACT'}, 'end': {'value': 664, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 665, 'modifier': 'EXACT'}, 'end': {'value': 665, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 675, 'modifier': 'EXACT'}, 'end': {'value': 675, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29036'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19764817'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HI7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HIG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3HII'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K5T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MPH'}], 'ligand': {'name': 'Cu(2+)', 'id': 'ChEBI:CHEBI:29036'}}], 'extraAttributes': {'uniParcId': 'UPI00001AF136'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CNc1cncc(N(C)C)c1CN.Cl.Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '61.0', 'CHEMBLID': 'CHEMBL828122', 'description': 'Inhibition of putrescine binding to against Diamine oxidase of porcine kidney'}, {'\u5206\u5b50SMILES': 'CN(C)C(=O)c1ccc(OC/C(=C\\\\F)CN)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '100.0', 'CHEMBLID': 'CHEMBL3888274', 'description': 'DAO Inhibition Assay: Recombinant human DAO (2.4 \u03bcg/mL) was used as source of DAO enzyme activities. The assay was performed as described in the method for human SSAO/VAP-1 (Example 5) except the substrate used was 200 \u03bcM putrescine, and the control wells contained 10 \u03bcM aminoguanidine instead of Mofegiline: Briefly, in a standard 96 well plate assay 50 \u03bcL of purified human SSAO/VAP-1 (0.25 \u03bcg/mL) in 0.1 M NaPO4 buffer (pH 7.4) was added into each well. Test compounds were dissolved in DMSO and tested in a Concentration Response Curve (CRC) with 4-9 data points, typically in the micromolar or nanomolar range after incubation with human SSAO/VAP-1 for 30 min at 37 \u00b0C. After 30 min incubation, 50 \u03bcL of the reaction mixture containing 600 \u03bcM benzylamine (Sigma Aldrich), 120 \u03bcM Amplex Red (Sigma Aldrich) and 1.5 U/mL horseradish peroxidase (Sigma Aldrich) prepared in 0.1 M NaPO4 buffer (pH 7.4) were added to the corresponding well. The fluorescence unit (RFU) was read every 2.5 min for 30 min at 37 \u00b0C. excitation 565 nm and emission 590 (Optima; BMG labtech). The slope of the kinetics for each well was calculated using MARS data analysis software (BMG labtech) and this value was used to deduce the IC50 value (Dotmatics).'}, {'\u5206\u5b50SMILES': 'NC/C(=C/F)COc1ccc(C(N)=O)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '100.0', 'CHEMBLID': 'CHEMBL3888274', 'description': 'DAO Inhibition Assay: Recombinant human DAO (2.4 \u03bcg/mL) was used as source of DAO enzyme activities. The assay was performed as described in the method for human SSAO/VAP-1 (Example 5) except the substrate used was 200 \u03bcM putrescine, and the control wells contained 10 \u03bcM aminoguanidine instead of Mofegiline: Briefly, in a standard 96 well plate assay 50 \u03bcL of purified human SSAO/VAP-1 (0.25 \u03bcg/mL) in 0.1 M NaPO4 buffer (pH 7.4) was added into each well. Test compounds were dissolved in DMSO and tested in a Concentration Response Curve (CRC) with 4-9 data points, typically in the micromolar or nanomolar range after incubation with human SSAO/VAP-1 for 30 min at 37 \u00b0C. After 30 min incubation, 50 \u03bcL of the reaction mixture containing 600 \u03bcM benzylamine (Sigma Aldrich), 120 \u03bcM Amplex Red (Sigma Aldrich) and 1.5 U/mL horseradish peroxidase (Sigma Aldrich) prepared in 0.1 M NaPO4 buffer (pH 7.4) were added to the corresponding well. The fluorescence unit (RFU) was read every 2.5 min for 30 min at 37 \u00b0C. excitation 565 nm and emission 590 (Optima; BMG labtech). The slope of the kinetics for each well was calculated using MARS data analysis software (BMG labtech) and this value was used to deduce the IC50 value (Dotmatics).'}, {'\u5206\u5b50SMILES': 'CNc1cncc(NC)c1CN.Cl.Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '120.0', 'CHEMBLID': 'CHEMBL828122', 'description': 'Inhibition of putrescine binding to against Diamine oxidase of porcine kidney'}, {'\u5206\u5b50SMILES': 'CNc1cnccc1CN.Cl.Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '160.0', 'CHEMBLID': 'CHEMBL828122', 'description': 'Inhibition of putrescine binding to against Diamine oxidase of porcine kidney'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Association of intestinal mucosal barrier function with intestinal microbiota in Spleen-Kidney Yang Deficiency IBS-D mice.', 'abstract': 'To establish and evaluate an IBS-D mouse model with Spleen-Kidney Yang Deficiency, explore the microecological mechanisms of IBS-D, and provide experimental evidence for the clinical diagnosis and treatment of IBS-D with Spleen-Kidney Yang Deficiency.'}, {'title': 'Exploring the Relationship Between Primary Sarcopenia and Intestinal Barrier Dysfunction in Geriatric Patients: Insights from SARC-F, Serum DAO, Zonulin, LPS, and I-FABP Levels.', 'abstract': 'The objective of this study is to assess the correlation between serum levels of DAO (Diamine oxidase), LPS (Lipopolysaccharide), I-FABP (Intestinal Fatty Acid Binding Protein), and Zonulin with primary sarcopenia in elderly patients, and to compare the diagnostic performance of these biomarkers with the SARC-F score.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2118"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q16853', 'features': [{'type': 'Active site', 'location': {'start': {'value': 386, 'modifier': 'EXACT'}, 'end': {'value': 386, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P19801'}]}, {'type': 'Active site', 'location': {'start': {'value': 471, 'modifier': 'EXACT'}, 'end': {'value': 471, 'modifier': 'EXACT'}}, 'description': 'Schiff-base intermediate with substrate; via topaquinone', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}]}, {'type': 'Binding site', 'location': {'start': {'value': 520, 'modifier': 'EXACT'}, 'end': {'value': 520, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29036'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Cu(2+)', 'id': 'ChEBI:CHEBI:29036'}}, {'type': 'Binding site', 'location': {'start': {'value': 522, 'modifier': 'EXACT'}, 'end': {'value': 522, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29036'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Cu(2+)', 'id': 'ChEBI:CHEBI:29036'}}, {'type': 'Binding site', 'location': {'start': {'value': 529, 'modifier': 'EXACT'}, 'end': {'value': 529, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 530, 'modifier': 'EXACT'}, 'end': {'value': 530, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 531, 'modifier': 'EXACT'}, 'end': {'value': 531, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 572, 'modifier': 'EXACT'}, 'end': {'value': 572, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 641, 'modifier': 'EXACT'}, 'end': {'value': 641, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 663, 'modifier': 'EXACT'}, 'end': {'value': 663, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 665, 'modifier': 'EXACT'}, 'end': {'value': 665, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 667, 'modifier': 'EXACT'}, 'end': {'value': 667, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 673, 'modifier': 'EXACT'}, 'end': {'value': 673, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 674, 'modifier': 'EXACT'}, 'end': {'value': 674, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 684, 'modifier': 'EXACT'}, 'end': {'value': 684, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29036'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16046623'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24304424'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PU4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1US1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4BTY'}], 'ligand': {'name': 'Cu(2+)', 'id': 'ChEBI:CHEBI:29036'}}], 'extraAttributes': {'uniParcId': 'UPI00000009FC'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC(C)(C)NC(=O)c1ccc(OC/C(=C/F)CN)cc1.Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5.0', 'CHEMBLID': 'CHEMBL3870772', 'description': 'Inhibition of human recombinant VAP-1 using benzylamine as substrate incubated for 30 mins followed by substrate addition measured every 2.5 mins for 30 mins by fluorometric assay'}, {'\u5206\u5b50SMILES': 'Cc1cc(/C=C/C(=O)O)cnc1N1CCN(c2ncc(-c3cccc(CN(C)C(=O)CN)c3)cn2)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.9', 'CHEMBLID': 'CHEMBL3705460', 'description': 'Inhibition Assay: A human VAP-1 enzyme (SSAO) activity was measured by a radiochemistry-enzymatic assay using 14C-benzylamine as an artificial substrate. An enzyme suspension prepared from CHO (Chinese Hamster Ovary) cells stably expressing a human VAP-1 enzyme (SSAO) was preincubated with the compound of the present invention in a 96-well microplate at room temperature for 30 minutes. Subsequently, the enzyme suspension was incubated with 14C-benzylamine (a final concentration of 1\u00d710\u22125 mol/L) to a final volume of 50 mL at 37\u00b0 C. for 1 hour. The enzymatic reaction was stopped by the addition of 2 mol/L (50 \u03bcL) of citric acid. The oxidation products were extracted directly in a 200-\u03bcL toluene scintillator, and the radioactivity was measured with a scintillation spectrometer.'}, {'\u5206\u5b50SMILES': 'CN(Cc1cccc(-c2cnc(N3CC=C(c4cccnc4)CC3)nc2)c1)C(=O)CN', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '7.0', 'CHEMBLID': 'CHEMBL3705460', 'description': 'Inhibition Assay: A human VAP-1 enzyme (SSAO) activity was measured by a radiochemistry-enzymatic assay using 14C-benzylamine as an artificial substrate. An enzyme suspension prepared from CHO (Chinese Hamster Ovary) cells stably expressing a human VAP-1 enzyme (SSAO) was preincubated with the compound of the present invention in a 96-well microplate at room temperature for 30 minutes. Subsequently, the enzyme suspension was incubated with 14C-benzylamine (a final concentration of 1\u00d710\u22125 mol/L) to a final volume of 50 mL at 37\u00b0 C. for 1 hour. The enzymatic reaction was stopped by the addition of 2 mol/L (50 \u03bcL) of citric acid. The oxidation products were extracted directly in a 200-\u03bcL toluene scintillator, and the radioactivity was measured with a scintillation spectrometer.'}, {'\u5206\u5b50SMILES': 'Cl.N=C(N)NC(=O)OCc1cccc(-c2cnc(N3CCOCC3)nc2)c1F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '9.2', 'CHEMBLID': 'CHEMBL4047930', 'description': 'Inhibition of human VAP-1 expressed in CHO cells preincubated for 20 mins followed by [14C]-benzylamine addition measured after 1 hr by scintillation spectrometric analysis'}, {'\u5206\u5b50SMILES': 'Cc1cc(CCC(=O)O)cnc1N1CCN(c2ncc(-c3cccc(CN(C)C(=O)CN)c3)cn2)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '9.4', 'CHEMBLID': 'CHEMBL3705460', 'description': 'Inhibition Assay: A human VAP-1 enzyme (SSAO) activity was measured by a radiochemistry-enzymatic assay using 14C-benzylamine as an artificial substrate. An enzyme suspension prepared from CHO (Chinese Hamster Ovary) cells stably expressing a human VAP-1 enzyme (SSAO) was preincubated with the compound of the present invention in a 96-well microplate at room temperature for 30 minutes. Subsequently, the enzyme suspension was incubated with 14C-benzylamine (a final concentration of 1\u00d710\u22125 mol/L) to a final volume of 50 mL at 37\u00b0 C. for 1 hour. The enzymatic reaction was stopped by the addition of 2 mol/L (50 \u03bcL) of citric acid. The oxidation products were extracted directly in a 200-\u03bcL toluene scintillator, and the radioactivity was measured with a scintillation spectrometer.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'The tree of life of copper-containing amine oxidases.', 'abstract': 'Copper-containing amine oxidases (CuAOs) catalyze the terminal oxidation of polyamines (PAs), producing ammonium, an aminoaldehyde, and hydrogen peroxide (H'}, {'title': 'Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease.', 'abstract': 'Inflammatory diseases are a major source of morbidity and mortality world-wide, the pathogenesis of which are characterised by the interplay of key pro-inflammatory and oxidative enzymes. Here, we report the development of a small molecule dual inhibitor targeting vascular adhesion protein-1 (VAP-1) and myeloperoxidase (MPO), two clinically relevant pro-inflammatory/oxidative enzymes that play complementary pathogenic roles in various inflammatory diseases. This agent, SNT-8370 [(E)-3-(3-((2-(aminomethyl)-3-fluoroallyl)oxy)benzyl)-2-thioxo-1,2,3,7-tetrahydro-6H-purin-6-one)], irreversibly inhibits VAP-1 and MPO activity with equivalent and enhanced nanomolar potency, respectively, when compared to benchmark clinical VAP-1 and MPO inhibitors. SNT-8370 is selective, exhibiting >100-1000-fold more potency for VAP-1 and MPO versus other mammalian (per)oxidases and shows no significant off-target activity in established preclinical screening panels. In vivo, SNT-8370 is metabolically stable, exhibits a favourable pharmacokinetic/pharmacodynamic profile without CNS penetration, and effectively inhibits VAP-1 and MPO activities. Moreover, compared to monotherapy, SNT-8370 more effectively inhibits leukocyte infiltration in mouse peritonitis, carrageenan air pouch, and lipopolysaccharide-induced lung injury models of acute inflammation. SNT-8370 is also protective in preclinical models of myocardial ischemia-reperfusion injury and unilateral-ureteral-obstruction-induced nephropathy. Collectively, our results support SNT-8370 as a first-in-class, mechanism-based dual inhibitor of VAP-1 and MPO, and as a promising therapeutic for the clinical treatment of inflammatory disorders.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3437"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P21397', 'features': [{'type': 'Site', 'location': {'start': {'value': 335, 'modifier': 'EXACT'}, 'end': {'value': 335, 'modifier': 'EXACT'}}, 'description': 'Important for substrate specificity', 'evidences': [{'evidenceCode': 'ECO:0000250'}]}, {'type': 'Site', 'location': {'start': {'value': 374, 'modifier': 'EXACT'}, 'end': {'value': 374, 'modifier': 'EXACT'}}, 'description': 'Important for catalytic activity'}], 'extraAttributes': {'uniParcId': 'UPI0000125B99'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C#CCN(C)CCCOc1ccc(Cl)cc1Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.004', 'CHEMBLID': 'CHEMBL5352829', 'description': 'Inhibition of human MAO-A using p-tyramine as substrate incubated for 15 mins by Amplex red and horseradish peroxidase based fluorescence assay'}, {'\u5206\u5b50SMILES': 'C#CCN(C)CCCOc1ccc(Cl)cc1Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0049', 'CHEMBLID': 'CHEMBL1663828', 'description': 'Inhibition of human monoamine oxidase A'}, {'\u5206\u5b50SMILES': 'C#CCN(C)CCCOc1cc(NC(=O)CCCCCCCCC(=O)NO)ccc1Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5157482', 'description': 'Inhibition of MAO-A (unknown origin) expressed in mouse GL26 cells using 14C 5-hydroxytryptamine as substrate pre-incubated for 20 mins followed by substrate addition measured after 20 mins by liquid scintillation spectroscopy'}, {'\u5206\u5b50SMILES': 'COc1ccc2c(c1)-c1nnc(-c3cccc(C(F)(F)F)c3)cc1C2=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL862690', 'description': 'Inhibition of MAO-B in baboon liver mitochondria'}, {'\u5206\u5b50SMILES': 'C#CCN(C)CCCOc1cc(C#N)c(Cl)cc1Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.103', 'CHEMBLID': 'CHEMBL5328525', 'description': 'Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cells'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Rosa multiflora fructus and its active compound ellagic acid improve depressive-like behaviors in mice via monoamine oxidase inhibition.', 'abstract': 'Depression is a significant global health challenge, imposing severe social and economic burdens. Rosa multiflora fructus possesses a range of biological properties; however, its role in reducing stress hormone-induced depression remains unclear. This study examined the antidepressant effects of Rosa multiflora fructus extract (RMFE) on corticosterone (CORT)-induced depressive-like behaviors in mice and explored the underlying molecular mechanisms. ICR mice were administered CORT (40\\u202fmg/kg/day, i.p.) for 8 weeks to induce depressive-like behaviors. They were then treated with RMFE (100 or 300\\u202fmg/kg/day, p.o.) or selegiline (10\\u202fmg/kg/day, p.o.) as a positive control. RMFE treatment significantly alleviated depressive-like behaviors, as evaluated by the tail suspension and forced swimming tests. Furthermore, RMFE reduced hippocampal astrocyte hypertrophy and lowered the protein and mRNA expression of monoamine oxidase A and B (MAOA and MAOB). Phytochemical analysis using UPLC-MS/MS identified five flavonoids in RMFE, including ellagic acid (EA), hyperoside, isoquercetin, quercetin, and quercetin-3-glucuronide. In silico molecular docking revealed that these phenolic compounds interact with MAOA and MAOB, with EA exhibiting the strongest binding affinity. Consistently, EA administration effectively alleviated depressive-like behaviors and increased monoamine neurotransmitter levels in CORT-treated mice. These results suggest that RMFE exerts antidepressant effects by inhibiting MAO, restoring monoamine levels, and modulating hippocampal astrocytic hypertrophy, with EA identified as the primary bioactive compound driving its efficacy.'}, {'title': \"A Sensitive SERS Sensor for Simultaneous Detection of Two Potential Biomarkers of Alzheimer's Disease: AChE and MAO-B.\", 'abstract': \"Monoamine oxidase B (MAO-B) and acetylcholinesterase (AChE) are potential biomarkers for Alzheimer's disease (AD). However, few methods exist to detect both AChE and MAO-B simultaneously. In this study, we developed a SERS sensor for the simultaneous detection of AChE and MAO-B based on the one-pot reaction system, which provided more valuable information for early AD diagnosis. Au NPs modified with Raman reporter 4-aminothiophenol (Au\"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1951"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P27338', 'features': [{'type': 'Site', 'location': {'start': {'value': 156, 'modifier': 'EXACT'}, 'end': {'value': 156, 'modifier': 'EXACT'}}, 'description': 'Important for catalytic activity'}, {'type': 'Site', 'location': {'start': {'value': 365, 'modifier': 'EXACT'}, 'end': {'value': 365, 'modifier': 'EXACT'}}, 'description': 'Important for catalytic activity'}, {'type': 'Site', 'location': {'start': {'value': 382, 'modifier': 'EXACT'}, 'end': {'value': 382, 'modifier': 'EXACT'}}, 'description': 'Important for catalytic activity'}], 'extraAttributes': {'uniParcId': 'UPI0000049071'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cc1cc2c(nn1)-c1cc(OCCCC(F)(F)F)ccc1C2=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.014', 'CHEMBLID': 'CHEMBL734179', 'description': 'Inhibitory concentration against Monoamine oxidase B was measured in baboon liver.'}, {'\u5206\u5b50SMILES': 'C#CCN(C)[C@H](C)Cc1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.017', 'CHEMBLID': 'CHEMBL1663829', 'description': 'Inhibition of human monoamine oxidase B'}, {'\u5206\u5b50SMILES': 'C#CCN(C)[C@H](C)Cc1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.017', 'CHEMBLID': 'CHEMBL5352830', 'description': 'Inhibition of human MAO-B using p-tyramine as substrate incubated for 15 mins by Amplex red and horseradish peroxidase based fluorescence assay'}, {'\u5206\u5b50SMILES': 'C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.023', 'CHEMBLID': 'CHEMBL5352830', 'description': 'Inhibition of human MAO-B using p-tyramine as substrate incubated for 15 mins by Amplex red and horseradish peroxidase based fluorescence assay'}, {'\u5206\u5b50SMILES': 'O=C(O)c1coc2ccccc2c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.048', 'CHEMBLID': 'CHEMBL1647187', 'description': 'Inhibition of human recombinant MAOB expressed in baculovirus-infected BTI insect cells after 15 mins by fluorimetric assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Rosa multiflora fructus and its active compound ellagic acid improve depressive-like behaviors in mice via monoamine oxidase inhibition.', 'abstract': 'Depression is a significant global health challenge, imposing severe social and economic burdens. Rosa multiflora fructus possesses a range of biological properties; however, its role in reducing stress hormone-induced depression remains unclear. This study examined the antidepressant effects of Rosa multiflora fructus extract (RMFE) on corticosterone (CORT)-induced depressive-like behaviors in mice and explored the underlying molecular mechanisms. ICR mice were administered CORT (40\\u202fmg/kg/day, i.p.) for 8 weeks to induce depressive-like behaviors. They were then treated with RMFE (100 or 300\\u202fmg/kg/day, p.o.) or selegiline (10\\u202fmg/kg/day, p.o.) as a positive control. RMFE treatment significantly alleviated depressive-like behaviors, as evaluated by the tail suspension and forced swimming tests. Furthermore, RMFE reduced hippocampal astrocyte hypertrophy and lowered the protein and mRNA expression of monoamine oxidase A and B (MAOA and MAOB). Phytochemical analysis using UPLC-MS/MS identified five flavonoids in RMFE, including ellagic acid (EA), hyperoside, isoquercetin, quercetin, and quercetin-3-glucuronide. In silico molecular docking revealed that these phenolic compounds interact with MAOA and MAOB, with EA exhibiting the strongest binding affinity. Consistently, EA administration effectively alleviated depressive-like behaviors and increased monoamine neurotransmitter levels in CORT-treated mice. These results suggest that RMFE exerts antidepressant effects by inhibiting MAO, restoring monoamine levels, and modulating hippocampal astrocytic hypertrophy, with EA identified as the primary bioactive compound driving its efficacy.'}, {'title': \"A Sensitive SERS Sensor for Simultaneous Detection of Two Potential Biomarkers of Alzheimer's Disease: AChE and MAO-B.\", 'abstract': \"Monoamine oxidase B (MAO-B) and acetylcholinesterase (AChE) are potential biomarkers for Alzheimer's disease (AD). However, few methods exist to detect both AChE and MAO-B simultaneously. In this study, we developed a SERS sensor for the simultaneous detection of AChE and MAO-B based on the one-pot reaction system, which provided more valuable information for early AD diagnosis. Au NPs modified with Raman reporter 4-aminothiophenol (Au\"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2039"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q06278', 'features': [{'type': 'Active site', 'location': {'start': {'value': 1270, 'modifier': 'EXACT'}, 'end': {'value': 1270, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor; for azaheterocycle hydroxylase activity', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'O54754'}]}, {'type': 'Binding site', 'location': {'start': {'value': 44, 'modifier': 'EXACT'}, 'end': {'value': 44, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190135'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}], 'ligand': {'name': '[2Fe-2S] cluster', 'id': 'ChEBI:CHEBI:190135', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 49, 'modifier': 'EXACT'}, 'end': {'value': 49, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190135'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': '[2Fe-2S] cluster', 'id': 'ChEBI:CHEBI:190135', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 52, 'modifier': 'EXACT'}, 'end': {'value': 52, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190135'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': '[2Fe-2S] cluster', 'id': 'ChEBI:CHEBI:190135', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 74, 'modifier': 'EXACT'}, 'end': {'value': 74, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190135'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': '[2Fe-2S] cluster', 'id': 'ChEBI:CHEBI:190135', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 113, 'modifier': 'EXACT'}, 'end': {'value': 113, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:71302'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}], 'ligand': {'name': 'Mo-molybdopterin', 'id': 'ChEBI:CHEBI:71302'}}, {'type': 'Binding site', 'location': {'start': {'value': 114, 'modifier': 'EXACT'}, 'end': {'value': 114, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190135'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': '[2Fe-2S] cluster', 'id': 'ChEBI:CHEBI:190135', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 117, 'modifier': 'EXACT'}, 'end': {'value': 117, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190135'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': '[2Fe-2S] cluster', 'id': 'ChEBI:CHEBI:190135', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 149, 'modifier': 'EXACT'}, 'end': {'value': 149, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190135'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': '[2Fe-2S] cluster', 'id': 'ChEBI:CHEBI:190135', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 151, 'modifier': 'EXACT'}, 'end': {'value': 151, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190135'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': '[2Fe-2S] cluster', 'id': 'ChEBI:CHEBI:190135', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 151, 'modifier': 'EXACT'}, 'end': {'value': 151, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:71302'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': 'Mo-molybdopterin', 'id': 'ChEBI:CHEBI:71302'}}, {'type': 'Binding site', 'location': {'start': {'value': 264, 'modifier': 'EXACT'}, 'end': {'value': 271, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57692'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': 'FAD', 'id': 'ChEBI:CHEBI:57692'}}, {'type': 'Binding site', 'location': {'start': {'value': 345, 'modifier': 'EXACT'}, 'end': {'value': 345, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57692'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}], 'ligand': {'name': 'FAD', 'id': 'ChEBI:CHEBI:57692'}}, {'type': 'Binding site', 'location': {'start': {'value': 354, 'modifier': 'EXACT'}, 'end': {'value': 354, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57692'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': 'FAD', 'id': 'ChEBI:CHEBI:57692'}}, {'type': 'Binding site', 'location': {'start': {'value': 358, 'modifier': 'EXACT'}, 'end': {'value': 358, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57692'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': 'FAD', 'id': 'ChEBI:CHEBI:57692'}}, {'type': 'Binding site', 'location': {'start': {'value': 367, 'modifier': 'EXACT'}, 'end': {'value': 367, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57692'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': 'FAD', 'id': 'ChEBI:CHEBI:57692'}}, {'type': 'Binding site', 'location': {'start': {'value': 411, 'modifier': 'EXACT'}, 'end': {'value': 411, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57692'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': 'FAD', 'id': 'ChEBI:CHEBI:57692'}}, {'type': 'Binding site', 'location': {'start': {'value': 806, 'modifier': 'EXACT'}, 'end': {'value': 807, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:71302'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': 'Mo-molybdopterin', 'id': 'ChEBI:CHEBI:71302'}}, {'type': 'Binding site', 'location': {'start': {'value': 1047, 'modifier': 'EXACT'}, 'end': {'value': 1047, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:71302'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': 'Mo-molybdopterin', 'id': 'ChEBI:CHEBI:71302'}}, {'type': 'Binding site', 'location': {'start': {'value': 1088, 'modifier': 'EXACT'}, 'end': {'value': 1091, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:71302'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': 'Mo-molybdopterin', 'id': 'ChEBI:CHEBI:71302'}}, {'type': 'Binding site', 'location': {'start': {'value': 1203, 'modifier': 'EXACT'}, 'end': {'value': 1203, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:71302'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26842593'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5EPG'}], 'ligand': {'name': 'Mo-molybdopterin', 'id': 'ChEBI:CHEBI:71302'}}, {'type': 'Binding site', 'location': {'start': {'value': 1268, 'modifier': 'EXACT'}, 'end': {'value': 1268, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:71302'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26322824'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4UHX'}], 'ligand': {'name': 'Mo-molybdopterin', 'id': 'ChEBI:CHEBI:71302'}}], 'extraAttributes': {'uniParcId': 'UPI0000071863'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.0', 'CHEMBLID': 'CHEMBL1640077', 'description': 'Inhibition of human aldehyde oxidase'}, {'\u5206\u5b50SMILES': 'C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5.0', 'CHEMBLID': 'CHEMBL5233652', 'description': 'Inhibition of human liver AOX using phthalazine as substrate incubated for 2.5 mins by HPLC-MS analysis'}, {'\u5206\u5b50SMILES': 'C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5.0', 'CHEMBLID': 'CHEMBL5233652', 'description': 'Inhibition of human liver AOX using phthalazine as substrate incubated for 2.5 mins by HPLC-MS analysis'}, {'\u5206\u5b50SMILES': 'O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5.0', 'CHEMBLID': 'CHEMBL5233652', 'description': 'Inhibition of human liver AOX using phthalazine as substrate incubated for 2.5 mins by HPLC-MS analysis'}, {'\u5206\u5b50SMILES': 'O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5.7', 'CHEMBLID': 'CHEMBL5233653', 'description': 'Inhibition of human AOX using phthalazine as substrate preincubated for 30 mins followed by substrate addition by HPLC-MS analysis'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'pH and Glucose Dual-Responsive Hydrogels Promoted Diabetic Wound Healing by Remodeling the Wound Microenvironment.', 'abstract': 'The microenvironment of diabetic wounds is complicated and characterized by hyperglycemia, hyperinflammation, persistent infection, hypoxia, and ischemia, making wound restoration and healing extremely challenging. Therefore, functional hydrogel dressings with the ability to regulate the microenvironment of diabetic wounds are a promising strategy for the treatment of diabetic wounds. In this study, a pH/glucose dual-responsive hydrogel based on phenylboric acid-modified carboxymethyl chitosan (CMCSPBA), aldehyde-terminated polyethylene glycol (PEGCHO), and polyvinyl alcohol (PVA) has been developed for diabetic wound treatment via Schiff base and phenylboric ester interactions. Glucose oxidase (GOX), catalase (CAT), and deferoxamine mesylate (DFO) are incorporated into the hydrogel to endow it with multi-functionality. In the hyperglycemic environment of diabetic wounds, a benign feedback loop is formed through the synergistic action of each component of the hydrogel, which enables the reshaping of the microenvironment of diabetic wounds by adjusting the pH and glucose, alleviating oxidative stress and hypoxia, regulating the inflammatory response, inhibiting bacterial infection, and promoting angiogenesis, thus accelerating diabetic wound healing in streptozotocin (STZ)-induced diabetic mice.'}, {'title': 'The novel brain penetrant ATM inhibitor WSD0628 provides robust radiosensitization of brain tumor patient derived xenografts.', 'abstract': 'The ataxia telangiectasia mutated (ATM) protein coordinates the cellular response to therapeutic radiation, and ATM inhibitors can potentially enhance the efficacy of radiation in otherwise radiation-resistant tumors.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3257"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P25098', 'features': [{'type': 'Active site', 'location': {'start': {'value': 317, 'modifier': 'EXACT'}, 'end': {'value': 317, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}]}, {'type': 'Binding site', 'location': {'start': {'value': 197, 'modifier': 'EXACT'}, 'end': {'value': 205, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 220, 'modifier': 'EXACT'}, 'end': {'value': 220, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Site', 'location': {'start': {'value': 3, 'modifier': 'EXACT'}, 'end': {'value': 3, 'modifier': 'EXACT'}}, 'description': 'Required for receptor phosphorylation', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19715378'}]}, {'type': 'Site', 'location': {'start': {'value': 4, 'modifier': 'EXACT'}, 'end': {'value': 4, 'modifier': 'EXACT'}}, 'description': 'Required for receptor phosphorylation', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19715378'}]}, {'type': 'Site', 'location': {'start': {'value': 10, 'modifier': 'EXACT'}, 'end': {'value': 10, 'modifier': 'EXACT'}}, 'description': 'Required for receptor phosphorylation', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19715378'}]}], 'extraAttributes': {'uniParcId': 'UPI0000001C68'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CCCn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.2', 'CHEMBLID': 'CHEMBL4040375', 'description': 'Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay'}, {'\u5206\u5b50SMILES': 'O=C(NCc1c(F)cccc1F)c1cccc(NCc2nnc3n2CCOc2cnccc2-3)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.7', 'CHEMBLID': 'CHEMBL4040375', 'description': 'Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay'}, {'\u5206\u5b50SMILES': 'O=C(NCc1ccccc1C(F)(F)F)c1cccc(NCc2nnc3n2CCOc2cnccc2-3)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.8', 'CHEMBLID': 'CHEMBL4040375', 'description': 'Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay'}, {'\u5206\u5b50SMILES': 'CCCn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.9', 'CHEMBLID': 'CHEMBL4040375', 'description': 'Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay'}, {'\u5206\u5b50SMILES': 'CC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '2.0', 'CHEMBLID': 'CHEMBL3721218', 'description': 'Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'GRK2-facilitated TLR4 signaling promotes cardiac fibrosis in rheumatic mice.', 'abstract': 'Patients with rheumatoid arthritis (RA) have a much higher prevalence of cardiac dysfunction, which explains the high mortality rate in RA patients despite treatment with anti-arthritic drugs. This study elucidates a molecular mechanism that causes abnormal activation of cardiac fibroblasts in the inflammatory state of RA through transactivation of canonical TLR4 signaling by GRK2-dependent signaling mechanisms, and which ultimately induces heart disease.'}, {'title': 'Esaxerenone Improves Vascular Endothelial Dysfunction by Reducing Serum and Glucocorticoid-Regulated Kinase 1 Activity and Enhancing the Akt Pathway in Type 2 Diabetic Mice.', 'abstract': 'Mineralocorticoid receptor (MR) blockers reduce cardiovascular complications as MRs play a crucial role in cardiovascular regulation. Diabetic cardiovascular complications are caused by vascular endothelial dysfunction. This study used a type 2 diabetic mouse model (DM) to investigate whether esaxerenone (ESAX), an MR blocker, ameliorates vascular endothelial dysfunction. ESAX (3 mg/kg/d) was administered via diet to KK-Ay mice or C57BL/6J mice, a nondiabetic control (Control), for 8 weeks, and metabolic parameters and blood pressure were measured. Vascular responses of the aortic segments were analyzed with acetylcholine, sodium nitroprusside, UK14304, or phenylephrine (PE). The other aortas were used for Western blot analysis. DM mice exhibited higher plasma glucose, insulin, metabolic parameters, and blood pressure levels than those of the Control mice. Parameters that did not include blood pressure were unaltered by DM or ESAX-administered DM (DM + ESAX). However, DM impaired UK14304-induced endothelial-dependent relaxation and nitric oxide production and elevated PE-induced contraction. ESAX administration ameliorated endothelial dysfunction and improved the protein kinase B (Akt) phosphorylation under \u03b1'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4079"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P05089', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 101, 'modifier': 'EXACT'}, 'end': {'value': 101, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16141327'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17469833'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17562323'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18802628'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21728378'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AEB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PLL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2ZAV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3DJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6V'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3F80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MJL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SJT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SKK'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FCI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GSZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HWW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HXQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE1'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 124, 'modifier': 'EXACT'}, 'end': {'value': 124, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16141327'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17469833'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17562323'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18802628'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21728378'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AEB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PLL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2ZAV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3DJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6V'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3F80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MJL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SJT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SKK'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FCI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GSZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HWW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HXQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE1'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 124, 'modifier': 'EXACT'}, 'end': {'value': 124, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16141327'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17469833'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17562323'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18802628'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21728378'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AEB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PLL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2ZAV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3DJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6V'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3F80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MJL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SJT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SKK'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FCI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GSZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HWW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HXQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE1'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 126, 'modifier': 'EXACT'}, 'end': {'value': 130, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3THJ'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 126, 'modifier': 'EXACT'}, 'end': {'value': 126, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16141327'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17469833'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17562323'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18802628'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21728378'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AEB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PLL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2ZAV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3DJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6V'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3F80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MJL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SJT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SKK'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FCI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GSZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HWW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HXQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE1'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 128, 'modifier': 'EXACT'}, 'end': {'value': 128, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16141327'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17469833'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17562323'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18802628'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21728378'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AEB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PLL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2ZAV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3DJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6V'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3F80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MJL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SJT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SKK'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FCI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GSZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HWW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HXQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE1'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 137, 'modifier': 'EXACT'}, 'end': {'value': 139, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3THJ'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 183, 'modifier': 'EXACT'}, 'end': {'value': 183, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3THJ'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 232, 'modifier': 'EXACT'}, 'end': {'value': 232, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16141327'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17469833'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17562323'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18802628'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21728378'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AEB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PLL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2ZAV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3DJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6V'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3F80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MJL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SJT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SKK'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FCI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GSZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HWW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HXQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE1'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 232, 'modifier': 'EXACT'}, 'end': {'value': 232, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16141327'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17469833'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17562323'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18802628'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21728378'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AEB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PLL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2ZAV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3DJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6V'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3F80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MJL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SJT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SKK'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FCI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GSZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HWW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HXQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE1'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 234, 'modifier': 'EXACT'}, 'end': {'value': 234, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16141327'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17469833'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17562323'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18802628'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21728378'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WVB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2AEB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PHO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2PLL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2ZAV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3DJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3E6V'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3F80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GMZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3GN0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3KV2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3LP7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFV'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MFW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3MJL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SJT'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SKK'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FCI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GSZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GWD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HWW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HXQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE1'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 246, 'modifier': 'EXACT'}, 'end': {'value': 246, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P53608'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 277, 'modifier': 'EXACT'}, 'end': {'value': 277, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P78540'}], 'ligand': {'name': 'substrate'}}], 'extraAttributes': {'uniParcId': 'UPI0000125EBF'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'NCCNS(=O)(=O)N1C[C@H](CCCB(O)O)[C@](N)(C(=O)O)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL4729732', 'description': 'Inhibition of human Arg1'}, {'\u5206\u5b50SMILES': 'N[C@H](C(=O)N[C@H]1CN[C@H](C(=O)O)[C@@H]1CCCB(O)O)C1CCCC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.8', 'CHEMBLID': 'CHEMBL4729729', 'description': 'Inhibition of human Arg1 by TOGA assay'}, {'\u5206\u5b50SMILES': 'CC(C)(C)[C@H](N)C(=O)N[C@H]1CN[C@H](C(=O)O)[C@@H]1CCCB(O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.8', 'CHEMBLID': 'CHEMBL4729729', 'description': 'Inhibition of human Arg1 by TOGA assay'}, {'\u5206\u5b50SMILES': 'CSCC[C@H](N)C(=O)NC[C@@H]1CC[C@@H](CCB(O)O)C[C@]1(N)C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.0', 'CHEMBLID': 'CHEMBL5130940', 'description': 'Inhibition of recombinant human ARG1 expressed in Escherichia coli using L-arginine hydrochloride as substrate incubated for 1 hr by colorimetric assay'}, {'\u5206\u5b50SMILES': 'N[C@]1(C(=O)O)C[C@H](CCB(O)O)CC[C@H]1CN1CCCCC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.0', 'CHEMBLID': 'CHEMBL4729732', 'description': 'Inhibition of human Arg1'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Endothelial dysfunction in patients with type 2 diabetes: the truth is in the blood.', 'abstract': \"Endothelial dysfunction remains a cornerstone of diabetic vascular complications. RBCs emerge as pivotal players in endothelial dysfunction, yet the underlying mechanisms remain elusive. In this issue of the JCI, Collado et al. show that the detrimental action of RBCs on the endothelium is mediated by extracellular vesicles (EVs). EVs derived from RBCs (RBC-EVs) of patients with diabetes were taken up by the endothelium and were able to impair endothelium-dependent relaxation via an EV-mediated transfer of the prooxidant enzyme arginase-1 (Arg1) from RBCs to endothelial cells. These findings reveal events implicated in vascular oxidative stress and set the stage for personalized approaches preventing RBC-EVs' uptake by the endothelium.\"}, {'title': \"Impact of Reduction in Myeloid-derived Suppressor Cells by Wilms' Tumor 1-targeted Dendritic Cell Vaccines on Clinical Outcomes in Acute Leukemia Patients.\", 'abstract': 'Myeloid-derived suppressor cells (MDSCs) play a critical role in immunotherapy.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1075097"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P78540', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 120, 'modifier': 'EXACT'}, 'end': {'value': 120, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 143, 'modifier': 'EXACT'}, 'end': {'value': 143, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 143, 'modifier': 'EXACT'}, 'end': {'value': 143, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 145, 'modifier': 'EXACT'}, 'end': {'value': 149, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 145, 'modifier': 'EXACT'}, 'end': {'value': 145, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 147, 'modifier': 'EXACT'}, 'end': {'value': 147, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 156, 'modifier': 'EXACT'}, 'end': {'value': 158, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 202, 'modifier': 'EXACT'}, 'end': {'value': 202, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 251, 'modifier': 'EXACT'}, 'end': {'value': 251, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 251, 'modifier': 'EXACT'}, 'end': {'value': 251, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 253, 'modifier': 'EXACT'}, 'end': {'value': 253, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 265, 'modifier': 'EXACT'}, 'end': {'value': 265, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P53608'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 296, 'modifier': 'EXACT'}, 'end': {'value': 296, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12859189'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1PQ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4HZE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4I06'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IE3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXU'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4IXV'}], 'ligand': {'name': 'substrate'}}], 'extraAttributes': {'uniParcId': 'UPI0000125DF2'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'NCCNS(=O)(=O)N1C[C@H](CCCB(O)O)[C@](N)(C(=O)O)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL4729733', 'description': 'Inhibition of human Arg2'}, {'\u5206\u5b50SMILES': 'N[C@H]1CCN[C@@](CCCCB(O)O)(C(=O)O)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.0', 'CHEMBLID': 'CHEMBL4672977', 'description': \"Inhibition of human recombinant arginase 2 expressed in Escherichia coli using thioarginine by Ellman's assay\"}, {'\u5206\u5b50SMILES': 'N[C@@H](CCCCB(O)O)C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '8.5', 'CHEMBLID': 'CHEMBL5241487', 'description': 'Binding affinity to human ARG2 assessed as inhibition constant'}, {'\u5206\u5b50SMILES': 'CN[C@H]1CN[C@@](CCCCB(O)O)(C(=O)O)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '10.0', 'CHEMBLID': 'CHEMBL4729736', 'description': 'Inhibition of human Arg2 by TOGA assay'}, {'\u5206\u5b50SMILES': 'CC(C)C[C@H](N)C(=O)N[C@H]1CCN[C@@](CCCCB(O)O)(C(=O)O)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '15.0', 'CHEMBLID': 'CHEMBL4672977', 'description': \"Inhibition of human recombinant arginase 2 expressed in Escherichia coli using thioarginine by Ellman's assay\"}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Hypoxia responses in arginase 2 deficient mice enhance cardiovascular health.', 'abstract': 'Physiological responses to hypoxia involve adaptations in the hematopoietic and cardiovascular systems, which work together to ensure adequate oxygen delivery to tissues for energy production. The arginine/nitric oxide (NO) pathway regulates both systems through its effects on erythropoiesis and vasodilation. In Tibetan populations native to high-altitude hypoxia, increased NO production from arginine and decreased arginine metabolism by arginase contribute to these adaptive mechanisms. These metabolic changes enhance tissue oxygen delivery and reduce the risk of hypoxic pulmonary hypertension. Here, we hypothesize that genetic deletion of mitochondrial arginase 2 ( '}, {'title': 'Striatum-enriched protein, arginase 2 localizes to medium spiny neurons and controls striatal metabolic profile.', 'abstract': \"Arginase 2 (Arg2) is the predominant arginase isoenzyme in the brain, however its distribution appears to be limited to selected, region-specific subpopulations of cells. Although striatum is highly enriched with Arg2, precise localization and function of striatal Arg2 have never been studied. Here, we confirm that Arg2 is the only arginase isoenzyme in the striatum, and, using genetic model of total Arg2 loss, we show that Arg2 in this region is fully responsible for arginase catalytic activity, and its loss doesn't induce compensatory activation of Arg1. We exhibit that Arg2 is present in medium spiny neurons (MSNs), striatum-specific projecting neurons, where it localizes in soma and neuronal processes, and is absent in astrocytes or microglia. Finally, analysis of NMR spectroscopy-measured metabolic profiles of striata of Arg2-null mice enabled to recognize two metabolites (NADH and malonic acid) to be significantly altered compared to control animals. Multivariate comparison of the data using orthogonal projections to latent structures discriminant analysis, allowed for discrimination between control and Arg2-null mice and identified metabolites that contributed the most to this between-group dissimilarity. Our study reveals for the first time the localization of Arg2 in MSNs and demonstrates significant role of this enzyme in regulating striatal metabolism. These findings may be especially interesting in the context of Huntington's disease (HD), a disorder that specifically affects MSNs and in which, with the use of mouse models, the onset of pathological phenotypes was recently shown to be preceded by progressive impairment of striatal Arg2, a phenomenon of an unknown significance for disease pathogenesis.\"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1795148"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q6PL18', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 467, 'modifier': 'EXACT'}, 'end': {'value': 474, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI0000052A8C'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cc1nnc2c(NC3CCN(CC(C)(C)F)CC3)cc(C(=O)N3[C@@H]4c5ccccc5C[C@H]3C(=O)N[C@@H]4C(C)C)nn12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.31', 'CHEMBLID': 'CHEMBL5045649', 'description': 'Inhibition of GST-ATAD2 BD (981 to 1108 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) and biotinylated tetra-acetylated histone H4 peptides as substrate incubated for 30 mins by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1nnc2c(NC3CCN(CC(C)(C)F)CC3)cc(C(=O)N3[C@@H]4c5ccccc5C[C@H]3C(=O)N[C@@H]4C(C)C)nn12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '7.0', 'CHEMBLID': 'CHEMBL5045652', 'description': 'Inhibition of GST-ATAD2 BD (951 to 1132 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) and biotinylated tetra-acetylated histone H4 peptides as substrate incubated for 30 mins by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1nnc2c(NCCCN3CCCC3)cc(C(=O)N3[C@@H]4c5ccccc5C[C@H]3C(=O)N[C@@H]4C(C)C)nn12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '14.0', 'CHEMBLID': 'CHEMBL5045652', 'description': 'Inhibition of GST-ATAD2 BD (951 to 1132 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) and biotinylated tetra-acetylated histone H4 peptides as substrate incubated for 30 mins by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1nnc2c(NCCCN3CCCC3)cc(C(=O)N3[C@@H]4c5ccccc5C[C@H]3C(=O)N[C@@H]4C(C)C)nn12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '15.85', 'CHEMBLID': 'CHEMBL5045649', 'description': 'Inhibition of GST-ATAD2 BD (981 to 1108 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) and biotinylated tetra-acetylated histone H4 peptides as substrate incubated for 30 mins by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1nnc2c(NC3CCN(CC(C)(F)F)CC3)cc(C(=O)N3[C@@H]4c5ccccc5C[C@H]3C(=O)N[C@@H]4C(C)C)nn12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '19.95', 'CHEMBLID': 'CHEMBL5045649', 'description': 'Inhibition of GST-ATAD2 BD (981 to 1108 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) and biotinylated tetra-acetylated histone H4 peptides as substrate incubated for 30 mins by TR-FRET assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'ATAD2 bromodomain in cancer therapy: current status and future perspectives.', 'abstract': \"ATPase family AAA domain-containing protein 2, or ATAD2, is a novel carcinogen, essential for cancer development, chromatin remodeling, and transcriptional control. It contains a bromodomain, which binds to acetylated histones to control gene expression. It also impacts pathways that regulate the cell cycle, DNA replication, and hormone signalling. ATAD2 is overexpressed in several malignancies, including colorectal, lung, ovarian, and breast cancers, and cancer metastasis. Investigations into the function of ATAD2 in oncogenesis and its interactions may offer fresh approaches to creating cancer treatment plans. Although preclinical research is very encouraging, many unresolved aspects regarding therapeutic development remain, including toxicity being explored concurrently. Investigations into the function of ATAD2 in oncogenesis may offer fresh approaches to developing chemotherapy strategies. Most of ATAD2's molecular mechanisms behind carcinogenesis and functions are discussed here. Additionally, we included progress, including potential monoclonal antibodies, RNA-based therapies, and small chemical inhibitors, in the review. Therefore, we guarantee this study will provide researchers with new opportunities and directions for cancer therapeutics.\"}, {'title': 'Hereditary Ataxia Overview', 'abstract': 'The purpose of this overview is to: 1.. Briefly describe the clinical characteristics of hereditary ataxias (sometimes referred to as \"primary hereditary ataxias\") for which an adult with ataxia or the caregivers of a child with ataxia would seek diagnosis and management from a neurologist as part of a multidisciplinary team; 2.. Review common and notable genetic causes of hereditary ataxia; 3.. Provide an evaluation strategy to identify the genetic cause of hereditary ataxia in a proband; 4.. Review management of hereditary ataxia; 5.. Inform genetic counseling of family members of an individual with hereditary ataxia.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2150837"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q9UHI8', 'features': [{'type': 'Active site', 'location': {'start': {'value': 402, 'modifier': 'EXACT'}, 'end': {'value': 402, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00276'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10095'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}]}, {'type': 'Binding site', 'location': {'start': {'value': 198, 'modifier': 'EXACT'}, 'end': {'value': 198, 'modifier': 'EXACT'}}, 'description': 'in inhibited form', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 261, 'modifier': 'EXACT'}, 'end': {'value': 261, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 261, 'modifier': 'EXACT'}, 'end': {'value': 261, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 344, 'modifier': 'EXACT'}, 'end': {'value': 344, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 344, 'modifier': 'EXACT'}, 'end': {'value': 344, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 351, 'modifier': 'EXACT'}, 'end': {'value': 351, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 401, 'modifier': 'EXACT'}, 'end': {'value': 401, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 405, 'modifier': 'EXACT'}, 'end': {'value': 405, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 411, 'modifier': 'EXACT'}, 'end': {'value': 411, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 462, 'modifier': 'EXACT'}, 'end': {'value': 462, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 465, 'modifier': 'EXACT'}, 'end': {'value': 465, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 465, 'modifier': 'EXACT'}, 'end': {'value': 465, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29108'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17897672'}], 'ligand': {'name': 'Ca(2+)', 'id': 'ChEBI:CHEBI:29108', 'label': '2'}}], 'extraAttributes': {'uniParcId': 'UPI000013DDC6'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@@]1(O)CCCN(S(=O)(=O)c2ccc(OCc3ccc(F)cc3Cl)cc2)[C@H]1C(=O)NO', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '79.0', 'CHEMBLID': 'CHEMBL2167995', 'description': 'Inhibition of ADAMTS-1 using FAM (5-carbosyfluorescein)-AE*LQGRPISIAK substrate after 2 hrs'}, {'\u5206\u5b50SMILES': 'O=C1NC(=O)C(CCC(=O)N2CCN(c3cccc(Cl)c3)CC2)(C2CC2)N1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '328.0', 'CHEMBLID': 'CHEMBL4835174', 'description': 'Inhibition of human recombinant ADAMTS-1 (AA253 to 734) assessed as cleavage of fluorescent substrate using 5(6)-fluorescein-NH-AELQGRPISIAK-5(6)-TAMRA as substrate incubated for 120 mins by biochemical assay'}, {'\u5206\u5b50SMILES': 'O=C1NC(=O)C(CCC(=O)N2CCN(c3ccc(F)c(Cl)c3)CC2)(c2ccccn2)N1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '631.0', 'CHEMBLID': 'CHEMBL4835174', 'description': 'Inhibition of human recombinant ADAMTS-1 (AA253 to 734) assessed as cleavage of fluorescent substrate using 5(6)-fluorescein-NH-AELQGRPISIAK-5(6)-TAMRA as substrate incubated for 120 mins by biochemical assay'}, {'\u5206\u5b50SMILES': 'CC(C)C(CC1(C)NC(=O)NC1=O)C(=O)N1CCN(c2cc(Cl)cc(Cl)c2)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3247.0', 'CHEMBLID': 'CHEMBL4835174', 'description': 'Inhibition of human recombinant ADAMTS-1 (AA253 to 734) assessed as cleavage of fluorescent substrate using 5(6)-fluorescein-NH-AELQGRPISIAK-5(6)-TAMRA as substrate incubated for 120 mins by biochemical assay'}, {'\u5206\u5b50SMILES': 'C[C@H]1CN(C(=O)CC[C@@]2(C3CC3)NC(=O)NC2=O)CCN1c1cc(F)cc(F)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3460.0', 'CHEMBLID': 'CHEMBL4835174', 'description': 'Inhibition of human recombinant ADAMTS-1 (AA253 to 734) assessed as cleavage of fluorescent substrate using 5(6)-fluorescein-NH-AELQGRPISIAK-5(6)-TAMRA as substrate incubated for 120 mins by biochemical assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Secreted Protein Acidic and Rich in Cysteine (SPARC) Induced by the Renin-Angiotensin System Causes Endothelial Inflammation in the Early Stages of Hypertensive Vascular Injury.', 'abstract': 'Secreted protein acidic rich in cysteine (SPARC), one of the extracellular matrix proteins, is highly induced during inflammation. We investigated the pathophysiological regulation and role of SPARC in vascular inflammation in a rat model of hypertension created using deoxycorticosterone acetate (DOCA, 40 mg/kg/week, s.c.) and salt (1% in drinking water). DOCA-salt administration time-dependently increased systolic blood pressure during the 3-week treatment period, blunted endothelium-dependent vasodilation, and increased monocyte chemoattractant protein-1 (MCP-1) and lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) expression in the aorta. SPARC expression transiently increased until week 2 in the DOCA-salt rat aorta. Interestingly, aortic SPARC levels correlated with blood pressure and the levels of MCP-1 and LOX-1 during 0-2 weeks. The AT'}, {'title': 'ADAMTS- 1 rs402007 Polymorphism Modulates Carotid Plaque Vulnerability and Atorvastatin Efficacy in Cerebral Infarction Patients.', 'abstract': \"To investigate the association between rs402007 polymorphism in the ADAMTS-1 gene and carotid atherosclerotic plaque vulnerability, as well as the lipid-lowering efficacy of atorvastatin in cerebral infarction patients. Clinical data from 684 cerebral infarction patients admitted to The First Hospital of Hebei Medical University (2016-2019) were analyzed. Patients were stratified into stable plaque (n\\u2009=\\u2009338) and vulnerable plaque (n\\u2009=\\u2009346) groups based on carotid ultrasound. General information, biochemical markers, rs402007 (G/C) genotypes (dominant model), and allele frequencies were compared. Polymorphism genotyping was performed using TaqMan SNP assays (Applied Biosystems) on an ABI 7500 Fast Real-Time PCR system. Logistic regression evaluated plaque vulnerability risk factors and gene-risk factor interactions. Atorvastatin's lipid-lowering efficacy was compared across genotypes. Diabetes prevalence, LDL-C, TC, HCY, and FIB levels differed significantly between groups (P\\u2009<\\u20090.05). Genotypic distribution analysis revealed a higher frequency of the GG genotype in the stable plaque group (29.59% vs. 21.68%, \u03c7\"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5133"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'O75173', 'features': [{'type': 'Active site', 'location': {'start': {'value': 362, 'modifier': 'EXACT'}, 'end': {'value': 362, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00276'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10095'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18042673'}]}, {'type': 'Binding site', 'location': {'start': {'value': 194, 'modifier': 'EXACT'}, 'end': {'value': 194, 'modifier': 'EXACT'}}, 'description': 'in inhibited form', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 361, 'modifier': 'EXACT'}, 'end': {'value': 361, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18042673'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 365, 'modifier': 'EXACT'}, 'end': {'value': 365, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18042673'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 371, 'modifier': 'EXACT'}, 'end': {'value': 371, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18042673'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}], 'extraAttributes': {'uniParcId': 'UPI000014194C'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cc1cc(F)ccc1CCC1CCN(S(=O)(=O)C[C@](C)(C[C@H](C)c2ncc(F)cn2)N(O)C=O)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.18', 'CHEMBLID': 'CHEMBL1686369', 'description': 'Inhibition of ADAMTS-4 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs'}, {'\u5206\u5b50SMILES': 'Cc1nsc(C)c1CCC1CCN(S(=O)(=O)C[C@](C)(C[C@H](C)c2ncc(F)cn2)N(O)C=O)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.26', 'CHEMBLID': 'CHEMBL1686369', 'description': 'Inhibition of ADAMTS-4 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs'}, {'\u5206\u5b50SMILES': 'Cc1cc(Cl)ccc1CCC1CCN(S(=O)(=O)C[C@](C)(C[C@H](C)c2ncc(F)cn2)N(O)C=O)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.36', 'CHEMBLID': 'CHEMBL1686369', 'description': 'Inhibition of ADAMTS-4 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs'}, {'\u5206\u5b50SMILES': 'Cc1cc(CCC2CCN(S(=O)(=O)C[C@](C)(C[C@H](C)c3ncc(F)cn3)N(O)C=O)CC2)c(C)cn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.43', 'CHEMBLID': 'CHEMBL1686369', 'description': 'Inhibition of ADAMTS-4 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs'}, {'\u5206\u5b50SMILES': 'C[C@@H](C[C@@](C)(CS(=O)(=O)N1CCC(CCc2ccc(C(F)(F)F)cc2Cl)CC1)N(O)C=O)c1ncc(F)cn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.48', 'CHEMBLID': 'CHEMBL1686369', 'description': 'Inhibition of ADAMTS-4 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'The age-dependent influence of the infrapatellar fat pad on chondrocyte extracellular matrix production.', 'abstract': 'Despite the growing burden of knee osteoarthritis (KOA) on aging populations, our mechanistic understanding of this disease remains lacking. Though KOA is a whole joint disease, the impact of intra-articular structures, like the infrapatellar fat pad (IFP), on cartilage health is unclear. This study investigated the effect of age on paracrine communication between IFPs and chondrocytes. To isolate the effects of the IFP secretome on chondrocytes, aged chondrocytes from male and female mice were incubated with conditioned media from sex-matched young IFPs, aged IFPs, or control media. ECM protein expression increased in both male and female chondrocytes exposed to young, but not aged, conditioned media relative to control media. The effect of the young IFP was not concomitant with changes in ECM degradation proteins, ADAMTS4 or MMP13. To identify factors mediating the effects of the IFP on chondrocytes that are altered with aging, we performed mass spectrometry of young and aged conditioned media and transcriptomics of aged chondrocytes treated with this media. We then integrated the two datasets using network analyses. From the conditioned media, two secreted proteins, Mfge8 and Apoa4, were significantly changed with aging. In silico perturbation of the corresponding receptors of these IFP-secreted factors identified multiple enriched pathways, including negative regulation of nitric oxide synthase activity, in chondrocytes. Overall, the data suggest that young IFPs release paracrine factors that promote ECM production in chondrocytes, potentially via regulation of nitric oxide levels, but that this effect is diminished with aging.'}, {'title': 'Unveiling the mechanisms of mechanical loading-induced knee osteoarthritis through transcriptomics.', 'abstract': 'To establish a novel model of mechanical loading-induced knee osteoarthritis (KOA) and explore its regulatory mechanisms through transcriptomics.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2318"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q9UNA0', 'features': [{'type': 'Active site', 'location': {'start': {'value': 411, 'modifier': 'EXACT'}, 'end': {'value': 411, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00276'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10095'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18042673'}]}, {'type': 'Binding site', 'location': {'start': {'value': 209, 'modifier': 'EXACT'}, 'end': {'value': 209, 'modifier': 'EXACT'}}, 'description': 'in inhibited form', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 410, 'modifier': 'EXACT'}, 'end': {'value': 410, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18042673'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 414, 'modifier': 'EXACT'}, 'end': {'value': 414, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18042673'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 420, 'modifier': 'EXACT'}, 'end': {'value': 420, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18042673'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'note': 'catalytic'}}, {'type': 'Site', 'location': {'start': {'value': 261, 'modifier': 'EXACT'}, 'end': {'value': 261, 'modifier': 'EXACT'}}, 'description': 'Cleavage; by furin and PCSK7', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '18992360'}]}], 'extraAttributes': {'uniParcId': 'UPI00001AEAC2'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@@]1(O)CCCN(S(=O)(=O)c2ccc(OCc3ccc(F)cc3Cl)cc2)[C@H]1C(=O)NO', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.0', 'CHEMBLID': 'CHEMBL3388951', 'description': 'Inhibition of human ADAMTS-5 using VQTVTWPDMELPLPRNITEGEARGSVILTVKPIFEVSPSPLKG peptide substrate by AlphaScreen assay'}, {'\u5206\u5b50SMILES': 'C[C@@]1(O)CCCN(S(=O)(=O)c2ccc(OCc3ccc(F)cc3Cl)cc2)[C@H]1C(=O)NO', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.0', 'CHEMBLID': 'CHEMBL4013265', 'description': 'Inhibition of human ADAMTS5 using VQTVTWPDMELPLPRNITEGEARGSVILTVKPIFEVSPSPLKG peptide as substrate after 3 hrs by Alphascreen assay'}, {'\u5206\u5b50SMILES': 'C[C@H](Cc1ccc(C(F)(F)F)cc1)C(=O)NC[C@@]1(C2CC2)NC(=O)NC1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.0', 'CHEMBLID': 'CHEMBL4013265', 'description': 'Inhibition of human ADAMTS5 using VQTVTWPDMELPLPRNITEGEARGSVILTVKPIFEVSPSPLKG peptide as substrate after 3 hrs by Alphascreen assay'}, {'\u5206\u5b50SMILES': 'C[C@H](Cc1ccc(C(F)(F)F)cc1)C(=O)NC[C@@]1(C2CC2)NC(=O)NC1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.0', 'CHEMBLID': 'CHEMBL3887658', 'description': 'AlphaScreen Assay: The compounds of the present invention can be evaluated by using an aggrecanase ADAMTS-4 and ADAMTS-5 AlphaScreen assay (Miller J. A., et al. Anal. Biochem. 2003, 314, 260-265), with the following modifications: Typically 3 or 4 nM ADAMTS-4 or 2.1 nM ADAMTS-5 is incubated with 80 nM 43-mer peptide substrate+/- inhibitors (1% final DMSO concentration) for 3 hours at room temperature in a white non-binding surface 96 well plate (Corning 3990). Inhibitors are serially diluted 3-fold and tested at final starting concentrations of up to approximately 100 uM. The assay is then quenched with a cocktail containing EDTA (62.5 mM), 50 mM Tris(hydroxymethyl)aminomethane (Tris), (pH 7.5), 10 mM calcium chloride, 100 mM sodium chloride, 0.2% Brij 35 (main component of polyoxyethylene (23) lauryl ether), 0.1% Bovine Serum Albumin (BSA), BC3 monoclonal antibody hybridoma supernatant (1:2000 final dilution), streptavidin conjugated donor beads and anti-mouse IgG conjugated acceptor beads.'}, {'\u5206\u5b50SMILES': 'CC1(C)C[C@@H](O)CN(S(=O)(=O)c2ccc(OCc3ccc(Cl)cc3Cl)cc2)[C@H]1C(=O)NO', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.4', 'CHEMBLID': 'CHEMBL1768098', 'description': 'Inhibition of human recombinant aggrecanase 2 after 150 mins by fluorescence plate reader'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Exosomes of Human Fetal Cartilage Progenitor Cells (hFCPCs) Inhibited Interleukin-1\u03b2 (IL-1\u03b2)-Induced Osteoarthritis Phenotype via miR-125b-5p In Vitro.', 'abstract': 'This study investigated anti-inflammatory effects of exosomes derived from human fetal cartilage progenitor cells (hFCPC-Exo) and their microRNAs (miRNAs) on the osteoarthritis (OA) phenotype in vitro in comparison with exosomes from bone marrow mesenchymal stem cells (MSC-Exo).'}, {'title': 'In Silico Insights into the Inhibition of ADAMTS-5 by Punicalagin and Ellagic Acid for the Treatment of Osteoarthritis.', 'abstract': 'ADAMTS-5 (aggrecanase-2) is a major metalloprotease involved in regulating the cartilage extracellular matrix. Due to its role in removing aggrecan in the progression of osteoarthritis (OA), ADAMTS-5 is often regarded as a potential therapeutic target for OA. Punicalagin (PCG), a polyphenolic ellagitannin found in pomegranate ('}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2285"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'O14965', 'features': [{'type': 'Active site', 'location': {'start': {'value': 256, 'modifier': 'EXACT'}, 'end': {'value': 256, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '14580337'}]}, {'type': 'Binding site', 'location': {'start': {'value': 143, 'modifier': 'EXACT'}, 'end': {'value': 143, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '27837025'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5G1X'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 162, 'modifier': 'EXACT'}, 'end': {'value': 162, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '27837025'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5G1X'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 211, 'modifier': 'EXACT'}, 'end': {'value': 213, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '27837025'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5G1X'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 260, 'modifier': 'EXACT'}, 'end': {'value': 261, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '27837025'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5G1X'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 274, 'modifier': 'EXACT'}, 'end': {'value': 274, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '27837025'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '5G1X'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI000013C70F'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)c(O)c2)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.01', 'CHEMBLID': 'CHEMBL3706327', 'description': 'Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.'}, {'\u5206\u5b50SMILES': 'COc1ccc(Oc2nc(Nc3ccc(-c4nnn[nH]4)cc3)ncc2Cl)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.012', 'CHEMBLID': 'CHEMBL4365307', 'description': 'Inhibition of Aurora A (unknown origin)'}, {'\u5206\u5b50SMILES': 'Fc1ccc(Oc2nc(Nc3ccc(-c4nnn[nH]4)cc3)ncc2Cl)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.012', 'CHEMBLID': 'CHEMBL4365307', 'description': 'Inhibition of Aurora A (unknown origin)'}, {'\u5206\u5b50SMILES': 'Fc1ccccc1Oc1nc(Nc2ccc(-c3nnn[nH]3)cc2)ncc1Cl', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.012', 'CHEMBLID': 'CHEMBL4365307', 'description': 'Inhibition of Aurora A (unknown origin)'}, {'\u5206\u5b50SMILES': 'CC(C)c1cc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)[nH]n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03', 'CHEMBLID': 'CHEMBL3706327', 'description': 'Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'N', 'abstract': 'Chemical modification of mRNA regulates its stability and translation efficiency. The most prevalent modification is the N'}, {'title': 'AURKA controls oocyte spindle assembly checkpoint and chromosome alignment by HEC1 phosphorylation.', 'abstract': 'In human oocytes, meiosis I is error-prone, causing early miscarriages and developmental disorders. The Aurora protein kinases are key regulators of chromosome segregation in mitosis and meiosis, and their dysfunction is associated with aneuploidy. Oocytes express three Aurora kinase (AURK) proteins, but only AURKA is necessary and sufficient to support oocyte meiosis in mice. However, the unique molecular contributions to ensuring high egg quality of AURKA remain unclear. Here, using a combination of genetic and pharmacological approaches, we evaluated how AURKA phosphorylation regulates outer kinetochore function during oocyte meiosis. We found that the outer kinetochore protein Ndc80/HEC1 is constitutively phosphorylated at multiple residues by Aurora kinases during meiosis I, but that serine 69 is specifically phosphorylated by AURKA in mouse and human oocytes. We further show that serine 69 phosphorylation contributes to spindle assembly checkpoint activation and chromosome alignment during meiosis I. These results provide a fundamental mechanistic understanding of how AURKA regulates meiosis and kinetochore function to ensure meiosis I fidelity.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4722"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q96GD4', 'features': [{'type': 'Active site', 'location': {'start': {'value': 200, 'modifier': 'EXACT'}, 'end': {'value': 200, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}]}, {'type': 'Binding site', 'location': {'start': {'value': 83, 'modifier': 'EXACT'}, 'end': {'value': 91, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 106, 'modifier': 'EXACT'}, 'end': {'value': 106, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI000013FD00'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.042', 'CHEMBLID': 'CHEMBL3707758', 'description': 'Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.'}, {'\u5206\u5b50SMILES': 'NC(=O)c1cccc2c(NCc3ccc(NC(=O)c4cc(C(F)(F)F)n[nH]4)cc3)ncnc12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.045', 'CHEMBLID': 'CHEMBL3707758', 'description': 'Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.'}, {'\u5206\u5b50SMILES': 'CCN(CC)c1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.046', 'CHEMBLID': 'CHEMBL3707758', 'description': 'Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.'}, {'\u5206\u5b50SMILES': 'N#Cc1ccnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.06', 'CHEMBLID': 'CHEMBL3707758', 'description': 'Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.'}, {'\u5206\u5b50SMILES': 'Cc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.061', 'CHEMBLID': 'CHEMBL3707758', 'description': 'Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'In Silico Network Toxicology, Molecular Docking, and Multi-Level Bioinformatics Reveal Methyl Eugenol-Induced Hepatocellular Carcinoma Mechanisms in Humans.', 'abstract': 'Methyl eugenol (ME), a natural compound found in various essential oils, has recently been classified as a Group 2A carcinogen by the International Agency for Research on Cancer.'}, {'title': 'Prolonged metaphase II arrest weakens Aurora B/C-dependent error correction in mouse oocytes.', 'abstract': 'Chromosome segregation during meiosis is highly error-prone in mammalian oocytes. The mechanisms controlling chromosome attachments and the spindle assembly checkpoint (SAC) have been extensively studied in meiosis I, but our knowledge of these mechanisms during meiosis II is rather limited. Although mammalian oocytes arrest in metaphase II for an extended period awaiting fertilization, some misattached chromosomes may persist. This suggests that the mechanism correcting misattachments is not fully functional during the arrest. In this study, we investigated whether low inter-kinetochore tension, which characterizes incorrect attachments, can be detected by Aurora B/C-dependent error correction in meiosis II. We found that low tension, induced by low dose of STLC in early metaphase II, does indeed mediate microtubule detachment by Aurora B/C and, consequently, anaphase II delay through SAC activation. Surprisingly, we also found that, during prolonged metaphase II arrest, Aurora B/C activity is no longer sufficient to detach low-tension attachments, correlating with high accumulation of PP2A at kinetochores. As a result, the SAC is not activated, and sister chromatids segregate in anaphase II without delay even in the presence of low tension. Hence, during the prolonged metaphase II arrest to await fertilization, oocytes become unable to discriminate between correct and incorrect attachments and may allow errors to persist.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2185"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q07817', 'features': [{'type': 'Site', 'location': {'start': {'value': 61, 'modifier': 'EXACT'}, 'end': {'value': 62, 'modifier': 'EXACT'}}, 'description': 'Cleavage; by caspase-1'}], 'extraAttributes': {'uniParcId': 'UPI0000000CEC'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.5', 'CHEMBLID': 'CHEMBL2399239', 'description': 'Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay'}, {'\u5206\u5b50SMILES': 'CCNC[C@@H]1COCCN1CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.5', 'CHEMBLID': 'CHEMBL3887910', 'description': 'Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization (\"FP\") described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization (\"FP\")assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.'}, {'\u5206\u5b50SMILES': 'CCN(CC)CC1CN(CC[C@H](CSc2ccccc2)Nc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCC([C@@H](O)c5ccccc5-c5ccc(Cl)cc5)CC4)cc3)cc2S(=O)(=O)C(F)(F)F)CCO1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.5', 'CHEMBLID': 'CHEMBL3887910', 'description': 'Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization (\"FP\") described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization (\"FP\")assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.'}, {'\u5206\u5b50SMILES': 'CCN(CC)C[C@@H]1COCCN1CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.5', 'CHEMBLID': 'CHEMBL3705975', 'description': 'Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization (\"FP\") described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization (\"FP\") assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.'}, {'\u5206\u5b50SMILES': 'CCN(CC)CC1CN(CC[C@@H](CSc2ccccc2)Nc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCC([C@H](O)c5ccccc5-c5ccc(Cl)cc5)CC4)cc3)cc2S(=O)(=O)C(F)(F)F)CCO1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.5', 'CHEMBLID': 'CHEMBL3705975', 'description': 'Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization (\"FP\") described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization (\"FP\") assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': \"Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib's efficacy.\", 'abstract': \"Hepatocellular carcinoma (HCC) is characterized by poor prognosis and remains a leading cause of cancer mortality worldwide. Advanced HCC is managed with several first-line therapies, including tyrosine kinase inhibitors (TKI) and immunotherapy (mAb-PD-1 and mAb-VEGF). However, the efficacy of HCC therapeutics is often short-lived.\\xa0Recent studies have demonstrated that the activation of the Nrf2-Bcl-xL pathway contributes to poor prognosis in a subset of HCC patients. Here, we found that dimethyl fumarate (DMF), a drug used for treating psoriasis and multiple sclerosis, regulates the Nrf2-Bcl-xL signaling axis to inhibit HCC growth in a mice xenograft model. Mechanistically, the downregulation of the Nrf2-Bcl-xL axis led to mitochondria stress and apoptosis in vitro and in vivo. Enforced Nrf2 or Bcl-xL expression in HCC cells markedly reversed the antitumor effects of DMF in HCC cells. Importantly, DMF enhanced sorafenib's antitumor effects. Collectively, our results demonstrate new mechanism insights into the antitumor effects of DMF and that Nrf2-targeted therapy might improve HCC treatment outcomes.\"}, {'title': '[Role of miR-140-5p/BCL2L1 in apoptosis and autophagy of HFOB1.19 and effect of Bushen Jianpi Huoxue Decoction].', 'abstract': 'Osteoporosis(OP) is a senile bone disease characterized by an imbalance between bone remodeling and bone formation. Targeting pathogenesis of kidney deficiency, spleen deficiency, and blood stasis, Bushen Jianpi Huoxue Decoction has a significant effect on the treatment of OP by tonifying kidney, invigorating spleen, and activating blood circulation. MicroRNA(miRNA) and the anti-apoptotic protein B-cell lymphoma-2-like protein 1(BCL2L1) are closely related to bone cell metabolism. Therefore, in this study, the binding of miR-140-5p to BCL2L1 was detected by dual luciferase assay and polymerase chain reaction(PCR). After silencing or overexpressing miR-140-5p, the apoptosis, autophagy, and osteogenic function of human fetal osteoblast cell line 1.19(HFOB1.19) were observed by flow cytometry and Western blot. Bushen Jianpi Huoxue Decoction-containing serum was prepared by intragastric administration of Bushen Jianpi Huoxue Decoction in rats. Different concentrations of Bushen Jianpi Huoxue Decoction-containing serum were used to treat HFOB1.19 with or without miR-140-5p mimic. The expression of osteogenic proteins in each group was observed, and the role of miR-140-5p/BCL2L1 in apoptosis and autophagy of HFOB1.19 was studied, along with the effect of Bushen Jianpi Huoxue Decoction on these processes. As indicated by the dual luciferase assay, miR-140-5p bound to BCL2L1. Flow cytometry and Western blot showed that miR-140-5p promoted apoptosis and inhibited autophagy in HFOB1.19. After intervention with high, medium, and low doses of Bushen Jianpi Huoxue Decoction-medicated serum, compared with the miR-140-5p NC group, the expression of osteocalcin(OCN), osteopontin(OPN), Runt-related transcription factor 2(RUNX2), and transforming growth factor beta 1(TGF-\u03b21) decreased in the miR-140-5p mimic group, while the expression of bone morphogenetic protein 2(BMP2) showed no significant difference under high-dose intervention. Therefore, miR-140-5p/BCL2L1 can promote apoptosis and inhibit autophagy in HFOB1.19. Bushen Jianpi Huoxue Decoction can affect the osteogenic effect of miR-140-5p through BMP2.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4625"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P15291', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 183, 'modifier': 'EXACT'}, 'end': {'value': 187, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:66914'}], 'ligand': {'name': 'UDP-alpha-D-galactose', 'id': 'ChEBI:CHEBI:66914'}}, {'type': 'Binding site', 'location': {'start': {'value': 222, 'modifier': 'EXACT'}, 'end': {'value': 224, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:66914'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'UDP-alpha-D-galactose', 'id': 'ChEBI:CHEBI:66914'}}, {'type': 'Binding site', 'location': {'start': {'value': 249, 'modifier': 'EXACT'}, 'end': {'value': 250, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:66914'}], 'ligand': {'name': 'UDP-alpha-D-galactose', 'id': 'ChEBI:CHEBI:66914'}}, {'type': 'Binding site', 'location': {'start': {'value': 250, 'modifier': 'EXACT'}, 'end': {'value': 250, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035'}}, {'type': 'Binding site', 'location': {'start': {'value': 310, 'modifier': 'EXACT'}, 'end': {'value': 310, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:66914'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16497331'}], 'ligand': {'name': 'UDP-alpha-D-galactose', 'id': 'ChEBI:CHEBI:66914'}}, {'type': 'Binding site', 'location': {'start': {'value': 312, 'modifier': 'EXACT'}, 'end': {'value': 315, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:506227'}], 'ligand': {'name': 'N-acetyl-D-glucosamine', 'id': 'ChEBI:CHEBI:506227'}}, {'type': 'Binding site', 'location': {'start': {'value': 343, 'modifier': 'EXACT'}, 'end': {'value': 346, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:66914'}], 'ligand': {'name': 'UDP-alpha-D-galactose', 'id': 'ChEBI:CHEBI:66914'}}, {'type': 'Binding site', 'location': {'start': {'value': 343, 'modifier': 'EXACT'}, 'end': {'value': 343, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035'}}, {'type': 'Binding site', 'location': {'start': {'value': 355, 'modifier': 'EXACT'}, 'end': {'value': 355, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:506227'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16157350'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '19106107'}], 'ligand': {'name': 'N-acetyl-D-glucosamine', 'id': 'ChEBI:CHEBI:506227'}}, {'type': 'Site', 'location': {'start': {'value': 77, 'modifier': 'EXACT'}, 'end': {'value': 78, 'modifier': 'EXACT'}}, 'description': 'Cleavage; to produce soluble form'}], 'extraAttributes': {'uniParcId': 'UPI000002D22E'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[n+]1ccn(CCCCCCCCCCCCCCCCCCCCn2cc[n+](C)c2)c1.[Cl-].[Cl-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1960000.0', 'CHEMBLID': 'CHEMBL2329317', 'description': 'Inhibition of human recombinant soluble His-tagged beta4-GalT1 expressed in Escherichia coli BL21 using GlcNAcbeta-Bn as substrate after 1 hr relative to control'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'B4GALT5 inhibits CD8', 'abstract': 'Immune evasion is a crucial event in the progression of pancreatic ductal adenocarcinoma (PDAC). The identification of new immunotherapeutic targets may provide a promising platform for advancing PDAC treatment. This study aims to investigate the role of beta-1,4-galactosyltransferase-5 (B4GALT5) in immune evasion by pancreatic cancer cells and evaluate its potential as an immunotherapeutic target.'}, {'title': 'Cytosolic UDP-Gal biosynthetic machinery is required for dimerization of SLC35A2 in the Golgi membrane and its interaction with B4GalT1.', 'abstract': \"Glycosylation is a vital post-translational modification involving the addition of sugars to proteins and lipids, facilitated by glycosyltransferases and dependent on nucleotide sugar donors like UDP-galactose (UDP-Gal). This study examines how disruptions in UDP-Gal synthesis affect protein-protein interactions critical for glycosylation. Using CRISPR/Cas9, we generated HEK293T cell lines lacking key enzymes of the Leloir pathway: UDP-galactose 4'-epimerase (GALE), galactose-1-phosphate uridylyltransferase (GALT), or both. The knockout of GALE led to a significant reduction in intracellular UDP-Gal levels and altered N-glycan profiles, indicating impaired galactosylation. Through the NanoBiT assay, we observed that knocking out GALE alone or both GALE and GALT diminished the ability of the UDP-Gal transporter SLC35A2 to form homomers and to interact with the beta-1,4-galactosyltransferase 1 (B4GALT1). These findings suggest that the nucleotide sugar availability and/or the presence of the corresponding enzymes in the cytoplasm influences the formation of protein complexes involved in glycosylation in the Golgi apparatus, potentially affecting the glycosylation process itself. Our study highlights the dynamic nature of the glycosylation machinery and suggests that the interactions between glycosylation proteins are responsive to changes in nucleotide sugar levels. This opens new avenues for understanding the mechanisms underlying glycosylation and for investigating congenital glycosylation disorders.\"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4384"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P56817', 'features': [{'type': 'Active site', 'location': {'start': {'value': 93, 'modifier': 'EXACT'}, 'end': {'value': 93, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10094'}]}, {'type': 'Active site', 'location': {'start': {'value': 289, 'modifier': 'EXACT'}, 'end': {'value': 289, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10094'}]}], 'extraAttributes': {'uniParcId': 'UPI0000048186'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC1(C)C(N)=N[C@](C)(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CS1(=O)=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0002', 'CHEMBLID': 'CHEMBL3888079', 'description': \"Cellular A\u03b2-Lowering Assay: The Abeta 40 AlphaLISA Assay can be used. The HEK293 APP cells were seeded in 96 well Microtiter plates in cell culture medium (Iscove's, plus 10% (v/v) fetal bovine serum, penicillin/streptomycin) to about 80% confluency and the compounds were added at a 3x concentration in 1/3 volume of culture medium (final DMSO concentration was kept at 1% v/v). After 18-20 hrs incubation at 37\u00b0 C. and 5% CO2 in a humidified incubator, the culture supernatants were harvested for the determination of A\u03b2 40 concentrations using Perkin-Elmer Human Amyloid beta 1-40 (high specificity) Kit (Cat#AL275C).In a Perkin-Elmer White Optiplate-384 (Cat#6007290), 2 ul culture supernatants were combined with 2 ul of a 10x AlphaLISA Anti-hA\u03b2Acceptor beads+Biotinylated Antibody Anti-A\u03b2 1-40 Mix (50 ug/mL/5 nM). After 1 hour room temperature incubation, 16 ul of a 1.25x preparation of Streptavidin (SA) Donor beads (25 ug/mL) were added and incubated for 30 minutes in the Dark.\"}, {'\u5206\u5b50SMILES': 'COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CS(=O)(=O)C(C)(C)C(N)=N3)c2)cn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0009', 'CHEMBLID': 'CHEMBL3888079', 'description': \"Cellular A\u03b2-Lowering Assay: The Abeta 40 AlphaLISA Assay can be used. The HEK293 APP cells were seeded in 96 well Microtiter plates in cell culture medium (Iscove's, plus 10% (v/v) fetal bovine serum, penicillin/streptomycin) to about 80% confluency and the compounds were added at a 3x concentration in 1/3 volume of culture medium (final DMSO concentration was kept at 1% v/v). After 18-20 hrs incubation at 37\u00b0 C. and 5% CO2 in a humidified incubator, the culture supernatants were harvested for the determination of A\u03b2 40 concentrations using Perkin-Elmer Human Amyloid beta 1-40 (high specificity) Kit (Cat#AL275C).In a Perkin-Elmer White Optiplate-384 (Cat#6007290), 2 ul culture supernatants were combined with 2 ul of a 10x AlphaLISA Anti-hA\u03b2Acceptor beads+Biotinylated Antibody Anti-A\u03b2 1-40 Mix (50 ug/mL/5 nM). After 1 hour room temperature incubation, 16 ul of a 1.25x preparation of Streptavidin (SA) Donor beads (25 ug/mL) were added and incubated for 30 minutes in the Dark.\"}, {'\u5206\u5b50SMILES': 'CC1(C)C(N)=N[C@](C)(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)CS1(=O)=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0009', 'CHEMBLID': 'CHEMBL3888079', 'description': \"Cellular A\u03b2-Lowering Assay: The Abeta 40 AlphaLISA Assay can be used. The HEK293 APP cells were seeded in 96 well Microtiter plates in cell culture medium (Iscove's, plus 10% (v/v) fetal bovine serum, penicillin/streptomycin) to about 80% confluency and the compounds were added at a 3x concentration in 1/3 volume of culture medium (final DMSO concentration was kept at 1% v/v). After 18-20 hrs incubation at 37\u00b0 C. and 5% CO2 in a humidified incubator, the culture supernatants were harvested for the determination of A\u03b2 40 concentrations using Perkin-Elmer Human Amyloid beta 1-40 (high specificity) Kit (Cat#AL275C).In a Perkin-Elmer White Optiplate-384 (Cat#6007290), 2 ul culture supernatants were combined with 2 ul of a 10x AlphaLISA Anti-hA\u03b2Acceptor beads+Biotinylated Antibody Anti-A\u03b2 1-40 Mix (50 ug/mL/5 nM). After 1 hour room temperature incubation, 16 ul of a 1.25x preparation of Streptavidin (SA) Donor beads (25 ug/mL) were added and incubated for 30 minutes in the Dark.\"}, {'\u5206\u5b50SMILES': 'C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CS(=O)(=O)C2(CCCC2)C(N)=N1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.001', 'CHEMBLID': 'CHEMBL3888079', 'description': \"Cellular A\u03b2-Lowering Assay: The Abeta 40 AlphaLISA Assay can be used. The HEK293 APP cells were seeded in 96 well Microtiter plates in cell culture medium (Iscove's, plus 10% (v/v) fetal bovine serum, penicillin/streptomycin) to about 80% confluency and the compounds were added at a 3x concentration in 1/3 volume of culture medium (final DMSO concentration was kept at 1% v/v). After 18-20 hrs incubation at 37\u00b0 C. and 5% CO2 in a humidified incubator, the culture supernatants were harvested for the determination of A\u03b2 40 concentrations using Perkin-Elmer Human Amyloid beta 1-40 (high specificity) Kit (Cat#AL275C).In a Perkin-Elmer White Optiplate-384 (Cat#6007290), 2 ul culture supernatants were combined with 2 ul of a 10x AlphaLISA Anti-hA\u03b2Acceptor beads+Biotinylated Antibody Anti-A\u03b2 1-40 Mix (50 ug/mL/5 nM). After 1 hour room temperature incubation, 16 ul of a 1.25x preparation of Streptavidin (SA) Donor beads (25 ug/mL) were added and incubated for 30 minutes in the Dark.\"}, {'\u5206\u5b50SMILES': 'CC1(C)C(N)=N[C@](C)(c2cc(NC(=O)c3cnc(C(F)F)cn3)ccc2F)CS1(=O)=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0018', 'CHEMBLID': 'CHEMBL3888079', 'description': \"Cellular A\u03b2-Lowering Assay: The Abeta 40 AlphaLISA Assay can be used. The HEK293 APP cells were seeded in 96 well Microtiter plates in cell culture medium (Iscove's, plus 10% (v/v) fetal bovine serum, penicillin/streptomycin) to about 80% confluency and the compounds were added at a 3x concentration in 1/3 volume of culture medium (final DMSO concentration was kept at 1% v/v). After 18-20 hrs incubation at 37\u00b0 C. and 5% CO2 in a humidified incubator, the culture supernatants were harvested for the determination of A\u03b2 40 concentrations using Perkin-Elmer Human Amyloid beta 1-40 (high specificity) Kit (Cat#AL275C).In a Perkin-Elmer White Optiplate-384 (Cat#6007290), 2 ul culture supernatants were combined with 2 ul of a 10x AlphaLISA Anti-hA\u03b2Acceptor beads+Biotinylated Antibody Anti-A\u03b2 1-40 Mix (50 ug/mL/5 nM). After 1 hour room temperature incubation, 16 ul of a 1.25x preparation of Streptavidin (SA) Donor beads (25 ug/mL) were added and incubated for 30 minutes in the Dark.\"}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Harnessing computational tools for drug discovery: An integrated computational approach to identify potential BACE-1 inhibitors.', 'abstract': \"The hallmark of Alzheimer's disease (AD), a progressive neurodegenerative condition, is the buildup of amyloid-beta (A\u03b2) plaque, which is mainly caused by \u03b2-secretase 1 (BACE-1) activity. BACE-1 inhibition is a potentially effective treatment strategy to lower the progression of AD. In order to find possible BACE-1 inhibitors using a drug repurposing technique, this study uses an integrated computational approach that includes pharmacophore modelling, virtual screening, molecular docking, MM-GBSA, molecular dynamics (MD) simulations, in-silico ADMET profiling, and PBPK modelling. A pharmacophore model, was created with known BACE-1 inhibitors to enable virtual screening of both novel and FDA-approved chemical libraries. Top candidates with good free energy scores and strong binding affinities were found using molecular docking and MM-GBSA calculations. The stability of shortlisted Hits inside the BACE-1 active site was further validated using MD simulations, which showed that some of the important interactions were maintained across a period of 50ns. ADMET and PBPK studies predicted favorable pharmacokinetic and safety profiles for the shortlisted hits, particularly for B2 and B9. These findings identify potential candidates for future experimental validation, offering an inexpensive approach for identification of compounds as potential BACE-1 inhibitors.\"}, {'title': \"Intranasal Delivery of BACE1 siRNA and Berberine via Engineered Stem Cell Exosomes for the Treatment of Alzheimer's Disease.\", 'abstract': \"Alzheimer's disease (AD) is a common progressive and irreversible neurodegenerative disease. AD accounts for 60%-70% of all dementia cases, ranking as the seventh leading cause of death globally. Human umbilical cord mesenchymal stem cells (hUC-MSCs) characterized by their abundant availability and low immunogenicity, have demonstrated significant therapeutic potential for AD in both preclinical studies and clinical trials. The use of exosomes can help mitigate the issues associated with cellular therapies. However, the clinical application of hUC-MSCs remains challenging due to their inability to effectively traverse the blood-brain barrier (BBB) and reach pathological sites. Therapeutic strategies utilizing exosomes derived from hUC-MSCs (Exos) have emerged as an effective approach for AD intervention.\"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4822"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q9Y5Z0', 'features': [{'type': 'Active site', 'location': {'start': {'value': 110, 'modifier': 'EXACT'}, 'end': {'value': 110, 'modifier': 'EXACT'}}, 'description': ''}, {'type': 'Active site', 'location': {'start': {'value': 303, 'modifier': 'EXACT'}, 'end': {'value': 303, 'modifier': 'EXACT'}}, 'description': ''}], 'extraAttributes': {'uniParcId': 'UPI00000396BC'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@@]1(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)C[C@@H](C(F)F)SC(N)=N1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.19', 'CHEMBLID': 'CHEMBL4342612', 'description': 'Inhibition of BACE2 (unknown origin)'}, {'\u5206\u5b50SMILES': 'CN1C(N)=N[C@](C)(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)CS1(=O)=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.38', 'CHEMBLID': 'CHEMBL4183172', 'description': 'Inhibition of human BACE2'}, {'\u5206\u5b50SMILES': 'NC1=N[C@@]2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)CN(c3ncc(F)cn3)C[C@H]2CS1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.388', 'CHEMBLID': 'CHEMBL5034202', 'description': 'Inhibition of recombinant human BACE2 using (MCA)-S-E-V-N-L-D-A-E-F-R-K(dinitrophenol)-R-R-R-R-NH2 as substrate by FRET assay'}, {'\u5206\u5b50SMILES': 'CC(F)(F)[C@@H]1C[C@@](C)(c2cc(NC(=O)c3ccc(OCF)cn3)ccc2F)N=C(N)S1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.5', 'CHEMBLID': 'CHEMBL4342612', 'description': 'Inhibition of BACE2 (unknown origin)'}, {'\u5206\u5b50SMILES': 'NC1=N[C@@]2(c3cc(NC(=O)c4ncc(F)cc4F)ccc3F)CN(c3ncc(F)cn3)C[C@H]2CS1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.555', 'CHEMBLID': 'CHEMBL5034202', 'description': 'Inhibition of recombinant human BACE2 using (MCA)-S-E-V-N-L-D-A-E-F-R-K(dinitrophenol)-R-R-R-R-NH2 as substrate by FRET assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Ergothioneine Suppresses Amyloid \u0392-Induced Tau Phosphorylation and Cytotoxicity by Inactivating Glycogen Synthase Kinase-3\u03b2 in Cultured Neurons.', 'abstract': \"Amyloid-beta (A\u03b2) oligomers, formed by A\u03b2 aggregation, are the causative agent of Alzheimer's disease and induce the hyperphosphorylation of tau protein (Tau) and neurotoxicity. The antioxidant ergothioneine (ERGO) is transferred to the brain after oral ingestion and protects against A\u03b2- induced neurotoxicity and cognitive dysfunction. However, the impact of ERGO on A\u03b2 oligomer-induced Tau phosphorylation remains unclear.\"}, {'title': \"Alzheimer's Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of A\u03b2PP; Proteolytic Production of A\u03b2 Is Suppressed in AD-Affected Neurons: Evolution of a Theory.\", 'abstract': 'The present '}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2525"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q9UIF8', 'features': [], 'extraAttributes': {'uniParcId': 'UPI0000D74C4A'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '174.0', 'CHEMBLID': 'CHEMBL4650000', 'description': 'Alphascreen assay. Binding to BAZ2BA (domain start/stop: S1858-S1972) by alphascreen assay'}, {'\u5206\u5b50SMILES': 'Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '180.0', 'CHEMBLID': 'CHEMBL3419225', 'description': 'Displacement of H3K14Ac from BAZ2B (unknown origin) preincubated for 30 mins with non-biotinylated peptide followed by addition of biotinylated peptide measured after 30 mins by AlphaScreen assay'}, {'\u5206\u5b50SMILES': 'CCCOc1ccn2c(C(C)=O)cc(-c3ccccc3S(C)(=O)=O)c2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '360.0', 'CHEMBLID': 'CHEMBL3811646', 'description': 'Competitive binding affinity to His-tagged BRAZ2B (unknown origin) expressed in Escherichia coli BL21(DE3) cells by AlphaScreen assay in presence of biotinylated histone H3 peptide (1 to 21 residues) K9/14Ac'}, {'\u5206\u5b50SMILES': 'CC(=O)c1cc(-c2ccccc2CO)c2cc(C)ccn12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '370.0', 'CHEMBLID': 'CHEMBL3772736', 'description': 'Inhibition of recombinant His6-TEV fused human BAZ2B expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha screen assay'}, {'\u5206\u5b50SMILES': 'COc1ccn2c(C(C)=O)cc(-c3ccccc3CO)c2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '410.0', 'CHEMBLID': 'CHEMBL3772736', 'description': 'Inhibition of recombinant His6-TEV fused human BAZ2B expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha screen assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Neurodevelopmental and other phenotypes recurrently associated with heterozygous BAZ2B loss-of-function variants.', 'abstract': 'The bromodomain adjacent to zinc finger 2B (BAZ2B) gene encodes a chromatin remodeling protein that has been shown to perform a variety of regulatory functions. It has been proposed that loss of BAZ2B function is associated with neurodevelopmental phenotypes, and some recurrent structural birth defects and dysmorphic features have been documented among individuals carrying heterozygous loss-of-function BAZ2B variants. However, additional evidence is needed to confirm that these phenotypes are attributable to BAZ2B deficiency. Here, we report 10 unrelated individuals with heterozygous deletions, stop-gain, frameshift, missense, splice junction, indel, and start-loss variants affecting BAZ2B. These included a paternal intragenic deletion and a maternal frameshift variant that were inherited from mildly affected or asymptomatic parents. The analysis of molecular and clinical data from this cohort, and that of individuals previously reported, suggests that BAZ2B haploinsufficiency causes an autosomal dominant neurodevelopmental syndrome that is incompletely penetrant. The phenotypes most commonly seen in association with loss of BAZ2B function include developmental delay, intellectual disability, autism spectrum disorder, speech delay-with some affected individuals being non-verbal-behavioral abnormalities, seizures, vision-related issues, congenital heart defects, poor fetal growth, and an indistinct pattern of dysmorphic features in which epicanthal folds and small ears are particularly common.'}, {'title': 'Risk of neurodegeneration among residents of electronic waste recycling areas.', 'abstract': 'The abnormal disposal process of electronic waste (e-waste) always emits a variety of toxic substances that enter the human body through various environmental media and can have many adverse health effects. Metals are thought to be inextricably linked to neurodegeneration. In the present study, we tried to explore the neurodegenerative status of subjects exposed to e-waste and the association between metal intake and neurodegeneration. We recruited the residents near the e-waste recycling area (the exposed group) and the residents without any e-waste contact history (the reference group) for a comparative study with detection and analysis of metals, biomarkers associated with neurodegeneration or oxidative stress (OS). The results showed that the metals between the reference and exposed group were significantly different. The concentrations of Brain-derived neurotrophic factor (BDNF) and \u03b2-amyloid protein 42 (A\u03b242) in the exposed groups were significantly lower, while the levels of Euchromatic Histone lysine Methyltransferase 1 (EHMT1), Bromodomain Adjacent to Zinc finger domain 2B (BAZ2B) and Malondialdehyde (MDA) were significantly higher than in the reference groups. Although the ratio of A\u03b242/A\u03b240 had no statistical significance in the two groups, the medians of the ratio in the exposed group was lower than in the reference group. The linear regression and mediating effect analysis showed that MDA (OS) might mediate the effects of metals on EHMT1(p'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1741220"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P10415', 'features': [{'type': 'Site', 'location': {'start': {'value': 34, 'modifier': 'EXACT'}, 'end': {'value': 35, 'modifier': 'EXACT'}}, 'description': 'Cleavage; by caspase-3'}], 'extraAttributes': {'uniParcId': 'UPI000000D90E'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CCN(CC)C[C@@H]1COCCN1CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL3707482', 'description': 'Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization (\"FP\") described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization (\"FP\") assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.'}, {'\u5206\u5b50SMILES': 'CN(CCO)CC[C@@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL3707482', 'description': 'Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization (\"FP\") described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization (\"FP\") assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.'}, {'\u5206\u5b50SMILES': 'CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL3887911', 'description': 'Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization (\"FP\") described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization (\"FP\")assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.'}, {'\u5206\u5b50SMILES': 'CN(C)C[C@H]1COCCN1CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL3887911', 'description': 'Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization (\"FP\") described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization (\"FP\")assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.'}, {'\u5206\u5b50SMILES': 'CCNC[C@@H]1COCCN1CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL3887911', 'description': 'Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization (\"FP\") described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization (\"FP\")assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction.', 'abstract': 'Giant congenital melanocytic nevus (GCMN) is a RAS/RAF mutation-driven syndrome characterized by extensive melanocytic lesions, posing psychological challenges and a lifelong risk of malignancy. Existing treatments like surgical resection and laser therapy fail to fully remove lesions, and MAPK inhibitors show limited efficacy. This study identified a predominant population of senescent cells and a minority of proliferative cells in GCMN, necessitating dual-targeted strategies. We found that the anti-apoptotic protein BCL2 is expressed in both senescent and proliferative cells from GCMN patients with various gene mutations. Coexpression of P16 and BCL2 indicated a phenotype of growth arrest and cell survival. BCL2 inhibitors (BCL2i) showed significant cytotoxicity to GCMN cells in vitro. Hypopigmentation and GCMN cell clearance were observed in patient-derived xenograft models and in Nras'}, {'title': 'Augmenting the Anti-Leukemic Activity of the BCL-2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL-2/HDAC1 and Dual BCL-2/HDAC6 Inhibitors.', 'abstract': 'Motivated by the anti-leukemic synergy between histone deacetylase (HDAC) inhibitors and the FDA-approved BCL-2 inhibitor venetoclax, coupled with our interests in polypharmacology, we sought to bolster the anti-leukemic efficacy of the clinical drug by grafting HDAC1-selective or HDAC6-selective inhibitor motifs onto a solvent-accessible domain of venetoclax. We discovered multiple polypharmacological agents that both retained the potent BCL-2 inhibitory activity of venetoclax and effectively inhibited either HDAC1 or HDAC6 with excellent (up to 80-fold) selectivities for the desired HDAC isoform. In addition, relative to parental venetoclax, two of our lead compounds, BD-4-213 and AMC-4-154, exhibited superior activities against the acute myeloid leukemia cell line MV4;11 and an MV4;11 cell line engineered to overexpress BCL-2. Annexin-V assay results confirmed an on-target mechanism of apoptosis for these novel chimeric molecules. Efforts to further boost the HDAC1 or HDAC6 binding affinities and/or selectivities proved unsuccessful due to synthetic chemistry challenges and solubility problems, which may underscore the difficulties of polypharmacology approaches involving a large inhibitor, such as venetoclax.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4860"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P16278', 'features': [{'type': 'Active site', 'location': {'start': {'value': 188, 'modifier': 'EXACT'}, 'end': {'value': 188, 'modifier': 'EXACT'}}, 'description': 'Proton donor', 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '22128166'}]}, {'type': 'Active site', 'location': {'start': {'value': 268, 'modifier': 'EXACT'}, 'end': {'value': 268, 'modifier': 'EXACT'}}, 'description': 'Nucleophile', 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'PubMed', 'id': '22128166'}]}, {'type': 'Binding site', 'location': {'start': {'value': 83, 'modifier': 'EXACT'}, 'end': {'value': 83, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22128166'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24737316'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3THC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3WF3'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 129, 'modifier': 'EXACT'}, 'end': {'value': 129, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22128166'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24737316'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3THC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3WF3'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 187, 'modifier': 'EXACT'}, 'end': {'value': 187, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22128166'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24737316'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3THC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3WF3'}], 'ligand': {'name': 'substrate'}}, {'type': 'Binding site', 'location': {'start': {'value': 333, 'modifier': 'EXACT'}, 'end': {'value': 333, 'modifier': 'EXACT'}}, 'description': '', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22128166'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '24737316'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3THC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3WF3'}], 'ligand': {'name': 'substrate'}}], 'extraAttributes': {'uniParcId': 'UPI0000E9BBE7'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CCCCCCCCC[C@H]1NC[C@@H](O)[C@@H](O)[C@H]1CO', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.4', 'CHEMBLID': 'CHEMBL4276023', 'description': 'Inhibition of beta-galactosidase derived from human peripheral blood mononuclear cell lysate using 4-methylumbelliferyl beta-D-galactopyranoside as substrate after 2 hrs by fluorescence analysis'}, {'\u5206\u5b50SMILES': 'CCCCC[C@H]1NC[C@@H](O)[C@@H](O)[C@H]1CO', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '8.0', 'CHEMBLID': 'CHEMBL4007590', 'description': 'Inhibition of beta-galactosidase in human PBMC using 4-methylumbelliferyl beta-D-galactopyranoside as substrate at pH 7.3 after 2 hrs by fluorescence assay'}, {'\u5206\u5b50SMILES': 'OC[C@@H]1[C@H](O)[C@H](O)CN[C@@H]1CCc1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '10.0', 'CHEMBLID': 'CHEMBL4276023', 'description': 'Inhibition of beta-galactosidase derived from human peripheral blood mononuclear cell lysate using 4-methylumbelliferyl beta-D-galactopyranoside as substrate after 2 hrs by fluorescence analysis'}, {'\u5206\u5b50SMILES': 'CCCCC[C@H]1NC[C@@H](O)[C@@H](O)[C@H]1CO', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '10.0', 'CHEMBLID': 'CHEMBL4276023', 'description': 'Inhibition of beta-galactosidase derived from human peripheral blood mononuclear cell lysate using 4-methylumbelliferyl beta-D-galactopyranoside as substrate after 2 hrs by fluorescence analysis'}, {'\u5206\u5b50SMILES': 'CCCCCCCCN[C@@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '125.0', 'CHEMBLID': 'CHEMBL3774077', 'description': 'Inhibition of human lysosomal beta-galactosidase using 4-MU beta-gal as substrate incubated for 96 hrs by fluorescence assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Exosome miR-152-3p derived from small intestinal epithelium modulates aging process in adipocytes.', 'abstract': 'Exosomes play a crucial role in facilitating intracellular communication between cells and tissues. The small intestine epithelium secretes exosomes, which is involved in various physiologic and pathologic processes. In this study, we investigated the effects of exosomal miR-152-3p derived from small intestinal epithelium on the aging process of adipocytes and its potential downstream mechanism. The exosomes derived from small intestinal epithelial cells were identified and characterized by TEM, NTA, and Western blot (WB). CCK-8 assay demonstrated the concentration-dependently increased 3T3-L1 cell viability by exosomes. PCR, Mito-Tracker red and DCFH-DA staining demonstrated the increased mtDNA content, mitochondrial activity, and the declined ROS content in 3T3-L1 adipocytes co-cultured with young exosomes. WB, PCR, \u03b2-galactosidase staining and ELISA demonstrated that the senescence was suppressed, uncoupling protein 1 (UCP1) and PPARgamma coactivator 1-alpha (PGC-1\u03b1) expression were upregulated, the levels of proinflammatory tumor necrosis factor-alpha (TNF-\u03b1) and interleukin 6 (IL-6) were decreased in 3T3-L1 adipocytes co-cultured with young exosomes. Luciferase reporter assay determined the binding between miR-152-3p and PGC-1\u03b1. WB and PCR manifested that miR-152-3p was lowly expressed in young exosomes and miR-152-3p could decrease PGC-1\u03b1 expression and increase the expression of senescence-related genes. Moreover, ITT and GTT and H&E staining in in vivo elderly mouse model demonstrated that miR-152-3p inhibitor decreased visceral fat, improved glucose tolerance and insulin sensitivity and inhibited aging. WB and PCR suggested that miR-152-3p inhibitor enhanced PGC-1\u03b1 expression, suppressed the expression of senescence-related genes and proinflammatory factors in vivo. In summary, intestinal exosomes affect the browning function of adipocytes through miR-152-3p, modulating the aging process.'}, {'title': 'Endogenous Galectin-8 protects against Th17 infiltration and fibrosis following acute kidney injury.', 'abstract': 'Acute kidney injury (AKI) is a serious clinical condition characterized by a rapid decline in renal function, often progressing to chronic kidney disease (CKD) and fibrosis. The endogenous mechanisms influencing kidney injury resolution or maladaptive repair remain poorly understood. Galectin-8 (Gal-8), a tandem-repeat \u03b2-galactoside-binding lectin, plays a role in epithelial cell proliferation, epithelial-mesenchymal transition, and immune regulation, all of which are critical in AKI outcomes. While exogenous Gal-8 administration has shown renoprotective effects, its endogenous role in kidney injury progression and resolution remains unclear.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2522"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P16442', 'features': [{'type': 'Active site', 'location': {'start': {'value': 303, 'modifier': 'EXACT'}, 'end': {'value': 303, 'modifier': 'EXACT'}}, 'description': 'Nucleophile', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'P14769'}]}, {'type': 'Binding site', 'location': {'start': {'value': 121, 'modifier': 'EXACT'}, 'end': {'value': 123, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:67138'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12198488'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12972418'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15475562'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16326711'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17259183'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LZI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LZJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R7Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R81'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R82'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WT3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8U'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8W'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2O1H'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Y7A'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0D'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3U0Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGF'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FQW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRH'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRM'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GBP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC4'}], 'ligand': {'name': 'UDP-N-acetyl-alpha-D-galactosamine', 'id': 'ChEBI:CHEBI:67138'}}, {'type': 'Binding site', 'location': {'start': {'value': 126, 'modifier': 'EXACT'}, 'end': {'value': 126, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:67138'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12198488'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12972418'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15475562'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16326711'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17259183'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LZI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LZJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R7Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R81'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R82'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WT1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WT2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WT3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8U'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8W'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2O1H'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Y7A'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0D'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3U0Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGF'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FQW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRH'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRM'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GBP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC4'}], 'ligand': {'name': 'UDP-N-acetyl-alpha-D-galactosamine', 'id': 'ChEBI:CHEBI:67138'}}, {'type': 'Binding site', 'location': {'start': {'value': 211, 'modifier': 'EXACT'}, 'end': {'value': 213, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:67138'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12198488'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12972418'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15475562'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16326711'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17259183'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LZI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LZJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R7Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R81'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R82'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WT1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WT2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WT3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8U'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8W'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2O1H'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2Y7A'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0D'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0I'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0K'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3U0Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGF'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FQW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRH'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRM'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GBP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC4'}], 'ligand': {'name': 'UDP-N-acetyl-alpha-D-galactosamine', 'id': 'ChEBI:CHEBI:67138'}}, {'type': 'Binding site', 'location': {'start': {'value': 211, 'modifier': 'EXACT'}, 'end': {'value': 211, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12198488'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12972418'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16326711'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17259183'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LZJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8U'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2O1H'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3U0Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0M'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0O'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGF'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRH'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GBP'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035'}}, {'type': 'Binding site', 'location': {'start': {'value': 213, 'modifier': 'EXACT'}, 'end': {'value': 213, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29035'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12198488'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12972418'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16326711'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17259183'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LZJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R80'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8U'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2O1H'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RIX'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0F'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3U0Y'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0M'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0O'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGF'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRH'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GBP'}], 'ligand': {'name': 'Mn(2+)', 'id': 'ChEBI:CHEBI:29035'}}, {'type': 'Binding site', 'location': {'start': {'value': 233, 'modifier': 'EXACT'}, 'end': {'value': 233, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:140327'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16326711'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZHJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8U'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0M'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0N'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0O'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGF'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FQW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRH'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRM'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GBP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC4'}], 'ligand': {'name': 'an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative', 'id': 'ChEBI:CHEBI:140327'}}, {'type': 'Binding site', 'location': {'start': {'value': 245, 'modifier': 'EXACT'}, 'end': {'value': 245, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:140327'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12972418'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15475562'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16326711'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R7T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R7U'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WT2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZHJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZIZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8U'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RIY'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ6'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0M'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0O'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FQW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRH'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRM'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GBP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC4'}], 'ligand': {'name': 'an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative', 'id': 'ChEBI:CHEBI:140327'}}, {'type': 'Binding site', 'location': {'start': {'value': 303, 'modifier': 'EXACT'}, 'end': {'value': 303, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:140327'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12972418'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '15475562'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16326711'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R7T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R7U'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1WT2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZHJ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZIZ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ0'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2A8U'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RIY'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ6'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0G'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3I0L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3IOI'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SX8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXC'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3SXG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0L'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0M'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0O'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3ZGG'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FQW'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRA'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRB'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRD'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRE'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRH'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRL'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRM'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRO'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FRQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4GBP'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC4'}], 'ligand': {'name': 'an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative', 'id': 'ChEBI:CHEBI:140327'}}, {'type': 'Binding site', 'location': {'start': {'value': 326, 'modifier': 'EXACT'}, 'end': {'value': 326, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:140327'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12972418'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '16326711'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1R7T'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZI5'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1ZJ3'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RIY'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ4'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ6'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ7'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ8'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2RJ9'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0M'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0O'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0P'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3V0Q'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4C2S'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC1'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC2'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4KC4'}], 'ligand': {'name': 'an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative', 'id': 'ChEBI:CHEBI:140327'}}], 'extraAttributes': {'uniParcId': 'UPI00001268F6'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'O=c1[nH]c(=O)c2[nH]c(=O)n(C[C@@H](O)[C@H](O)[C@H](O)CO[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)c2[nH]1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '389000.0', 'CHEMBLID': 'CHEMBL2329772', 'description': 'Inhibition of human blood group B Galactosyltransferase using UDP-Gal as substrate by STD NMR analysis in presence of magnesium ions'}, {'\u5206\u5b50SMILES': 'O=c1[nH]c(=O)c2[nH]c(=O)n(C[C@@H](O)[C@H](O)[C@H](O)CO[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)c2[nH]1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1600000.0', 'CHEMBLID': 'CHEMBL2329771', 'description': 'Inhibition of human blood group B Galactosyltransferase using radiolabeled UDP-Gal as substrate in presence of manganese ions'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Histo-blood group ABO system transferase plasma levels and risk of future venous thromboembolism: The HUNT Study.', 'abstract': 'The non-O blood group is a well-established risk factor for venous thromboembolism (VTE). However, the association between plasma levels of the histo-blood group ABO system transferase (BGAT), the gene product of the ABO locus, and VTE risk remains unclear. We aimed to investigate the association between plasma BGAT levels and risk of future VTE, and whether this relationship was mediated by plasma von Willebrand factor (VWF) or coagulation factor VIII (FVIII) as VWF is glycosylated by BGAT. Incident VTE-cases (n=294) and randomly sampled age- and-sex-weighted subcohort (n=1,066) were derived from the third survey of the Tr\u00f8ndelag Health Study (HUNT3). Baseline plasma samples (2006-08) were subjected to the SomaScan\u00ae aptamer-based-7K platform for protein measurements. Weighted Cox regression was used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs) across BGAT quartiles. We found that ABO haplotypes (A1/A2/B/O1/O2) explained ~80% of the BGAT plasma variability. Participants with BGAT levels in the highest quartile had 2-fold higher VTE risk (HR 2.12, 95%CI:1.39-3.22) compared with those with BGAT in the lowest quartile in age-, sex- and sample batch-adjusted models. The associations were particularly pronounced for unprovoked VTE (HR 3.71, 95%CI:1.79-7.67) and deep vein thrombosis (HR 3.28, 95%CI:1.63-6.59). The HRs were similar after further adjustment for body mass index, C-reactive protein, and estimated estimated glomerular filtration rate, and moderately attenuated when adding VWF or FVIII plasma levels to the models. Our findings indicate that elevated BGAT plasma levels are associated with increased risk of future VTE beyond what is explained by VWF and FVIII.'}, {'title': 'The Plasma Proteome and Risk of Future Venous Thromboembolism-Results from the HUNT Study.', 'abstract': '\\u2003This study aimed to identify novel plasma proteins associated with first-lifetime venous thromboembolism (VTE) and molecular pathways involved in VTE pathogenesis.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2321639"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q93088', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 217, 'modifier': 'EXACT'}, 'end': {'value': 217, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00333'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12220488'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LT8'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 299, 'modifier': 'EXACT'}, 'end': {'value': 299, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00333'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12220488'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LT8'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 300, 'modifier': 'EXACT'}, 'end': {'value': 300, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00333'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '12220488'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '1LT8'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}], 'extraAttributes': {'uniParcId': 'UPI000006D864'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC(C)(CCSCC[C@H](N)C(=O)O)CC(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '64.0', 'CHEMBLID': 'CHEMBL947843', 'description': 'Inhibition of human recombinant BHMT expressed in Escherichia coli using 2 mM betaine and 1 mM DL-homocysteine as substrate'}, {'\u5206\u5b50SMILES': 'CC(C)(CCSCCC(N)C(=O)O)CC(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '84.0', 'CHEMBLID': 'CHEMBL947843', 'description': 'Inhibition of human recombinant BHMT expressed in Escherichia coli using 2 mM betaine and 1 mM DL-homocysteine as substrate'}, {'\u5206\u5b50SMILES': 'NC(CCSCCCCC(=O)O)C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '87.0', 'CHEMBLID': 'CHEMBL865953', 'description': 'Inhibition of human BHMT'}, {'\u5206\u5b50SMILES': 'NC(CCSCCCCC(=O)O)C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '93.0', 'CHEMBLID': 'CHEMBL2405889', 'description': 'Inhibition of human recombinant BHMT using N-methyl-[14C]-betaine/D,L-homocysteine as substrate after 30 mins by scintiillation counting analysis'}, {'\u5206\u5b50SMILES': 'NC(CCSCCSCC(=O)O)C(=O)O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '96.0', 'CHEMBLID': 'CHEMBL865953', 'description': 'Inhibition of human BHMT'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Correction: Ribosomal modification protein rimK-like family member A activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosis.', 'abstract': '\u6458\u8981\u4e0d\u53ef\u7528'}, {'title': 'Ribosomal modification protein rimK-like family member A activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosis.', 'abstract': \"Nonalcoholic fatty liver disease (NAFLD) is a serious threat to public health, but its underlying mechanism remains poorly understood. In screening important genes using Gene Importance Calculator (GIC) we developed previously, ribosomal modification protein rimK-like family member A (RIMKLA) was predicted as one essential gene but its functions remained largely unknown. The current study determined the roles of RIMKLA in regulating glucose and lipid metabolism. RIMKLA expression was reduced in livers of human and mouse with NAFLD. Hepatic RIMKLA overexpression ameliorated steatosis and hyperglycemia in obese mice. Hepatocyte-specific RIMKLA knockout aggravated high-fat diet (HFD)-induced dysregulated glucose/lipid metabolism in mice. Mechanistically, RIMKLA is a new protein kinase that phosphorylates betaine-homocysteine S-methyltransferase 1 (BHMT1) at threonine 45 (Thr45) site. Upon phosphorylation at Thr45 and activation, BHMT1 eliminated homocysteine (Hcy) to inhibit the activity of transcription factor activator protein 1 (AP1) and its induction on fatty acid synthase (FASn) and cluster of differentiation 36 (CD36) gene transcriptions, concurrently repressing lipid synthesis and uptake in hepatocytes. Thr45 to alanine (T45A) mutation inactivated BHMT1 to abolish RIMKLA's repression on Hcy level, AP1 activity, FASn/CD36 expressions, and lipid deposition. BHMT1 overexpression rescued the dysregulated lipid metabolism in RIMKLA-deficient hepatocytes. In summary, RIMKLA is a novel protein kinase that phosphorylates BHMT1 at Thr45 to repress lipid synthesis and uptake. Under obese condition, inhibition of RIMKLA impairs BHMT1 activity to promote hepatic lipid deposition.\"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4328"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q13490', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 306, 'modifier': 'EXACT'}, 'end': {'value': 306, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 309, 'modifier': 'EXACT'}, 'end': {'value': 309, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 326, 'modifier': 'EXACT'}, 'end': {'value': 326, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 333, 'modifier': 'EXACT'}, 'end': {'value': 333, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}], 'extraAttributes': {'uniParcId': 'UPI00000015E7'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nc(CO)c(Cc4ccc(F)cc4)cc32)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL4157561', 'description': 'Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs'}, {'\u5206\u5b50SMILES': 'C[C@@H]1CN(CC(=O)N2CC(C)(C)c3[nH]c(=O)c(Cc4ccc(F)cc4)cc32)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.13', 'CHEMBLID': 'CHEMBL4157561', 'description': 'Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs'}, {'\u5206\u5b50SMILES': 'C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nnc(Cc4ccc(F)cc4F)cc32)[C@@H](CN2Cc3c(F)cccc3C2=O)CN1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.17', 'CHEMBLID': 'CHEMBL4157561', 'description': 'Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs'}, {'\u5206\u5b50SMILES': 'C[C@@H]1CN(CC(=O)N2CC(C)(C)c3c2cc(Cc2ccc(F)cc2)c(=O)n3C)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.18', 'CHEMBLID': 'CHEMBL4157561', 'description': 'Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs'}, {'\u5206\u5b50SMILES': 'C[C@@H]1CN(CC(=O)N2CC(C)(C)c3ncc(Cc4ccc(F)cc4)cc32)[C@@H](CN2[C@H](C)COC[C@H]2C)CN1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.19', 'CHEMBLID': 'CHEMBL4157561', 'description': 'Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrs'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Inhibition of the Foxo3/Txnip Axis Alleviates Ventilator-Induced Diaphragmatic Dysfunction by Downregulating MuRF1.', 'abstract': 'Ventilator-induced diaphragm dysfunction (VIDD) is one of the main causes of weaning from mechanical ventilation (MV). The forkhead box O3 (Foxo3) has been identified as being involved in regulating the contractile function of skeletal muscle. This study aimed to figure out the regulatory role and mechanism of Foxo3 on VIDD. The mouse myoblast C2C12 cells were stimulated using different intensities of stress to mimic the in-vitro VIDD model. 3- (4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and TdT-mediated dUTP nick end labeling (TUNEL) assays were applied to check cell viability and apoptosis, respectively. Cellular inflammation and oxidative stress levels were evaluated by measuring cellular inflammatory factors (IL-1\u03b2 and TNF-\u03b1) and oxidative stress markers (SOD and MDA). The release of oxygen species (ROS) was assayed by cellular immunofluorescence. The expression of apoptosis-associated proteins (Bax and Bcl-2), Gpx4, Slc7a11, Ptgs2, Foxo3, Txnip, Murf1, Atrogin-1, Nlrp3, Asc, and Caspase1 was gauged using Western blot. The rats with or without MV therapy were treated with the Foxo3 inhibitor Carbenoxolone (CBX) to characterize the impact of Foxo3 on VIDD. Stress stimulation dampened myogenic cell viability, boosted apoptosis, inflammation, oxidative stress, and ROS release, and activated the expression of Foxo3 and Txnip pathways. Overexpression of Txnip or Murf1 lessened the protective effect of FOxO3 inhibition on myoblasts. Downregulation of Txnip or Murf1 mitigated myoblasts dysfunction that was induced by Foxo3 overexpression. In vivo, inhibition of Foxo3 mitigated MV-induced diaphragmatic atrophy and reduced contractility, inflammation, and oxidative stress in rats. Inhibition of Foxo3 eased VIDD by downregulating Txnip and Murf1.'}, {'title': 'Gossypin induces apoptosis and autophagy via the MAPK/JNK pathway in HT\u201129 human colorectal cancer cells.', 'abstract': 'Gossypin, a flavone found in '}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5462"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q96CA5', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 124, 'modifier': 'EXACT'}, 'end': {'value': 124, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 127, 'modifier': 'EXACT'}, 'end': {'value': 127, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 144, 'modifier': 'EXACT'}, 'end': {'value': 144, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 151, 'modifier': 'EXACT'}, 'end': {'value': 151, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Site', 'location': {'start': {'value': 52, 'modifier': 'EXACT'}, 'end': {'value': 53, 'modifier': 'EXACT'}}, 'description': 'Cleavage; by CASP3 and CASP7'}], 'extraAttributes': {'uniParcId': 'UPI00001269A6'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '9.0', 'CHEMBLID': 'CHEMBL5098727', 'description': 'Antagonist activity at N-terminal His-tagged wild type ML-IAP BIR domain (63 to 179 residues) (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay'}, {'\u5206\u5b50SMILES': 'CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)F)ccc1OC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2ccccc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '11.0', 'CHEMBLID': 'CHEMBL5098731', 'description': 'Antagonist activity at N-terminal His-tagged wild type ML-IAP BIR domain (63 to 179 residues)(unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate preincubated for 2 hrs with protein followed by substrate addition measured after 2 hrs by DELFIA assay'}, {'\u5206\u5b50SMILES': 'CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '15.0', 'CHEMBLID': 'CHEMBL5098731', 'description': 'Antagonist activity at N-terminal His-tagged wild type ML-IAP BIR domain (63 to 179 residues)(unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate preincubated for 2 hrs with protein followed by substrate addition measured after 2 hrs by DELFIA assay'}, {'\u5206\u5b50SMILES': 'CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '20.0', 'CHEMBLID': 'CHEMBL5098727', 'description': 'Antagonist activity at N-terminal His-tagged wild type ML-IAP BIR domain (63 to 179 residues) (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay'}, {'\u5206\u5b50SMILES': 'CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1ccc(S(=O)(=O)F)c(OC)c1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '35.0', 'CHEMBLID': 'CHEMBL5098727', 'description': 'Antagonist activity at N-terminal His-tagged wild type ML-IAP BIR domain (63 to 179 residues) (unknown origin) expressed in Escherichia coli BL21 using AVPIAQKSEK-biotinylated peptide as substrate incubated for 2 hrs by DELFIA assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Specific Targeting of Zinc Transporter LIV-1 with Immunocytokine Containing Anti-LIV-1 VHH and Human IL-2 and Evaluation of its ', 'abstract': 'Interleukin 2 (IL-2) is a vital cytokine in the induction of T and NK cell responses, the proliferation of CD8+ T cells, and the effective treatment of human cancers such as melanoma and renal cell carcinoma. However, widespread use of this cytokine is limited due to its short half-life, severe toxicity, lack of specific tumor targeting, and activation of Treg cells mediated by high-affinity interleukin-2 receptors.'}, {'title': 'Livin expression promotes keratinocyte release of inflammatory mediators in psoriasis.', 'abstract': 'Psoriasis is a prevalent, long-term skin condition characterized by inflammation. Keratinocytes (KCs) are important effector cells that release inflammatory factors and chemokines to promote the inflammatory cascade in psoriasis. However, the mechanisms underlying the activation of KCs in psoriasis remain unclear. Livin suppresses apoptotic proteins and directly affects the growth and spread of cancer cells. Livin expression reportedly increases significantly in lesions of patients with psoriasis; however, its specific role in KC activation remains unknown. This study aimed to examine the impact of Livin on KC activation and the subsequent release of inflammatory mediators.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1075127"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q9NSY1', 'features': [{'type': 'Active site', 'location': {'start': {'value': 180, 'modifier': 'EXACT'}, 'end': {'value': 180, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}]}, {'type': 'Binding site', 'location': {'start': {'value': 57, 'modifier': 'EXACT'}, 'end': {'value': 65, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 79, 'modifier': 'EXACT'}, 'end': {'value': 79, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI00001BDC7C'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COC(=O)Nc1cc(-c2cnc(OC[C@@](C)(N)CC(C)C)c(Cl)c2)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.0', 'CHEMBLID': 'CHEMBL5161241', 'description': 'Inhibition of BIKE (unknown origin)'}, {'\u5206\u5b50SMILES': 'COC(=O)Nc1cc(-c2cnc(OC[C@@](C)(N)CC(C)C)c(C)c2)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '10.0', 'CHEMBLID': 'CHEMBL5161241', 'description': 'Inhibition of BIKE (unknown origin)'}, {'\u5206\u5b50SMILES': 'COC(=O)Nc1cc(-c2ccc(OC[C@@](C)(N)CC(C)C)c(C(F)F)n2)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '20.0', 'CHEMBLID': 'CHEMBL5161241', 'description': 'Inhibition of BIKE (unknown origin)'}, {'\u5206\u5b50SMILES': 'COC(=O)Nc1cc(-c2ccc(OC[C@@](C)(N)CC(C)C)c(Cl)n2)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '30.0', 'CHEMBLID': 'CHEMBL5161241', 'description': 'Inhibition of BIKE (unknown origin)'}, {'\u5206\u5b50SMILES': 'NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(CN4CCOCC4)c3)ncc2Br)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '38.0', 'CHEMBLID': 'CHEMBL5046594', 'description': 'Inhibition of recombinant human BIKe using peptide as substrate incubated for 120 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations.', 'abstract': \"Bone morphogenetic proteins (BMPs) are growth factors that have a vital role in the production of bone, cartilage, ligaments, and tendons. Tumors' upregulation of bone morphogenetic proteins (BMPs) and their receptors are key features of cancer progression. Regulation of the BMP kinase system is a new promising strategy for the development of anti-cancer drugs. In this work, based on a careful literature study, a library of benzothiophene and benzofuran derivatives was subjected to different computational techniques to study the effect of chemical structure changes on the ability of these two scaffolds to target BMP-2 inducible kinase, and to reach promising candidates with proposed activity against BMP-2 inducible kinase. The results of screening against Lipinski's and Veber's Rules produced twenty-one outside eighty-four compounds having drug-like molecular nature. Computational ADMET studies favored ten compounds (\"}, {'title': 'BMP2K phosphorylates AP-2 and regulates clathrin-mediated endocytosis.', 'abstract': 'Phosphorylation of the central adaptor protein complex, AP-2 is pivotal for clathrin-mediated endocytosis (CME). Here, we uncover the role of an uncharacterized kinase (BMP-2 inducible kinase-BMP2K) in AP-2 phosphorylation. We demonstrate that BMP2K can phosphorylate AP-2 in vitro and in vivo. Functional impairment of BMP2K impedes AP-2 phosphorylation leading to defects in clathrin-coated pit (CCP) morphology and cargo internalization. BMP2K engages AP-2 via its extended C-terminus and this interaction is important for its CCP localization and function. Notably, endogenous BMP2K levels decline upon functional impairment of AP-2 indicating AP-2 dependent BMP2K stabilization in cells. Further, functional inactivation of BMP2K in zebrafish embryos yields gastrulation phenotypes which mirror AP-2 loss-of-function suggesting physiological relevance of BMP2K in vertebrates. Together, our findings propose involvement of a novel kinase in AP-2 phosphorylation and in the operation of CME.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL4522"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q13873', 'features': [{'type': 'Active site', 'location': {'start': {'value': 333, 'modifier': 'EXACT'}, 'end': {'value': 333, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}]}, {'type': 'Binding site', 'location': {'start': {'value': 209, 'modifier': 'EXACT'}, 'end': {'value': 217, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'Reference', 'id': 'Ref.17'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 230, 'modifier': 'EXACT'}, 'end': {'value': 230, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'Reference', 'id': 'Ref.17'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 280, 'modifier': 'EXACT'}, 'end': {'value': 282, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'Reference', 'id': 'Ref.17'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 337, 'modifier': 'EXACT'}, 'end': {'value': 338, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'Reference', 'id': 'Ref.17'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 351, 'modifier': 'EXACT'}, 'end': {'value': 351, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000305', 'source': 'Reference', 'id': 'Ref.17'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI0000126A3B'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'c1cc(N2CCOCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '15.9', 'CHEMBLID': 'CHEMBL2390520', 'description': 'Inhibition of BMPR2 (unknown origin)'}, {'\u5206\u5b50SMILES': 'COc1ccc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '24.0', 'CHEMBLID': 'CHEMBL2390520', 'description': 'Inhibition of BMPR2 (unknown origin)'}, {'\u5206\u5b50SMILES': 'N#CCc1ccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)cc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '36.2', 'CHEMBLID': 'CHEMBL5252292', 'description': 'Inhibition of BMPR2 (174 to end residues) (unknown origin) using MBP as substrate incubated for 60 mins in presence of ATP by ADP Glo assay'}, {'\u5206\u5b50SMILES': 'c1cc(N2CCNCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '59.0', 'CHEMBLID': 'CHEMBL2390520', 'description': 'Inhibition of BMPR2 (unknown origin)'}, {'\u5206\u5b50SMILES': 'c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '74.0', 'CHEMBLID': 'CHEMBL2390520', 'description': 'Inhibition of BMPR2 (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'BMPR-II, caspase-3, HIF-1\u03b1, and VE-cadherin profile in Down syndrome children with and without congenital heart disease and pulmonary hypertension.', 'abstract': 'Several cellular markers have been identified as effective in detecting vascular remodeling recently. The reduced activity of bone morphogenetic protein receptor type-II (BMPR-II), commonly observed in Down syndrome, results in insufficient production of vascular endothelial cadherin (VE-cadherin). This, in turn, increases hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) levels and leads to excessive production of caspase-3. The aim of this study was to compare the plasma levels of BMPR-II, VE-cadherin, HIF-1\u03b1, and caspase-3 between pediatric Down syndrome with and without congenital heart disease (CHD) and pulmonary hypertension (PH). This was to investigate the role of these biomarkers in the pathogenesis of PH associated or not associated with CHD. A cross-sectional study was conducted on Down syndrome children aged two months to five years at a tertiary hospital between January and December 2023. The children were classified into four groups: CHD with PH, CHD without PH, non-CHD with PH and normal heart. Plasma levels of BMPR-II, caspase-3, HIF-1\u03b1, and VE-cadherin were measured using ELISA and compared based on the presence or absence of CHD and PH using Kruskal-Wallis followed by post hoc Bonferroni tests. Elevated plasma HIF-1\u03b1 levels were observed in all patients with PH, with significantly higher levels in those with CHD-PH. Elevated levels of caspase-3 were also observed among children with PH groups, with the highest levels observed in the non-CHD PH group. Plasma levels of BMPR-II and VE-cadherin were elevated in PH, with significantly higher levels in the non-CHD PH group compared to other groups.'}, {'title': 'Altered maturation and activation state of circulating monocytes is associated with their enhanced recruitment in pulmonary arterial hypertension.', 'abstract': 'It is well-established that patients with pulmonary arterial hypertension (PAH) exhibit increased recruitment of circulating monocytes to their pulmonary arteries. However, it remains unclear whether these monocytes have intrinsic abnormalities that contribute to their recruitment and to PAH pathogenesis. This study aimed to characterize the gene expression profiles of circulating classical, intermediate, and non-classical monocytes and assess their maturation trajectory in patients with idiopathic (I) PAH compared to control subjects. Additionally, it sought to explore the relationship between the observed IPAH abnormalities and deficiencies in bone morphogenetic receptor 2 (BMPR2), the most frequently mutated gene in PAH, and to assess adhesion and transendothelial migration, key processes in monocyte infiltration of pulmonary arteries.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5467"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P51813', 'features': [{'type': 'Active site', 'location': {'start': {'value': 536, 'modifier': 'EXACT'}, 'end': {'value': 536, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10028'}]}, {'type': 'Binding site', 'location': {'start': {'value': 121, 'modifier': 'EXACT'}, 'end': {'value': 121, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00432'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 132, 'modifier': 'EXACT'}, 'end': {'value': 132, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00432'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 133, 'modifier': 'EXACT'}, 'end': {'value': 133, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00432'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 143, 'modifier': 'EXACT'}, 'end': {'value': 143, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00432'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 423, 'modifier': 'EXACT'}, 'end': {'value': 431, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 445, 'modifier': 'EXACT'}, 'end': {'value': 445, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}], 'extraAttributes': {'uniParcId': 'UPI0000000DFF'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.4', 'CHEMBLID': 'CHEMBL4843877', 'description': 'Inhibition of N-terminal GST-tagged BMX (1 to 675 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA'}, {'\u5206\u5b50SMILES': 'C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.4', 'CHEMBLID': 'CHEMBL4841670', 'description': 'Inhibition of full-length N-terminal GST-tagged BMX (1 to 675 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA'}, {'\u5206\u5b50SMILES': 'C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.5', 'CHEMBLID': 'CHEMBL4414918', 'description': 'Inhibition of human BMX using poly[Glu:Tyr] (4:1) as substrate preincubated for 60 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method'}, {'\u5206\u5b50SMILES': 'CN1CCN(C(C)(C)/C=C(\\\\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.6', 'CHEMBLID': 'CHEMBL5104911', 'description': 'Inhibition of BMX (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method'}, {'\u5206\u5b50SMILES': 'C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.62', 'CHEMBLID': 'CHEMBL5210356', 'description': 'Affinity Biochemical interaction (33P-ATP and filter-binding assay (Reaction Biology)) EUB0000646a BMX'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Machine learning-based transcriptmics analysis reveals ', 'abstract': 'Sepsis is a life-threatening condition characterized by a dysregulated host response to infection, resulting in high mortality rates and complex clinical management. This study leverages transcriptomics and machine learning (ML) to identify critical biomarkers and therapeutic targets in sepsis. Analyzing microarray data from the Gene Expression Omnibus (GEO) datasets GSE28750, GSE26440, GSE13205, and GSE9960, we discovered three pivotal biomarkers that '}, {'title': 'Design and synthesis of highly selective Janus kinase 3 covalent inhibitors for the treatment of rheumatoid arthritis.', 'abstract': 'Selective inhibition of Janus kinase 3 (JAK3) is a promising strategy for the treatment of autoimmune diseases. Based on the discovery of a hydrophobic pocket unutilized between the lead compound RB1 and the JAK3 protein, a series of covalent JAK3 inhibitors were prepared by introducing various aromatic fragments to RB1. Among them, J1b (JAK3 IC'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3834"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'O75936', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 38, 'modifier': 'EXACT'}, 'end': {'value': 38, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 40, 'modifier': 'EXACT'}, 'end': {'value': 40, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 43, 'modifier': 'EXACT'}, 'end': {'value': 43, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 82, 'modifier': 'EXACT'}, 'end': {'value': 82, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 202, 'modifier': 'EXACT'}, 'end': {'value': 202, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:24875'}], 'evidences': [{'evidenceCode': 'ECO:0000305'}], 'ligand': {'name': 'Fe cation', 'id': 'ChEBI:CHEBI:24875', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 204, 'modifier': 'EXACT'}, 'end': {'value': 204, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:24875'}], 'evidences': [{'evidenceCode': 'ECO:0000305'}], 'ligand': {'name': 'Fe cation', 'id': 'ChEBI:CHEBI:24875', 'note': 'catalytic'}}, {'type': 'Binding site', 'location': {'start': {'value': 347, 'modifier': 'EXACT'}, 'end': {'value': 347, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:24875'}], 'evidences': [{'evidenceCode': 'ECO:0000305'}], 'ligand': {'name': 'Fe cation', 'id': 'ChEBI:CHEBI:24875', 'note': 'catalytic'}}], 'extraAttributes': {'uniParcId': 'UPI0000126A4C'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CN(CCC(=O)[O-])[N+](C)(C)C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '90.0', 'CHEMBLID': 'CHEMBL3242135', 'description': 'Inhibition of human recombinant BBOX expressed in Saccharomyces cerevisiae AH22 assessed as formation of carnitine from gamma-butyrobetaine preincubated for 15 mins measured after 30 mins by UPLC-MS/MS analysis'}, {'\u5206\u5b50SMILES': 'C[N+](C)(C)CCCP(=O)(O)O.[Cl-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '100.0', 'CHEMBLID': 'CHEMBL3242135', 'description': 'Inhibition of human recombinant BBOX expressed in Saccharomyces cerevisiae AH22 assessed as formation of carnitine from gamma-butyrobetaine preincubated for 15 mins measured after 30 mins by UPLC-MS/MS analysis'}, {'\u5206\u5b50SMILES': 'C[N+](C)(CCCl)CCCC(=O)O.[Cl-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '260.0', 'CHEMBLID': 'CHEMBL3242135', 'description': 'Inhibition of human recombinant BBOX expressed in Saccharomyces cerevisiae AH22 assessed as formation of carnitine from gamma-butyrobetaine preincubated for 15 mins measured after 30 mins by UPLC-MS/MS analysis'}, {'\u5206\u5b50SMILES': 'C[N+]1(CCCC(=O)O)CCCC1.[Cl-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '490.0', 'CHEMBLID': 'CHEMBL3242135', 'description': 'Inhibition of human recombinant BBOX expressed in Saccharomyces cerevisiae AH22 assessed as formation of carnitine from gamma-butyrobetaine preincubated for 15 mins measured after 30 mins by UPLC-MS/MS analysis'}, {'\u5206\u5b50SMILES': 'C[N+](C)(C)CCC[PH](=O)[O-]', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '520.0', 'CHEMBLID': 'CHEMBL3242135', 'description': 'Inhibition of human recombinant BBOX expressed in Saccharomyces cerevisiae AH22 assessed as formation of carnitine from gamma-butyrobetaine preincubated for 15 mins measured after 30 mins by UPLC-MS/MS analysis'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human \u03b3-Butyrobetaine Hydroxylase.', 'abstract': 'The 2-oxoglutarate (2OG)/Fe(II)-dependent \u03b3-butyrobetaine hydroxylase (BBOX) catalyzes the final step in l-carnitine biosynthesis, '}, {'title': 'BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma.', 'abstract': 'Clear cell renal cell carcinoma (ccRCC), a metabolic disease originating from renal proximal convoluted tubule (PCT) epithelial cells, remains incompletely understood in terms of its initiating signaling events. Here, we identify \u03b3-butyrobetaine hydroxylase 1 (BBOX1), a key enzyme in carnitine synthesis predominantly expressed in PCT cells, as a tumor suppressor in ccRCC. BBOX1 expression is lost during ccRCC malignant transformation, and its restoration reduces cell viability in physiological medium and inhibits xenograft tumor growth. Transcriptomic analyses reveal that BBOX1 suppresses critical metabolic pathways including mTORC1 signaling and glycolysis in ccRCC. Further, we identify TANK-binding kinase 1 (TBK1) as an essential mediator of mTORC1 and glycolysis activation and as a target of BBOX1-mediated tumor suppression. Mechanistically, BBOX1 disrupts TBK1 activation by preventing its interaction with the upstream activator doublecortin-like kinase 2 (DCLK2). This BBOX1-DCLK2-TBK1 axis unveils an important mechanism in ccRCC metabolic dysregulation and highlights potential therapeutic strategies.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2163175"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P15056', 'features': [{'type': 'Active site', 'location': {'start': {'value': 576, 'modifier': 'EXACT'}, 'end': {'value': 576, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10027'}]}, {'type': 'Binding site', 'location': {'start': {'value': 235, 'modifier': 'EXACT'}, 'end': {'value': 235, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 248, 'modifier': 'EXACT'}, 'end': {'value': 248, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 251, 'modifier': 'EXACT'}, 'end': {'value': 251, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 261, 'modifier': 'EXACT'}, 'end': {'value': 261, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 264, 'modifier': 'EXACT'}, 'end': {'value': 264, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 269, 'modifier': 'EXACT'}, 'end': {'value': 269, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 272, 'modifier': 'EXACT'}, 'end': {'value': 272, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '2'}}, {'type': 'Binding site', 'location': {'start': {'value': 280, 'modifier': 'EXACT'}, 'end': {'value': 280, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000250'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105', 'label': '1'}}, {'type': 'Binding site', 'location': {'start': {'value': 463, 'modifier': 'EXACT'}, 'end': {'value': 471, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 483, 'modifier': 'EXACT'}, 'end': {'value': 483, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Site', 'location': {'start': {'value': 380, 'modifier': 'EXACT'}, 'end': {'value': 381, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form KIAA1549-BRAF fusion protein'}, {'type': 'Site', 'location': {'start': {'value': 438, 'modifier': 'EXACT'}, 'end': {'value': 439, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form KIAA1549-BRAF fusion protein'}], 'extraAttributes': {'uniParcId': 'UPI000013DF26'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cn1cc(-c2ccc3c(c2)CC/C3=N\\\\O)c(-c2ccncc2)n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.02', 'CHEMBLID': 'CHEMBL1008210', 'description': 'Inhibition of human recombinant B-Raf by fluorescence anisotropy'}, {'\u5206\u5b50SMILES': 'O/N=C1\\\\CCc2cc(-c3cn(C4CCNCC4)nc3-c3ccncc3)ccc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03', 'CHEMBLID': 'CHEMBL1008210', 'description': 'Inhibition of human recombinant B-Raf by fluorescence anisotropy'}, {'\u5206\u5b50SMILES': 'O/N=C1\\\\CCc2cc(-c3cn(C4CCNCC4)nc3-c3ccncc3)ccc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.03', 'CHEMBLID': 'CHEMBL3239797', 'description': 'Inhibition of BRAF (unknown origin)'}, {'\u5206\u5b50SMILES': 'O/N=C1\\\\CCc2cc(-c3cn([C@@H]4CCC[C@H](O)C4)nc3-c3ccncc3)ccc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.04', 'CHEMBLID': 'CHEMBL1008210', 'description': 'Inhibition of human recombinant B-Raf by fluorescence anisotropy'}, {'\u5206\u5b50SMILES': 'OCCCn1cc(-c2ccc3c(c2)CC/C3=N\\\\O)c(-c2ccncc2)n1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.05', 'CHEMBLID': 'CHEMBL1008210', 'description': 'Inhibition of human recombinant B-Raf by fluorescence anisotropy'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Response to a novel type II RAF inhibitor in diffuse leptomeningeal glioneuronal tumor with BRAF fusion.', 'abstract': 'Diffuse leptomeningeal glioneuronal tumor (DL-GNT) is a rare disease which is more often diagnosed in children and adolescents than adults. Activation of the MAPK/ERK pathway is implicated in the majority of cases, and BRAF fusions are the most common genetic alteration. BRAF fusions result in dimerization and constitutive downstream MAPK/ERK activity, against which type I RAF inhibitors have limited efficacy. Type II RAF inhibitors stabilize RAF in an inactive conformation and inhibit both dimer protomers, thus inhibiting downstream MAPK/ERK activity in the setting of BRAF fusions.'}, {'title': 'Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction.', 'abstract': 'Giant congenital melanocytic nevus (GCMN) is a RAS/RAF mutation-driven syndrome characterized by extensive melanocytic lesions, posing psychological challenges and a lifelong risk of malignancy. Existing treatments like surgical resection and laser therapy fail to fully remove lesions, and MAPK inhibitors show limited efficacy. This study identified a predominant population of senescent cells and a minority of proliferative cells in GCMN, necessitating dual-targeted strategies. We found that the anti-apoptotic protein BCL2 is expressed in both senescent and proliferative cells from GCMN patients with various gene mutations. Coexpression of P16 and BCL2 indicated a phenotype of growth arrest and cell survival. BCL2 inhibitors (BCL2i) showed significant cytotoxicity to GCMN cells in vitro. Hypopigmentation and GCMN cell clearance were observed in patient-derived xenograft models and in Nras'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5145"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'O95696', 'features': [], 'extraAttributes': {'uniParcId': 'UPI0000126ACA'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.0', 'CHEMBLID': 'CHEMBL5214112', 'description': 'Selectivity interaction (Enzyme activity assay (BROMOscan\u00ae)) EUB0000191c BRD1'}, {'\u5206\u5b50SMILES': 'Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.0', 'CHEMBLID': 'CHEMBL4052871', 'description': 'Inhibition of recombinant human BRD1 (E556 to A688 residues) expressed in bacterial expression system by BROMOscan assay'}, {'\u5206\u5b50SMILES': 'Cc1cc2c(cc1N1C(=O)c3cccc4c(Cl)ccc(c34)C1=O)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '37.0', 'CHEMBLID': 'CHEMBL4051532', 'description': 'Inhibition of human BRPF2 (563 to 688 residues) expressed in Escherichia coli BL21 (DE3)-R3-pRARE2 preincubated for 15 mins followed by addition of C-terminal biotinylated synthetic K5,12 diacetylated histone H4 (1 to 20 residues) peptide as substrate measured after 1 hr by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '45.0', 'CHEMBLID': 'CHEMBL5214113', 'description': 'Selectivity interaction (ITC) EUB0000191c BRD1'}, {'\u5206\u5b50SMILES': 'COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '46.0', 'CHEMBLID': 'CHEMBL4030908', 'description': 'Inhibition of human BRPF2 (556 to 688 residues) expressed in Escherichia coli BL21 after 1 hr by BROMOscan assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'NIT2 dampens BRD1 phase separation and restrains oxidative phosphorylation to enhance chemosensitivity in gastric cancer.', 'abstract': '5-Fluorouracil (5-FU) chemoresistance contributes to poor therapeutic response and prognosis of gastric cancer (GC), for which effective strategies to overcome chemoresistance are limited. Here, using a CRISPR-Cas9 system, we identified that nitrilase family member 2 (NIT2) reverses chemoresistance independent of its metabolic function. Depletion or low expression of NIT2 led to 5-FU resistance in GC cell lines, patient-derived organoids, and xenografted tumors. Mechanistically, NIT2 interacted with bromodomain-containing protein 1 (BRD1) to inhibit HBO1-mediated acetylation of histone H3 at lysine-14 (H3K14ac) and RELA-targeted oxidative phosphorylation (OXPHOS) gene expression. Upon 5-FU stimulation, NIT2 phosphorylation by Src at Y49 promoted the dissociation of NIT2 from BRD1, followed by binding to E3 ligase CCNB1IP1, causing autophagic degradation of NIT2. Consequently, reduced NIT2 protein resulted in BRD1 forming phase separation and binding to histone H3, as well as increased RELA stability due to suppression of inhibitor of growth family member 4-mediated RELA ubiquitination. In addition, NIT2 expression negatively correlated with H3K14ac and OXPHOS and positively correlated with the chemotherapeutic responses and prognosis of patients with GC. Our findings reveal the moonlighting function of NIT2 in chemoresistance and underscore that OXPHOS blockade by metformin enhances 5-FU chemosensitivity upon NIT2 loss.'}, {'title': 'Structural insights into acetylated histone ligand recognition by the BDP1 bromodomain of Plasmodium falciparum.', 'abstract': 'Plasmodium falciparum requires a two-host system, moving between Anopheles mosquito and humans, to complete its life cycle. To overcome such dynamic growth conditions its histones undergo various post-translational modifications to regulate gene expression. The P. falciparum Bromodomain Protein 1 (PfBDP1) has been shown to interact with acetylated lysine modifications on histone H3 to regulate the expression of invasion-related genes. Here, we investigated the ability of the PfBDP1 bromodomain to interact with acetyllsyine modifications on additional core and variant histones. A crystal structure of the PfBDP1 bromodomain (PfBDP1-BRD) reveals it contains the conserved bromodomain fold, but our comparative analysis between the PfBDP1-BRD and human bromodomain families indicates it has a unique binding mechanism. Solution NMR spectroscopy and ITC binding assays carried out with acetylated histone ligands demonstrate that it preferentially recognizes tetra-acetylated histone H4, and we detected weaker interactions with multi-acetylated H2A.Z in addition to the previously reported interactions with acetylated histone H3. Our findings indicate PfBDP1 may play additional roles in the P. falciparum life cycle, and the distinctive features of its bromodomain binding pocket could be leveraged for the development of new therapeutic agents to help overcome the continuously evolving resistance of P. falciparum against currently available drugs.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2176774"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'O95696', 'features': [], 'extraAttributes': {'uniParcId': 'UPI0000126ACA'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.0', 'CHEMBLID': 'CHEMBL5214112', 'description': 'Selectivity interaction (Enzyme activity assay (BROMOscan\u00ae)) EUB0000191c BRD1'}, {'\u5206\u5b50SMILES': 'Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.0', 'CHEMBLID': 'CHEMBL4052871', 'description': 'Inhibition of recombinant human BRD1 (E556 to A688 residues) expressed in bacterial expression system by BROMOscan assay'}, {'\u5206\u5b50SMILES': 'Cc1cc2c(cc1N1C(=O)c3cccc4c(Cl)ccc(c34)C1=O)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '37.0', 'CHEMBLID': 'CHEMBL4051532', 'description': 'Inhibition of human BRPF2 (563 to 688 residues) expressed in Escherichia coli BL21 (DE3)-R3-pRARE2 preincubated for 15 mins followed by addition of C-terminal biotinylated synthetic K5,12 diacetylated histone H4 (1 to 20 residues) peptide as substrate measured after 1 hr by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '45.0', 'CHEMBLID': 'CHEMBL5214113', 'description': 'Selectivity interaction (ITC) EUB0000191c BRD1'}, {'\u5206\u5b50SMILES': 'COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '46.0', 'CHEMBLID': 'CHEMBL4030908', 'description': 'Inhibition of human BRPF2 (556 to 688 residues) expressed in Escherichia coli BL21 after 1 hr by BROMOscan assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'NIT2 dampens BRD1 phase separation and restrains oxidative phosphorylation to enhance chemosensitivity in gastric cancer.', 'abstract': '5-Fluorouracil (5-FU) chemoresistance contributes to poor therapeutic response and prognosis of gastric cancer (GC), for which effective strategies to overcome chemoresistance are limited. Here, using a CRISPR-Cas9 system, we identified that nitrilase family member 2 (NIT2) reverses chemoresistance independent of its metabolic function. Depletion or low expression of NIT2 led to 5-FU resistance in GC cell lines, patient-derived organoids, and xenografted tumors. Mechanistically, NIT2 interacted with bromodomain-containing protein 1 (BRD1) to inhibit HBO1-mediated acetylation of histone H3 at lysine-14 (H3K14ac) and RELA-targeted oxidative phosphorylation (OXPHOS) gene expression. Upon 5-FU stimulation, NIT2 phosphorylation by Src at Y49 promoted the dissociation of NIT2 from BRD1, followed by binding to E3 ligase CCNB1IP1, causing autophagic degradation of NIT2. Consequently, reduced NIT2 protein resulted in BRD1 forming phase separation and binding to histone H3, as well as increased RELA stability due to suppression of inhibitor of growth family member 4-mediated RELA ubiquitination. In addition, NIT2 expression negatively correlated with H3K14ac and OXPHOS and positively correlated with the chemotherapeutic responses and prognosis of patients with GC. Our findings reveal the moonlighting function of NIT2 in chemoresistance and underscore that OXPHOS blockade by metformin enhances 5-FU chemosensitivity upon NIT2 loss.'}, {'title': 'Structural insights into acetylated histone ligand recognition by the BDP1 bromodomain of Plasmodium falciparum.', 'abstract': 'Plasmodium falciparum requires a two-host system, moving between Anopheles mosquito and humans, to complete its life cycle. To overcome such dynamic growth conditions its histones undergo various post-translational modifications to regulate gene expression. The P. falciparum Bromodomain Protein 1 (PfBDP1) has been shown to interact with acetylated lysine modifications on histone H3 to regulate the expression of invasion-related genes. Here, we investigated the ability of the PfBDP1 bromodomain to interact with acetyllsyine modifications on additional core and variant histones. A crystal structure of the PfBDP1 bromodomain (PfBDP1-BRD) reveals it contains the conserved bromodomain fold, but our comparative analysis between the PfBDP1-BRD and human bromodomain families indicates it has a unique binding mechanism. Solution NMR spectroscopy and ITC binding assays carried out with acetylated histone ligands demonstrate that it preferentially recognizes tetra-acetylated histone H4, and we detected weaker interactions with multi-acetylated H2A.Z in addition to the previously reported interactions with acetylated histone H3. Our findings indicate PfBDP1 may play additional roles in the P. falciparum life cycle, and the distinctive features of its bromodomain binding pocket could be leveraged for the development of new therapeutic agents to help overcome the continuously evolving resistance of P. falciparum against currently available drugs.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL2176774"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P25440', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 112, 'modifier': 'EXACT'}, 'end': {'value': 112, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:197459'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '37731000'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '8SB6'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-N(6)-methyl-L-lysine residue', 'id': 'ChEBI:CHEBI:197459'}}, {'type': 'Binding site', 'location': {'start': {'value': 155, 'modifier': 'EXACT'}, 'end': {'value': 155, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:197459'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '37731000'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '8SB6'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-N(6)-methyl-L-lysine residue', 'id': 'ChEBI:CHEBI:197459'}}, {'type': 'Binding site', 'location': {'start': {'value': 156, 'modifier': 'EXACT'}, 'end': {'value': 156, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:61930'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20048151'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVS'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-L-lysine residue', 'id': 'ChEBI:CHEBI:61930'}}, {'type': 'Binding site', 'location': {'start': {'value': 156, 'modifier': 'EXACT'}, 'end': {'value': 156, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:197459'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '37731000'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '8SB6'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-N(6)-methyl-L-lysine residue', 'id': 'ChEBI:CHEBI:197459'}}, {'type': 'Binding site', 'location': {'start': {'value': 157, 'modifier': 'EXACT'}, 'end': {'value': 157, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:197459'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '37731000'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '8SB6'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-N(6)-methyl-L-lysine residue', 'id': 'ChEBI:CHEBI:197459'}}, {'type': 'Binding site', 'location': {'start': {'value': 160, 'modifier': 'EXACT'}, 'end': {'value': 160, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:61930'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20048151'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVS'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-L-lysine residue', 'id': 'ChEBI:CHEBI:61930'}}, {'type': 'Binding site', 'location': {'start': {'value': 161, 'modifier': 'EXACT'}, 'end': {'value': 161, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:61930'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20048151'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVS'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-L-lysine residue', 'id': 'ChEBI:CHEBI:61930'}}], 'extraAttributes': {'uniParcId': 'UPI0000126ACC'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COC(=O)CNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5349005', 'description': 'Inhibition of BRD2 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1nncs1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5349005', 'description': 'Inhibition of BRD2 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCc1ccon1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5349005', 'description': 'Inhibition of BRD2 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCc1ncco1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5349005', 'description': 'Inhibition of BRD2 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': '[2H]C([2H])([2H])c1nnn(C)c1-c1cnc2c3cc(F)c(C(C)(C)O)cc3n([C@H](c3ccccc3)C3CCOCC3)c2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL5125726', 'description': 'Inhibition of BRD2 (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'BRD4 regulates m', 'abstract': 'The interaction between m'}, {'title': 'Unveiling New Triazoloquinoxaline-based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9.', 'abstract': 'PROteolysis Targeting Chimera (PROTAC) technology is an innovative and potent approach for achieving targeted protein degradation (TPD). Within bromodomain-containing proteins, various degraders targeting BET family-related targets, e.g., BRD4, were developed in the last years. On the other hand, a limited number of PROTACs acting against non-BET proteins have been reported so far. Among them, BRD9 has been recently linked to oncogenic roles in the tumorigenesis processes, especially in sarcomas and leukemias. Herein, we describe the design and synthesis of a focused collection of new BRD9-targeting degraders based on the [1,2,4]triazolo[4,3-a]quinoxaline heterocyclic scaffold employing two distinct E3 ubiquitin ligase ligands. Through in silico evaluation, synthesis, binding affinity determination, and in vitro analysis, we identified two new VHL-based PROTACs (2 and 9), which showed remarkable degradation of the protein of interest and antiproliferative activity in acute myeloid leukemia (AML) cells. Notably, compound 9 exhibited selective degradation of BRD9 over BRD7. These results enlarge and differentiate the pool of heterobifunctional molecules able to degrade BRD9 through the proteasome machinery, providing a promising reference for the discovery of new tools to further explore both the involvement of this epigenetic regulatory factor in tumor processes and to evaluate novel strategies for AML treatment.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1293289"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P25440', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 112, 'modifier': 'EXACT'}, 'end': {'value': 112, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:197459'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '37731000'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '8SB6'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-N(6)-methyl-L-lysine residue', 'id': 'ChEBI:CHEBI:197459'}}, {'type': 'Binding site', 'location': {'start': {'value': 155, 'modifier': 'EXACT'}, 'end': {'value': 155, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:197459'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '37731000'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '8SB6'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-N(6)-methyl-L-lysine residue', 'id': 'ChEBI:CHEBI:197459'}}, {'type': 'Binding site', 'location': {'start': {'value': 156, 'modifier': 'EXACT'}, 'end': {'value': 156, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:61930'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20048151'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVS'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-L-lysine residue', 'id': 'ChEBI:CHEBI:61930'}}, {'type': 'Binding site', 'location': {'start': {'value': 156, 'modifier': 'EXACT'}, 'end': {'value': 156, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:197459'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '37731000'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '8SB6'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-N(6)-methyl-L-lysine residue', 'id': 'ChEBI:CHEBI:197459'}}, {'type': 'Binding site', 'location': {'start': {'value': 157, 'modifier': 'EXACT'}, 'end': {'value': 157, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:197459'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '37731000'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '8SB6'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-N(6)-methyl-L-lysine residue', 'id': 'ChEBI:CHEBI:197459'}}, {'type': 'Binding site', 'location': {'start': {'value': 160, 'modifier': 'EXACT'}, 'end': {'value': 160, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:61930'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20048151'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVS'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-L-lysine residue', 'id': 'ChEBI:CHEBI:61930'}}, {'type': 'Binding site', 'location': {'start': {'value': 161, 'modifier': 'EXACT'}, 'end': {'value': 161, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:16541'}, {'database': 'ChEBI', 'id': 'CHEBI:61930'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20048151'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVQ'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '2DVS'}], 'ligand': {'name': 'a protein', 'id': 'ChEBI:CHEBI:16541'}, 'ligandPart': {'name': 'N(6)-acetyl-L-lysine residue', 'id': 'ChEBI:CHEBI:61930'}}], 'extraAttributes': {'uniParcId': 'UPI0000126ACC'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COC(=O)CNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5349005', 'description': 'Inhibition of BRD2 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1nncs1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5349005', 'description': 'Inhibition of BRD2 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCc1ccon1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5349005', 'description': 'Inhibition of BRD2 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCc1ncco1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5349005', 'description': 'Inhibition of BRD2 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': '[2H]C([2H])([2H])c1nnn(C)c1-c1cnc2c3cc(F)c(C(C)(C)O)cc3n([C@H](c3ccccc3)C3CCOCC3)c2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL5125726', 'description': 'Inhibition of BRD2 (unknown origin)'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'BRD4 regulates m', 'abstract': 'The interaction between m'}, {'title': 'Unveiling New Triazoloquinoxaline-based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9.', 'abstract': 'PROteolysis Targeting Chimera (PROTAC) technology is an innovative and potent approach for achieving targeted protein degradation (TPD). Within bromodomain-containing proteins, various degraders targeting BET family-related targets, e.g., BRD4, were developed in the last years. On the other hand, a limited number of PROTACs acting against non-BET proteins have been reported so far. Among them, BRD9 has been recently linked to oncogenic roles in the tumorigenesis processes, especially in sarcomas and leukemias. Herein, we describe the design and synthesis of a focused collection of new BRD9-targeting degraders based on the [1,2,4]triazolo[4,3-a]quinoxaline heterocyclic scaffold employing two distinct E3 ubiquitin ligase ligands. Through in silico evaluation, synthesis, binding affinity determination, and in vitro analysis, we identified two new VHL-based PROTACs (2 and 9), which showed remarkable degradation of the protein of interest and antiproliferative activity in acute myeloid leukemia (AML) cells. Notably, compound 9 exhibited selective degradation of BRD9 over BRD7. These results enlarge and differentiate the pool of heterobifunctional molecules able to degrade BRD9 through the proteasome machinery, providing a promising reference for the discovery of new tools to further explore both the involvement of this epigenetic regulatory factor in tumor processes and to evaluate novel strategies for AML treatment.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1293289"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q15059', 'features': [{'type': 'Site', 'location': {'start': {'value': 647, 'modifier': 'EXACT'}, 'end': {'value': 648, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form BDR3-NUTM1 fusion protein', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17934517'}]}], 'extraAttributes': {'uniParcId': 'UPI0000126ACD'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2512', 'CHEMBLID': 'CHEMBL3383417', 'description': 'Binding affinity to full-length BRD4 short isoform (unknown origin) by BROMOscan assay'}, {'\u5206\u5b50SMILES': 'CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.631', 'CHEMBLID': 'CHEMBL3383410', 'description': 'Inhibition of human BRD3 bromodomain 1 by BROMOscan assay'}, {'\u5206\u5b50SMILES': 'CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.88', 'CHEMBLID': 'CHEMBL5162525', 'description': 'Inhibition of C-terminal His6-tagged BRD3 BD2 (unknown origin) using H-YSGRGK(Ac)GGK(Ac)GLGK(Ac)-GGAK(Ac)RHRK-Biotin-OH as substrate incubated for 1 hrs by HTRF assay'}, {'\u5206\u5b50SMILES': 'Cc1nnn(C)c1-c1cnc2c3ccc(C(C)(C)O)cc3n([C@H](c3ccccc3)C3CCOCC3)c2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.1', 'CHEMBLID': 'CHEMBL5054312', 'description': 'Inhibition of human BRD3 measured by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3C[C@@H](O)C[C@@H]32)cc2c1OC[C@@]2(C)c1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.259', 'CHEMBLID': 'CHEMBL4836617', 'description': 'Inhibition of recombinant human BRD3 BD2 (306 to 416 residues) expressed in bacterial expression system by bromoscan assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'BRD4 regulates m', 'abstract': 'The interaction between m'}, {'title': 'Unveiling New Triazoloquinoxaline-based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9.', 'abstract': 'PROteolysis Targeting Chimera (PROTAC) technology is an innovative and potent approach for achieving targeted protein degradation (TPD). Within bromodomain-containing proteins, various degraders targeting BET family-related targets, e.g., BRD4, were developed in the last years. On the other hand, a limited number of PROTACs acting against non-BET proteins have been reported so far. Among them, BRD9 has been recently linked to oncogenic roles in the tumorigenesis processes, especially in sarcomas and leukemias. Herein, we describe the design and synthesis of a focused collection of new BRD9-targeting degraders based on the [1,2,4]triazolo[4,3-a]quinoxaline heterocyclic scaffold employing two distinct E3 ubiquitin ligase ligands. Through in silico evaluation, synthesis, binding affinity determination, and in vitro analysis, we identified two new VHL-based PROTACs (2 and 9), which showed remarkable degradation of the protein of interest and antiproliferative activity in acute myeloid leukemia (AML) cells. Notably, compound 9 exhibited selective degradation of BRD9 over BRD7. These results enlarge and differentiate the pool of heterobifunctional molecules able to degrade BRD9 through the proteasome machinery, providing a promising reference for the discovery of new tools to further explore both the involvement of this epigenetic regulatory factor in tumor processes and to evaluate novel strategies for AML treatment.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1795186"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q15059', 'features': [{'type': 'Site', 'location': {'start': {'value': 647, 'modifier': 'EXACT'}, 'end': {'value': 648, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form BDR3-NUTM1 fusion protein', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '17934517'}]}], 'extraAttributes': {'uniParcId': 'UPI0000126ACD'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2512', 'CHEMBLID': 'CHEMBL3383417', 'description': 'Binding affinity to full-length BRD4 short isoform (unknown origin) by BROMOscan assay'}, {'\u5206\u5b50SMILES': 'CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.631', 'CHEMBLID': 'CHEMBL3383410', 'description': 'Inhibition of human BRD3 bromodomain 1 by BROMOscan assay'}, {'\u5206\u5b50SMILES': 'CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.88', 'CHEMBLID': 'CHEMBL5162525', 'description': 'Inhibition of C-terminal His6-tagged BRD3 BD2 (unknown origin) using H-YSGRGK(Ac)GGK(Ac)GLGK(Ac)-GGAK(Ac)RHRK-Biotin-OH as substrate incubated for 1 hrs by HTRF assay'}, {'\u5206\u5b50SMILES': 'Cc1nnn(C)c1-c1cnc2c3ccc(C(C)(C)O)cc3n([C@H](c3ccccc3)C3CCOCC3)c2c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.1', 'CHEMBLID': 'CHEMBL5054312', 'description': 'Inhibition of human BRD3 measured by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3C[C@@H](O)C[C@@H]32)cc2c1OC[C@@]2(C)c1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.259', 'CHEMBLID': 'CHEMBL4836617', 'description': 'Inhibition of recombinant human BRD3 BD2 (306 to 416 residues) expressed in bacterial expression system by bromoscan assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'BRD4 regulates m', 'abstract': 'The interaction between m'}, {'title': 'Unveiling New Triazoloquinoxaline-based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9.', 'abstract': 'PROteolysis Targeting Chimera (PROTAC) technology is an innovative and potent approach for achieving targeted protein degradation (TPD). Within bromodomain-containing proteins, various degraders targeting BET family-related targets, e.g., BRD4, were developed in the last years. On the other hand, a limited number of PROTACs acting against non-BET proteins have been reported so far. Among them, BRD9 has been recently linked to oncogenic roles in the tumorigenesis processes, especially in sarcomas and leukemias. Herein, we describe the design and synthesis of a focused collection of new BRD9-targeting degraders based on the [1,2,4]triazolo[4,3-a]quinoxaline heterocyclic scaffold employing two distinct E3 ubiquitin ligase ligands. Through in silico evaluation, synthesis, binding affinity determination, and in vitro analysis, we identified two new VHL-based PROTACs (2 and 9), which showed remarkable degradation of the protein of interest and antiproliferative activity in acute myeloid leukemia (AML) cells. Notably, compound 9 exhibited selective degradation of BRD9 over BRD7. These results enlarge and differentiate the pool of heterobifunctional molecules able to degrade BRD9 through the proteasome machinery, providing a promising reference for the discovery of new tools to further explore both the involvement of this epigenetic regulatory factor in tumor processes and to evaluate novel strategies for AML treatment.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1795186"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'O60885', 'features': [{'type': 'Site', 'location': {'start': {'value': 140, 'modifier': 'EXACT'}, 'end': {'value': 140, 'modifier': 'EXACT'}}, 'description': 'Acetylated histone binding', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22464331'}]}, {'type': 'Site', 'location': {'start': {'value': 433, 'modifier': 'EXACT'}, 'end': {'value': 433, 'modifier': 'EXACT'}}, 'description': 'Acetylated histone binding', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22464331'}]}, {'type': 'Site', 'location': {'start': {'value': 719, 'modifier': 'EXACT'}, 'end': {'value': 720, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form BDR4-NUTM1 fusion protein'}], 'extraAttributes': {'uniParcId': 'UPI0000126ACE'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COC(=O)CNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5349003', 'description': 'Inhibition of BRD4 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1nncs1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL5349003', 'description': 'Inhibition of BRD4 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCc1ccon1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL5349003', 'description': 'Inhibition of BRD4 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)N/N=C/c1ncc[nH]1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.24', 'CHEMBLID': 'CHEMBL3888340', 'description': \"Alpha Assay: BRD4(2): Assays were performed as described previously with minor modifications from the manufacturer's protocol (PerkinElmer, USA). All reagents were diluted in 50 mM HEPES, 100 mM NaCl, 0.1% BSA, pH 7.4 supplemented with 0.05% CHAPS and allowed to equilibrate to room temperature prior to addition to plates. A 24-point 1:2 serial dilution of the ligands was prepared over the range of 150-0 \u03bcM and 4 \u03bcl transferred to low-volume 384-well plates (ProxiPlate\u2122-384 Plus, PerkinElmer, USA), followed by 4 \u03bcl of HIS-tagged protein (BRD4/1, 250 nM, BRD4/2 and CREBBP, 2000 nM). Plates were sealed and incubated at room temperature for 30 minutes, before the addition of 4 \u03bcl of biotinylated peptide at equimolar concentration to the protein [peptide for BRD4(1) & BRD4(2): H4K5acK8acK12acK16ac, H-SGRGK(Ac)GGK(Ac)GLGK(Ac)GGAK(Ac)RHRK(Biotin)-OH (SEQ ID NO: 5); peptide for CREBBP: H3K36ac, Biotin-KSAPATGGVK(Ac)KPHRYRPGT-OH (SEQ ID NO: 6) (Cambridge Research Biochemicals, UK)]. Plates were sealed and incubated for a further 30 minutes, before the addition of 4 \u03bcl of streptavidin-coated donor beads (25 \u03bcg/ml) and 4 \u03bcl nickel chelate acceptor beads (25 \u03bcg/ml) under low light conditions. Plates were foil-sealed to protect from light, incubated at room temperature for 60 minutes and read on a PHERAstar FS plate reader (BMG Labtech, Germany) using an AlphaScreen 680 excitation/570 emission filter set. IC50 values were calculated in Prism 5 (GraphPad Software, USA) after normalization against corresponding DMSO controls and are given as the final concentration of compound in the 20 \u03bcl reaction volume.\"}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCc1ccccc1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL5349003', 'description': 'Inhibition of BRD4 BD2 (unknown origin) by TR-FRET assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'BRD4 regulates m', 'abstract': 'The interaction between m'}, {'title': 'Biomimetic Hybrid PROTAC Nanovesicles Block Multiple DNA Repair Pathways to Overcome Temozolomide Resistance Against Orthotopic Glioblastoma.', 'abstract': 'Glioblastoma (GBM) remains one of the deadliest forms of cancer due to its high rates of postoperative recurrence and resistance to treatment. Temozolomide (TMZ) is the standard chemotherapy for GBM. However, the therapeutic efficacy of TMZ is significantly compromised by the activation of various intracellular DNA repair mechanisms that facilitate TMZ resistance. Herein, the upregulation of bromodomain-containing protein 4 (BRD4) expression is demonstrated to be a key contributor to TMZ resistance in GBM. To address this challenge, a biomimetic hybrid PROteolysis TArgeting Chimeras (PROTAC) liposome delivery system (M@TP) is developed. This system efficiently penetrates the blood-brain barrier (BBB) and specifically targets GBM cells through homotypic recognition. Once within TMZ-resistant GBM cells, the released PROTAC from M@TP can specifically degrade BRD4, effectively inhibiting multiple DNA repair pathways and restoring sensitivity to TMZ treatment. In vivo, studies showed that M@TP demonstrated significant efficacy in suppressing tumor growth in both TMZ-resistant and postoperative GBM, with prolonged mouse survival times. These findings highlight the potential of M@TP as a promising strategy to overcome TMZ resistance and improve therapeutic outcomes in GBM.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1163125"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'O60885', 'features': [{'type': 'Site', 'location': {'start': {'value': 140, 'modifier': 'EXACT'}, 'end': {'value': 140, 'modifier': 'EXACT'}}, 'description': 'Acetylated histone binding', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22464331'}]}, {'type': 'Site', 'location': {'start': {'value': 433, 'modifier': 'EXACT'}, 'end': {'value': 433, 'modifier': 'EXACT'}}, 'description': 'Acetylated histone binding', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22464331'}]}, {'type': 'Site', 'location': {'start': {'value': 719, 'modifier': 'EXACT'}, 'end': {'value': 720, 'modifier': 'EXACT'}}, 'description': 'Breakpoint for translocation to form BDR4-NUTM1 fusion protein'}], 'extraAttributes': {'uniParcId': 'UPI0000126ACE'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COC(=O)CNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.1', 'CHEMBLID': 'CHEMBL5349003', 'description': 'Inhibition of BRD4 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1nncs1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL5349003', 'description': 'Inhibition of BRD4 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCc1ccon1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.2', 'CHEMBLID': 'CHEMBL5349003', 'description': 'Inhibition of BRD4 BD2 (unknown origin) by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)N/N=C/c1ncc[nH]1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.24', 'CHEMBLID': 'CHEMBL3888340', 'description': \"Alpha Assay: BRD4(2): Assays were performed as described previously with minor modifications from the manufacturer's protocol (PerkinElmer, USA). All reagents were diluted in 50 mM HEPES, 100 mM NaCl, 0.1% BSA, pH 7.4 supplemented with 0.05% CHAPS and allowed to equilibrate to room temperature prior to addition to plates. A 24-point 1:2 serial dilution of the ligands was prepared over the range of 150-0 \u03bcM and 4 \u03bcl transferred to low-volume 384-well plates (ProxiPlate\u2122-384 Plus, PerkinElmer, USA), followed by 4 \u03bcl of HIS-tagged protein (BRD4/1, 250 nM, BRD4/2 and CREBBP, 2000 nM). Plates were sealed and incubated at room temperature for 30 minutes, before the addition of 4 \u03bcl of biotinylated peptide at equimolar concentration to the protein [peptide for BRD4(1) & BRD4(2): H4K5acK8acK12acK16ac, H-SGRGK(Ac)GGK(Ac)GLGK(Ac)GGAK(Ac)RHRK(Biotin)-OH (SEQ ID NO: 5); peptide for CREBBP: H3K36ac, Biotin-KSAPATGGVK(Ac)KPHRYRPGT-OH (SEQ ID NO: 6) (Cambridge Research Biochemicals, UK)]. Plates were sealed and incubated for a further 30 minutes, before the addition of 4 \u03bcl of streptavidin-coated donor beads (25 \u03bcg/ml) and 4 \u03bcl nickel chelate acceptor beads (25 \u03bcg/ml) under low light conditions. Plates were foil-sealed to protect from light, incubated at room temperature for 60 minutes and read on a PHERAstar FS plate reader (BMG Labtech, Germany) using an AlphaScreen 680 excitation/570 emission filter set. IC50 values were calculated in Prism 5 (GraphPad Software, USA) after normalization against corresponding DMSO controls and are given as the final concentration of compound in the 20 \u03bcl reaction volume.\"}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCc1ccccc1)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.3', 'CHEMBLID': 'CHEMBL5349003', 'description': 'Inhibition of BRD4 BD2 (unknown origin) by TR-FRET assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'BRD4 regulates m', 'abstract': 'The interaction between m'}, {'title': 'Biomimetic Hybrid PROTAC Nanovesicles Block Multiple DNA Repair Pathways to Overcome Temozolomide Resistance Against Orthotopic Glioblastoma.', 'abstract': 'Glioblastoma (GBM) remains one of the deadliest forms of cancer due to its high rates of postoperative recurrence and resistance to treatment. Temozolomide (TMZ) is the standard chemotherapy for GBM. However, the therapeutic efficacy of TMZ is significantly compromised by the activation of various intracellular DNA repair mechanisms that facilitate TMZ resistance. Herein, the upregulation of bromodomain-containing protein 4 (BRD4) expression is demonstrated to be a key contributor to TMZ resistance in GBM. To address this challenge, a biomimetic hybrid PROteolysis TArgeting Chimeras (PROTAC) liposome delivery system (M@TP) is developed. This system efficiently penetrates the blood-brain barrier (BBB) and specifically targets GBM cells through homotypic recognition. Once within TMZ-resistant GBM cells, the released PROTAC from M@TP can specifically degrade BRD4, effectively inhibiting multiple DNA repair pathways and restoring sensitivity to TMZ treatment. In vivo, studies showed that M@TP demonstrated significant efficacy in suppressing tumor growth in both TMZ-resistant and postoperative GBM, with prolonged mouse survival times. These findings highlight the potential of M@TP as a promising strategy to overcome TMZ resistance and improve therapeutic outcomes in GBM.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1163125"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q9H8M2', 'features': [{'type': 'Site', 'location': {'start': {'value': 169, 'modifier': 'EXACT'}, 'end': {'value': 169, 'modifier': 'EXACT'}}, 'description': 'Histone H4K5ac H4K8ac and histone H4K5bu H4K8bu binding', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26365797'}]}, {'type': 'Site', 'location': {'start': {'value': 222, 'modifier': 'EXACT'}, 'end': {'value': 222, 'modifier': 'EXACT'}}, 'description': 'Histone H4K5ac H4K8ac and histone H4K5bu H4K8bu binding', 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '26365797'}]}], 'extraAttributes': {'uniParcId': 'UPI000020BEBE'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'C/C=C/Cn1cc(-c2cc(OC)c(C(=O)N3CCOCC3)cc2OC)c2cc(C)[nH]c2c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5.0', 'CHEMBLID': 'CHEMBL5261606', 'description': 'Displacement of biotinylated small-molecule ligand from recombinant His-tagged BRD9 (unknown origin) measured after 10 mins by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)c(OC)c2)c2cc(C)[nH]c2c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '6.0', 'CHEMBLID': 'CHEMBL5261606', 'description': 'Displacement of biotinylated small-molecule ligand from recombinant His-tagged BRD9 (unknown origin) measured after 10 mins by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)c(Cl)c2)c2cc(C)[nH]c2c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '7.0', 'CHEMBLID': 'CHEMBL5261606', 'description': 'Displacement of biotinylated small-molecule ligand from recombinant His-tagged BRD9 (unknown origin) measured after 10 mins by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'COc1ccc(-c2cn(C)c(=O)c3cc(C(=N)NC4CCS(=O)(=O)CC4)sc23)cc1OC', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '7.943', 'CHEMBLID': 'CHEMBL3773446', 'description': 'Inhibition of BRD9 (unknown origin) incubated in dark for 30 mins by TR-FRET assay'}, {'\u5206\u5b50SMILES': 'C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)c(C#N)c2)c2cc(C)[nH]c2c1=O', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '8.0', 'CHEMBLID': 'CHEMBL5261606', 'description': 'Displacement of biotinylated small-molecule ligand from recombinant His-tagged BRD9 (unknown origin) measured after 10 mins by TR-FRET assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Unveiling New Triazoloquinoxaline-based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9.', 'abstract': 'PROteolysis Targeting Chimera (PROTAC) technology is an innovative and potent approach for achieving targeted protein degradation (TPD). Within bromodomain-containing proteins, various degraders targeting BET family-related targets, e.g., BRD4, were developed in the last years. On the other hand, a limited number of PROTACs acting against non-BET proteins have been reported so far. Among them, BRD9 has been recently linked to oncogenic roles in the tumorigenesis processes, especially in sarcomas and leukemias. Herein, we describe the design and synthesis of a focused collection of new BRD9-targeting degraders based on the [1,2,4]triazolo[4,3-a]quinoxaline heterocyclic scaffold employing two distinct E3 ubiquitin ligase ligands. Through in silico evaluation, synthesis, binding affinity determination, and in vitro analysis, we identified two new VHL-based PROTACs (2 and 9), which showed remarkable degradation of the protein of interest and antiproliferative activity in acute myeloid leukemia (AML) cells. Notably, compound 9 exhibited selective degradation of BRD9 over BRD7. These results enlarge and differentiate the pool of heterobifunctional molecules able to degrade BRD9 through the proteasome machinery, providing a promising reference for the discovery of new tools to further explore both the involvement of this epigenetic regulatory factor in tumor processes and to evaluate novel strategies for AML treatment.'}, {'title': 'Broad Target Screening Reveals Abundance of FKBP12-Based Molecular Glues in Focused Libraries.', 'abstract': 'Competitive (nondegradative) molecular glues represent a promising drug modality that remains underexplored primarily due to the lack of adequate hit identification approaches. In this study, we screened our historically grown FKBP-focused library containing >1000 drug-like molecules to identify FKBP-assisted molecular glues targeting a diverse panel of 57 proteins. In addition to establishing a robust and generalizable screening approach, we discovered three novel FKBP-dependent molecular glues targeting PTPRN, BRD4'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3108640"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q58F21', 'features': [{'type': 'Binding site', 'location': {'start': {'value': 109, 'modifier': 'EXACT'}, 'end': {'value': 109, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:137113'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '22901802'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '4FLP'}], 'ligand': {'name': 'JQ1', 'id': 'ChEBI:CHEBI:137113', 'note': 'inhibitor'}}, {'type': 'Site', 'location': {'start': {'value': 109, 'modifier': 'EXACT'}, 'end': {'value': 109, 'modifier': 'EXACT'}}, 'description': 'Histone H4K5ac binding', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'Q91Y44'}]}, {'type': 'Site', 'location': {'start': {'value': 114, 'modifier': 'EXACT'}, 'end': {'value': 114, 'modifier': 'EXACT'}}, 'description': 'Histone H4K5ac binding', 'evidences': [{'evidenceCode': 'ECO:0000250', 'source': 'UniProtKB', 'id': 'Q91Y44'}]}], 'extraAttributes': {'uniParcId': 'UPI000013D0E1'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3C[C@@H](O)C[C@@H]32)cc2c1OC[C@@]2(C)c1ccccc1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '1.585', 'CHEMBLID': 'CHEMBL4836613', 'description': 'Inhibition of recombinant human BRDT BD2 (250 to 382 residues) expressed in bacterial expression system by bromoscan assay'}, {'\u5206\u5b50SMILES': 'Cc1nnc2n1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)C[C@H]2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.0', 'CHEMBLID': 'CHEMBL4716999', 'description': 'Inhibition of BRDT BD1 (unknown origin) using biotinylated JQ1 analog as substrate measured after 20 mins by AlphaLISA assay'}, {'\u5206\u5b50SMILES': 'Cc1nnc2n1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)C[C@H]2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.0', 'CHEMBLID': 'CHEMBL4717000', 'description': 'Inhibition of BRDT BD2 (unknown origin) using biotinylated JQ1 analog as substrate measured after 20 mins by AlphaLISA assay'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.0', 'CHEMBLID': 'CHEMBL5210063', 'description': 'Affinity Phenotypic Cellular interaction (Cell Proliferation (Cell TiterGlo assay Promega in NMC 11060 cells)) EUB0000330a BRDT'}, {'\u5206\u5b50SMILES': 'Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '4.0', 'CHEMBLID': 'CHEMBL5210062', 'description': 'Affinity Phenotypic Cellular interaction (Cell Proliferation (Cell TiterGlo assay Promega in NMC 11060 cells)) EUB0000330a BRDT'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Ectopic expression of testis-specific transcription elongation factor in driving cancer.', 'abstract': 'The testis-specific BET protein BRDT structurally resembles the ubiquitous BRD4 and is misexpressed in cancer, and we show that BRDT misexpression may affect lung cancer progression. BRDT knockdown in lung cancer cells slowed tumor growth and prolonged survival in a xenograft model. Comparative characterization of PTEFb complex participation and chromatin binding indicates BRD4-redundant and BRD4-distinct BRDT functions. Unlike dual depletion, individual BRD4 or BRDT knockdown did not impair transcriptional responses to hypoxia in BRDT-expressing cells, consistent with redundant function. However, BRD4 depletion/BRDT complementation revealed that BRDT can also release paused RNA polymerase II independently of its bromodomains as we previously demonstrated not to be required for Pol II pause/release function of BRD4, underscoring the functional importance of the C-terminal domains in both BRD4 and BRDT and their potential as therapeutic targets in solid tumors. Based on this study, future investigations should explore BRD4-distinct BRDT functions and BRDT misexpression driving cancer pathogenesis.'}, {'title': 'H4K5 Butyrylation Coexist with Acetylation during Human Spermiogenesis and Are Retained in the Mature Sperm Chromatin.', 'abstract': 'Male germ cells experience a drastic chromatin remodeling through the nucleo-histone to nucleo-protamine (NH-NP) transition necessary for proper sperm functionality. Post-translational modifications (PTMs) of H4 Lys5, such as acetylation (H4K5ac), play a crucial role in epigenetic control of nucleosome disassembly facilitating protamine incorporation into paternal DNA. It has been shown that butyrylation on the same residue (H4K5bu) participates in temporal regulation of NH-NP transition in mice, delaying the bromodomain testis specific protein (BRDT)-dependent nucleosome disassembly and potentially marking retained nucleosomes. However, no information was available so far on this modification in human sperm. Here, we report a dual behavior of H4K5bu and H4K5ac in human normal spermatogenesis, suggesting a specific role of H4K5bu during spermatid elongation, coexisting with H4K5ac although with different starting points. This pattern is stable under different testicular pathologies, suggesting a highly conserved function of these modifications. Despite a drastic decrease of both PTMs in condensed spermatids, they are retained in ejaculated sperm, with 30% of non-colocalizing nucleosome clusters, which could reflect differential paternal genome retention. Whereas no apparent effect of these PTMs was observed associated with sperm quality, their presence in mature sperm could entail a potential role in the zygote.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL1795185"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P55201', 'features': [], 'extraAttributes': {'uniParcId': 'UPI000013E784'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1ccccc1C(=O)Nc1cc2c(cc1N1CCNC[C@H]1C)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '2.512', 'CHEMBLID': 'CHEMBL3830593', 'description': 'Inhibition of full length BRPF1 in human HUT78 cell nuclear/chromatin extract after 45 mins by chemoproteomic competition binding assay'}, {'\u5206\u5b50SMILES': 'COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.1', 'CHEMBLID': 'CHEMBL5214158', 'description': 'Selectivity interaction (BromoScan panel) EUB0000205c BRPF1'}, {'\u5206\u5b50SMILES': 'COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.1', 'CHEMBLID': 'CHEMBL4030905', 'description': 'Inhibition of human BRPF1 (627 to 740 residues) expressed in Escherichia coli BL21 after 1 hr by BROMOscan assay'}, {'\u5206\u5b50SMILES': 'CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.981', 'CHEMBLID': 'CHEMBL3383420', 'description': 'Inhibition of human BRPF1 by BROMOscan assay'}, {'\u5206\u5b50SMILES': 'COc1ccccc1C(=O)Nc1cc2c(cc1N1CCC[C@H]1C)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5.012', 'CHEMBLID': 'CHEMBL3830584', 'description': 'Inhibition of synthetic fluorescent ligand binding to recombinant truncated 6H-Flag-TEV-BRPF1 (622 to 738 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) cells after 30 mins by TR-FRET assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Shc1 cooperates with Frs2 and Shp2 to recruit Grb2 in FGF-induced lens development.', 'abstract': \"Fibroblast growth factor (FGF) signaling elicits multiple downstream pathways, most notably the Ras/MAPK cascade facilitated by the adaptor protein Grb2. However, the mechanism by which Grb2 is recruited to the FGF signaling complex remains unresolved. Here, we showed that genetic ablation of FGF signaling prevented murine lens induction by disrupting transcriptional regulation and actin cytoskeletal arrangements, which could be reproduced by deleting the juxtamembrane region of the FGF receptor and rescued by Kras activation. Conversely, mutations affecting the Frs2-binding site on the FGF receptor or the deletion of Frs2 and Shp2 primarily impact later stages of lens vesicle development involving lens fiber cell differentiation. Our study further revealed that the loss of Grb2 abolished MAPK signaling, resulting in a profound arrest of lens development. However, removing Grb2's putative Shp2 dephosphorylation site (Y209) neither produced a detectable phenotype nor impaired MAPK signaling during lens development. Furthermore, the catalytically inactive Shp2 mutation (C459S) only modestly impaired FGF signaling, whereas replacing Shp2's C-terminal phosphorylation sites (Y542/Y580) previously implicated in Grb2 binding only caused placental defects, perinatal lethality, and reduced lacrimal gland branching without impacting lens development, suggesting that Shp2 only partially mediates Grb2 recruitment. In contrast, we observed that FGF signaling is required for the phosphorylation of the Grb2-binding sites on Shc1 and the deletion of Shc1 exacerbates the lens vesicle defect caused by Frs2 and Shp2 deletion. These findings establish Shc1 as a critical collaborator with Frs2 and Shp2 in targeting Grb2 during FGF signaling.\"}, {'title': 'Single-cell profiling of trabecular meshwork identifies mitochondrial dysfunction in a glaucoma model that is protected by vitamin B3 treatment.', 'abstract': \"Since the trabecular meshwork (TM) is central to intraocular pressure (IOP) regulation and glaucoma, a deeper understanding of its genomic landscape is needed. We present a multimodal, single-cell resolution analysis of mouse limbal cells (includes TM). In total, we sequenced 9,394 wild-type TM cell transcriptomes. We discovered three TM cell subtypes with characteristic signature genes validated by immunofluorescence on tissue sections and whole-mounts. The subtypes are robust, being detected in datasets for two diverse mouse strains and in independent data from two institutions. Results show compartmentalized enrichment of critical pathways in specific TM cell subtypes. Distinctive signatures include increased expression of genes responsible for 1) extracellular matrix structure and metabolism (TM1 subtype), 2) secreted ligand signaling to support Schlemm's canal cells (TM2), and 3) contractile and mitochondrial/metabolic activity (TM3). ATAC-sequencing data identified active transcription factors in TM cells, including LMX1B. Mutations in \"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3132741"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'P55201', 'features': [], 'extraAttributes': {'uniParcId': 'UPI000013E784'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'COc1ccccc1C(=O)Nc1cc2c(cc1N1CCNC[C@H]1C)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '2.512', 'CHEMBLID': 'CHEMBL3830593', 'description': 'Inhibition of full length BRPF1 in human HUT78 cell nuclear/chromatin extract after 45 mins by chemoproteomic competition binding assay'}, {'\u5206\u5b50SMILES': 'COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.1', 'CHEMBLID': 'CHEMBL5214158', 'description': 'Selectivity interaction (BromoScan panel) EUB0000205c BRPF1'}, {'\u5206\u5b50SMILES': 'COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.1', 'CHEMBLID': 'CHEMBL4030905', 'description': 'Inhibition of human BRPF1 (627 to 740 residues) expressed in Escherichia coli BL21 after 1 hr by BROMOscan assay'}, {'\u5206\u5b50SMILES': 'CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '3.981', 'CHEMBLID': 'CHEMBL3383420', 'description': 'Inhibition of human BRPF1 by BROMOscan assay'}, {'\u5206\u5b50SMILES': 'COc1ccccc1C(=O)Nc1cc2c(cc1N1CCC[C@H]1C)n(C)c(=O)n2C', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '5.012', 'CHEMBLID': 'CHEMBL3830584', 'description': 'Inhibition of synthetic fluorescent ligand binding to recombinant truncated 6H-Flag-TEV-BRPF1 (622 to 738 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) cells after 30 mins by TR-FRET assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Shc1 cooperates with Frs2 and Shp2 to recruit Grb2 in FGF-induced lens development.', 'abstract': \"Fibroblast growth factor (FGF) signaling elicits multiple downstream pathways, most notably the Ras/MAPK cascade facilitated by the adaptor protein Grb2. However, the mechanism by which Grb2 is recruited to the FGF signaling complex remains unresolved. Here, we showed that genetic ablation of FGF signaling prevented murine lens induction by disrupting transcriptional regulation and actin cytoskeletal arrangements, which could be reproduced by deleting the juxtamembrane region of the FGF receptor and rescued by Kras activation. Conversely, mutations affecting the Frs2-binding site on the FGF receptor or the deletion of Frs2 and Shp2 primarily impact later stages of lens vesicle development involving lens fiber cell differentiation. Our study further revealed that the loss of Grb2 abolished MAPK signaling, resulting in a profound arrest of lens development. However, removing Grb2's putative Shp2 dephosphorylation site (Y209) neither produced a detectable phenotype nor impaired MAPK signaling during lens development. Furthermore, the catalytically inactive Shp2 mutation (C459S) only modestly impaired FGF signaling, whereas replacing Shp2's C-terminal phosphorylation sites (Y542/Y580) previously implicated in Grb2 binding only caused placental defects, perinatal lethality, and reduced lacrimal gland branching without impacting lens development, suggesting that Shp2 only partially mediates Grb2 recruitment. In contrast, we observed that FGF signaling is required for the phosphorylation of the Grb2-binding sites on Shc1 and the deletion of Shc1 exacerbates the lens vesicle defect caused by Frs2 and Shp2 deletion. These findings establish Shc1 as a critical collaborator with Frs2 and Shp2 in targeting Grb2 during FGF signaling.\"}, {'title': 'Single-cell profiling of trabecular meshwork identifies mitochondrial dysfunction in a glaucoma model that is protected by vitamin B3 treatment.', 'abstract': \"Since the trabecular meshwork (TM) is central to intraocular pressure (IOP) regulation and glaucoma, a deeper understanding of its genomic landscape is needed. We present a multimodal, single-cell resolution analysis of mouse limbal cells (includes TM). In total, we sequenced 9,394 wild-type TM cell transcriptomes. We discovered three TM cell subtypes with characteristic signature genes validated by immunofluorescence on tissue sections and whole-mounts. The subtypes are robust, being detected in datasets for two diverse mouse strains and in independent data from two institutions. Results show compartmentalized enrichment of critical pathways in specific TM cell subtypes. Distinctive signatures include increased expression of genes responsible for 1) extracellular matrix structure and metabolism (TM1 subtype), 2) secreted ligand signaling to support Schlemm's canal cells (TM2), and 3) contractile and mitochondrial/metabolic activity (TM3). ATAC-sequencing data identified active transcription factors in TM cells, including LMX1B. Mutations in \"}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL3132741"
    ],
    [
        "SMILES\u751f\u6210\u4e0e\u6821\u9a8c\u7ed3\u6784\u5316\u6307\u5357\n\uff08\u5206\u6b65\u9aa4\u4efb\u52a1\u6267\u884c\u6a21\u677f\uff09\n\n\u4e00\u3001\u539f\u5b50\u89c4\u8303\n\n\u5143\u7d20\u7b26\u53f7\u89c4\u5219\n\n\u5355\u539f\u5b50\uff1aC O N \u2192 \u6b63\u5e38\u4ef7\u6001\u65e0\u9700\u62ec\u53f7\n\n\u53cc\u539f\u5b50\uff1aCl Br \u2192 \u7b2c\u4e8c\u5b57\u6bcd\u5fc5\u987b\u5c0f\u5199\n\n\u975e\u5e38\u89c1\u4ef7\u6001\uff1a[Fe+3] [S-2]\n\n\u82b3\u9999\u539f\u5b50\uff1ac1ccccc1\uff08\u82ef\u73af\uff09\n\n!\u9519\u8bef\u68c0\u6d4b!\n\u00d7 Cl \u2192 \u2717\n\u221a Cl \u2192 \u2713\n\n\u4e8c\u3001\u5316\u5b66\u952e\u5904\u7406\u6d41\u7a0b\n\n\u952e\u7c7b\u578b\u4f18\u5148\u7ea7\n\u9ed8\u8ba4\u5355\u952e\uff1aCC\uff08\u4e59\u70f7\uff09\n\u53cc\u952e\uff1aC=C\uff08\u4e59\u70ef\uff09\n\u4e09\u952e\uff1aC#C\uff08\u4e59\u7094\uff09\n\u82b3\u9999\u952e\uff1ac:c\uff08\u9690\u5f0f\uff09\n\n\u7acb\u4f53\u5316\u5b66\u6807\u8bb0\n\u987a\u5f0f\uff1aF/C=C/F\n\u53cd\u5f0f\uff1aF\\C=C\\F\n\u56db\u9762\u4f53\u624b\u6027\uff1aC@Br \u2192 \u987a\u65f6\u9488\nC@@Br \u2192 \u9006\u65f6\u9488\n\n\u4e09\u3001\u7ed3\u6784\u6784\u5efa\u6b65\u9aa4\n\n\u4e3b\u94fe\u6784\u5efa\n\u7ebf\u6027\u7ed3\u6784\uff1aCCCC\uff08\u4e01\u70f7\uff09\n\u73af\u72b6\u7ed3\u6784\uff1aC1CCCC1\uff08\u73af\u620a\u70f7\uff09\n\n\u5206\u652f\u5904\u7406\n\u5355\u5206\u652f\uff1aCC(C)C\uff08\u5f02\u4e01\u70f7\uff09\n\u591a\u5206\u652f\uff1aCC(C)(C)C\uff08\u65b0\u620a\u70f7\uff09\n\n\u56db\u3001\u7279\u6b8a\u5143\u7d20\u5904\u7406\u89c4\u8303\n\n\u6c22\u539f\u5b50\u6807\u6ce8\n\u5fc5\u987b\u663e\u5f0f\u7684\u60c5\u51b5\uff1a\n\n\u5e26\u7535\uff1a[H+]\n\n\u540c\u4f4d\u7d20\uff1a[2H]\n\n\u5355\u8d28\uff1a[H][H]\n\n\u7535\u8377\u8868\u793a\u6807\u51c6\n\u5355\u7535\u8377\uff1a[Na+]\n\u591a\u7535\u8377\uff1a[Fe+3] \u6216 [Fe+++]\n\n\u4e94\u3001\u590d\u5408\u7ed3\u6784\u5904\u7406\n\n\u5206\u79bb\u7ec4\u5206\uff1a\u7528.\u5206\u9694\n[Na+].[Cl-]\uff08\u6c2f\u5316\u94a0\uff09\nCC(=O)O.CCO\uff08\u4e59\u9178+\u4e59\u9187\uff09\n\n\u73af\u7f16\u53f7\u89c4\u5219\n\n\u6210\u5bf9\u6570\u5b57\u6807\u8bb0\uff1aC1CCCCC1\n\n\u907f\u514d\u6570\u5b57\u51b2\u7a81\uff1aC1CC2CCCC2C1\n\n\u516d\u3001\u9a8c\u8bc1\u68c0\u67e5\u6e05\u5355\n\n\u8bed\u6cd5\u6821\u9a8c\u70b9\n\u25a1 \u6240\u6709\u975e\u6807\u51c6\u4ef7\u6001\u5143\u7d20\u662f\u5426\u52a0[]\n\u25a1 \u82b3\u9999\u73af\u662f\u5426\u95ed\u5408\uff08\u5982c1ccccc1\uff09\n\u25a1 \u73af\u7f16\u53f7\u662f\u5426\u6210\u5bf9\u51fa\u73b0\n\u25a1 \u7acb\u4f53\u6807\u8bb0\u662f\u5426\u914d\u5957\uff08@/@@\uff0c/\u4e0e\\\uff09\n\n\u8bed\u4e49\u6821\u9a8c\u70b9\n\u25a1 \u6c22\u539f\u5b50\u6570\u91cf\u662f\u5426\u7b26\u5408\u4ef7\u952e\u89c4\u5219\n\u25a1 \u7535\u8377\u662f\u5426\u5e73\u8861\uff08\u6574\u4f53\u4e2d\u6027\u4f18\u5148\uff09\n\u25a1 \u540c\u4f4d\u7d20\u6807\u8bb0\u662f\u5426\u6b63\u786e\uff08\u5982[13C]\uff09\n\n\u4e03\u3001\u793a\u4f8b\u751f\u6210\u6a21\u677f\n\u8f93\u5165\u7ed3\u6784\uff1a\u73af\u5df1\u70f7\uff08\u6905\u5f0f\u6784\u578b\uff09\n\u6b63\u786eSMILES\uff1aC1CCCCC1\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u987a\u5f0f\u4e8c\u6c2f\u4e59\u70ef\n\u6b63\u786eSMILES\uff1aCl/C=C/Cl\n\n\u8f93\u5165\u7ed3\u6784\uff1a\u786b\u9178\u6839\u79bb\u5b50\n\u6b63\u786eSMILES\uff1aS(=O)([O-])[O-]\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u73b0\u5728\uff0c\u4f60\u5df2\u7ecf\u63a5\u53d7\u4e86\u6587\u732e\uff0c\u5e76\u4ece\u4e2d\u603b\u7ed3\u51fa\u4e86\u4e00\u4e9b\u77e5\u8bc6\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u7ed3\u5408\u4f4d\u70b9\u89e3\u6790\uff08\u7ed3\u6784\u5bf9\u63a5\uff09\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7ed3\u5408\u4f4d\u70b9\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceuniprotKB\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u7ed3\u5408\u4f4d\u70b9\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u7ed3\u6784\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a{'entryType': 'UniProtKB reviewed (Swiss-Prot)', 'primaryAccession': 'Q06187', 'features': [{'type': 'Active site', 'location': {'start': {'value': 521, 'modifier': 'EXACT'}, 'end': {'value': 521, 'modifier': 'EXACT'}}, 'description': 'Proton acceptor', 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}, {'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU10028'}]}, {'type': 'Binding site', 'location': {'start': {'value': 26, 'modifier': 'EXACT'}, 'end': {'value': 26, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10196129'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 28, 'modifier': 'EXACT'}, 'end': {'value': 28, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10196129'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 39, 'modifier': 'EXACT'}, 'end': {'value': 39, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10196129'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 53, 'modifier': 'EXACT'}, 'end': {'value': 53, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:57895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10196129'}], 'ligand': {'name': '1D-myo-inositol 1,3,4,5-tetrakisphosphate', 'id': 'ChEBI:CHEBI:57895'}}, {'type': 'Binding site', 'location': {'start': {'value': 143, 'modifier': 'EXACT'}, 'end': {'value': 143, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00432'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10196129'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9218782'}, {'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.50'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 154, 'modifier': 'EXACT'}, 'end': {'value': 154, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00432'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10196129'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9218782'}, {'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.50'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 155, 'modifier': 'EXACT'}, 'end': {'value': 155, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00432'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10196129'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9218782'}, {'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.50'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 165, 'modifier': 'EXACT'}, 'end': {'value': 165, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:29105'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00432'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '10196129'}, {'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '9218782'}, {'evidenceCode': 'ECO:0000269', 'source': 'Reference', 'id': 'Ref.50'}], 'ligand': {'name': 'Zn(2+)', 'id': 'ChEBI:CHEBI:29105'}}, {'type': 'Binding site', 'location': {'start': {'value': 408, 'modifier': 'EXACT'}, 'end': {'value': 416, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 430, 'modifier': 'EXACT'}, 'end': {'value': 430, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:30616'}], 'evidences': [{'evidenceCode': 'ECO:0000255', 'source': 'PROSITE-ProRule', 'id': 'PRU00159'}], 'ligand': {'name': 'ATP', 'id': 'ChEBI:CHEBI:30616'}}, {'type': 'Binding site', 'location': {'start': {'value': 474, 'modifier': 'EXACT'}, 'end': {'value': 477, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:187895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21280133'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3PIY'}], 'ligand': {'name': 'clofedanol', 'id': 'ChEBI:CHEBI:187895', 'note': 'inhibitor'}}, {'type': 'Binding site', 'location': {'start': {'value': 474, 'modifier': 'EXACT'}, 'end': {'value': 477, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:190514'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '20052711'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3K54'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3OCT'}], 'ligand': {'name': 'dasatinib', 'id': 'ChEBI:CHEBI:190514', 'note': 'inhibitor'}}, {'type': 'Binding site', 'location': {'start': {'value': 542, 'modifier': 'EXACT'}, 'end': {'value': 542, 'modifier': 'EXACT'}}, 'description': '', 'featureCrossReferences': [{'database': 'ChEBI', 'id': 'CHEBI:187895'}], 'evidences': [{'evidenceCode': 'ECO:0000269', 'source': 'PubMed', 'id': '21280133'}, {'evidenceCode': 'ECO:0007744', 'source': 'PDB', 'id': '3PIY'}], 'ligand': {'name': 'clofedanol', 'id': 'ChEBI:CHEBI:187895', 'note': 'inhibitor'}}], 'extraAttributes': {'uniParcId': 'UPI0000126B16'}}\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u63d0\u53d6\u7ed3\u5408\u4f4d\u7f6e\u7684\u7ed3\u6784\u7279\u5f81\n2.\u8054\u60f3\u4e0e\u8be5\u7ed3\u5408\u4f4d\u7f6e\u80fd\u591f\u7ed3\u5408\u7684\u5206\u5b50\u6216\u8005\u6b8b\u57fa\uff0c\u4ee5\u53ca\u5206\u6790\u4ed6\u4eec\u7684\u7279\u5f81\n3.\u5c1d\u8bd5\u662f\u5426\u53ef\u4ee5\u5c06\u8be5\u4f4d\u7f6e\u7ed3\u5408\u7684\u5206\u5b50\u6b8b\u57fa\u62fc\u51d1\u6210\u4e00\u4e2a\u5206\u5b50\n4.\u5b8f\u89c2\u7684\u7ed9\u51fa\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u6240\u8574\u542b\u7684\u7a7a\u95f4\u610f\u4e49\uff0c\u4e3a\u540e\u7eed\u751f\u6210\u7ed3\u5408\u7684\u5206\u5b50\u5960\u5b9a\u57fa\u7840\u3002\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u7ed3\u5408\u4f4d\u70b9\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u901a\u8fc7\u4e0a\u4e0b\u6587\u6765\u83b7\u5f97\u4f60\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5b9e\u9a8c\u9a8c\u8bc1\u5df2\u7ed3\u5408\u914d\u4f53\u5206\u6790\uff0c\u7814\u7a76\u6211\u63d0\u4f9b\u7ed9\u4f60\u7684\u8be5\u9776\u70b9\u7684\u5df2\u6709\u7ed3\u5408\u914d\u4f53\u7684\u4fe1\u606f\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u7ed3\u6784\u5206\u6790\u6a21\u5f0f\uff09\n###\u5177\u4f53\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u5206\u6790\u4ee5\u4e0b\u4eceCHEMBL\u6570\u636e\u5e93\u4e0a\u4e0b\u8f7d\u7684json\u683c\u5f0f\u7684\u8be5\u9776\u70b9\u7684\u4e00\u4e9b\u9ad8\u6d3b\u6027\u914d\u4f53\u76f8\u5173\u4fe1\u606f\uff0c\u4ece\u4f60\u5b66\u4e60\u8be5\u9776\u70b9\u914d\u4f53\u76f8\u5173\u77e5\u8bc6\uff0c\u4f5c\u4e3a\u540e\u7eed\u5206\u5b50\u751f\u6210\u7684\u4e0a\u4e0b\u6587\u3002\n###\u8f93\u5165\uff1a[{'\u5206\u5b50SMILES': 'CC(C)(N)/C=C(/C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.0', 'CHEMBLID': 'CHEMBL5104905', 'description': 'Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method'}, {'\u5206\u5b50SMILES': 'C=CC(=O)N(C)Cc1c[nH]c2ncnc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)c12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.014', 'CHEMBLID': 'CHEMBL4668253', 'description': 'Inhibition of full length human unphosphorylated BTK using FITC-Ahx-TSELKKVVALYDYMPMNAND-NH2 as substrate incubated for 60 mins in presence of ATP at Km concentration'}, {'\u5206\u5b50SMILES': 'C[C@@H]1CC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]12', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.058', 'CHEMBLID': 'CHEMBL3889266', 'description': 'LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) Assay: BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay. In this assay, the potency (IC50) of each compound was determined from an eleven point (1:3 serial dilution; final compound concentration range in assay from 1 uM to 0.017 nM) titration curve using the following outlined procedure. To each well of a black non-binding surface Corning 384-well microplate (Corning Catalog #3820), 5 nL of compound (2000 fold dilution in final assay volume of 10 uL) was dispensed, followed by the addition of 7.5 uL of 1x kinase buffer (50 mM Hepes 7.5, 10 mM MgCl2, 0.01% Brij-35, 1 mM EGTA, 0.05% BSA & 1 mM DTT) containing 5.09 pg/uL (66.67 pM) of BTK enzyme (recombinant protein from baculovirus-transfected Sf9 cells: full-length BTK, 6HIS-tag cleaved). Following a 60 minute compound & enzyme incubation, each reaction was initiated by the addition of 2.5 uL 1x kinase buffer containing 8 uM biotinylated \"A5\" peptide (Biotin-EQEDEPEGDYFEWLE-NH2) (SEQ ID NO: 1), and 100 uM ATP. The final reaction in each well of 10 uL consists of 100 pM hBTK, 2 uM biotin-A5-peptide, and 25 uM ATP. Phosphorylation reactions were allowed to proceed for 120 minutes. Reactions were immediately quenched by the addition of 20 uL of 1x quench buffer (15 mM EDTA, 25 mM Hepes 7.3, and 0.1% Triton X-100) containing detection reagents (0.626 nM of LANCE-Eu-W1024-anti-phosphoTyrosine antibody, PerkinElmer and 86.8 nM of Streptavidin-conjugated Dylight 650, Dyomics/ThermoFisher Scientific). After 60 minutes incubation with detection reagents, reaction plates were read on a PerkinElmer EnVision plate reader using standard TR-FRET protocol. Briefly, excitation of donor molecules (Eu-chelate:anti-phospho-antibody) with a laser light source at 337 nm produces energy that can be transferred to Dylight-650 acceptor molecules if this donor:acceptor pair is within close proximity. Fluorescence intensity at both 665 nm (acceptor) and 615 nm (donor) are measured and a TR-FRET ratio calculated for each well (acceptor intensity/donor intensity). IC50 values were determined by 4 parameter robust fit of TR-FRET ratio values vs. (Log10) compound concentrations.'}, {'\u5206\u5b50SMILES': 'C=CS(=O)(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.068', 'CHEMBLID': 'CHEMBL4235696', 'description': 'Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled peptide as substrate measured after 60 mins by fluorescence assay'}, {'\u5206\u5b50SMILES': 'C#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1', 'Ki\u503c\uff08\u8d8a\u5c0f\u4eb2\u548c\u529b\u8d8a\u5f3a\uff09': '0.07', 'CHEMBLID': 'CHEMBL4616764', 'description': 'Inhibition of recombinant human BTK using fluoresceinated peptide as substrate after 60 mins fluorescence assay'}]\uff08UniProt\u5bfc\u51fa\u7684\u7ed3\u5408\u4f4d\u70b9\u6570\u636e\uff09\n###\u5206\u6790\u6b65\u9aa4\uff1a\n1.\u5efa\u7acb2D-QSAR\u6a21\u578b\uff1a\u8bc6\u522b\u5f71\u54cdpIC50\u7684\u5173\u952e\u63cf\u8ff0\u7b26\uff08\u5982AlogP\u3001TPSA\uff09\n2.\u8fdb\u884c3D\u836f\u6548\u56e2\u6bd4\u5bf9\uff1a\u8ba1\u7b97\u5206\u5b50\u53e0\u5408RMSD\uff0c\u63d0\u53d6\u4fdd\u5b88\u7279\u5f81\n3.\u6784\u5efa\u6d3b\u6027\u60ac\u5d16\u5206\u6790\uff1a\u8bc6\u522b\u5bfc\u81f4\u6d3b\u6027\u9aa4\u53d8\u7684\u53d6\u4ee3\u57fa\u6a21\u5f0f\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u76f8\u5173\u914d\u4f53\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u5b66\u4e60\u5230\u7684\u77e5\u8bc6\n",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\uff0c\u4f60\u4f1a\u7ecf\u8fc7\u4e0e\u6211\u7684\u591a\u8f6e\u5bf9\u8bdd\u6765\u4e00\u6b65\u4e00\u6b65\u83b7\u5f97\u76f8\u5173\u77e5\u8bc6\uff0c\u4e00\u6b65\u4e00\u6b65\u63d0\u9ad8\u81ea\u5df1\u751f\u6210\u8be5\u9776\u70b9\u914d\u4f53\u5206\u5b50\u7684\u80fd\u529b\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u6587\u732e\u77e5\u8bc6\u7ed3\u6784\u5316\uff08\u77e5\u8bc6\u951a\u5b9a\uff09\uff0c\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u8fdb\u884c\u67d0\u9776\u70b9\u7684\u7ed3\u5408\u914d\u4f53\u76f8\u5173\u7814\u7a76\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08\u6587\u732e\u89e3\u6790\u6a21\u5f0f\uff09  \n###\u8f93\u5165\uff1a[{'title': 'Chronic lymphocytic leukemia: what clinical progress have we seen in the last five years?', 'abstract': 'Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults. Although treatment has shifted from immunochemotherapy to novel targeted drugs over the last 10 years, novel therapies remain under investigation, particularly in relapsed and refractory patients.'}, {'title': 'Treatment outcomes of BTK inhibitors and venetoclax with or without anti-CD20 monoclonal antibody in relapsed or refractory mantle cell lymphoma.', 'abstract': 'To characterise the effectiveness of Bruton tyrosine kinase inhibitors with venetoclax in patients with refractory or relapsed mantle cell lymphoma, with or without the addition of an anti-CD20 antibody. Progression-free and overall survival were estimated for forty-nine patients treated with Bruton tyrosine kinase inhibitors and venetoclax (200\\xa0mg, daily) or in combination with an anti-CD20 monoclonal antibody between June 2018 and February 2022 in China. The median number of treatment lines before combination therapy was three (range, 2-7). The median patient age was 62 years, with a male-to-female ratio of 3.08:1. Patients exhibited high-risk features including Ki-67\\u2009\u2265\\u200930% (89.8%), blastoid/pleomorphic histology (36.7%), high-risk mantle cell lymphoma International Prognostic Index group (42.9%), complex karyotype (27.7%), TP53 mutations (71.4%), TP53 mutations combined with other high-risk gene mutations including KMT2D, NSD2, CCND1, NOTCH1, CDKN2A, NOTCH2 and SMARCA4 (57.1%), and progression of disease within 24 months (65.3%), with similar efficacy and prognosis to low-risk cases. Basic clinical and cytogenetic characteristics, as well as efficacy and survival, were similar between the dual and triple combination therapy groups (all p\\u2009>\\u20090.05). The optimal overall response and complete remission rates were 67.4% and 53.1%, respectively. The 3-year progression-free and overall survival rates were 37.5% and 50.8%, respectively. Eastern Cooperative Oncology Group\u22652was an independent predictor of progression-free survival. Eastern Cooperative Oncology Group performance status\\u2009\u2265\\u20092, TP53 mutations combined with other high-risk gene mutationswere independent factors for poor overall survival. The most common adverse reactions were haematological and pulmonary infections. The leading cause of death was disease progression (19/22). The combination of Bruton tyrosine kinase inhibitors and venetoclax, demonstrated good efficacy in patients with refractory or relapsed mantle cell lymphoma, particularly in the early treatment. There was no efficacy or survival advantages of adding CD20 antibodies. Patients in the ultrahigh-risk group required more aggressive treatments.'}]\uff08\u6765\u81ea\u8bba\u6587/\u7f51\u7edc\u7684\u9776\u70b9\u4fe1\u606f\uff09  \n###\u4efb\u52a1\uff1a\u6267\u884c\u4ee5\u4e0b\u5206\u6790\u6d41\u7a0b\uff1a  \n1. \u8be5\u9776\u70b9\u7684\u57fa\u672c\u4fe1\u606f\u5206\u6790 \n2. \u8be5\u9776\u70b9\u7684\u7ed3\u6784\u4fe1\u606f\u5206\u6790\n3. \u8be5\u9776\u70b9\u5df2\u77e5\u7684\u5b9e\u9a8c\u4fe1\u606f\u5206\u6790  \n4. \u8be5\u9776\u70b9\u7684\u914d\u4f53\u751f\u6210\u65b9\u5f0f\u5206\u6790\n\uff08\u4ee5\u4e0a\u6b65\u9aa4\u662f\u975e\u5316\u5b66\u9886\u57df\u5b66\u751f\u7684\u731c\u6d4b\uff0c\u5982\u679c\u4f60\u6709\u66f4\u597d\u7684\u5206\u6790\u6b65\u9aa4\uff0c\u8bf7\u81ea\u884c\u51b3\u65ad\uff0c\u76ee\u7684\u662f\u66f4\u597d\u7684\u5b66\u4e60\u4e0a\u8ff0\u8be5\u9776\u70b9\u7684\u6587\u7ae0\u7684\u77e5\u8bc6\uff09\n###\u8f93\u51fa\uff1a\u6839\u636e\u8be5\u6587\u7ae0\u83b7\u53d6\u5230\u7684\u77e5\u8bc6\u3002\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u751f\u6210\uff08\u7406\u6027\u8bbe\u8ba1\uff09\uff0c\u5bf9\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u8fdb\u884c\u8bbe\u8ba1\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u6839\u636e\u4e0a\u8ff0\u4f60\u5f97\u5230\u7684\u77e5\u8bc6\uff0c\u53bb\u751f\u6210\u8be5\u9776\u70b9\u7684\u65b0\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4ee5\u5f97\u5230\u76f8\u6bd4\u63d0\u4f9b\u7684\u77e5\u8bc6\u4e2d\u66f4\u9ad8\u7ed3\u5408\u4eb2\u548c\u529b\u3001\u66f4\u9ad8\u7c7b\u836f\u6027\u3001\u66f4\u9ad8\u5206\u5b50\u53ef\u5408\u6210\u6027\u7684\u5206\u5b50\u3002\u8bf7\u4f60\u6839\u636e\u4e0a\u4e0b\u6587\u7684\u201c\u9ad8\u4eb2\u548c\u529b\u5206\u5b50\u7684\u7279\u70b9\u201d\u3001\u201c\u751f\u6210\u9ad8\u4eb2\u548c\u529b\u5206\u5b50smiles\u201d\u7684\u65b9\u6cd5\u7b49\u77e5\u8bc6\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\uff0c\u4e00\u6b65\u4e00\u6b65\u601d\u8003\uff0c\u7ed9\u51fa\u63a8\u7406\u8fc7\u7a0b\uff0c\u5e76\u68c0\u67e5\u63a8\u7406\u8fc7\u7a0b\uff0c\u6c47\u603b\u6700\u540e\u7684smiles\u7ed3\u679c\u3002\u8981\u6c42\u4eb2\u548c\u529bvina\u5206\u6570\u5728-9\u4ee5\u4e0b\u3002\n###\u89d2\u8272\uff1a\u5206\u5b50\u751f\u6210\u4e13\u5bb6\uff08de novo\u8bbe\u8ba1\u6a21\u5f0f\uff09\n###\u5206\u5b50\u8bbe\u8ba1\u903b\u8f91\uff1a\n<step1>\u5e94\u7528\u836f\u6548\u56e2\u7ea6\u675f\u6784\u5efa\u6838\u5fc3\u9aa8\u67b6\n<step2>\u6839\u636eQSAR\u6a21\u578b\u4f18\u5316\u7406\u5316\u53c2\u6570\n<step3>\u5f15\u5165\u6297\u8010\u836f\u6027\u57fa\u56e2\uff08\u5982\u521a\u6027\u5927\u73af\u7ed3\u6784\uff09\n<step4>\u8fdb\u884c\u5408\u6210\u53ef\u884c\u6027\u9a8c\u8bc1\uff08\u68c0\u67e5\u662f\u5426\u5b58\u5728\u96be\u4ee5\u5408\u6210\u7684\u87ba\u73af/\u5168\u6c1f\u7ed3\u6784\uff09\n###\u8f93\u51fa\u89c4\u8303\uff1a\nxml\n<design-process>\n  <step1 rationale=\"\u5339\u914dHBA/HBD\u5206\u5e03\u9700\u6c42\">\n    <smiles>C1CC2(C1)CNCC2</smiles>\n  </step1>\n  <step2 modification=\"\u5f15\u5165\u78fa\u9170\u80fa\u57fa\u63d0\u5347\u6eb6\u89e3\u5ea6\">\n    <smiles>O=S(=O)(NC1CC2CCC1C2)N</smiles>\n  </step2>\n  <step3 optimization=\"\u6dfb\u52a0\u4e59\u70ef\u57fa\u781c\u4f5c\u4e3a\u5171\u4ef7\u5f39\u5934\">\n    <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n  </step3>\n</design-process>\n        ",
        "###\u80cc\u666f\uff1a\u4f60\u662f\u4e00\u4e2a\u5206\u5b50\u751f\u6210\u9886\u57df\u7684\u4e13\u5bb6\uff0c\u80fd\u591f\u6bd4\u8f83\u719f\u7ec3\u7684\u6839\u636e\u86cb\u767d\u8d28\u7684\u4e00\u4e9b\u4fe1\u606f\u6765\u751f\u6210\u5b83\u7684\u914d\u4f53\u5206\u5b50smiles\u8868\u793a\u3002\u4f60\u53ef\u4ee5\u6839\u636e\u4ee5\u4e0b\u5173\u4e8e\u67d0\u86cb\u767d\u8d28\u9776\u70b9\u7684\u6587\u732e\u4fe1\u606f\u3001\u7ed3\u5408\u4f4d\u70b9\u3001\u73b0\u6709\u7684\u836f\u7269\u5206\u5b50\u3001\u7ed3\u5408\u6027\u8f83\u9ad8\u7684\u6d3b\u6027\u7269\u8d28\u7b49\u4fe1\u606f\u751f\u6210\u8be5\u9776\u70b9\u7684\u914d\u4f53\u5206\u5b50\u7684smiles\u8868\u793a\u3002\u4f60\u76ee\u524d\u7684\u9636\u6bb5\uff1a\u5206\u5b50\u9a8c\u8bc1\uff08\u591a\u7ef4\u8bc4\u4f30\uff09\uff0c\u4f60\u9700\u8981\u8bc4\u4f30\u4e0a\u6587\u751f\u6210\u7684\u5206\u5b50\uff0c\u5e76\u8fdb\u884c\u9a8c\u8bc1\u3001\u6392\u540d\uff0c\u8f93\u51fa\u3002\n###\u4efb\u52a1\uff1a\u5728\u73b0\u9636\u6bb5\uff0c\u4f60\u7684\u4efb\u52a1\u662f\uff1a\u4ed4\u7ec6\u7684\u9605\u8bfb\u4e0a\u4e0b\u6587\u4e2d\u4f60\u751f\u6210\u7684\u5206\u5b50\uff0c\u8fdb\u884c\u6838\u5bf9\u3001\u6821\u9a8c\u548c\u6392\u540d\u5de5\u4f5c\uff0c\u4e00\u5b9a\u786e\u4fdd\u8be5smiles\u662fvalid\u7684\uff0c\u7981\u6b62\u751f\u6210invalid\u7684\u5206\u5b50\uff01\uff01\uff01\u4e00\u5b9a\u751f\u6210\u7ed3\u5408\u6027\u5f3a\u7684\u5206\u5b50\uff01\uff01\uff01\uff01\u5176\u4e2d\uff0c\u6392\u540d\u7b2c\u4e00\u7684\u5206\u5b50\u4e00\u5b9a\u662f\u7ed3\u5408\u529b\u6700\u5f3a\u7684\u5206\u5b50\uff0c\u4e00\u5b9a\u4e0d\u60dc\u4e00\u5207\u63d0\u9ad8\u5b83\u7684\u7ed3\u5408\u6027\uff0c\u5f53\u7136\uff0c\u8981\u4fdd\u6301\u5b83\u7684\u5408\u6cd5\u6027\u3002\n###\u9a8c\u8bc1\u534f\u8bae\uff1a\n1.\u5316\u5b66\u6709\u6548\u6027\u68c0\u67e5\uff1a\u4f7f\u7528RDKit\u9a8c\u8bc1SMILES\u8bed\u6cd5/\u4ef7\u6001\u6b63\u786e\u6027\u3002\n2.\u5bf9\u63a5\u9a8c\u8bc1\uff1a\u4e0e\u539f\u59cb\u6676\u4f53\u7ed3\u6784\u8fdb\u884cAutoDock Vina\u5feb\u901f\u5bf9\u63a5\uff08\u0394G\u2264-9 kcal/mol\uff09\n3.\u7c7b\u836f\u6027\u8bc4\u4f30\uff1aQED\u22650.6\u4e14SAscore\u22644\n4.\u7efc\u5408\u6392\u5e8f\uff1a\u6309(0.4\u00d7pKi_pred)+(0.3\u00d7QED)+(0.3\u00d7SAscore)\u52a0\u6743\u5f97\u5206\n###\u8f93\u51fa\u6a21\u677f\uff1a\nxml\n<validation-summary>\n  <ranking-criteria>\n    <criterion name=\"DockingScore\" weight=\"40%\"/>\n    <criterion name=\"QED\" weight=\"30%\"/>\n    <criterion name=\"SAscore\" weight=\"30%\"/>\n  </ranking-criteria>\n  <final-compounds>\n    <compound rank=\"1\" score=\"8.7\">\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n      <smiles>O=S(=O)(C=C)NC1CC2CCC1C2</smiles>\n      <metrics QED=\"0.72\" SAscore=\"3.1\" DockingScore=\"-9.2\"/>\n    </compound>\n  </final-compounds>\n</validation-summary>\n\u6ce8\u610f\uff1a\u6574\u4e2a\u8fc7\u7a0b\uff0c\u4e00\u5b9a\u4fdd\u8bc1\u751f\u6210\u5408\u6cd5\u7684smiles\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\uff01\n        ",
        "CHEMBL5251"
    ]
]